QTL_RGD_ID SPECIES QTL_SYMBOL QTL_NAME PEAK_OFFSET CHROMOSOME LOD P_VALUE VARIANCE FLANK_1_RGD_ID FLANK_1_SYMBOL FLANK_2_RGD_ID FLANK_2_SYMBOL PEAK_RGD_ID PEAK_MARKER_SYMBOL TRAIT_NAME SUBTRAIT_NAME TRAIT_DESC CURATED_REF_RGD_ID CURATED_REF_PUBMED_ID UNCURATED_REF_PUBMED_ID RATMAP_ID LOCUSLINK_ID UNCURATED_REF_MEDLINE_ID CANDIDATE_GENE_RGD_ID CANDIDATE_GENE_SYMBOL STRAIN_SYMBOL STRAIN_RGD_ID INHERITANCE_TYPE qtl_related_qtls qtl_cross_type qtl_cross_pair
61384 rat Bp48 Blood pressure QTL 48 18 19.4 61297 Ofl 33814 D18Mit9 Blood pressure 61055 9199194 39726 BB/OK,SHR/Mol 61107,61110 Bp46,Bp47,Bp34 intercross,F2 BB/OK x SHR/Mol
61385 rat Edpm9 Estrogen-dependent pituitary mass QTL 9 9 3.43 .36 6.5 61298 D9Mgh12 Gland mass pituitary 61074 9337394 45206 BN/SsNHsd,F344/NHsd 10008,61109 additive intercross F344/NHsd x BN/SsNHsd
61386 rat Bp49 Blood pressure QTL 49 5 16.6 33836 D5Mit9 43930 D5Wox4 3193 Nppa Blood pressure 61056 9241273 39770 SHRSP,WKY 61010,61103 F2 SHRSP x WKY
61387 rat Bp1 Blood pressure QTL 1 10 5.1 33941 D10Mit11 3138 Myh3 2686 Gh1 Blood pressure 61036 1655275 104 2493 Ace SHRSP,WKY 61010,61103 Bp4,Dcp1 intercross,F2 SHRSPxWKY
61388 rat Bp2 Blood pressure QTL 2 18 3.23 33971 D18Mit7 Blood pressure diastolic 61036 1655275 105 SHRSP,WKY 61010,61103 Bp 41, Bp46 F2 SHRSPxWKY
61389 rat Bp3 Blood pressure QTL 3 X Blood pressure 61052 1656270 106 SHRSP,WKY 61010,61103 F2 SHRSP x WKY
61390 rat Bp4 Blood pressure QTL 4 10 Blood pressure 61052 1656270 107 SHRSP,WKY 61010,61103 Bp1 F2 SHRSP x WKY
61391 rat Bp5 Blood pressure QTL 5 13 5.6 3554 Ren1 Blood pressure diastolic 61057 7981757 108 LH,LN 60990,61015 Bp11, Bp24, Bp25, Bp31 F2 LH x LN
61392 rat Bp6 Blood pressure QTL 6 2 7 2391 Cpb1 Blood pressure 61057 7981757 109 LH,LN 60990,61015 Bp13 F2 LH x LN
61393 rat Bp7 Blood pressure QTL 7 5 4.5 .0001 33836 D5Mit9 61299 D5Mco10 2533 Edn2 Blood pressure salt-loaded systolic indirect systolic blood pressure measured by tail cuff method on rats fed a diet containing 8% NaCl 61059,61040,619653 8201007,9685318,11161799 110 2533 Edn2 SS/Jr,LEW 10041,60999 F2 SS/Jr x LEW
61394 rat Bp8 Blood pressure QTL 8 17 2.2 8.5 61300 D17Mco3 61301 D17Mco10 10709 D17Mgh3 Blood pressure salt-loaded systolic indirect systolic blood pressure measured by tail cuff method on rats fed a diet containing 8% NaCl 61059,61040 8201007,9685318 111 SS/Jr,LEW 10041,60999 F2 SS/Jr x LEW
61395 rat Nka1 Natural killer alloreactivity QTL 1 4 Natural killer alloreactivity 61084,61085 9521051,8642329 34231 DA,PVG 60997,61006
61396 rat Bp9 Blood pressure QTL 9 10 4.8 .0001 2493 Ace Blood pressure salt-loaded systolic systolic blood pressure measured by tail cuff method in rats fed a diet containing 8% NaCl 61037,61039 1363813,7537756 34598 2493 Ace SS/Jr,MNS 10041,60992 F2 SS/Jr x MNS, LEW x SS/Jr, WKY x SS/Jr
61397 rat Bw17 Body weight QTL 17 7 6.3 24 10935 D7Wox14 10427 D7Wox19 10431 D7Wox18 Body weight body weight was measured at 16, 20, 24, 28 and 29 weeks; plasma insulin were measured on fasting animals at 29 weeks; plasma triglycerides were measured at 8, 10, 18, and 29 weeks 61061 8528248 116 GK,BN 10017,60985 intercross,F2 GK x BN
61398 rat Bp50 Blood pressure QTL 50 2 4.4 33727 D2Mit14 33763 D2Mit15 Blood pressure systolic 61058 9329963 44495 LH,LN 60990,61015 F2 LH x LN
61399 rat Ttr1 Tongue tumor resistance QTL 1 1 3.3 34037 D1Mit1 33959 D1Mit3 Tongue tumor resistance 61091 9563479 44502 WF,DA/Slc 61007,61111 F1 DA/Slc x WF
61400 rat Niddm1 Non-insulin dependent diabetes mellitus QTL 1 1 11 33945 D1Mit18 10805 D1Mgh13 33903 D1Mit7 Glucose level postprandial intraperitoneal glucose tolerance test (IPGTT) performed at 65 days of age, blood glucose levels measured after tail-vein incision at 0, 30min, 60 min, and 120 min after injection 61082 8528247 34228 GK,F344/N 10017,70509 Nidd/Gk1 F2,intercross GK x F344,GKxF344
61401 rat Niddm2 Non-insulin dependent diabetes mellitus QTL 2 2 4.54 33763 D2Mit15 33727 D2Mit14 Glucose level postprandial intraperitoneal glucose tolerance test (IPGTT) performed at 65 days of age, blood glucose levels measured after tail-vein incision at 0, 30min, 60 min, and 120 min after injection 61082 8528247 34229 GK,F344/N 10017,70509 Nidd/Gk2 intercross,F2 GK x F344,GKxF344
61402 rat Niddm3 Non-insulin dependent diabetes mellitus QTL 3 10 4.58 34274 D10Mgh5 34445 D10Mgh6 Glucose level postprandial intraperitoneal glucose tolerance test (IPGTT) performed at 65 days of age, blood glucose levels measured after tail-vein incision at 0, 30min, 60 min, and 120 min after injection 61082 8528247 34230 GK,F344/N 10017,70509 intercross,F2 GK x F344,GKxF344
61403 rat Niddm4 Non-insulin dependent diabetes mellitus QTL 4 1 3750 Spn 43424 D1Wox10 Glucose level non-insulin-dependant 61083 9169130 37839 WKY,13M 61103,61112 F2 13M x WKY,13MxWKY
61404 rat Niddm5 Non-insulin dependent diabetes mellitus QTL 5 12 5.1 33961 D12Mit5 34373 D12Mgh6 Body weight body mass index body weight and body mass index, plasma insulin, and pancreatic morphology was assessed; body mass index was calculated from body weight and nasoanal body length; plasma glucose concentration was determined by glucose oxidase assay 61083,61021 9169130,10051320 37840 WKY,13M 61103,61112 F2 13M x WKY,13MxWKY
61405 rat Niddm6 Non-insulin dependent diabetes mellitus QTL 6 16 3.66 .001 35457 D1Rat90 33848 D16Mit2 Glucose level 61083,61021 9169130,10051320 37841 WKY,13M 61103,61112 F2 13M x WKY,13MxWKY
61406 rat Scwia1 Streptococcal cell wall induced arthritis QTL 1 4 2.3 42168 D4Arb30 10266 D4Arb4 61302 D4Arb24 Joint/bone inflammation streptococcal cell wall induced 61064 10331011 45717 3197,3834 Npy,Tcrb LEW,F344/N 60999,70509 Cia3, Aia3, Iddm/Lyp, Eau1 F2 LEWxF344
61407 rat Scl12 Serum cholesterol level QTL 12 19 .001 2571 Es2 2535 Ednra 33802 D19Mit2 Lipid level HDL cholesterol 61079 8698878 37898 SHR/Ola,BN-Lx 61100,61113 F2 SHR/Ola x BN-lx,SHR/OlaxBN-lx
61408 rat Scl23 Serum cholesterol level QTL 23 4 .0005 2901 Il6 Lipid level HDL phospholipid 61079 8698878 37899 SHR/Ola,BN-Lx 61100,61113 F2 SHR/Ola x BN-lx
61409 rat Scl13 Serum cholesterol level QTL 13 20 .00035 61303 D20Utr1 Lipid level HDL cholesterol 61079 8698878 37900 SHR/Ola,BN-Lx 61100,61113 F2 SHR/Ola x BN-lx
61410 rat Bw19 Body weight QTL 19 7 6.2 .001 10764 D7Mit23 Body weight 61082 8528247 34543 2868 Igf1 GK,F344/N 10017,70509 Bw/gk1 F2 GK x F344
61411 rat Pia1 Pristane induced arthritis QTL 1 20 Joint/bone inflammation pristane induced arthritis was induced at the age of 8 to 14 weeks by an intradermal injection at the base of the tail with pristane (2,6,10,14-tetramethylpentadecane) and was monitored by a macroscopic scoring system of the four limbs ranging from 0 to 4 (1 point for swelling and redness of one joint, 2 for two joints involved, 3 for more than two joints and 4 for severe arthritis) 61088,61089 8909256,9843218 44531 DA,E3 60997,61013 Pia21 intercross
61412 rat Pia2 Pristane induced arthritis QTL 2 4 3.9 34200 D4Mgh1 35260 D4Rat22 34716 D4Mgh14 Joint/bone inflammation pristane induced arthritis was induced at the age of 8 to 14 weeks by an intradermal injection at the base of the tail with pristane (2,6,10,14-tetramethylpentadecane) and was monitored by a macroscopic scoring system of the four limbs ranging from 0 to 4 (1 point for swelling and redness of one joint, 2 for two joints involved, 3 for more than two joints and 4 for severe arthritis) 61089 9843218 44526 DA,E3 60997,61013 dominant Aia2 F2,intercross E3 x DA
61413 rat Eae10 Experimental allergic encephalomyelitis QTL 10 14 3.5 33551 D14Mit6 10135 D14Wox11 Brain/spinal cord inflammation relapsing disease experimental autoimmune encephalomyelitis severity following injection with DA rat spinal cord homogenate was assayed daily; assay consists of scoring animals for degree of tail and limb paralysis on a nine point scale with paralysis increasing from 0 to 8; relapsing disease is defined as more than one relapse, or period of increase in clinical score of one or more for three days 61031 10640775 44541 DA,E3 60997,61013 Pia 6 F2 E3 x DA
61414 rat Pia3 Pristane induced arthritis QTL 3 6 4.5 33662 D6Mit1 36057 D6Rat4 44173 D6Wox5 Joint/bone inflammation pristane induced arthritis was induced at the age of 8 to 14 weeks by an intradermal injection at the base of the tail with pristane (2,6,10,14-tetramethylpentadecane) and was monitored by a macroscopic scoring system of the four limbs ranging from 0 to 4 (1 point for swelling and redness of one joint, 2 for two joints involved, 3 for more than two joints and 4 for severe arthritis) 61089,728382 9843218,14611807 44527 DA,E3 60997,61013 dominant intercross,F2 E3 x DA
61415 rat Eae11 Experimental allergic encephalomyelitis QTL 11 4 2.9 11378 D4Wox30 34716 D4Mgh14 Brain/spinal cord inflammation onset of disease experimental autoimmune encephalomyelitis severity following injection with DA rat spinal cord homogenate was assayed daily; assay consists of scoring animals for degree of tail and limb paralysis on a nine point scale with paralysis increasing from 0 to 8; onset of disease is defined as the first day a clinical score of 1 or higher was obtained 61031 10640775 44542 DA,E3 60997,61013 Pia 2 F2 E3 x DA
61416 rat Pia4 Pristane induced arthritis QTL 4 12 8.4 44950 D12Wox5 35433 D12Rat17 11449 D12Wox14 Joint/bone inflammation pristane induced arthritis was induced at the age of 8 to 14 weeks by an intradermal injection at the base of the tail with pristane (2,6,10,14-tetramethylpentadecane) and was monitored by a macroscopic scoring system of the four limbs ranging from 0 to 4 (1 point for swelling and redness of one joint, 2 for two joints involved, 3 for more than two joints and 4 for severe arthritis) 61089 9843218 44528 DA,E3 60997,61013 additive F2,intercross E3 x DA,E3xDA
61417 rat Cia10 Type II Collagen induced arthritis QTL 10 2 3.4 34461 D2Mgh12 Joint/bone inflammation type II collagen induced arthritis severity was measured via a scoring system for the swelling size of multiple joints; joints were measured twice weekly following collagen injection 61063,61064,61065 9870869,10331011,10631556 45677 61304,2297,2902,2310,3205,3174,3952 Il12,Cd2,Il6r,Cd53,Nras,Ngfb,Vcam1 ACI/N,DA/Bkl 10000,61114 additive might represent an extension effect from Cia7 F2 DA/Bkl x ACI
61418 rat Pia5 Pristane induced arthritis QTL 5 4 4.5 35260 D4Rat22 33933 D4Mit16 10561 D4Wox20 Joint/bone inflammation pristane induced arthritis was induced at the age of 8 to 14 weeks by an intradermal injection at the base of the tail with pristane (2,6,10,14-tetramethylpentadecane) and was monitored by a macroscopic scoring system of the four limbs ranging from 0 to 4 (1 point for swelling and redness of one joint, 2 for two joints involved, 3 for more than two joints and 4 for severe arthritis) 61089 9843218 44529 DA,E3 60997,61013 additive Cia3, Aia3,Aia3 F2,intercross E3 x DA
61419 rat Cia11 Type II Collagen induced arthritis QTL 11 3 5.6 12.1 33862 D3Mit9 34228 D3Mgh5 11261 D3Wox9 Joint/bone inflammation type II collagen induced 61066 10857786 45678 2726,2237,3439,3632 Gpd2,C5,Ptgs1,Scn2a1 DA/Bkl,BN/SsN 61114,61115 F2,intercross DA/Bkl x BN/SsN
61420 rat Pia6 Pristane induced arthritis QTL 6 14 4.9 10622 D14Mgh3 11030 D14Mit4 35342 D14Rat8 Joint/bone inflammation pristane induced arthritis was induced at the age of 8 to 14 weeks by an intradermal injection at the base of the tail with pristane (2,6,10,14-tetramethylpentadecane) and was monitored by a macroscopic scoring system of the four limbs ranging from 0 to 4 (1 point for swelling and redness of one joint, 2 for two joints involved, 3 for more than two joints and 4 for severe arthritis) 61089 9843218 44530 DA,E3 60997,61013 recessive F2,intercross E3 x DA
61421 rat Cia12 Type II Collagen induced arthritis QTL 12 12 4.6 10.2 44950 D12Wox5 41962 D12Arb6 10888 D12Wox10 Joint/bone inflammation type II collagen induced 61066 10857786 45679 61306,61307,3282,2621,61308 Hspb1,Ncf1,Pdgfa,Flt1,Flt3 DA/Bkl,BN/SsN 61114,61115 Pia4 F2 DA/Bkl x BN/SsN
61422 rat Cia13 Type II Collagen induced arthritis QTL 13 4 4.5 34001 D4Mit17 34338 D4Mgh11 33768 D4Mit14 Joint/bone inflammation type II collagen induced arthritis severity was measured via a scoring system for the swelling size of multiple joints; joints were measured twice weekly following collagen injection 61067,61066,629560 11001927,10857786,12571866 45680 BBDR,BN 10003,60985 Pia7, Oia2,Oia2 F2 BB/DRxBN
61423 rat Cia14 Type II Collagen induced arthritis QTL 14 19 3 7.3 33951 D19Mit8 61309 D19Arb7 34033 D19Mit5 Joint/bone inflammation type II collagen induced 61066 10857786 45681 DA/Bkl,BN/SsN 61114,61115 F2 DA/Bkl x BN/SsN
61424 rat Scl1 Serum cholesterol level QTL 1 15 7.7 .001 16 34453 D15Mgh7 2536 Ednrb 34353 D15Mgh2 Lipid level cholesterol 61092 10634822 45712 WKY,SHRSP/A3 61103,61116 F2,intercross SHRSP/A3 x WKY
61425 rat Cia15 Type II Collagen induced arthritis QTL 15 9 4.6 35695 D9Rat44 42251 D9Arb7 34264 D9Mgh5 Joint/bone inflammation type II collagen induced 61067 11001927 45682 BBDR,BN 10003,60985 F2 BB/DRxBN
61426 rat Scl2 Serum cholesterol level QTL 2 5 7.3 .001 28 34322 D5Mgh10 34443 D5Mgh8 34041 D5Mit5 Lipid level cholesterol 61092 10634822 45713 WKY,SHRSP/A3 61103,61116 F2,intercross SHRSP/A3 x WKY
61427 rat Cia16 Type II Collagen induced arthritis QTL 16 10 3.2 37464 D10Rat95 35256 D10Rat11 35449 D10Rat49 Joint/bone inflammation type II collagen induced 61067 11001927 45683 BBDR,BN 10003,60985 F2 BB/DRxBN
61428 rat Scl3 Serum cholesterol level QTL 3 7 3.2 14 38334 D7Rat77 36442 D7Rat20 33729 D7Mit10 Lipid level cholesterol 61092 10634822 45714 WKY,SHRSP/A3 61103,61116 F2 SHRSP/A3 x WKY
61429 rat Cia17 Type II Collagen induced arthritis QTL 17 18 4.6 10689 D18Mit5 41356 D18Rat82 41356 D18Rat82 Joint/bone inflammation type II collagen induced 61067 11001927 45684 BBDR,BN 10003,60985 F2 BB/DRxBN
61430 rat Cia18 Type II Collagen induced arthritis QTL 18 X 3.1 45715 DXWox2 43947 DXWox3 45715 DXWox2 Joint/bone inflammation type II collagen induced 61067 11001927 45685 BBDR,BN 10003,60985 F2 BB/DRxBN
61431 rat Cia19 Type II Collagen induced arthritis QTL 19 X 4.4 34192 DXMgh9 43947 DXWox3 34991 DXRat66 Joint/bone inflammation type II collagen induced 61067 11001927 45686 BBDR,BN 10003,60985 Cia18, Iddm F2 BB/DRxBN
61432 rat Cia1 Type II Collagen induced arthritis QTL 1 20 11428 D20Wox3 40318 D20Rat60 11428 D20Wox3 Joint/bone inflammation type II collagen induced 61062 8782824 32927 F344/NHsd,DA/Bkl 61109,61114 F2 DA/Bkl x F344/NHsd
61433 rat Cia2 Type II Collagen induced arthritis QTL 2 1 5 42083 D1Arb37 10335 D1Arb36 39312 D1Rat212 Joint/bone inflammation type II collagen induced arthritis severity was measured via a scoring system for cartilage surface area and joint size; joints were measured twice weekly for six weeks following type II collagen injection 61062,61068 8782824,9692888 32928 61310,3852 Pkrcg,Tgfbr1 F344/NHsd,DA/Bkl 61109,61114 F2 DA/Bkl x F344/NHsd
61434 rat Cia3 Type II Collagen induced arthritis QTL 3 4 4.8 10562 D4Arb21 61302 D4Arb24 Joint/bone inflammation type II collagen induced arthritis severity was measured via a scoring system for cartilage surface area and joint size; joints were measured twice weekly for six weeks following type II collagen injection 61062,61068 8782824,9692888 32929 F344/NHsd,DA/Bkl 61109,61114 Aia3, Pia5,Pia5 F2 DA/Bkl x F344/NHsd
61435 rat Cia4 Type II Collagen induced arthritis QTL 4 7 5.3 10221 D7Arb17 34999 D7Rat44 Joint/bone inflammation type II collagen induced arthritis severity was measured via a scoring system for cartilage surface area and joint size; joints were measured twice weekly for six weeks following type II collagen injection 61069,61062,61068 10398805,8782824,9692888 32930 2896,3285 Il2rb,Pdgfrb F344/NHsd,DA/Bkl 61109,61114 recessive Cia8 F2 DA/Bkl x F344/NHsd
61436 rat Cia5 Type II Collagen induced arthritis QTL 5 10 4.9 2686 Gh1 61275 D10Arb22 Joint/bone inflammation type II collagen induced arthritis severity was measured via a scoring system for cartilage surface area and joint size; joints were measured twice weekly for six weeks following type II collagen injection 61062,61068 8782824,9692888 32931 3395,61312 Prkca,Timp2 F344/NHsd,DA/Bkl 61109,61114 Aia5,Cia20, Cia21, Cia22, Cia23 F2 DA/Bkl x F344/NHsd
61437 rat Cia6 Type II Collagen induced arthritis QTL 6 8 34310 D8Mgh4 38898 D8Rat71 34068 D8Mgh11 Joint/bone inflammation type II collagen induced 61067 11001927 45674 BBDR,BN 10003,60985 F2 BB/DRxBN
61438 rat Cia7 Type II Collagen induced arthritis QTL 7 2 4.6 .0001 20 11156 D2Mit24 33983 D2Mit23 33674 D2Mit17 Joint/bone inflammation type II collagen induced arthritis severity was measured via a scoring system for cartilage surface area and joint size; joints were measured twice weekly for six weeks following type II collagen injection 61067,61063 11001927,9870869 45675 2391 Cpb1 BBDR,BN 10003,60985 dominant F2 BB/DRxBN
61439 rat Cia8 Type II Collagen induced arthritis QTL 8 7 5.1 36422 D7Rat26 Joint/bone inflammation type II collagen induced 61069 10398805 44497 F344/NHsd,DA/Bkl 61109,61114 F2 DA/Bkl x F344/NHsd
70172 rat Eae15 Experimental allergic encephalomyelitis QTL 15 18 .001 34290 D18Mgh4 33814 D18Mit9 33715 D18Mit6 Brain/spinal cord inflammation demyelination inflammation severity was assayed daily following injection with recombinant rat myelin oligodendrocyte glycoprotein (MOG) AA 1-125; animals were scored as affected if they had paresis for at least two days and/or histopathological evidence of demyelination or CNS inflammation at 40 days post-immunization 70067,69695 10545597 45702 ACI/N,DA 10000,60997 F2 DAxACI
70173 rat Niddm19 Non-insulin dependent diabetes mellitus QTL 19 7 4.33 .00005 34132 D7Mgh18 60819 D7Wox3 44295 D7Wox6 Glucose level postprandial plasma glucose levels were determined using the oral glucose tolerance test (OGTT) administered after overnight fasting; levels were measured at time 0 for fasting glucose and at 30 min intervals until 120 min post OGTT administration; glucose level over the entire time course was calculated as an area under the curve (AUC) of the glucose levels from 0 to 120 min 70067,69691,69696,625760 9824537,10594234,12420133 10051320 45189 F344/Crj,OLETF/Got,F344.OLETF-(D7Rat18-D7Mit2)/Tj 69643,734526,1302654 F2 OLETF/OtkxF344/Crj
70174 rat BpQTLCluster2 Blood pressure QTL cluster 2 2 2.86 34397 D2Mgh2 2391 Cpb1 Blood pressure 70067,68932 10779487 45658 LH,LN 60990,61015 F2 LHxLN
70175 rat BpQTLCluster3 Blood pressure QTL cluster 2 2 2.76 34461 D2Mgh12 34497 D2Mgh24 Blood pressure 70067,68932 10779487 45659 SHR,WKY 61000,61103 F2 SHRxWKY
70176 rat Mcsm1 Mammary carcinoma susceptibility modifier QTL 1 6 33993 D6Mit2 Mammary tumor susceptibility modification 70067,62417 11139513 45611
70177 rat Xhs1 X-ray hypersensitivity QTL 1 4 25.1 41200 D4Rat169 34592 D4Mgh20 36043 D4Rat49 X-ray sensitivity 70067,69702 11003700 45720 LEC,BN/Sea 68066,634377 (LECxBN)xLEC
70178 rat Eae18 Experimental Autoimmune (allergic) Encephalomyelitis QTL 18 18 2.3 33971 D18Mit7 60774 D18Wox1 Brain/spinal cord inflammation severity of disease inflammation severity was assayed daily following injection with DA rat spinal cord homogenate with animals scored for degree of tail and limb paralysis on a nine point scale with paralysis increasing from 0 to 8 70067,61031 10640775 45695 DA,E3 60997,61013 F2,resistant E3 rat x susceptible DA, LOD=2.4 (severity)=2.3 (duration af disease) E3xDA
70179 rat Xhs2 X-ray hypersensitivity QTL 2 1 3.2 37198 D1Rat186 42448 D1Rat392 42449 D1Rat391 X-ray sensitivity 70067,69702 11003700 45721 LEC,BN/Sea 68066,634377 (LECxBN)xLEC
70180 rat BpQTLcluster10 Blood pressure QTL cluster 10 11 3.19 33642 D11Mit1 33700 D11Mit5 Blood pressure experimental autoimmune encephalomyelitis severity following injection with DA rat spinal cord homogenate was assayed daily; assay consists of scoring animals for degree of tail and limb paralysis on a nine point scale with paralysis increasing from 0 to 8 70067,68932 10779487 45666 BN,SHR 60985,61000 F2 SHRxBN
70181 rat BpQTLcluster11 Blood pressure QTL cluster 11 13 3.4 10462 D13Mgh13 34080 D13Mgh10 Blood pressure 70067,68932 10779487 45667 BN,SS 60985,69369 F2 SSxBN
70182 rat BpQTLcluster12 Blood pressure QTL cluster 12 15 3.53 34160 D15Mgh5 34222 D15Mgh8 2536 Ednrb Blood pressure systolic 70067,68932 10779487 45668 BN,SS 60985,69369 F2 SSxBN
70183 rat BpQTLcluster13 Blood pressure QTL cluster 13 16 3.325 33848 D16Mit2 34066 D16Mgh1 2708 Glud1 Blood pressure 70067,68932 10779487 45669 BN,SHR 60985,61000 F2 SHRxBN
70184 rat BpQTLcluster14 Blood pressure QTL cluster 14 17 3.38 33882 D17Mit2 33654 D17Mit7 2518 Drd1a Blood pressure systolic 70067,68932 10779487 45670 ACI/N,FHH 10000,60993 F2 FHHxACI
70185 rat BpQTLcluster15 Blood pressure QTL cluster 15 18 3.64 34290 D18Mgh4 34218 D18Mgh2 2060 Adrb2 Blood pressure systolic 70067,68932 10779487 45671 BN,SS 60985,69369 F2 SSxBN
70186 rat Niddm26 Non-insulin dependent diabetes mellitus QTL 26 9 3.87 44567 D9Wox19 34088 D9Mgh2 36582 D9Rat21 Glucose level postprandial plasma glucose levels were determined using the oral glucose tolerance test (OGTT) administered after overnight fasting; levels were measured at time 0 for fasting glucose and at 30 min intervals until 120 min post OGTT administration; glucose level over the entire time course was calculated as an area under the curve (AUC) of the glucose levels from 0 to 120 min 70067,69696,625760 10594234,12420133 10051320 45196 F344/Crj,OLETF/Got,F344.OLETF-(D9Mgh8-D9Rat15)/Tj 69643,734526,1302650 F2 OLETF/OtkxF344/Crj
70187 rat Niddm18 Non-insulin dependent diabetes mellitus QTL 18 14 16.7 35342 D14Rat8 2670 Gck Gland mass pancreas pancreatic remnant weight as a percentage of body weight was determined after sacrifice at 28 days post surgery surgery consisted of 70% pancreatectomy carried out in males at 6 weeks of age 70067,69697 9745032 45091 OLETF,F344/Crj 61014,69643 F2 OLETFxF344/Crj
70188 rat BpQTLcluster1 Blood pressure QTL cluster 1 1 4.82 33891 D10Mit5 3710 Slc4a1 Blood pressure 70067,68932 10779487 45657 BN,SHR 60985,61000 F2 SHRxBN
70189 rat Mcs5 Mammary carcinoma susceptibility QTL 5 5 10.51 34501 D5Mgh26 69569 D5Uwm38 35771 D5Rat22 Mammary tumor susceptibility 70067,62417 11139513 45607
70190 rat Mcs6 Mammary carcinoma susceptibility QTL 6 7 2.29 34051 D7Mit28 35749 D7Rat45 34051 D7Mit28 Mammary tumor susceptibility 70067,62417 11139513 45608
70191 rat BpQTLcluster4 Blood pressure QTL cluster 4 3 2.575 34347 D3Mgh16 11260 D3Mit8 3632 Scn2a1 Blood pressure systolic 70067,68932 10779487 45660 BN,SHR 60985,61000 F2 SHRxBN
70192 rat BpQTLcluster5 Blood pressure QTL cluster 5 4 2.6 11383 D4Mit23 10144 D4Mgh16 3711 Slc4a2 Blood pressure 70067,68932 10779487 45661 BN,SHR 60985,61000 F2 SHRxBN
70193 rat Mcs7 Mammary carcinoma susceptibility QTL 7 10 2.38 35627 D10Rat12 Mammary tumor susceptibility 70067,62417 11139513 45609
70194 rat BpQTLcluster6 Blood pressure QTL cluster 6 5 Blood pressure systolic 70067,68932 10779487 45662 BN,SHR 60985,61000 F2 SHRxBN
70195 rat Mcs8 Mammary carcinoma susceptibility QTL 8 14 4.28 36536 D14Rat1 40104 D14Rat99 60763 D14Wox3 Mammary tumor susceptibility 70067,62417 11139513 45610
70196 rat BpQTLcluster7 Blood pressure QTL cluster 7 6 6.82 11241 D6Mit3 33624 D6Mit12 Blood pressure intra-arterial blood pressures measured using both intra-arterial and tail-cuff methods 70067,68932 10779487 45663 GH,BN 60984,60985 F2 GHxBN
70197 rat BpQTLcluster8 Blood pressure QTL cluster 8 8 3.4 10177 D8Mit7 67379 Acaa1 Blood pressure systolic 70067,68932 10779487 45664 BN,SS 60985,69369 F2 SSxBN
70198 rat BpQTLcluster9 Blood pressure QTL cluster 9 10 2.94 33891 D10Mit5 3710 Slc4a1 Blood pressure 70067,68932 10779487 45665 BN,SHR 60985,61000 F2 SHRxBN
70199 rat Crg1 Compensatory renal growth QTL 1 6 11.8 12 36787 D6Rat37 33977 D6Mit4 33828 D6Mit9 Renal function compensatory growth 70067,69708 10732705 45631 2003,2023 A,Acpp SHR/Ola,BN-Lx/Cub 61100,61117 co-recessive Cia1,Aia1,Oia1,Pia1 SHR/OlaxBN-lx/Cub
70200 rat Alc18 Alcohol consumption QTL 18 4 9.2 11 34308 D4Mgh9 33656 D4Mit9 35409 D4Rat34 Consumption level alcohol preference 70067,69704 9880658 45083 3197,3729 Npy,Snca P,NP 634380,634381 additive intercross PxNP
70201 rat Gcr1 Gastric cancer resistance QTL 1 4 2.7 35315 D4Rat82 35088 D4Rat59 2112 Ampp Gastric tumor resistance tumor size 70067,69698 10706129 45705 ACI/N,BUF/N 10000,60986 (ACIxBUF)xACI
70202 rat Alc19 Alcohol consumption QTL 19 3 2.5 33782 D3Mit10 37010 D3Rat49 Consumption level alcohol preference 70067,69704 9880658 45084 69364 Scn1a P,NP 634380,634381 intercross PxNP
70203 rat Gcr2 Gastric cancer resistance QTL 2 3 2.6 34186 D3Mgh9 37010 D3Rat49 35054 D3Rat55 Gastric tumor resistance tumor size 70067,69698 10706129 45706 ACI/N,BUF/N 10000,60986 (ACIxBUF)xACI
70204 rat Niddm20 Non-insulin dependent diabetes mellitus QTL 20 14 5.1 .000008 34981 D14Rat23 45195 D14Wox7 37030 D14Rat3 Glucose level postprandial plasma glucose levels were determined using the oral glucose tolerance test (OGTT) administered after overnight fasting; levels were measured at time 0 for fasting glucose and at 30 min intervals until 120 min post OGTT administration; glucose level over the entire time course was calculated as an area under the curve (AUC) of the glucose levels from 0 to 120 min 70067,69691,69696,625760 9824537,10594234,12420133 10051320 45190 F344/Crj,OLETF/Got,F344.OLETF-(D14Rat23-D14Rat12)/Tj 69643,734526,1302661 F2 OLETF/OtkxF344/Crj
70205 rat Gcr3 Gastric cancer resistance QTL 3 16 2.2 11446 D16Mgh4 42018 D16Arb3 37054 D16Rat17 Gastric tumor resistance tumor invasions depth 70067,69698 10706129 45707 ACI/N,BUF/N 10000,60986 F2 (ACIxBUF)xACI
70206 rat Alc20 Alcohol consumption QTL 20 8 2 33559 D8Mit5 36117 D8Rat46 Consumption level alcohol preference 70067,69704 9880658 45085 2520,2846 Drd2,Htr1b P,NP 634380,634381 intercross PxNP
70207 rat Niddm31 Non-insulin dependent diabetes mellitus QTL 31 7 3.9 35237 D7Rat35 34880 D7Rat31 Glucose level fasting plasma glucose levels were determined using the oral glucose tolerance test (OGTT) administered after overnight fasting; levels were measured at time 0 for fasting glucose and at 30 min intervals until 120 min post OGTT administration; glucose level over the entire time course was calculated as an area under the curve (AUC) of the glucose levels from 0 to 120 min 70067,69696 10594234 45201 F344/Crj,OLETF/Got 69643,734526 F2 OLETF/OtkxF344/Crj
70208 rat Niddm22 Non-insulin dependent diabetes mellitus QTL 22 11 3.61 10375 D11Mgh1 34112 D11Mgh4 Glucose level fasting plasma glucose levels were determined using the oral glucose tolerance test (OGTT) administered after overnight fasting; levels were measured at time 0 for fasting glucose and at 30 min intervals until 120 min post OGTT administration; glucose level over the entire time course was calculated as an area under the curve (AUC) of the glucose levels from 0 to 120 min 70067,69691,69696,625760 9824537,10594234,12420133 10051320 45192 F344/Crj,OLETF/Got,F344.OLETF-(D11Rat4-D11Rat1)/Tj 69643,734526,1302663 F2 OLETF/OtkxF344/Crj
70209 rat Niddm23 Non-insulin dependent diabetes mellitus QTL 23 1 2.82 11439 D1Mit30 43377 D1Wox9 Glucose level fasting plasma glucose levels were determined using the oral glucose tolerance test (OGTT) administered after overnight fasting; levels were measured at time 0 for fasting glucose and at 30 min intervals until 120 min post OGTT administration; glucose level over the entire time course was calculated as an area under the curve (AUC) of the glucose levels from 0 to 120 min 70067,69696,625760 10594234,12420133 10051320 45193 F344/Crj,OLETF/Got 69643,734526 F2 OLETF/OtkxF344/Crj
70210 rat Cm15 Cardiac mass QTL 15 17 6.5 22 45485 D17Wox9 35883 D17Rat44 36315 D17Rat41 Cardiac mass right ventricle pulmonary artery pressure and cardiac chamber volume were measured after placement in a normobaric hypoxic chamber (10% oxygen) for 3 weeks; right ventricle was dissected free and weighed 70067,69699 11157698 45709 2343,620314 Chrm3,Ryr2 WKY,F344/N 61103,70509 dominant F2 F344xWKY
70211 rat Niddm24 Non-insulin dependent diabetes mellitus QTL 24 1 3.79 10674 D1Mgh12 35457 D1Rat90 Glucose level postprandial plasma glucose levels were determined using the oral glucose tolerance test (OGTT) administered after overnight fasting; levels were measured at time 0 for fasting glucose and at 30 min intervals until 120 min post OGTT administration; glucose level over the entire time course was calculated as an area under the curve (AUC) of the glucose levels from 0 to 120 min 70067,69696,625760 10594234,12420133 10051320 45194 F344/Crj,OLETF/Got 69643,734526 F2 OLETF/OtkxF344/Crj
70212 rat Niddm25 Non-insulin dependent diabetes mellitus QTL 25 5 3.54 34377 D5Mgh4 33680 D5Mit13 34047 D5Mit1 Glucose level fasting plasma glucose levels were determined using the oral glucose tolerance test (OGTT) administered after overnight fasting; levels were measured at time 0 for fasting glucose and at 30 min intervals until 120 min post OGTT administration; glucose level over the entire time course was calculated as an area under the curve (AUC) of the glucose levels from 0 to 120 min 70067,69696,625760 10594234,12420133 10051320 45195 F344/Crj,OLETF/Got,F344.OLETF-(D5Mgh5-D5Mgh23)/Tj 69643,734526,1302667 F2 OLETF/OtkxF344/Crj
70213 rat Niddm27 Non-insulin dependent diabetes mellitus QTL 27 12 3.72 34417 D12Mgh2 33963 D12Mit4 34729 D12Mgh5 Glucose level fasting plasma glucose levels were determined using the oral glucose tolerance test (OGTT) administered after overnight fasting; levels were measured at time 0 for fasting glucose and at 30 min intervals until 120 min post OGTT administration; glucose level over the entire time course was calculated as an area under the curve (AUC) of the glucose levels from 0 to 120 min 70067,69696,625760 10594234,12420133 10051320 45197 F344/Crj,OLETF/Got,F344.OLETF-(D12Rat8-D12Rat16)/Tj 69643,734526,1302635 F2 OLETF/OtkxF344/Crj
70214 rat Niddm28 Non-insulin dependent diabetes mellitus QTL 28 14 4.06 60765 D14Wox5 35837 D14Rat27 2289 Cckar Glucose level postprandial plasma glucose levels were determined using the oral glucose tolerance test (OGTT) administered after overnight fasting; levels were measured at time 0 for fasting glucose and at 30 min intervals until 120 min post OGTT administration; glucose level over the entire time course was calculated as an area under the curve (AUC) of the glucose levels from 0 to 120 min 70067,69696,625760 10594234,12420133 10051320 45198 F344/Crj,OLETF/Got,F344.OLETF-(D14Rat8-D14Rat26)/Tj 69643,734526,1302685 F2 OLETF/OtkxF344/Crj
70215 rat Niddm29 Non-insulin dependent diabetes mellitus QTL 29 16 3.54 35527 D16Rat7 36988 D16Rat15 Glucose level postprandial plasma glucose levels were determined using the oral glucose tolerance test (OGTT) administered after overnight fasting; levels were measured at time 0 for fasting glucose and at 30 min intervals until 120 min post OGTT administration; glucose level over the entire time course was calculated as an area under the curve (AUC) of the glucose levels from 0 to 120 min 70067,69696,625760 10594234,12420133 10051320 45199 F344/Crj,OLETF/Got,F344.OLETF-(D16Wox4-D16Rat13)/Tj 69643,734526,1302625 F2 OLETF/OtkxF344/Crj
70216 rat Cm14 Cardiac mass QTL 14 3 2.1 10387 D2Mgh26 3781 Stnl 66594 D3Mco5 Cardiac mass body-weight adjusted heart weight measured in rats fed a diet containing 8% NaCl for 35 days and adjusted for gender differences 70067,69705 9922389 45642 SR/Jr,SS/Jr 10040,10041 (SxR)xS
70217 rat Bp52 Blood pressure QTL 52 3 4.4 .0001 36717 D3Rat17 35947 D3Rat45 34918 D3Rat29 Cardiac mass salt-loaded measured after 4 weeks on an 8% NaCl diet and adjusted for differences in body weight 70067,69706 10205229 45643 3439 Ptgs1 WKY,F344/N 61103,70509 intercross WKYxF344,(SxR)xS
70218 rat Cm28 Cardiac mass QTL 28 9 7.3 37416 D9Rat70 61287 D9Uia6 35819 D9Rat26 Cardiac mass salt-loaded measured after 4 weeks on an 8% NaCl diet and adjusted for differences in body weight 70067,61516 11015598 45644 SS/Jr,SHR 10041,61000 additive intercross,F2 SS/JrxSHR,SxSHR
70219 rat Bp54 Blood pressure QTL 54 18 2.8 11461 D18Mit1 34043 D18Mit16 10689 D18Mit5 Blood pressure salt-loaded 70067,69700 11015589 45645 BN/NHsdMcwi,SS/JrHsdMcwi 61498,61499 F2 SSxBN
70220 rat Bp55 Blood pressure QTL 55 13 5.75 33733 D13Mit2 Blood pressure 70067,61043 8952608 45646 SHR,WKY 61000,61103 F2 SHRxWKY
70221 rat Bp56 Blood pressure QTL 56 X 4.9 34192 DXMgh9 33717 DXMit4 Blood pressure salt-loaded systolic systolic, diastolic, mean blood pressures and heart rate measured directly through a femoral catheter inserted in rats following treatment for 13 days with a diet including water with 1% NaCl 70067,69713 9931114 45647 SBH/Ygl,SBN/Ygl 631572,631573 F2 SBHxSBN
70222 rat Eae2 Experimental allergic encephalomyelitis QTL 2 4 4.3 34200 D4Mgh1 34716 D4Mgh14 34200 D4Mgh1 Brain/spinal cord inflammation severity of disease experimental autoimmune encephalomyelitis severity following injection with guinea pig myelin was assayed daily by scoring animals for neurological dysfunction on a scale of 0-4; at17 days post injection, degree of histological disease was measured in brain and spinal cord sections by counting inflammatory foci with 20 or more aggregated mononuclear cells 70067,69694 9973459 45696 BN,LEW 60985,60999 F2 LEWxBN
70223 rat Bp57 Blood pressure QTL 57 10 5 33891 D10Mit5 35503 D10Rat20 35731 D10Rat33 Blood pressure indirect systolic measured by tail-cuff method at 12 to 16 wks of age 70067,69692 11082136 45648 MHS/Gib,MNS/Gib 10025,10028 F2 MHSxMNS
70224 rat Eae3 Experimental allergic encephalomyelitis QTL 3 10 4.1 33632 D10Mit10 34445 D10Mgh6 34318 D10Mgh10 Brain/spinal cord inflammation severity of disease experimental autoimmune encephalomyelitis severity following injection with guinea pig myelin was assayed daily by scoring animals for neurological dysfunction on a scale of 0-4; at17 days post injection, degree of histological disease was measured in brain and spinal cord sections by counting inflammatory foci with 20 or more aggregated mononuclear cells 70067,69694 9973459 45697 BN,LEW 60985,60999 F2 LEWxBN
70225 rat Bp58 Blood pressure QTL 58 1 3.3 36596 D1Rat53 36640 D1Rat14 38028 D1Rat121 Blood pressure direct systolic 70067,69692 11082136 45649 MHS/Gib,MNS/Gib 10025,10028 F2 MHSxMNS
1331632 human COPD7_H Chronic obstructive pulmonary disease QTL 7 (human) 1 2.24 1331563 G15725 1331570 G15727 Chronic airflow obstruction post-bronchodilator FEV1 genome wide scan for loci affecting persistent airflow obstruction in 72 pedigrees with probands having severe early onset COPD 1331518 12719384
1331633 human COPD23_H Chronic obstructive pulmonary disease QTL 23 (human) 19 1.47 1298168 D19S433 1299939 D19S245 1331583 D19S559 Chronic airflow obstruction FEV1/FVC ratio genome-wide scan for irreversible airflow obstruction in relatives of probands with severe early-onset COPD; COPD was measured by spirometric indices, including forced expiratory volume at 1 second (FEV1) and the ratio of FEV1 to forced vital capacity (FVC) 1331515 11914989
70226 rat Eae4 Experimental allergic encephalomyelitis QTL 4 9 36984 D9Rat29 33842 D9Mit6 34264 D9Mgh5 Brain/spinal cord inflammation severity of disease experimental autoimmune encephalomyelitis severity following injection with DA rat spinal cord homogenate and adjuvant was assayed by scoring animals for degree of tail and limb paralysis on a four point scale; severity of disease is defined as maximum score obtained; degree of inflammation was assayed by immunohistochemical analysis of spinal cord infiltrating cells and by in situ detection of IFN-gamma mRNA levels 70067,69712 10072499 45698 BN,DA 60985,60997 F2 DAxBN
70363 rat Bp71 Blood pressure QTL 71 10 .04 34445 D10Mgh6 38516 D10Rat106 Blood pressure 69734 11471055 45767 3185 Nos2 SS.LEW-(D10Mco1-D10Mco31)/Ayd 631220
70364 rat Bp72 Blood pressure QTL 72 10 40794 D10Rat141 35256 D10Rat11 Blood pressure 69734 11471055 45768 2493 Ace SS.LEW-(D10Rat11-D10Mgh1),SS.LEW-(D10Rat141-D10Mgh1),SS.LEW-(D10Rat207-D10Mgh1)/Ayd 631701,631702,631703
71111 rat Iddm8 Insulin dependent diabetes mellitus QTL 8 6 1.9 .002 10507 D6Mgh2 2880 Ighe 10507 D6Mgh2 Insulin level 61077 9571179 41097 BB/OK,SHR/Mol,BB/OK.SHR-(D6Rat184-D6Rat101) 61107,61110,631699 backcross,F1 BB/OKxSHR/Mol
71112 rat Niddm13 Non-insulin dependent diabetes mellitus QTL 13 1 6 .0001 35457 D1Rat90 33903 D1Mit7 33694 D1Mit8 Body weight 61072,619678 9585427,10373320 39277 BN,OLETF 60985,61014 additive Niddm42 intercross,F2 OLETFxBN
71113 rat Cari2 Carrageenan-induced inflammation QTL 2 2 2.7 .009 33983 D2Mit23 34461 D2Mgh12 10582 D2Mit12 Carrageenan-induced Inflammation 70860,69693 11306811,10087293 45673 LEW,F344/N 60999,70509 recessive F2,intercross F344xLEW
71114 rat Niddm14 Non-insulin dependent diabetes mellitus QTL 14 7 4.5 10431 D7Wox18 Glucose level plasma glucose homeostasis 61072 9585427 39278 OLETF,F344/N 61014,70509 F2 OLETFxF344
71115 rat Niddm15 Non-insulin dependent diabetes mellitus QTL 15 14 4.8 34981 D14Rat23 33953 D14Mit1 33579 D14Mit5 Glucose level plasma glucose homeostasis 61072 9585427 39279 OLETF,F344/N 61014,70509 F2 OLETFxF344
71116 rat Niddm16 Non-insulin dependent diabetes mellitus QTL 16 X 7.81 34405 DXMgh2 Glucose level 70858,619678 7607056,10373320 34243 3225 Odb1 BN,OLETF 60985,61014 backcross,F2 OLETFxBN
71117 rat Niddm17 Non-insulin dependent diabetes mellitus QTL 17 14 2.35 11030 D14Mit4 10113 D14Mit2 11030 D14Mit4 Glucose level plasma glucose plasma glucose levels were determined using the oral glucose tolerance test (OGTT) administered to 30 week old male rats 70861 8702404 34244 3226 Odb2 BN,OLETF 60985,61014 F2 OLETFxBN
71118 rat Ten1 Thymus enlargement QTL 1 1 10.17 .001 33571 D1Mit6 10952 D1Wox21 11201 D1Mgh11 Gland mass thymus 70859 10792781 34480 3871 Tlag1 BUF/Mna,WKY/NCrj 61118,61119 F1,backcross WKY/NCrjxBUF/Mna
71119 rat Ten2 Thymus enlargement QTL 2 13 3.8 10205 D13Mgh17 3804 Syt2 41967 D13Arb10 Gland mass thymus 70859,634747 10792781,8672128 34481 BUF/Mna,WKY/NCrj 61118,61119 F1,backcross WKY/NCrjxBUF/Mna
71120 rat Niddm21 Non-insulin dependent diabetes mellitus QTL 21 8 3.73 10435 D8Mgh7 36039 D8Rat58 34723 D8Mgh9 Glucose level postprandial plasma glucose levels were determined using the oral glucose tolerance test (OGTT) administered after overnight fasting; levels were measured at time 0 for fasting glucose and at 30 min intervals until 120 min post OGTT administration; glucose level over the entire time course was calculated as an area under the curve (AUC) of the glucose levels from 0 to 120 min 61021,625760 10051320,12420133 45191 F344/Crj,OLETF/Got,F344.OLETF-(D8Rat54-D8Mgh12)/Tj 69643,734526,1302713 F2 OLETF/OtkxF344/Crj
619613 rat Bp77 Blood pressure QTL 77 1 .01 10165 D1Wox34 36566 D1Rat55 Blood pressure blood pressure measured by indirect tail-cuff method and directly through an aortic catheter 70855 11509479 3616 Sa SHR.WKY-(D1Wox34-D1Rat164),SHR.WKY-(D1Wox34-Sah) 631589,631590 intercross,F2 WKY.SHR-SaxSHR.WKY-Sa,SHRxWKY
619614 rat Bp78 Blood pressure QTL 78 1 .001 36454 D1Rat56 36239 D1Rat111 Blood pressure blood pressure measured by indirect tail-cuff method and directly through an aortic catheter 70855 11509479 62086,3616 Sah,Sa WKY.SHR-(D1Rat56-D1M7Mit206),WKY.SHR-(D1Rat236-D1M7Mit206) 631591,631592 intercross,F2 WKY.SHR-SaxSHR.WKY-Sa,SHRxWKY
619615 rat Bp80 Blood pressure QTL 80 13 .0354 34029 D3Mit1 2168 Atp1a2 11230 D13Uwm1 Blood pressure systolic 70857 9299556 3554 Ren1 BB/OK,SHR/Mol 61107,61110 dominant backcross,F2 SHR/MolxBB/OK
619616 rat Bp79 Blood pressure QTL 79 4 .0292 2901 Il6 11015 D4Mit24 60732 D4Mit6 Blood pressure systolic 70857 9299556 3197 Npy BB/OK,SHR/Mol 61107,61110 dominant backcross,F2 SHR/MolxBB/OK
619617 rat Bpfh2 Blood pressure FH QTL 2 17 2.61 .002 35505 D17Rat54 Blood pressure systolic 70856 11053483 45970 ACI/N,FHH/Eur 10000,10015 F2 FHH/EurxACI
619618 rat Rf3 Renal disease susceptibility QTL 3 3 6.5 .001 33808 D3Mit4 Renal function urine albumin level urine albumin levels were determined colorimetrically using bromocresol-green in urine collected 8 weeks after unilateral nephrectomy 70856 11053483 ACI/N,FHH/Eur 10000,10015 F2 FHH/EurxACI
619619 rat Rf4 Renal disease susceptibility QTL 4 14 4.1 .002 34479 D14Mgh7 Renal function urine albumin level urine protein levels were determined colorimetrically using pyrogallol red/molybdate complex in urine collected 8 weeks after unilateral nephrectomy 70856 11053483 ACI/N,FHH/Eur 10000,10015 F2 FHH/EurxACI
619620 rat Rf5 Renal disease susceptibility QTL 5 17 2.99 .001 36331 D17Mit12 Renal function urine albumin level urine protein levels were determined colorimetrically using pyrogallol red/molybdate complex in urine collected 8 weeks after unilateral nephrectomy 70856 11053483 ACI/N,FHH/Eur 10000,10015 F2 FHH/EurxACI
631198 rat Cm22 Cardiac mass QTL 22 2 4.3 .0008 22.4 33620 D2Mit6 34204 D2Mgh7 34114 D2Mgh15 Cardiac mass left ventricle relative left ventricular mass equals ventricular mass divided by body weight. 61484 9495256 45967 DRY,SHR 60995,61000 recessive intercross SHRxDRY
631199 rat Cm23 Cardiac mass QTL 23 1 4.6 .0004 24.5 34399 D1Mgh9 34011 D1Mit2 33959 D1Mit3 Cardiac mass left ventricle relative left ventricular mass equals ventricular mass divided by body weight. 61484 9495256 45968 DRY,SHR 60995,61000 recessive Lvm1 intercross SHRxDRY
631200 rat Cm25 Cardiac mass QTL 25 3 4.8 .0001 16.5 35380 D3Rat27 34979 D3Rat38 34918 D3Rat29 Cardiac mass left ventricle the left ventricle and septum were weighed together 69706 10205229 3439 Ptgs1 WKY,F344/N 61103,70509 dominant Lvm1,Lvm2 intercross WKYxF344
631201 rat Pi1 Pancreas inflammation QTL 1 7 17.1 .001 12 35304 D7Rat4 38306 D7Rat97 Pancreas inflammation score pancreatitis measured by histological examination for fibrosis, hemorrhage, inflammatory infiltration, adipose replacement, and edema 619682 11414764 BN,WBN/Kob,BN/Crj,WBN/KobSlc 60985,631218,634367,634369 additive intercross BNxWBN/Kob,BN/CrjxWBN/KobSlc
631202 rat Gisdt1 Glucose intolerance STD QTL 1 1 .0001 .1 36023 D1Rat38 619844 Cnga4 33959 D1Mit3 Glucose level postprandial fasting rats were administered 2g/kg glucose and blood glucose concentrations measured at times 0, 60 and 120 min. 631173 12705906 BN,SDT 60985,631219 Gisdt2,Gisdt3 backcross SDTxBN
631203 rat Gisdt2 Glucose intolerance STD QTL 2 2 .0001 .1 38466 D2Rat118 38942 D2Rat156 2591 Fabp2 Glucose level postprandial fasting rats were administered 2g/kg glucose and blood glucose concentrations measured at times 0, 60 and 120 min. 631173 12705906 2591 Fabp2 BN,SDT 60985,631219 Gisdt1,Gisdt3 backcross SDTxBN
631204 rat Gisdt3 Glucose intolerance STD QTL 3 X .001 .08 11236 DXWox11 39154 DXRat83 11494 DXWox20 Glucose level postprandial fasting rats were administered 2g/kg glucose and blood glucose concentrations measured at times 0, 60 and 120 min. 631173 12705906 BN,SDT 60985,631219 Gisdt1,Gisdt2 backcross SDTxBN
631205 rat Bp196 Blood pressure QTL 196 1 4 .0001 34.4 34244 D1Mgh10 34134 D1Mgh1 33959 D1Mit3 Blood pressure mean arterial 61484 9495256 DRY,SHR 60995,61000 additive intercross SHRxDRY
631206 rat Niddm40 Non-insulin dependent diabetes mellitus QTL 40 1 33806 D1Mit24 60788 D1Wox7 33770 D1Mit12 Glucose level postprandial postparandial blood glucose measurment. 619671 10902185 OLETF,F344/N 61014,70509 intercross OLETFxF344
631207 rat Niddm41 Non-insulin dependent diabetes mellitus QTL 41 17 34276 D17Mgh2 Glucose level postprandial postparandial blood glucose measurment. 619671 10902185 OLETF,F344/N 61014,70509 intercross OLETFxF344
631208 rat Obs1 Obesity QTL 1 2 5.09 13.8 60793 D2Wox3 34190 D2Mgh19 Body fat amount mesenteric 619690 11087657 OLETF,F344/N 61014,70509 semidominant F2 OLETFxF344
631209 rat Obs2 Obesity QTL 2 4 4.2 11.3 36476 D4Rat3 35625 D4Rat14 34200 D4Mgh1 Body fat amount retroperitoneal 619690 11087657 OLETF,F344/N 61014,70509 recessive F2 OLETFxF344
631210 rat Obs3 Obesity QTL 3 8 5.9 34152 D8Mgh17 35717 D8Rat9 34310 D8Mgh4 Body fat amount mesenteric 619690 11087657 OLETF,F344/N 61014,70509 additive OLETFxF344
631211 rat Obs4 Obesity QTL 4 9 5.31 16.5 35695 D9Rat44 Body fat amount retroperitoneal 619690 11087657 OLETF,F344/N 61014,70509 recessive OLETFxF344
631212 rat Obs5 Obesity QTL 5 14 5.43 12.4 35342 D14Rat8 33953 D14Mit1 60763 D14Wox3 Body fat amount retroperitoneal 619690 11087657 OLETF,F344/N 61014,70509 recessive intercross OLETFxF344
631213 rat Obs6 Obesity QTL 6 14 4.51 13.8 36512 D14Rat18 35897 D14Rat22 Body fat amount retroperitoneal determined adiposity index, percentage of retroperitoneal fat pad weight/body weight 619690 11087657 OLETF,F344/N 61014,70509 recessive intercross OLETFxF344
631214 rat Obs7 Obesity QTL 7 1 3.4 .0001 5 33903 D1Mit7 37754 D1Rat123 Body fat amount intramuscular musculus longismus was stained with Oil Red O and area was measured. 619672 11853145 OLETF,F344/N 61014,70509 recessive Obs1,Obs2,Obs3,Obs4,Obs5,Obs6 intercross F344xOLETF
631215 rat Stl8 Serum triglyceride level QTL 8 1 9.27 .0001 13.6 34009 D1Mit34 35457 D1Rat90 Lipid level triglyceride triglyceride levels were measured in blood taken from tail veins of rats under fasting conditions. 70852 10644432 BN,OLETF 60985,61014 Tgl1,Tgl2,Tgl3 backcross BNxOLETF
631216 rat Stl9 Serum triglyceride level QTL 9 8 4.71 .0001 7.1 35987 D8Rat30 33858 D8Mit4 33973 D8Mit2 Lipid level triglyceride triglyceride levels were measured in blood from tail veins of rats under fasting conditions. 70852 10644432 BN,OLETF 60985,61014 Tgl1,Tgl2,Tgl3,Tgl4 backcross BNxOLETF
631217 rat Act1 Activity QTL 1 8 15.9 35 33919 D8Mit15 10169 D8Wox11 34068 D8Mgh11 Activity level novel environment number of interruptions over 60 min. of two horizontal photobeams after placement in a wire cage 631170,631228 8944030,12660808 BN,WKY,WKHA 60985,61103,68186 intercross WKYxWKHA
631260 rat Tts2 Tongue tumor susceptibility QTL 2 1 4.5 34326 D1Mgh21 34244 D1Mgh10 33753 D1Mit5 Tongue tumor susceptibility 631169 12448007 DA,WF 60997,61007 intercross DAxWF
631261 rat Tts3 Tongue tumor susceptibility QTL 3 4 6 33905 D4Mit11 3186 Nos3 Tongue tumor susceptibility 631169 12448007 DA,WF 60997,61007 intercross WFxDA
631262 rat Tts4 Tongue tumor susceptibility QTL 4 14 60762 D14Wox10 11030 D14Mit4 Tongue tumor susceptibility 631169 12448007 DA,WF 60997,61007 intercross DAxWF
631263 rat Cm24 Cardiac mass QTL 24 5 3.5 18.6 40376 D5Rat173 11001 D5Wox10 39168 D5Rat99 Cardiac mass left ventricle LV (including the septal wall) was blotted dry and weighed individually. LVM was determined by the ratio of LV weight/Body weight 619659 11157676 45969 3193 Nppa WKY/Cfd,WKHA/Cfd 631275,631276 codominant intercross WKY/CfdxWKHA/Cfd
631264 rat Scl22 Serum cholesterol level QTL 22 18 6.2 3916 Ttr 2741 Nr3c1 3916 Ttr Lipid level cholesterol 61055 9199194 BB/OK,SHR/Mol 61107,61110 intercross BB/OKxSHR/Mol
631265 rat Aiid1 Atps induced immunological disorder QTL 1 20 8.3 17 34260 D20Mgh5 45676 D20Got13 37872 D20Rat31 Anti-DNA antibody level F2 rats were injected subcutaneously with 20 mg/Kg body weights of Atps (aurothiopropanol sulfonate) three time a week for 5 weeks 619646 10898507 LEW/Rj.BN/Rj 631277 additive intercross LEW/RjxBN/Rj
631266 rat Bp132 Blood pressure QTL 132 2 .0005 2633 Fst 34461 D2Mgh12 Blood pressure systolic systolic, diastolic, and mean arterial blood pressure measured in a congenic strain SHRSP/Gla.WKY/Gla-(Fst-D2Mgh12)/Gla and compared to blood pressure of the parental strain SHRSP/Gla 68910 10642295 2071,1298530,2167,2263 Agtr1b,Gca,Atp1a1,Camk2d SHRSP/Gcrc.WKY/Gcrc-(Fst-D2Mgh12)/Gcrc 631278 Bp13, Bp14,Bp14 congenic SS/JrxSR/Jr
631267 rat Cia20 Type II Collagen induced arthritis QTL 20 10 3.2 61274 D10Arb20 61275 D10Arb22 44839 D10Wox7 Joint/bone inflammation type II collagen induced 631168 11003387 BN/SsNHsd 10008 recessive Cia5, Cia21, Cia22, Cia23,Cia21 intercross
631268 rat Cia21 Type II Collagen induced arthritis QTL 21 10 3.1 33585 D10Mit6 61275 D10Arb22 36749 D10Rat19 Joint/bone inflammation type II collagen induced 631168 11003387 BN/SsNHsd 10008 Cia5, Cia20, Cia22, Cia23,Cia20
61440 rat Cia9 Type II Collagen induced arthritis QTL 9 Y Joint/bone inflammation type II collagen induced arthritis severity was measured via a scoring system for cartilage surface area and joint size; joints were measured twice weekly for six weeks following type II collagen injection 61064,61065 10331011,10631556 45676 ACI/N,DA/Bkl 10000,61114 F2 DA/Bkl x ACI
61441 rat Trs1 Thermal response to stress QTL 1 10 4 52 33846 D10Mit2 33909 D10Mit4 3138 Myh3 Body temperature under stress 61094 10679499 45718 SHR/Ola,BN-Lx/Cub 61100,61117 SHR/Ola x BN-lx/Cub
61442 rat Str1 Sensitivity to stroke QTL 1 1 7.4 33959 D1Mit3 Stroke susceptibility latency until stroke 61093 8696337 39099 SHR,SHRSP 61000,61010 F2 SHRSP x SHR
61443 rat Trs2 Thermal response to stress QTL 2 12 3.3 61306 Hspb1 33725 D12Mit1 3019 Lsn2 Body temperature under stress 61094 10679499 45719 SHR/Ola,BN-Lx/Cub 61100,61117 SHR/Ola x BN-lx/Cub
61444 rat Str2 Sensitivity to stroke QTL 2 5 4.7 3193 Nppa Stroke susceptibility latency until stroke 61093 8696337 39100 SHR,SHRSP 61000,61010 F2 SHRSP x SHR
61445 rat Str3 Sensitivity to stroke QTL 3 4 3 10144 D4Mgh16 Stroke susceptibility latency until stroke 61093 8696337 39101 SHR,SHRSP 61000,61010 F2 SHRSP x SHR
61446 rat Crg2 Compensatory renal growth QTL 2 4 3.5 54 3371 Pparg 2554 Eno2 61315 D4Cebr7s17 Renal growth compensatory 61071 10864582 2245 Cacna1c SHR/Ola,BN-Lx/Cub 61100,61117 F2 SHR/Ola x BN-lx/Cub
61447 rat Tts1 Tongue tumor susceptibility QTL 1 19 6.08 11471 D19Mit9 Tongue tumor susceptibility 61091 9563479 44501 2503 Nqo1 WF,DA/Slc 61007,61111 F1 DA/Slc x WF
61448 rat Ciaa1 CIA Autoantibody QTL 1 20 30 .001 11206 D20Arb2 61316 D20Arb8 11428 D20Wox3 Anti-type II collagen autoantibody titer collagen induced levels of IgG antibody titers for type II collagen were determined from serum samples 28 days after collagen injection 61066,61067 10857786,11001927 32932 BBDR,BN,DA,F344/N 10003,60985,60997,70509 appears to overlap with Cia1, Aia1, and Oia1 on chr 20 F2 DAxF344, DAxBN, BB/DRxBN
61449 rat Ciaa2 CIA Autoantibody QTL 2 10 7.1 10142 D10Arb9 10641 D10Wox22 10642 D10Mit12 Anti-type II collagen autoantibody titer collagen induced levels of IgG antibody titers for type II collagen were determined from serum samples 28 days after collagen injection 61518 32933 2836,61277,3877,3773,3774 Hsd17b1,Trim25,Tnfaip1,Stat5a,Stat5b DA,F344/N 60997,70509 Aia5, Eau3, Carrageenan, Atps2, Pia10, Cia5, Cia5b [this needs to be fixed!!] F2 DAxF344
61450 rat Ciaa3 CIA Autoantibody QTL 3 9 6.5 44567 D9Wox19 60827 D9Wox23 60827 D9Wox23 Anti-type II collagen autoantibody titer collagen induced levels of IgG antibody titers for type II collagen were determined from serum samples 28 days after collagen injection 61066,61067 10857786,11001927 45689 2232,3951 C3,Vav1 BN,DA 60985,60997 recessive Cia15 F2,intercross DAxBN, BB/DRxBN
61451 rat Ciaa4 CIA Autoantibody QTL 4 4 3.1 34256 D4Mgh18 34338 D4Mgh11 33768 D4Mit14 Anti-type II collagen autoantibody titer 61067 11001927 45690 2306,61318,3878,61319,61320 Cd4,Cd69,Tnfr1,Tnfrsf7,Kird1 BBDR,BN 10003,60985 Cia13, Oia2 F2 BB/DRxBN
61452 rat Ciaa5 CIA Autoantibody QTL 5 5 3.5 43928 D5Wox3 34443 D5Mgh8 34220 D5Mgh13 Anti-type II collagen autoantibody titer 61067 11001927 45691 2943 Jun BBDR,BN 10003,60985 F2 BB/DRxBN
61453 rat Pur1 Proteinuria QTL 1 13 18.06 34371 D13Mgh3 34351 D13Mgh4 Renal function urine protein level urine albumin level, urine protein level, focal glomerulosclerosis, and indirect systolic blood pressure were measured 8 weeks after unilateral nephrectomy 619599 9799838 45094 BUF/Mna,WKY/NCrj 61118,61119 (BUF/Mna x WKY/NCrj) x BUF/Mna backcross BUF/Mna x WKY/NCrj
61454 rat Dmo1 Diabetes Mellitus OLETF QTL 1 1 6 33694 D1Mit8 Body weight 61072 9585427 39277 BN,OLETF 60985,61014 F2 OLETF x BN
61455 rat Niddm7 Non-insulin dependent diabetes mellitus QTL 7 1 5.5 16 43424 D1Wox10 2470 Cyp2c40 43424 D1Wox10 Glucose level intravenous glucose tolerance and insulin secretion tests (IVGTT) were performed in 16 week old rats 61061 8528248 34222 2870,3786 Igf2,Abcc8 GK,BN 10017,60985 F2,intercross GK x BN,GKxBN
61456 rat Dmo2 Diabetes Mellitus OLETF QTL 2 7 4.5 10431 D7Wox18 Glucose level postprandial oral glucose tolerance test (OGTT) was administered after overnight fasting; blood was collected at time 0 for fasting glucose and at 30 min intervals until 120 min post OGTT administration; plasma glucose levels were measured by a glucose oxidase method 61072 9585427 39278 OLETF,F344/N 61014,70509 F2 OLETF x F344
61457 rat Niddm8 Non-insulin dependent diabetes mellitus QTL 8 2 4.1 .01 12 3336 Pklr 3195 Npr1 11048 D2Wox23 Insulin level fasting intravenous insulin secretion tests were performed in 16 week old rats and arginine induced insulin secretion was measured at 24 weeks of age 61061 8528248 34223 GK,BN 10017,60985 F2 GK x BN,GKxBN
61458 rat Bp10 Blood pressure QTL 10 2 3.42 2167 Atp1a1 2263 Camk2d 2167 Atp1a1 Blood pressure salt-loaded blood pressure measured by tail-cuff in F2 males maintained on high salt diet 61037,61038,619639 1363813,8040284,7768551 34599 3195 Npr1 WKY 61103 Bp14,Bp16,Bp19,Bp36 F2 SS/JrxWKY
61459 rat Dmo3 Diabetes Mellitus OLETF QTL 3 14 4.8 33579 D14Mit5 Glucose level postprandial oral glucose tolerance test (OGTT) was administered after overnight fasting; blood was collected at time 0 for fasting glucose and at 30 min intervals until 120 min post OGTT administration; plasma glucose levels were measured by a glucose oxidase method 61072 9585427 39279 OLETF,F344/N 61014,70509 F2 OLETF x F344
61460 rat Niddm9 Non-insulin dependent diabetes mellitus QTL 9 4 3.4 .0001 10 60802 D4Wox3 Insulin level intravenous glucose tolerance and insulin secretion tests (IVGTT) were performed in 16 week old rats 61061 8528248 34224 GK,BN 10017,60985 F2,intercross GK x BN,GKxBN
61461 rat Bp11 Blood pressure QTL 11 13 Blood pressure 61037 1363813 34600 MNS,WKY 60992,61103 Bp5, Bp24, Bp 25, Bp31 F2
61462 rat Niddm10 Non-insulin dependent diabetes mellitus QTL 10 5 3.9 .001 11 43870 D5Wox8 60809 D5Wox7 Glucose level intravenous glucose tolerance and insulin secretion tests (IVGTT) were performed in 16 week old rats 61061 8528248 34225 GK,BN 10017,60985 F2,intercross GK x BN,GKxBN
61463 rat Bp12 Blood pressure QTL 12 10 6.3 .0001 3185 Nos2 Blood pressure salt-loaded systolic systolic blood pressure measured by tail cuff method in rats fed a diet containing 8% NaCl 61037,61039,61040 1363813,7537756,9685318 34601 3185 Nos2 SR/Jr,SS/Jr,LEW 10040,10041,60999 F2 SS/Jr x LEW, SR/Jr x LEW
61464 rat Niddm11 Non-insulin dependent diabetes mellitus QTL 11 8 3.1 .001 10 10168 D8Wox5 Insulin level intravenous glucose tolerance and insulin secretion tests (IVGTT) were performed in 16 week old rats 61061 8528248 34226 GK,BN 10017,60985 F2,intercross GK x BN,GKxBN
61465 rat Bp13 Blood pressure QTL 13 2 3.3 33620 D2Mit6 2391 Cpb1 Blood pressure 61041 8901842 34966 SHRSP,WKY 61010,61103 Bp6 F2,backcross SHRSP x WKY
61466 rat Niddm12 Non-insulin dependent diabetes mellitus QTL 12 17 3.2 .001 11 10350 D17Wox12 45485 D17Wox9 Glucose level fasting 61061 8528248 34227 GK,BN 10017,60985 F2,intercorss GK x BN,GKxBN
61467 rat Bp14 Blood pressure QTL 14 2 3.1 34461 D2Mgh12 34278 D2Mgh14 Blood pressure 61041,631154 8901842,12624007 34967 SHRSP,WKY 61010,61103 Bp10, Bp16, Bp19, Bp166 F2,backcross SHRSP x WKY
61468 rat Bp15 Blood pressure QTL 15 3 4.4 34347 D3Mgh16 Blood pressure salt loaded systolic blood pressure measured in F2 males 61041 8901842 34969 recessive F2 SHRSP x WKY
61469 rat Bp16 Blood pressure QTL 16 2 5.64 60797 D2Wox7 Blood pressure 61043 8952608 36654 2167 Atp1a1 SHR,WKY 61000,61103 F2 SHRxWKY
61470 rat Bp17 Blood pressure QTL 17 2 .0008 33618 D19Mit7 61323 D2N35 61321 D2Nih4 Blood pressure 61044 7560090 36655 BN,SHR 60985,61000 F2 SHRxBN
61471 rat Bp18 Blood pressure QTL 18 2 3 3119 Mt1pb 34278 D2Mgh14 Blood pressure salt-loaded Systolic 61045 9132270 36643 BN,SHR 60985,61000 F2 SHRxBN
61472 rat Aia1 Adjuvant induced arthritis QTL 1 20 18 .001 11206 D20Arb2 61316 D20Arb8 11428 D20Wox3 Joint/bone inflammation adjuvant induced 61035 9780220 45637 DA,F344/N 60997,70509 Cia1, Ciaa1, Oia1, Pia1 F2 DAxF344
61473 rat Bp19 Blood pressure QTL 19 2 6.3 34292 D2Mgh8 3195 Npr1 Blood pressure salt-loaded Systolic 61045 9132270 36644 BN,SHR 60985,61000 Bp10, Bp14, Bp16, Bp19 F2 SHRxBN
61474 rat Eae1 Experimental allergic encephalomyelitis QTL 1 20 3 37594 D20Rat41 34280 D20Mgh4 Brain/spinal cord inflammation severity of disease 61031 10640775 44535 DA,E3 60997,61013 Pia 1 F2 E3 x DA
61475 rat Aia2 Adjuvant induced arthritis QTL 2 4 5.8 42158 D4Arb26 42168 D4Arb30 34282 D4Mgh15 Joint/bone inflammation adjuvant induced 61035,629560 9780220,12571866 45638 DA,F344/N 60997,70509 Iddm4, Eau1, Pia2,Pia2 F2 DAxF344
61476 rat Aia3 Adjuvant induced arthritis QTL 3 4 3.9 42168 D4Arb30 10158 D4Arb16 61302 D4Arb24 Joint/bone inflammation adjuvant induced 61035,629560 9780220,12571866 45639 3197,3834 Npy,Tcrb DA,F344/N 60997,70509 Cia3, Aia3, and Pia5,Cia3,Pia5 F2 DAxF344
61477 rat Aia4 Adjuvant induced arthritis QTL 4 15 3 33820 D15Mit6 34471 D15Mgh3 35230 D15Rat22 Joint/bone inflammation adjuvant induced 61035 9780220 45640 DA,F344/N 60997,70509 F2 DAxF344
70153 rat Bp59 Blood pressure QTL 59 14 3.2 40852 D14Rat90 41138 D14Rat94 2041 Add1 Blood pressure direct systolic 70067,69692 11082136 45650 MHS/Gib,MNS/Gib 10025,10028 F2 MHSxMNS
70154 rat Plil1 Plasma insulin level QTL 1 20 3.75 33563 D20Mit5 34280 D20Mgh4 Insulin level post-pancreatectomy 70067,69703 9819774 45142 OLETF,F344/N 61014,70509 F2 F344xOLETF
70155 rat Gcs1 Gastric cancer susceptibility QTL1 15 3.8 36602 D15Rat29 34357 D15Mgh4 40106 D15Rat102 Gastric tumor susceptibility tumor size 70067,69698 10706129 45708 ACI/N,BUF/N 10000,60986 (ACIxBUF)xACI
70156 rat Niddm30 Non-insulin dependent diabetes mellitus QTL 30 5 3.98 34581 D5Mgh27 34168 D5Mgh22 Glucose level postprandial plasma glucose levels were determined using the oral glucose tolerance test (OGTT) administered after overnight fasting; levels were measured at time 0 for fasting glucose and at 30 min intervals until 120 min post OGTT administration; glucose level over the entire time course was calculated as an area under the curve (AUC) of the glucose levels from 0 to 120 min 70067,69696 10594234 45200 F344/Crj,OLETF/Got 69643,734526 F2 OLETF/OtkxF344/Crj
70157 rat Niddm32 Non-insulin dependent diabetes Mellitus QTL 32 17 4.34 2532 Edn1 34120 D17Mgh5 Glucose level postprandial plasma glucose levels were determined using the oral glucose tolerance test (OGTT) administered after overnight fasting; levels were measured at time 0 for fasting glucose and at 30 min intervals until 120 min post OGTT administration; glucose level over the entire time course was calculated as an area under the curve (AUC) of the glucose levels from 0 to 120 min 70067,69696 10594234 45202 F344/Crj,OLETF/Got 69643,734526 F2 OLETF/OtkxF344/Crj
70158 rat Bp60 Blood pressure QTL 60 20 3 38216 D20Rat22 37570 D20Rat38 38762 D20Rat40 Blood pressure indirect systolic measured by tail-cuff method at 12 to 16 wks of age 70067,69692 11082136 45651 MHS/Gib,MNS/Gib 10025,10028 F2 MHSxMNS
70159 rat Bp61 Blood pressure QTL 61 7 .0001 62494 D7UIA1 33816 D7Mit11 Blood pressure systolic systolic blood pressure measured by tail-cuff method 70067,69709,69710,69711,619653 7981756,9383281,11247666,11161799 45652 2453 Cyp11b1 SR/Jr,SS/Jr 10040,10041 F2 SxR
70160 rat Bw18 Body weight QTL 18 1 5.7 33959 D1Mit3 3643 Sct Body weight body weight was measured at 16, 20, 24, 28 and 29 weeks; plasma insulin were measured on fasting animals at 29 weeks; plasma triglycerides were measured at 8, 10, 18, and 29 weeks 70067,69701 9530625 45097 SHR,BB/OK 61000,61107 F1xSHR (BB/OKxSHR)F1xSHR
70161 rat Bp62 Blood pressure QTL 62 8 2.9 33887 D8Mit3 40168 D8Rat133 35014 D8Rat24 Blood pressure salt-loaded systolic measured on two separate days by tail cuff method on ether-anesthetized rats fed a diet containing 8% NaCl 70067,61516 11015598 45653 SS/Jr,SHR 10041,61000 dominant intercross,F2 SS/JrxSHR,SxSHR
70162 rat Bp63 Blood pressure QTL 63 2 5.64 60797 D2Wox7 Blood pressure 70067,61043 8952608 45654 SHR,WKY 61000,61103 F2 SHRxWKY
70163 rat Bw20 Body weight QTL 20 1 5.1 62086 Sah 10674 D1Mgh12 Body weight 70067,69701 9530625 45098 SHR,BB/OK 61000,61107 F1xSHR SHRx(BB/OKxSHR)F1
70164 rat Bw21 Body weight QTL 21 10 3.41 44839 D10Wox7 11479 D10Mit8 Body weight 70067,69691,625760 9824537,12420133 45188 F344/Crj,F344/Crj.OLETF/Otk-(D10Wox7-D10Wox6),OLETF/Got,F344.OLETF-(D10Wox7-D10Wox6)/Tj 69643,631580,734526,1302630 intercross,F2 OLETF/OtkxF344/Crj
70165 rat Bp64 Blood pressure QTL 64 X 5.2 34559 DXMgh12 36111 DXRat8 Blood pressure salt-loaded systolic systolic, diastolic, mean blood pressures and heart rate measured directly through a femoral catheter inserted in rats following treatment for 13 days with a diet including water with 1% NaCl 70067,69713 9931114 45655 SBH/Ygl,SBN/Ygl 631572,631573 F2 SBHxSBN
70166 rat Bp65 Blood pressure QTL 65 X 5.8 35030 DXRat2 36474 DXRat4 Blood pressure salt-loaded systolic systolic, diastolic, mean blood pressures and heart rate measured directly through a femoral catheter inserted in rats following treatment for 13 days with a diet including water with 1% NaCl 70067,69713 9931114 45656 SBN/Ygl,Wild 631573,631574 F2 SBHxSBN
70167 rat Bw22 Body weight QTL 22 4 3.1 60732 D4Mit6 3753 Spr 11015 D4Mit24 Body weight 70067,69707 9530522 45203 SHR,BB/OK 61000,61107 (BB/OKxSHR)F1xBB/OK
70168 rat Eae12 Experimental allergic encephalomyelitis QTL 12 10 .0009 34941 D10Rat7 36283 D10Rat15 34100 D10Mgh3 Brain/spinal cord inflammation demyelination inflammation severity was assayed daily following injection with recombinant rat myelin oligodendrocyte glycoprotein (MOG) AA 1-125; animals were scored as affected if they had paresis for at least two days and/or histopathological evidence of demyelination or CNS inflammation at 40 days post-immunization 70067,69695 10545597 45699 ACI/N,DA 10000,60997 F2 DAxACI
70169 rat Eae13 Experimental allergic encephalomyelitis QTL 13 12 .032 36671 D12Rat19 36025 D12Rat23 36490 D12Rat18 Brain/spinal cord inflammation demyelination inflammation severity was assayed daily following injection with recombinant rat myelin oligodendrocyte glycoprotein (MOG) AA 1-125; animals were scored as affected if they had paresis for at least two days and/or histopathological evidence of demyelination or CNS inflammation at 40 days post-immunization 70067,69695 10545597 45700 ACI/N,DA 10000,60997 F2 DAxACI
70170 rat Eae14 Experimental allergic encephalomyelitis QTL 14 13 .0024 36069 D13Rat23 Brain/spinal cord inflammation demyelination inflammation severity was assayed daily following injection with recombinant rat myelin oligodendrocyte glycoprotein (MOG) AA 1-125; animals were scored as affected if they had paresis for at least two days and/or histopathological evidence of demyelination or CNS inflammation at 40 days post-immunization 70067,69695 10545597 45701 ACI/N,DA 10000,60997 F2 DAxACI
70171 rat Cari1 Carrageenan-induced inflammation QTL 1 10 4.9 .0005 18 33941 D10Mit11 11479 D10Mit8 34274 D10Mgh5 Carrageenan-induced inflammation exudate volume 70067,69693 10087293 45672 LEW,F344/N 60999,70509 dominant Cia5, Aia5 F2 F344xLEW
1331634 human AASTH1_H Allergic/atopic asthma related QTL 1 (human) 4 2.74 .0002 1331597 D4S2417 1298122 D4S408 Reversible airflow obstruction genome-wide scan for linkage to childhood atopic allergy to the house-dust mite Dermatophagoides farinae; affected individuals showed Df-specific RAST scores >3 and total serum IgE levels >1 standard deviation above the age-matched population mean 1331538 10860660
61324 rat Eae5 Experimental allergic encephalomyelitis QTL 5 12 13 11051 D12Mit2 34925 D12Rat9 Brain/spinal cord inflammation relapsing disease inflammation severity was assayed daily following injection with DA rat spinal cord homogenate with rats scored for degree of tail and limb paralysis on a nine point scale; relapsing disease is defined as more than one period of three-day increase in clinical score 61031 10640775 44536 DA,E3 60997,61013 Pia 4 F2 E3 x DA
61325 rat Aia5 Adjuvant induced arthritis QTL 5 10 .01 61274 D10Arb20 61275 D10Arb22 10466 D10Mit1 Joint/bone inflammation adjuvant induced arthritis severity after adjuvant injection was measured via a cumulative scoring system for multiple joints; animals were evaluated twice a week for six weeks 625379 11953987 45641 DA.F344(Cia5),DA/Bkl 61095,61114 Cia3 and Pia5; reported to be the same as Aia3,Cia5 Congenic DA.F344 Congenic
61326 rat Eae6 Experimental allergic encephalomyelitis QTL 6 1 5.3 34399 D1Mgh9 10951 D1Mit13 34326 D1Mgh21 Brain/spinal cord inflammation change in body weight experimental autoimmune encephalomyelitis severity following injection with DA rat spinal cord homogenate was assayed daily; assay consists of scoring animals for degree of tail and limb paralysis on a nine point scale with paralysis increasing from 0 to experimental autoimmune encephalomyelitis severity following injection with DA rat spinal cord homogenate was assayed daily; assay consists of scoring animals for degree of tail and limb paralysis on a nine point scale with paralysis increasing from 0 to 8; change in body weight from day 7 to 40 was determined in association with disease status 61031,629561 10640775,11817600 44537 DA,E3 60997,61013 F2 E3 x DA,E3xDA
61327 rat Eae7 Experimental allergic encephalomyelitis QTL 7 1 5.6 33903 D1Mit7 10674 D1Mgh12 10445 D1Wox25 Brain/spinal cord inflammation change in body weight inflammation severity was assayed daily following injection with DA rat spinal cord homogenate with animals scored for degree of tail and limb paralysis on a nine point scale with paralysis increasing from 0 to 8; change in body weight from day 7 to 40 was determined in association with disease status 61031,629561 10640775,11817600 44538 DA,E3 60997,61013 F2 E3 x DA,E3xDA
61328 rat Eae8 Experimental allergic encephalomyelitis QTL 8 19 4 11471 D19Mit9 34033 D19Mit5 Brain/spinal cord inflammation acute disease experimental autoimmune encephalomyelitis severity following injection with DA rat spinal cord homogenate was assayed daily; assay consists of scoring animals for degree of tail and limb paralysis on a nine point scale with paralysis increasing from 0 to 8; acute disease is defined as a monophasic disease pattern in the assay over time 61031 10640775 44539 DA,E3 60997,61013 F2 E3 x DA
61329 rat Eae9 Experimental allergic encephalomyelitis QTL 9 6 3.7 34098 D6Mgh3 35821 D6Rat10 Brain/spinal cord inflammation change in body weight inflammation severity was assayed daily following injection with DA rat spinal cord homogenate with animals scored for degree of tail and limb paralysis on a nine point scale with paralysis increasing from 0 to 8; change in body weight from day 7 to 40 was determined in association with disease status 61031 10640775 44540 DA,E3 60997,61013 F2 E3 x DA
61330 rat Eau1 Experimental allergic uveoritinitis QTL 1 4 .0003 11173 D4Arb8 34001 D4Mit17 11013 D4Arb7 Uvea inflammation score 61073 10323205 45703 3197,3834 Npy,Tcrb LEW,F344/N 60999,70509 Cia3, Aia3, Iddm/Lyp, Scwia1 F2 LEWxF344
61331 rat Eau2 Experimental allergic uveoritinitis QTL 2 12 .0005 41960 D12Arb2 61278 D12Arb5 41960 D12Arb2 Uvea inflammation score 61073 10323205 45704 LEW,F344/N 60999,70509 Cia12, Pia4 F2 LEWxF344
61332 rat Eau3 Experimental allergic uveoritinitis QTL 3 10 .004 61279 D10Arb3 33941 D10Mit11 34053 D10Mit3 Uvea inflammation score 61073 10323205 3772,3773,61276,3395,2836,61277,3877,3774 Stat3,Stat5a,Crhr1,Prkca,Hsd17b1,Trim25,Tnfaip1,Stat5b LEW,F344/N 60999,70509 Cia5, Oia3, Carrageenan, Pia10, Aia5, Atps2 F2 LEWxF344
61333 rat Irg1 Insulin resistance gene 1 4 4.3 42144 D4Arb13 3711 Slc4a2 Glucose level uptake insulin mediated and basal glucose uptake levels were measured in adipocytes isolated from male rats 61078 9171835 37903 SHR/NCrlBR,WKY/NCrlBR,BXH,HXB 61096,61097,61098,61099 F2
61334 rat Irg2 Insulin resistance gene 2 12 6.3 34025 D12Mit8 34439 D12Mgh1 Glucose level uptake insulin mediated and basal glucose uptake levels were measured in adipocytes isolated from male rats 61078 9171835 37904 SHR/NCrlBR,WKY/NCrlBR,BXH,HXB 61096,61097,61098,61099 F2
61335 rat Bp20 Blood pressure QTL 20 3 3 34316 D3Mgh2 33810 D3Mit2 Blood pressure salt-loaded systolic systolic, diastolic, mean blood pressures and heart rate measured directly through a femoral catheter inserted in rats following treatment for 13 days with a diet including water with 1% NaCl 61045 9132270 36645 BN,SHR 60985,61000 F2 SHR x BN
61336 rat Bp21 Blood pressure QTL 21 4 4.6 3197 Npy 33757 D4Mit2 Blood pressure salt-loaded systolic systolic, diastolic, mean blood pressures and heart rate measured directly through a femoral catheter inserted in rats following treatment for 13 days with a diet including water with 1% NaCl 61045,631223 9132270,11474180 36646 3239 Oxtr BN,SHR 60985,61000 F2 SHR x BN
61337 rat Bp22 Blood pressure QTL 22 8 5.1 33559 D8Mit5 33887 D8Mit3 Blood pressure salt-loaded systolic systolic, diastolic, mean blood pressures and heart rate measured directly through a femoral catheter inserted in rats following treatment for 13 days with a diet including water with 1% NaCl 61045 9132270 36647 BN,SHR 60985,61000 Bp35, Bp39 F2,intercross SHR x BN,SHRxBN
61338 rat Bp23 Blood pressure QTL 23 16 4.3 33848 D16Mit2 33652 D16Mit5 Blood pressure salt-loaded systolic systolic, diastolic, mean blood pressures and heart rate measured directly through a femoral catheter inserted in rats following treatment for 13 days with a diet including water with 1% NaCl 61045 9132270 36648 BN,SHR 60985,61000 F2,intercross SHR x BN,SHRxBN
61339 rat Bp24 Blood pressure QTL 24 13 .05 33923 D13Mit1 3554 Ren1 Blood pressure 61046 8567976 36649 SR/Jr,SS/Jr,SHR.BN-(D13Arb5-Ren)/Ipcv 10040,10041,628909 Bp5, Bp11, Bp25, Bp31 F2
61340 rat Bp25 Blood pressure QTL 25 13 4.2 .004 34371 D13Mgh3 61281 D13M1Mit108 Blood pressure salt-loaded systolic systolic blood pressure measured by tail cuff method in rats that were fed a diet containing 8% NaCl for 8 weeks 61047 9271663 36650 SR/Jr,SS/Jr,BN 10040,10041,60985 related to (Bpdsr106--place holder for new QTL number to be substituted here) Both QTLs from same paper, Bp25 contains mapping data from (SS/Jr X SR/Jr) F2 and Bpdsr106 describes the QTL defined by related congenic strains derived in the same reference F2 SS/Jr x SR/Jr
61341 rat Bp26 Blood pressure QTL 26 1 33959 D1Mit3 2870 Igf2 Blood pressure 61048 9336384 36651 SHR/Ola,BN/Cr 61100,61101 Bpfh1, Bp28, Bp29, Bp30 F2
61342 rat Bp27 Blood pressure QTL 27 1 3.4 61282 D1M7Mit69 61283 D1Mco2 61284 D1Mco1 Blood pressure salt-loaded systolic systolic blood pressure measured by tail cuff method in rats fed a diet containing 8% NaCl 61049,61040 8609235,9685318 36653 SS/Jr,LEW 10041,60999 F2
61343 rat Bp28 Blood pressure QTL 28 1 62086 Sah Blood pressure systolic 61050 8094726 36652 SHRSP,WKY 61010,61103 Bpfh1, Bp26, Bp29, Bp30 F2 SHRSP x WKY
61344 rat Bp29 Blood pressure QTL 29 1 7.5 34011 D1Mit2 60784 D1Wox29 Blood pressure systolic systolic and diastolic blood pressures measured directly in 25 week old rats through a lower aortic cannula inserted via the femoral artery 61051,628394 9774356,12215469 36713 SHR,WKY 61000,61103 Bpfh1, Bp26 Bp28, Bp30 F2 SHR x WKY
61345 rat Rf1 Renal disease susceptibility QTL 1 1 16.9 33571 D1Mit6 10674 D1Mgh12 Renal function urine albumin level 61060,61090 8528250,7704027 34362 ACI/N,FHH 10000,60993 (FHH x ACI) x FHH Backcross ACIxFHH,FHH x ACI
61346 rat Rf2 Renal disease susceptibility QTL 2 1 3.7 34011 D1Mit2 33959 D1Mit3 Renal function urine albumin level 61060,61090 8528250,7704027 34363 ACI/N,FHH 10000,60993 (FHH x ACI) x FHH Backcross ACIxFHH,FHH x ACI
61347 rat Bp197 Blood pressure QTL 197 1 4.2 3118 Mt1pa Blood pressure 61060 8528250 112 ACI/N,FHH 10000,60993 Bp26, Bp28, Bp29, Bp30 (FHH x ACI) x FHH Backcross FHH x ACI
61348 rat Bp30 Blood pressure QTL 30 1 2.4 2870 Igf2 61285 D1Nih1 62086 Sah Blood pressure salt-loaded systolic systolic blood pressure measured by tail cuff method in rats fed a diet containing 8% NaCl 61049,61040 8609235,9685318 36711 3616 Sa SS/Jr,LEW/NCrl 10041,61104 Bpfh1, Bp26, Bp28, Bp29 F2 SS/Jr x LEW/NCrLBR
61349 rat Bp31 Blood pressure QTL 31 13 5.75 33733 D13Mit2 Blood pressure 61043 8952608 36712 SHR,WKY 61000,61103 Bp5, Bp11, Bp24, Bp25 F2 SHR x WKY
61350 rat Bp32 Blood pressure QTL 32 19 .012 33618 D19Mit7 Blood pressure 61044 7560090 37901 BN,SHR 60985,61000 F2 SHR x BN
61351 rat Bp33 Blood pressure QTL 33 4 .018 61286 Il16 Blood pressure 61044 7560090 37902 BN,SHR 60985,61000 F2 SHR x BN
61352 rat Bp34 Blood pressure QTL 34 9 5 61287 D9Uia6 61288 D9Uia9 2912 Inha Blood pressure salt-loaded systolic systolic blood pressure measured by tail cuff method in rats fed a diet containing 8% NaCl for 8 weeks 61053,619653 9722941,11161799 39687 SR/Jr,SS/Jr 10040,10041 F2 SS/Jr x SR/Jr
61353 rat Bp35 Blood pressure QTL 35 8 33628 D8Mit6 3544 Rbp2 Blood pressure 61054 9045857 39688 SHR.BN-(D8Mit5-D8Mgh6)/Ipcv 61106 Bp22, Bp39 F2
61354 rat Pia10 Pristane induced arthritis QTL 10 10 .01 61274 D10Arb20 61275 D10Arb22 10466 D10Mit1 Joint/bone inflammation pristane induced arthritis was induced at the age of 8 to 14 weeks by an intradermal injection at the base of the tail with pristane (2,6,10,14-tetramethylpentadecane) and was monitored by a macroscopic scoring system of the four limbs ranging from 0 to 4 (1 point for swelling and redness of one joint, 2 for two joints involved, 3 for more than two joints and 4 for severe arthritis) 61519 45711 3772,3773,61276,3395,2836,61277,3877,3774 Stat3,Stat5a,Crhr1,Prkca,Hsd17b1,Trim25,Tnfaip1,Stat5b DA.F344(Cia5) 61095 Oia3, Eau3, Carrageenan, Cia5, Atps2, Aia5 Congenic DA/F344 Congenic
61355 rat Bp36 Blood pressure QTL 36 2 2.9 2071 Agtr1b 33943 D2Mit1 61289 D2Mco19 Blood pressure 61040 9685318 39689 SS/Jr,LEW 10041,60999 Bp10 F2 SS/Jr x LEW
61356 rat Bp37 Blood pressure QTL 37 3 3 34146 D3Mgh6 Blood pressure salt-loaded systolic systolic blood pressure measured by tail cuff method in rats fed a diet containing 8% NaCl 61040,631223 9685318,11474180 39690 3238 Oxt SS/Jr,LEW 10041,60999 F2 SS/Jr x LEW
61357 rat Bp38 Blood pressure QTL 38 7 1.6 34395 D7Mgh1 61290 DyUia3 33648 D7Mit5 Blood pressure 61040 9685318 39691 SS/Jr,LEW 10041,60999 F2 SS/Jr x LEW
61358 rat Bp39 Blood pressure QTL 39 8 2 44436 D8Wox2 Blood pressure 61040 9685318 39692 SR/Jr,SS/Jr 10040,10041 B22, Bp35 F2 SS/Jr x LEW
61359 rat Eae16 Experimental Autoimmune (allergic) Encephalomyelitis QTL 16 5 3 33678 D5Mit10 43924 D5Wox21 Brain/spinal cord inflammation onset of disease experimental autoimmune encephalomyelitis severity following injection with DA rat spinal cord homogenate was assayed daily; assay consists of scoring animals for degree of tail and limb paralysis on a nine point scale with paralysis increasing from 0 to 8; onset of disease is defined as the first day a clinical score of 1 or higher was obtained 61031 10640775 45693 DA,E3 60997,61013 F2 E3 x DA
61360 rat Eae17 Experimental Autoimmune (allergic) Encephalomyelitis QTL 17 18 3 34156 D18Mgh1 10648 D18Wox13 Brain/spinal cord inflammation duration of disease experimental autoimmune encephalomyelitis severity following injection with DA rat spinal cord homogenate was assayed daily; assay consists of scoring animals for degree of tail and limb paralysis on a nine point scale with paralysis increasing from 0 to 8; duration of disease is defined as number of days for which an animal is scored as 2-8 61031 10640775 45694 DA,E3 60997,61013 F2 E3 x DA
61361 rat Oia1 Oil induced arthritis QTL 1 20 Joint/bone inflammation oil induced 61086 8441169 39736 DA 60997 F2
61362 rat Oia2 Oil induced arthritis QTL 2 4 .001 34174 D4Mgh7 33778 D4Mit21 34473 D4Mgh10 Joint/bone inflammation oil induced arthritis severity after adjuvant injection was measured via a cumulative scoring system for multiple joints; animals were evaluated twice a week for six weeks 61087,61068,629560 9600974,9692888,12571866 39732 DA,LEW 60997,60999 Oia3, Pia7, Cia3, Cia13,Cia3,Cia13,Pia7 F2
61363 rat Oia3 Oil induced arthritis QTL 3 10 .001 11308 D10Wox20 34128 D10Mgh1 34128 D10Mgh1 Joint/bone inflammation oil induced 61087,61068,62404 9600974,9692888,11230175 39731 DA,LEW,LEW.1AV1.DA-(D10Rat92-D10Rat135)/Ubc,LEW.1AV1.DA-(D10Rat20-D10Mgh1) 60997,60999,631595,737831 Oia2,Cia5,Oia4,Oia5,Oia6 F2
61364 rat Iddm2 Insulin dependent diabetes mellitus QTL 2 4 11014 D4Mit7 10782 D4Mit8 11014 D4Mit7 Glucose level insulin-dependent 61075 1303251 34084 3024 Lyp BBDP,BBDR,LEW,F344/N 10002,10003,60999,70509 Lyp F2 BB/DP x BB/DR, BB/DP x F344, BB/DP x LEW
61365 rat Iddm1 Insulin dependent diabetes mellitus QTL 1 20 3.54 .001 Glucose level insulin-dependent 61076,61075 7026724,1303251 34085 BBDP,BBDR,LEW,F344/N 10002,10003,60999,70509 F2 BB/DP x BB/DR, BB/DP x F344, BB/DP x LEW
61366 rat Iddm3 Insulin dependent diabetes mellitus QTL 3 2 4.7 33727 D2Mit14 33763 D2Mit15 Glucose level IPGTT performed at 65 days of age 61075,61481 1303251,10441739 34086 BBDR,F344/N 10003,70509 F2 (F344 +/+,lv/lv x BB/DR lyp/lyp,u/u) x BB/DR lyp/lyp,u/u
61367 rat Iddm4 Insulin dependent diabetes mellitus QTL 4 18 2.33 .0074 10507 D6Mgh2 Glucose level insulin-dependent 61077,625443 9571179,8586150 41097 DA,BB/OK 60997,61107 F2,backcross BB/OKxDA
61368 rat Mcs1 Mammary carcinoma susceptibility QTL 1 2 4.4 33822 D2Mit29 61291 D2Uwm15 35901 D2Rat3 Mammary tumor susceptibility 61080,61081 8168109,9584103 34166 COP,WF 60998,61007 (WF x COP) F1 x WF backcross WF x COP
61369 rat Mcs2 Mammary carcinoma susceptibility QTL 2 7 3.38 34166 D7Mgh15 61292 D7Uwm9 34051 D7Mit28 Mammary tumor susceptibility 61081 9584103 39286 COP,WF 60998,61007 (WF x COP) F1 x WF backcross WF x COP
61370 rat Mcs3 Mammary carcinoma susceptibility QTL 3 1 2.15 33686 D1Mit11 34011 D1Mit2 60787 D1Wox6 Mammary tumor susceptibility 61081 9584103 39287 COP,WF 60998,61007 (WF x COP) F1 x WF backcross WF x COP
61371 rat Edpm1 Estrogen-dependent pituitary mass QTL 1 2 4 .66 9.6 34278 D2Mgh14 33824 D2Mit4 61293 Mit-R718 Gland mass pituitary 61074 9337394 41062 BN/SsNHsd,F344/NHsd 10008,61109 additive intercross F344/NHsd x BN/SsNHsd
61372 rat Bp40 Blood pressure QTL 40 16 2.2 11448 D16Wox11 33848 D16Mit2 11448 D16Wox11 Blood pressure 61040 9685318 39693 SS/Jr,LEW 10041,60999 F2 SS/Jr x LEW
61373 rat Mcs4 Mammary carcinoma susceptibility QTL 4 8 1.1 10437 D8Mgh13 34415 D8Mgh6 10437 D8Mgh13 Mammary tumor susceptibility 61081,737837 9584103 39288 2458,2459 Cyp1a1,Cyp1a2 COP,WF 60998,61007 (WF x COP) F1 x WF backcross WF x COP
61374 rat Edpm2 Estrogen-dependent pituitary mass QTL 2 2 4.42 .86 9.2 33620 D2Mit6 34461 D2Mgh12 34114 D2Mgh15 Gland mass pituitary 61074 9337394 41063 BN/SsNHsd,F344/NHsd 10008,61109 intercross F344/NHsd x BN/SsNHsd
61375 rat Bp41 Blood pressure QTL 41 18 2.4 61294 D18Mco3 11461 D18Mit1 33766 D18Mit4 Blood pressure 61040 9685318 39694 SR/Jr,SS/Jr 10040,10041 Bp2 F2 SS/Jr x SR/Jr
61376 rat Bp42 Blood pressure QTL 42 1 23.4 2870 Igf2 10674 D1Mgh12 Blood pressure 61055 9199194 39720 BB/OK,SHR/Mol 61107,61110 F2 BB/OK x SHR/Mol
61377 rat Edpm3 Estrogen-dependent pituitary mass QTL 3 3 7.05 .038 16.6 10293 D3Mit7 34146 D3Mgh6 Gland mass pituitary 61074 9337394 45204 BN/SsNHsd,F344/NHsd 10008,61109 additive intercross F344/NHsd x BN/SsNHsd
61378 rat Bp43 Blood pressure QTL 43 1 22.6 3750 Spn 3643 Sct Blood pressure 61055 9199194 39721 BB/OK,SHR/Mol 61107,61110 F2 BB/OK x SHR/Mol
61379 rat Bp44 Blood pressure QTL 44 1 19.2 62086 Sah 33959 D1Mit3 Blood pressure 61055 9199194 39722 BB/OK,SHR/Mol 61107,61110 F2 BB/OK x SHR/Mol
61380 rat Edpm5 Estrogen-dependent pituitary mass QTL 5 5 4.5 .92 9.4 34216 D5Mgh6 34041 D5Mit5 33985 D5Mit11 Gland mass pituitary 61074 9337394 45205 BN/SsNHsd,F344/NHsd 10008,61109 additive intercross F344/NHsd x BN/SsNHsd
61381 rat Bp45 Blood pressure QTL 45 10 23.2 3385 Ppy 61296 Abp1 Blood pressure 61055 9199194 39723 BB/OK,SHR/Mol 61107,61110 F2 BB/OK x SHR/Mol
61382 rat Bp46 Blood pressure QTL 46 18 18.8 3916 Ttr 2741 Nr3c1 Blood pressure 61055 9199194 39724 BB/OK,SHR/Mol 61107,61110 Bp47,Bp48,Bp2, Bp32 intercross,F2 BB/OK x SHR/Mol
61383 rat Bp47 Blood pressure QTL 47 18 17.3 2741 Nr3c1 2690 Gja1 Blood pressure 61055 9199194 39725 BB/OK,SHR/Mol 61107,61110 Bp46,Bp48 F2 BB/OK x SHR/Mol
631828 rat Alc5 Alcohol preference QTL 5 10 2.4 2 34361 D10Mgh25 41276 D10Rat182 34361 D10Mgh25 Consumption level alcohol preference in separate cage with free choice of water or 10% (v/v) of ethanol; consumption scores (grams/kg/day) were averaged; the amounts of ethanol consumed every 3 days over three weeks 631230,724636 10979603,12960747 HAD1,LAD1,HAD2,LAD2 631844,631845,731187,731188 additive Intercross,intercross HAD1xLAD1,HAD2xLAD2
631829 rat Alc6 Alcohol preference QTL 6 12 4.7 4 41626 D12Rat93 34389 D12Mgh10 36490 D12Rat18 Consumption level alcohol preference in separate cage with free choice of water or 10% (v/v) of ethanol; consumption scores (grams/kg/day) were averaged; the amounts of ethanol consumed every 3 days over three weeks 631230 10979603 HAD1,LAD1 631844,631845 additive intercross HAD1xLAD1
631830 rat Alc7 Alcohol preference QTL 7 16 2.9 33848 D16Mit2 Consumption level alcohol preference in separate cage with free choice of water or 10% (v/v) of ethanol; consumption scores (grams/kg/day) were averaged; the amounts of ethanol consumed every 3 days over three weeks 631230 10979603 HAD1,LAD1 631844,631845 additive Intercross HAD1xLAD1
631831 rat Alc8 Alcohol preference QTL 8 3 2.7 33782 D3Mit10 38148 D3Rat82 33782 D3Mit10 Consumption level alcohol preference individually housed rats with free access to 10% ethanol solution (v/v) and water for three weeks; consumed amount was measured twice a week; average the six drinking scores from adjusted body weight (g/kg/day) 631229 11958543 P,NP 634380,634381 Intercross W
631832 rat Sach1 Saccharin preference QTL 1 3 2.7 .02 3.3 37010 D3Rat49 36472 D3Rat44 36047 D3Rat46 Consumption level saccharin preference measure intake (0.1% w/v saccharin solution) per day with adjusted body weight (ml/kg body weight/day) during a 48-h preference test; test it four weeks following the completion of the measure of the alcohol phenotypes 631229 11958543 P,NP 634380,634381 Intercross W
631833 rat Sach2 Saccharin preference QTL 2 16 2.5 .02 5 34066 D16Mgh1 37054 D16Rat17 34553 D16Mgh6 Consumption level saccharin preference measure intake (0.1% w/v saccharin solution) per day with adjusted body weight (ml/kg body weight/day) during a 48-h preference test; test it four weeks following the completion of the measure of the alcohol phenotypes 631229 11958543 P,NP 634380,634381 additive Intercross W
631834 rat Sach3 Saccharin preference QTL 3 18 3.9 .01 3 39000 D18Rat61 34975 D18Rat13 39000 D18Rat61 Consumption level saccharin preference, males measured intake (0.1% w/v saccharin solution) per day with adjusted body weight (ml/kg body weight/day) during a 48-h preference test; test it four weeks following the completion of the measure of the alcohol phenotypes 631229 11958543 P,NP 634380,634381 recessive Intercross W
631835 rat Niddm33 Non-insulin dependent diabetes mellitus QTL 33 1 4.27 .0000116 16.1 40126 D1Rat306 Lipid level cholesterol 619669 11071303 2915 Ins1 BN/SsNHsd,F344/Crj,OLETF/Got 10008,69643,734526 Niddm13, Niddm42, Niddm45 backcross F344/NHsdxBN/SsNHsd
631836 rat Niddm34 Non-insulin dependent diabetes mellitus QTL 34 1 4.64 .00000487 16.9 35457 D1Rat90 Lipid level cholesterol 619669 11071303 2915 Ins1 BN/SsNHsd,F344/Crj,OLETF/Got 10008,69643,734526 Niddm13, Niddm42, Niddm45 backcross F344/NHsdxBN/SsNHsd
631837 rat Niddm35 Non-insulin dependent diabetes mellitus QTL 35 1 .01 631287 D1Arb42a 11148 D1Mgh25 Insulin level insulin release rate was measured from individual islets at 3 and 11 mmol/1glucose 619688,619677 11723056,10580437 F344.GK-(D1Arb42a-D1Rat90) 631294 Niddm1
631838 rat Niddm36 Non-insulin dependent diabetes mellitus QTL 36 1 33903 D1Mit7 11148 D1Mgh25 Glucose level 619688,619677 11723056,10580437 F344.GK-(D1Mit7-D1Mgh25) 631847
631839 rat Niddm37 Non-insulin dependent diabetes mellitus QTL 37 14 3.37 33953 D14Mit1 35897 D14Rat22 2670 Gck Glucose level post-pancreatectomy non-fasting blood glucose levels were measured in male rats before and at several intervals after 70% pancreatectomy surgery 619676 10218444 2670,2872,2874 Gck,Igfbp1,Igfbp3 OLETF,F344/N 61014,70509
631840 rat Niddm38 Non-insulin dependent diabetes mellitus QTL 38 19 3.86 36165 D19Rat13 34312 D19Mgh4 11389 D19Mgh2 Glucose level post-pancreatectomy non-fasting blood glucose levels were measured in male rats before and at several intervals after 70% pancreatectomy surgery 619676 10218444 2394,620475,3199 Cpe,Npy2r,Npy5r OLETF,F344/N 61014,70509
631841 rat Niddm39 Non-insulin dependent diabetes mellitus QTL 39 3 3.36 10502 D3Mgh10 33774 D3Mit15 11355 D3Wox8 Glucose level post-pancreatectomy non-fasting blood glucose levels were measured in male rats before and at several intervals after 70% pancreatectomy surgery 619676 10218444 2810,2954 Hnf4a,Kcnb1 OLETF,F344/N 61014,70509
631842 rat Inf1 Infertility severity QTL 1 8 4.1 .001 46 3898 Tpm1 Seminal vesicle mass the masses of testes, epididymides, and seminal vesicle were measured in 90-day male rats killed with an overdose of thiopental 631224 10615258 BN-Lx/Cub,SHR/OlaIpcv 61117,631848 SHR/OlaIpcvxBN-Lx/Cub
631843 rat Niddm42 Non-insulin dependent diabetes mellitus QTL 42 1 4.1 .016 37902 D1Rat169 42550 D1Rat459 35457 D1Rat90 Body fat amount adiposity index was calculated as the percentage of abdominal fat weight per total body weight in male rats at 30 weeks of age OLETF,F344/Crj,OLETF.F344-(D1Rat169-D1Rat459)/Got 61014,69643,734527 Niddm13 backcross OLETFxF344
634305 rat Mtr1 Mammary tumor resistance QTL 1 5 .0001 69542 D5Uwm8 35306 D5Rat26 Mammary tumor resistance 7,12-dimethylbenzanthracene induced animals were given a single dose of DMBA in oil by gastric intubation; mammary tumors greater than 3 mm were counted at 15 weeks post DMBA administration 631852 WF.WKY-(D5Wox7-D5Uwm37) 634359 dominant Mcs5
634306 rat Bp140 Blood pressure QTL 140 3 3.3 35609 D3Rat53 38552 D3Rat80 71061 Kynu Blood pressure systolic residuals of systolic blood pressure (RSBP) were measurements of systolic blood pressure after adjusting for heart rate and body weight 631322 11924719 71061 Kynu SHR/Hos,WKY/Hos 634360,634361 intercross SHR/HosxWKY/Hos
634307 rat Bp141 Blood pressure QTL 141 6 4 33977 D6Mit4 Blood pressure systolic measured at the tails of conscious rats at 10 and 11 weeks of age 631324 10523818 LEW/NIco,SHR/NIco 634363,634364 intercross LEW/NIcoxSHR/NIco
634308 rat Sach6 Saccharin preference QTL 6 2 4.9 31.5 38626 D2Rat171 67315 D2Arb24 36093 D2Rat26 Consumption level saccharin preference measured by the decrease of saccharin intake after a single injection of LiCl (lithium chloride) 631221 11958542 BXH,HXB 61098,61099 intercross HXBxBXH
634310 rat Bp142 Blood pressure QTL 142 12 4.2 33776 D12Mit3 Blood pressure systolic measured at the tails of conscious rats at 10 and 11 weeks of age 631324 10523818 LEW/NIco,SHR/NIco 634363,634364
634311 rat Sach7 Saccharin preference QTL 7 4 38.5 33757 D4Mit2 2813 Hoxa2 Consumption level saccharin preference measured by the decrease of saccharin intake after a single injection of LiCl (lithium chloride) 631221 11958542 BXH,HXB 61098,61099 intercross HXBxBXH
634312 rat Bp143 Blood pressure QTL 143 1 3 .0002 12 38326 D1Rat129 41036 D1Rat298 37184 D1Rat188 Blood pressure systolic measured by radiotelemetry after 8 weeks of high salt (8% NaCl) diet 631325 11984003 SS/Hsd,SR/Hsd 634365,634366 intercross SS/HsdxSR/Hsd
634313 rat Niddm43 Non-insulin dependent diabetes mellitus QTL 43 1 34244 D1Mgh10 35457 D1Rat90 Glucose level 619677 10580437 F344.GK-(D1Mgh10-D1Rat90) 631846 Niddm1,Niddm44
634314 rat Niddm44 Non-insulin dependent diabetes mellitus QTL 44 1 34244 D1Mgh10 35891 D1Rat19 Glucose level 619677 10580437 F344.GK-(D1Mgh10-D1Rat119) 634370 Niddm1,Niddm43
634315 rat Niddm45 Non-insulin dependent diabetes mellitus QTL 45 1 7.16 34399 D1Mgh9 33959 D1Mit3 Glucose level postprandial oral glucose tolerance tests given to male rats to measure fasting and postprandial (30 min after application) plasma glucose levels 619678 10373320 BN,OLETF 60985,61014 backcross OLETFxBN
634317 rat Niddm46 Non-insulin dependent diabetes mellitus QTL 46 3 3.58 34336 D3Mgh7 36456 D3Rat41 Body fat amount adiposity index was calculated as the percentage of abdominal fat weight per total body weight in male rats at 30 weeks of age 619678 10373320 BN,OLETF 60985,61014 intercross OLETFxBN
634318 rat Niddm47 Non-insulin dependent diabetes mellitus QTL 47 6 3.55 33977 D6Mit4 33828 D6Mit9 Body fat amount abdominal fat abdominal fat weight and total body weight were measured in 30 week old male rats; adiposity index is calculated as percentage of abdominal fat weight per total body weight 619678 10373320 BN,OLETF 60985,61014 intercross OLETFxBN
634319 rat Niddm48 Non-insulin dependent diabetes mellitus QTL 48 7 5.44 60737 D7Mit29 36691 D7Rat27 36715 D7Rat30 Body fat amount adiposity index adiposity index was calculated as the percentage of abdominal fat weight per total body weight in male rats at 30 weeks of age 619678 10373320 BN,OLETF 60985,61014 intercross OLETFxBN
634320 rat Niddm49 Non-insulin dependent diabetes mellitus QTL 49 10 4.41 11169 D10Mgh21 33941 D10Mit11 Glucose level postprandial oral glucose tolerance tests given to male rats to measure fasting and postprandial (30 min after application) plasma glucose levels 619678 10373320 BN,OLETF 60985,61014 intercross OLETFxBN
634321 rat Hc1 Hypercalciuria QTL 1 1 2.91 7 39006 D1Rat193 38078 D1Rat142 37902 D1Rat169 Renal function calcium excretion animals at 8 wk of age were placed in individual metabolic cages for measurement of urinary calcium excretion on a normal-calcium diet 631855 12819244 WKY,SD/GHS 61103,634372 intercross SD/GHSxWKY
634322 rat Bw12 Body weight QTL 12 7 8.6 37808 D7Rat86 38402 D7Rat102 38402 D7Rat102 Body weight body weight was measured at 16, 20, 24, 28 and 29 weeks; plasma insulin were measured on fasting animals at 29 weeks; plasma triglycerides were measured at 8, 10, 18, and 29 weeks 619682 11414764 BN/Crj,WBN/KobSlc 634367,634369 intercross BN/CrjxWBN/KobSlc
634323 rat Hc2 Hypercalciuria QTL 2 4 2.15 39704 D4Rat222 Renal function calcium excretion animals at 8 wk of age were placed in individual metabolic cages for measurement of urinary calcium excretion on a normal-calcium diet 631855 12819244 WKY,SD/GHS 61103,634372 intercross SD/GHSxWKY
634325 rat Bw13 Body weight QTL 13 X 12.2 35030 DXRat2 36111 DXRat8 Body weight body weight was measured at 16, 20, 24, 28 and 29 weeks; plasma insulin were measured on fasting animals at 29 weeks; plasma triglycerides were measured at 8, 10, 18, and 29 weeks 619682 11414764 BN/Crj,WBN/KobSlc 634367,634369 intercross BN/CrjxWBN/KobSlc
634326 rat Hc3 Hypercalciuria QTL 3 7 2.1 40164 D7Rat164 Renal function calcium excretion animals at 8 wk of age were placed in individual metabolic cages for measurement of urinary calcium excretion on a normal-calcium diet 631855 12819244 WKY,SD/GHS 61103,634372 intercross SD/GHSxWKY
634327 rat Hc4 Hypercalciuria QTL 4 10 2.4 35769 D10Rat47 Renal function calcium excretion animals at 8 wk of age were placed in individual metabolic cages for measurement of urinary calcium excretion on a normal-calcium diet 631855 12819244 WKY,SD/GHS 61103,634372 intercross SD/GHSxWKY
634328 rat Hc5 Hypercalciuria QTL 5 14 2.3 11086 D14Mgh1 Renal function calcium excretion animals at 8 wk of age were placed in individual metabolic cages for measurement of urinary calcium excretion on a normal-calcium diet 631855 12819244 WKY,SD/GHS 61103,634372
634329 rat Pia15 Pristane induced arthritis QTL 15 10 3.1 36319 D10Rat26 36522 D10Rat44 34318 D10Mgh10 Joint/bone inflammation pristane induced arthritis was induced at the age of 8 to 12 week by an intradermal injection at the base of the tail with pristane (2,6,10,14-tetramethylpentadecane) and was monitored by a macroscopic scoring system of the four limbs ranging from 0 to 15 (1 point for each swollen or red toe, 1 point for midfoot digit and knuckle, and 5 points for a swollen ankle) 631850 12817024 DA/Rhd,E3/Rhd 634373,634374 dominant backcross DA/RhdxE3/Rhd
634330 rat Pia16 Pristane induced arthritis QTL 16 6 3.9 34072 D6Mgh7 34108 D6Mgh10 35102 D6Rat16 Joint/bone inflammation pristane induced arthritis was induced at the age of 8 to 12 week by an intradermal injection at the base of the tail with pristane (2,6,10,14-tetramethylpentadecane) and was monitored by a macroscopic scoring system of the four limbs ranging from 0 to 15 (1 point for each swollen or red toe, 1 point for midfoot digit and knuckle, and 5 points for a swollen ankle) 631850 12817024 DA/Rhd,E3/Rhd 634373,634374 dominant backcross DA/RhdxE3/Rhd
634331 rat Pia17 Pristane induced arthritis QTL 17 7 4.7 11165 D7Mit9 37144 D7Rat74 33670 D7Mit2 Joint/bone inflammation pristane induced arthritis was induced at the age of 8 to 12 week by an intradermal injection at the base of the tail with pristane (2,6,10,14-tetramethylpentadecane) and was monitored by a macroscopic scoring system of the four limbs ranging from 0 to 15 (1 point for each swollen or red toe, 1 point for midfoot digit and knuckle, and 5 points for a swollen ankle) 631850 12817024 DA/Rhd,E3/Rhd 634373,634374 dominant backcross DA/RhdxE3/Rhd
634332 rat Pia18 Pristane induced arthritis QTL 18 8 4 35905 D8Rat21 35248 D8Rat26 34068 D8Mgh11 Joint/bone inflammation pristane induced arthritis was induced at the age of 8 to 12 week by an intradermal injection at the base of the tail with pristane (2,6,10,14-tetramethylpentadecane) and was monitored by a macroscopic scoring system of the four limbs ranging from 0 to 15 (1 point for each swollen or red toe, 1 point for midfoot digit and knuckle, and 5 points for a swollen ankle) 631850 12817024 DA/Rhd,E3/Rhd 634373,634374 dominant backcross DA/RhdxE3/Rhd
634333 rat Pia19 Pristane induced arthritis QTL 19 18 3.4 35282 D18Rat5 33715 D18Mit6 33715 D18Mit6 Joint/bone inflammation pristane induced arthritis was induced at the age of 8 to 12 week by an intradermal injection at the base of the tail with pristane (2,6,10,14-tetramethylpentadecane) and was monitored by a macroscopic scoring system of the four limbs ranging from 0 to 15 (1 point for each swollen or red toe, 1 point for midfoot digit and knuckle, and 5 points for a swollen ankle) 631850 12817024 DA/Rhd,E3/Rhd 634373,634374 dominant backcross DA/RhdxE3/Rhd
634334 rat Xhs3 X-ray hypersensitivity QTL 3 4 10 42306 D4Rat266 35262 D4Rat79 36043 D4Rat49 X-ray sensitivity animals wrere X-irradiated at 5 weeks of age at 0.2 Gy/min and somatic effects (moribundity with diarrhea) was examined twice a day within 7 days 631318 11381618 LEA/Ncu,BN/Sea 634376,634377 recessive Xhs1 intercross LEA/NcuxBN/Sea
634335 rat Arr16 Anxiety related response QTL 16 4 7.22 50.4 34338 D4Mgh11 35286 D4Rat37 34106 D4Mgh6 Anxiety response determined by number of outer squares crossed, number of inner squares crossed and total number of fecal boli 631324 10523818 3811 Tacr1 LEW/NIco,SHR/NIco 634363,634364 dominant intercross LEW/NIcoxSHR/NIco
634336 rat Arr17 Anxiety related response QTL 17 7 3.66 39648 D7Rat127 34039 D3Mit11 34164 D7Mgh11 Anxiety response determined by number of outer squares crossed, number of inner squares crossed and total number of fecal boli 631324 10523818 LEW/NIco,SHR/NIco 634363,634364 additive intercross LEW/NIcoxSHR/NIco
634338 rat Hcr4 Hepatocarcinoma resistance QTL 4 1 4.6 34021 D1Mit28 43424 D1Wox10 34244 D1Mgh10 Liver tumor resistance 3-methyl-4-dimethylaminoazobenezene induced number of enzyme altered foci (EAF) expressing glutathione S-transferase placental form per cm2 liver section was measured on histological analysis of livers of male rats who were fed 3-methyl-3-dimethylaminoazobenzene (3 Me-DAB), percent liver area occupied by foci, and average foci size were also correlated 619609,625382 10850431,11756240 2827,2829,2916,2870,2775,2315,2758 Hras,Hrasls3,Ins2,Igf2,H19,Cd81,Gstp1 F344/N,DRH/Seac 70509,625659 recessive intercross DRHxF344
634339 rat Niddm50 Non-insulin dependent diabetes mellitus QTL 50 11 3.32 34725 D11Mgh3 34150 D11Mgh5 Glucose level fasting oral glucose tolerance tests given to male rats to measure fasting and postprandial (30 min after application) plasma glucose levels 619678,61072 10373320,9585427 BN,OLETF 60985,61014 intercross OLETFxBN
634340 rat Hcr5 Hepatocarcinoma resistance QTL 5 1 8.1 43424 D1Wox10 41392 D1Rat302 Liver tumor resistance 3-methyl-4-dimethylaminoazobenezene induced number of enzyme altered foci (EAF) expressing glutathione S-transferase placental form per cm2 liver section, percent liver area occupied by foci, and GST placental form mRNA levels measured on histological and mRNA analysis of livers of male rats who were fed 3-methyl-3-dimethylaminoazobenzene (3 Me-DAB) 619609,625382 10850431,11756240 2469,2456 Cyp2c,Cyp17a1 F344/N,DRH/Seac 70509,625659 recessive intercross DRHxF344
634341 rat Niddm51 Non-insulin dependent diabetes mellitus QTL 51 11 3.5 34150 D11Mgh5 33899 D11Mit4 Body fat amount abdominal fat abdominal fat weight and total body weight were measured in male rats sacrificed at 30 weeks of age; adiposity index was calculated as the percentage of abdominal fat weight per total body weight 619678 10373320 BN,OLETF 60985,61014 backcross OLETFxBN
634342 rat Cia24 Type II Collagen induced arthritis QTL 24 4 4.5 7.6 33995 D4Mit19 10752 D4Wox12 11163 D4Arb2 Joint/bone inflammation type II collagen induced type II collagen was pepsin-solubilized from porcine (PII) and rat (RII) sternal cartilage samples; arthritis severity was determined by total score for each extremity; the 3 joints (interphalangeal, metatarsophalangeal, metacarpophalangeal) of each of the lateral 4 digits were scored 0 or 1 (0 5 no arthritis and 1 5 arthritis), and the wrist, mid-forepaw, ankle, and mid-foot were scored 04 (0 5 normal, 1 5 minimal swelling, 2 5 medium swelling, 3 5 severe swelling, and 4 5 ankylosis) 61066 10857786 2306,61318,61319,621237 Cd4,Cd69,Tnfrsf7,Tnfrsf1a DA/Bkl,BN/SsN 61114,61115 additive intercross DA/BklxBN/SsN
634343 rat Hcr6 Hepatocarcinoma resistance QTL 6 1 10674 D1Mgh12 Liver tumor resistance 3-methyl-4-dimethylaminoazobenezene induced percent liver area occupied by enzyme altered foci expressing glutathione S-transferase placental form, average foci size, and GST placental form mRNA levels measured on histological and mRNA analysis of livers of male rats who were fed 3-methyl-3-dimethylaminoazobenzene (3 Me-DAB) 619609 10850431 F344/N,DRH/Seac 70509,625659 recessive intercross DRHxF344
634344 rat Hcr7 Hepatocarcinoma resistance QTL 7 4 7.8 35811 D4Rat23 35286 D4Rat37 35286 D4Rat37 Liver tumor resistance 3-methyl-4-dimethylaminoazobenezene induced number of enzyme altered foci (EAF) expressing glutathione S-transferase placental form per cm2 liver section, percent liver area occupied by foci, and average foci size, and GST placental form mRNA levels were measured on histological and mRNA analysis of livers of male rats who were fed 3-methyl-3-dimethylaminoazobenzene (3 Me-DAB) 619609,625382 10850431,11756240 2688 Ghrhr F344/N,DRH/Seac 70509,625659 semidominant intercross DRHxF344
634346 rat Cpdm1 Chronic pancreatitis and diabetes mellitus QTL 1 X 20.8 12 39724 DXRat103 60694 DxGot62 Insulin level following a 9hr fast males underwent an oral glucose tolerance test; serum insulin was measured at 30 min. 619682 11414764 BN/Crj,WBN/KobSlc 634367,634369 additive intercross BN/CrjxWBN/KobSlc
634347 rat Hcr8 Hepatocarcinoma resistance QTL 8 4 36508 D4Rat48 Liver tumor resistance 3-methyl-4-dimethylaminoazobenezene induced number of enzyme altered foci (EAF) expressing glutathione S-transferase placental form per cm2 liver section, percent liver area occupied by foci, and average foci size were measured on histological analysis of livers of male rats who were fed 3-methyl-3-dimethylaminoazobenzene (3 Me-DAB) 619609,625382 10850431,11756240 3849 Tgfa F344/N,DRH/Seac 70509,625659 semidominant intercross DRHxF344
634348 rat Bp138 Blood pressure QTL 138 1 37428 D1Rat200 2254 Calca 34011 D1Mit2 Blood pressure 631321 12358148 621323,3214,2156,2254 Phox2a,Ntrk3,Arrb1,Calca WKY/Izm,SHRSP/Izm 631286,631599 intercross SHRSP/IzmxWKY/Izm
634349 rat Bp139 Blood pressure QTL 139 5 .001 10454 D5Wox12 43937 D5Wox20 Blood pressure systolic arterial blood pressures were measured continuously in conscious male rats between 80 and 100 days of age; at the end of study, body weight, heart and kidney weights were obtained from sacrificed animals 631851 12790759 SHR/OlaIpcv.BN/Crj-(D5Wox12-D5Wox20) 634382 Bp7
634350 rat Apr4 Acute phase response QTL 4 12 6 35889 D12Rat10 Alpha1 acid glycoprotein level pristane induced 629561 11817600 DA,E3 60997,61013 recessive intercross E3xDA
634351 rat Apr5 Acute phase response QTL 5 12 6.7 11449 D12Wox14 IL-6 level pristane induced 629561 11817600 DA,E3 60997,61013 recessive intercross E3xDA
634352 rat Apr6 Acute phase response QTL 6 14 3.7 10622 D14Mgh3 IL-6 level pristane induced 629561 11817600 DA,E3 60997,61013 recessive Pia6 intercross E3xDA
634353 rat Rds2 Renal damage susceptibility QTL 2 1 .05 36303 D1Rat6 37962 D1Rat201 38568 D1Rat238 Renal (cell morphology)/ histology renal lesions (renal lesion severity) transverse 5-mm sections of each individual kidney, including the apex of the pyramid, the corticomedullary junction, and the cortex, were examined; lesions were graded according to the degree of vascular and parenchymal damage, following classification as absence of renal lesions grade 0, presence of mild lesions as grade 0.5, presence of moderate lesions as grade 1, and presence of severe lesions as grades 2 and 3 631854 SHR,SHRSP 61000,61010 Rf2 intercross SHRSPxSHR
634354 rat Rds3 Renal damage susceptibility QTL 3 10 .05 35563 D10Rat21 34939 D10Rat55 2875 Igfbp4 Renal (cell morphology)/ histology renal lesions (renal lesion severity) transverse 5-mm sections of each individual kidney, including the apex of the pyramid, the corticomedullary junction, and the cortex, were examined; lesions were graded according to the degree of vascular and parenchymal damage, following classification as absence of renal lesions grade 0, presence of mild lesions as grade 0.5, presence of moderate lesions as grade 1, and presence of severe lesions as grades 2 and 3 631854 SHR,SHRSP 61000,61010 SHRSPxSHR
634355 rat Rds4 Renal damage susceptibility QTL 4 16 .05 33848 D16Mit2 Renal (cell morphology)/ histology renal lesions (renal lesion severity) transverse 5-mm sections of each individual kidney, including the apex of the pyramid, the corticomedullary junction, and the cortex, were examined; lesions were graded according to the degree of vascular and parenchymal damage, following classification as absence of renal lesions grade 0, presence of mild lesions as grade 0.5, presence of moderate lesions as grade 1, and presence of severe lesions as grades 2 and 3 631854 SHR,SHRSP 61000,61010 intercross SHRSPxSHR
724513 rat Uae14 Urinary albumin excretion QTL 14 6 6.5 36191 D6Rat6 37280 D6Rat104 36990 D6Rat12 Renal function urine albumin level measured by rat-specific ELISA 634633 12799471 SS/Jr,SHR/FubRkb 10041,631696 intercross SS/JrxSHR/Rkb
724514 rat Uae15 Urinary albumin excretion QTL 15 8 2.9 40746 D8Rat162 35987 D8Rat30 36117 D8Rat46 Renal function urine albumin level measured by rat-specific ELISA 634633 12799471 SS/Jr,SHR/FubRkb 10041,631696 intercross SS/JrxSHR/Rkb
724515 rat Uae16 Urinary albumin excretion QTL 16 9 8 8 36027 D9Rat3 34013 D9Mit3 35691 D9Rat5 Renal function urine albumin level measured by rat-specific ELISA 634633 12799471 SS/Jr,SHR/FubRkb 10041,631696 intercross SS/JrxSHR/Rkb
724516 rat Uae17 Urinary albumin excretion QTL 17 10 3.6 41534 D10Rat143 37460 D10Rat93 35108 D10Rat30 Renal function urine albumin level measured by rat-specific ELISA 634633 12799471 SS/Jr,SHR/FubRkb 10041,631696 intercross SS/JrxSHR/Rkb
724517 rat Uae18 Urinary albumin excretion QTL 18 11 3.7 35565 D11Rat20 36065 D11Rat6 33792 D11Mit2 Renal function urine albumin level measured by rat-specific ELISA 634633 12799471 SS/Jr,SHR/FubRkb 10041,631696 intercross SS/JrxSHR/Rkb
724518 rat Uae19 Urinary albumin excretion QTL 19 19 5.5 33618 D19Mit7 37042 D19Rat19 35881 D19Rat11 Renal function urine albumin level measured by rat-specific ELISA 634633 12799471 SS/Jr,SHR/FubRkb 10041,631696 intercross SS/JrxSHR/Rkb
724519 rat Bp144 Blood pressure QTL 144 20 .001 61303 D20Utr1 3876 Tnf 61303 D20Utr1 Blood pressure mean arterial averaging direct measurements of carotid arterial pressure in five or six males 619638 8938440 BXH,ZI 61098,67942 intercross ACI/KunxBN/M
724520 rat Bp145 Blood pressure QTL 145 1 2.1 .0024 38782 D1Rat136 Blood pressure systolic measured at 14 weeks of age by a tail-cuff method in awake animals 634618 12397040 MWF/FubRkb,LEW/Rkb 724569,724570 intercross MWF/RkbxLEW/Rkb
724521 rat Uae1 Urinary albumin excretion QTL 1 1 3.8 .0001 36765 D1Rat27 39314 D1Rat216 36023 D1Rat38 Renal function urine albumin level urine collected over a 24-h period from animals in metabolic cages; albumin concentrations measured by a rat-specific ELISA 634618 12397040 MWF/FubRkb,LEW/Rkb 724569,724570 intercross MWF/RkbxLEW/Rkb
724522 rat Bp146 Blood pressure QTL 146 4 2.2 .0021 35325 D4Rat41 Blood pressure systolic measured at 14 weeks of age by a tail-cuff method in awake animals 634618 12397040 MWF/FubRkb,LEW/Rkb 724569,724570
724523 rat Tsu1 Thymus enlargement suppressive QTL 1 3 3.84 33668 D3Mit13 3632 Scn2a1 2279 Cat Gland mass thymus thymus ratio was calculated by dividing the thymus weight by body weight 634729 9234381 45096 BUF/Mna,MITE/Mna 61118,724571 backcross BUF/MnaxMITE/Mna
724524 rat Uae2 Urinary albumin excretion QTL 2 6 2.7 .0005 36990 D6Rat12 34306 D6Mgh5 38246 D6Rat71 Renal function urine albumin level urine collected over a 24-h period from animals in metabolic cages; albumin concentrations measured by a rat-specific ELISA 634618 12397040 MWF/FubRkb,LEW/Rkb 724569,724570 intercross MWF/RkbxLEW/Rkb
724525 rat Bp147 Blood pressure QTL 147 5 4.3 .0001 35825 D5Rat41 Blood pressure systolic measured at 14 weeks of age by a tail-cuff method in awake animals 634618 12397040 MWF/FubRkb,LEW/Rkb 724569,724570 intercross MWF/RkbxLEW/Rkb
724526 rat Uae3 Urinary albumin excretion QTL 3 12 4.9 .0001 39744 D12Rat59 38052 D12Rat37 36538 D12Rat7 Renal function urine albumin level urine collected over a 24-h period from animals in metabolic cages; albumin concentrations measured by a rat-specific ELISA 634618 12397040 MWF/FubRkb,LEW/Rkb 724569,724570 intercross MWF/RkbxLEW/Rkb
724527 rat Bp148 Blood pressure QTL 148 10 .0001 631289 D10M11Mit119 37996 D10Rat127 Blood pressure 704345 SS.LEW-(D10Wox51-D10Rat27)/Ayd 724572
724528 rat Uae4 Urinary albumin excretion QTL 4 17 4.9 .0001 36011 D17Rat17 35473 D17Rat58 40276 D17Rat133 Renal function urine albumin level urine collected over a 24-h period from animals in metabolic cages; albumin concentrations measured by a rat-specific ELISA 634618 12397040 MWF/FubRkb,LEW/Rkb 724569,724570 intercross MWF/RkbxLEW/Rkb
724529 rat Cm16 Cardiac mass QTL 16 1 2.7 38420 D1Rat189 37168 D1Rat158 36007 D1Rat36 Cardiac mass calculated by adjusting heart weight for differences in body weight by regression analysis 634617 12707388 SS/JrMco,SHR/NHsd 724573,724574 intercross SS/JrMcoxSHR/NHsd
724530 rat Bp149 Blood pressure QTL 149 10 .0001 34896 D10Rat17 36958 D10Rat9 Blood pressure 704345 SS.LEW-(D10Rat17-D10Mgh1)/Ayd 724575
724531 rat Uae5 Urinary albumin excretion QTL 5 1 4 37168 D1Rat158 36703 D1Rat86 66610 D1Mco35 Renal function urine albumin level determined by SDS-PAGE 634617 12707388 SS/JrMco,SHR/NHsd 724573,724574 intercross SS/JrMcoxSHR/NHsd
724532 rat Cm17 Cardiac mass QTL 17 3 2 41442 D3Rat160 Cardiac mass calculated by adjusting heart weight for differences in body weight by regression analysis 634617 12707388 SS/JrMco,SHR/NHsd 724573,724574 intercross SS/JrMcoxSHR/NHsd
724533 rat Rhf1 Renal hemodynamic functions QTL 1 1 5.3 .0002 34194 D1Mgh14 33945 D1Mit18 33903 D1Mit7 Renal function renal blood flow the urinary bladder was catheterized to collect a urine sample; a blood sample was collected at the midpoint of the clearance study for determination of plasma inulin, PAH, and creatinine concentrations 619628 10545438 SHR,WKY 61000,61103 codominant intercross SHRxWKY
724534 rat Uae6 Urinary albumin excretion QTL 6 2 10 66661 D2Mco18 35915 D2Rat61 36773 D2Rat50 Renal function urine albumin level determined by SDS-PAGE 634617 12707388 SS/JrMco,SHR/NHsd 724573,724574 intercross SS/JrMcoxSHR/NHsd
724535 rat Cm18 Cardiac mass QTL 18 4 2.6 40642 D4Rat195 Cardiac mass calculated by adjusting heart weight for differences in body weight by regression analysis 634617 12707388 SS/JrMco,SHR/NHsd 724573,724574 intercross SS/JrMcoxSHR/NHsd
724536 rat Uae7 Urinary albumin excretion QTL 7 6 3.5 11241 D6Mit3 10361 D6Wox13 66623 D6Uia5 Renal function urine albumin level determined by SDS-PAGE 634617 12707388 SS/JrMco,SHR/NHsd 724573,724574 intercross SS/JrMcoxSHR/NHsd
724537 rat Niddm52 Non-insulin dependent diabetes mellitus QTL 52 7 .02 33648 D7Mit5 10939 D7Mit27 Glucose level determined using the oral glucose tolerance test after overnight starvation 619670 11381614 F344/Crj,OLETF/Got 69643,734526 intercross OLETF/OtkxF344/Crj
724538 rat Km1 Kidney mass 1 1 3.2 62481 D1UIA5 36703 D1Rat86 36703 D1Rat86 Kidney mass calculated by adjusting kidney weight for differences in body weight by regression analysis 634617 12707388 SS/JrMco,SHR/NHsd 724573,724574 intercross SS/JrMcoxSHR/NHsd
724539 rat Cm19 Cardiac mass QTL 19 8 2.6 41310 D8Rat130 35435 D8Rat3 37892 D8Rat90 Cardiac mass calculated by adjusting heart weight for differences in body weight by regression analysis 634617 12707388 SS/JrMco,SHR/NHsd 724573,724574 intercross SS/JrMcoxSHR/NHsd
724540 rat Uae8 Urinary albumin excretion QTL 8 8 5 33559 D8Mit5 41310 D8Rat130 40746 D8Rat162 Renal function urine albumin level determined by SDS-PAGE 634617 12707388 SS/JrMco,SHR/NHsd 724573,724574 intercross SS/JrMcoxSHR/NHsd
724541 rat Niddm53 Non-insulin dependent diabetes mellitus QTL 53 14 .001 36536 D14Rat1 37030 D14Rat3 Glucose level determined using the oral glucose tolerance test after overnight starvation 619670 11381614 F344/Crj,OLETF/Got 69643,734526 Niddm20 intercross OLETF/OtkxF344/Crj
724542 rat Km2 Kidney mass 2 18 2.6 38862 D18Rat69 Kidney mass calculated by adjusting kidney weight for differences in body weight by regression analysis 634617 12707388 SS/JrMco,SHR/NHsd 724573,724574 intercross SS/JrMcoxSHR/NHsd
724543 rat Cm20 Cardiac mass QTL 20 9 3.9 35871 D9Rat36 35819 D9Rat26 37416 D9Rat70 Cardiac mass calculated by adjusting heart weight for differences in body weight by regression analysis 634617 12707388 SS/JrMco,SHR/NHsd 724573,724574 intercross SS/JrMcoxSHR/NHsd
724544 rat Uae9 Urinary albumin excretion QTL 9 9 4.5 37416 D9Rat70 66431 D9Mco6 61287 D9Uia6 Renal function urine albumin level determined by SDS-PAGE 634617 12707388 SS/JrMco,SHR/NHsd 724573,724574 intercross SS/JrMcoxSHR/NHsd
724545 rat Niddm54 Non-insulin dependent diabetes mellitus QTL 54 15 .02 35362 D15Rat19 35230 D15Rat22 Glucose level determined using the oral glucose tolerance test after overnight starvation 619670 11381614 F344/Crj,OLETF/Got 69643,734526 intercross OLETF/OtkxF344/Crj
724546 rat Km3 Kidney mass 3 19 3.1 39018 D19Rat29 66451 D19Uia1 66451 D19Uia1 Kidney mass calculated by adjusting kidney weight for differences in body weight by regression analysis 634617 12707388 SS/JrMco,SHR/NHsd 724573,724574 intercross SS/JrMcoxSHR/NHsd
724547 rat Cm21 Cardiac mass QTL 21 9 2.7 61287 D9Uia6 66431 D9Mco6 38270 D9Rat97 Cardiac mass calculated by adjusting heart weight for differences in body weight by regression analysis 634617 12707388 SS/JrMco,SHR/NHsd 724573,724574 intercross SS/JrMcoxSHR/NHsd
724548 rat Niddm55 Non-insulin dependent diabetes mellitus QTL 55 15 .02 35230 D15Rat22 36663 D15Rat21 Glucose level determined using the oral glucose tolerance test after overnight starvation 619670 11381614 F344/Crj,OLETF/Got 69643,734526 intercross OLETF/OtkxF344/Crj
724549 rat Niddm56 Non-insulin dependent diabetes mellitus QTL 56 17 .03 33882 D17Mit2 34369 D17Mgh4 Glucose level determined using the oral glucose tolerance test after overnight starvation 619670 11381614 F344/Crj,OLETF/Got 69643,734526 Niddm32 intercross OLETF/OtkxF344/Crj
724550 rat Ten3 Thymus enlargement QTL 3 1 7.82 .001 33571 D1Mit6 10952 D1Wox21 38210 D1Rat197 Gland mass thymus the ratio of thymus weight to body weight increases for 6 months then decreases slowly increasing again after 9 months 70859 10792781 BUF/Mna,MITE/Mna 61118,724571 Ten1 backcross BUF/MnaxMITE/Mna
724551 rat Glom1 Glomerulus QTL 1 X 2.8 .0004 39966 DXRat96 Renal (cell morphology)/ histology number of superficial glomeruli (SfG) number of superficial glomeruli present in the renal cortex corticis zone but without direct surface contact counted in three mid-coronal sections for each animal 634618 12397040 MWF/FubRkb,LEW/Rkb 724569,724570 intercross MWF/RkbxLEW/Rkb
724552 rat Glom2 Glomerulus QTL 2 1 3.3 .0001 37506 D1Rat151 Renal (cell morphology)/ histology number of surface glomeruli (SG) measured by counting the number of surface glomeruli per section with direct contact to the surface 634618 12397040 MWF/FubRkb,LEW/Rkb 724569,724570 intercross MWF/RkbxLEW/Rkb
724553 rat Glom3 Glomerulus QTL 3 13 2.9 .0004 39348 D13Rat62 Renal (cell morphology)/ histology number of surface glomeruli (SG) measured by counting the number of surface glomeruli per section with direct contact to the surface 634618 12397040 MWF/FubRkb,LEW/Rkb 724569,724570 intercross MWF/RkbxLEW/Rkb
724554 rat Iddm17 Insulin dependent diabetes mellitus QTL 17 11 .001 67236 D11Arb6 Insulin level 634732 9329965 LETO,KDP 68074,724576 backcross LETOxPKDP
724555 rat Bp150 Blood pressure QTL 150 10 .0001 36203 D10Rat27 37460 D10Rat93 Blood pressure 704345 SS.LEW-(D10Rat27-Igfbp4)/Ayd 724577
724556 rat Pur2 Proteinuria QTL 2 10 5.5 62429 D10UIA2 34896 D10Rat17 66468 D10Mco57 Renal function level of protein excreted in urine was was determined colorimetrically using pyrogallol red/molybdate complex 634617 12707388 SS/JrMco,SHR/NHsd 724573,724574 intercross SS/JrMcoxSHR/NHsd
724557 rat Plsm1 Polydactyly-luxate syndrome (PLS) morphotypes QTL 1 4 .0003 2901 Il6 Limb morphology front feet phalanges number bone morphometrics of tibia and fibula from hind and front limbs measured at the age of 4 months 632346 8997636 2901 Il6 SHR/Ola,BN-Lx/Cub 61100,61117 intercross SHR/OlaxBN-lx/Cub
724558 rat Plsm2 Polydactyly-luxate syndrome (PLS) morphotypes QTL 2 4 .0003 2004 A2m Limb morphology hind feet phalanges number bone morphometrics of tibia and fibula from hind and front limbs measured at the age of 4 months 632346 8997636 2004 A2m SHR/Ola,BN-Lx/Cub 61100,61117 intercross SHR/OlaxBN-lx/Cub
724559 rat Pam1 Pancreatic morphology QTL 1 1 7.1 8 43424 D1Wox10 3750 Spn 11060 D1Wox23 Pancreatic morphology pancreatic sections were immunohistochemically stained and graded by two observers according to criteria; pancreatic histology was quantitatively analyzed for the number of islets, the area of the islets and average islet area, and the area of the entire pancreatic section 61083 9169130 61295 Lsn WKY,13M 61103,61112 Intercross 13MxWKY
724560 rat Plsm3 Polydactyly-luxate syndrome (PLS) morphotypes QTL 3 7 .0003 33721 D7Mit17 Limb morphology tibia length bone morphometrics of tibia and fibula from hind and front limbs measured at the age of 4 months 632346 8997636 SHR/Ola,BN-Lx/Cub 61100,61117 intercross SHR/OlaxBN-lx/Cub
724561 rat Plsm4 Polydactyly-luxate syndrome (PLS) morphotypes QTL 4 11 .0003 3761 Sst Limb morphology front feet phalanges number bone morphometrics of tibia and fibula from hind and front limbs measured at the age of 4 months 632346 8997636 SHR/Ola,BN-Lx/Cub 61100,61117 intercross SHR/OlaxBN-lx/Cub
724562 rat Rds1 Renal damage susceptibility QTL 1 1 .05 33959 D1Mit3 2870 Igf2 Renal (cell morphology)/ histology renal lesions (renal lesion severity) measured 33 days after deoxycorticosterone acetate (DOCA)-salt administration; abnormal glomeruli were defined by: (a) acute hypertensive injury (necrosis, thrombosis, microembolisms, and capillary wall disruption), (b) segmental glomerular sclerosis (collapsed capillary loops with mesangial matrix expansion), and (c) ischemic injury (globally shrunk glomeruli with collapsed capillary loops); the total number of acute vascular hypertensive injury (fibrinoid necrosis, myointimal proliferation, fragmentation of internal elastic lamellae, and aneurysmal dilatation) were counted in each section 632218 10454439 SHR.BN-(D1Mit2-Igf2) 724578 Rf2
724563 rat Uae10 Urinary albumin excretion QTL 10 11 6 36906 D11Rat17 37512 D11Rat50 39698 D11Rat67 Renal function urine albumin level determined by SDS-PAGE 634617 12707388 SS/JrMco,SHR/NHsd 724573,724574 intercross SS/JrMcoxSHR/NHsd
724564 rat Uae11 Urinary albumin excretion QTL 11 13 5.7 11231 D13Wox5 37240 D13Rat63 38990 D13Rat58 Renal function urine albumin level determined by SDS-PAGE 634617 12707388 SS/JrMco,SHR/NHsd 724573,724574 intercross SS/JrMcoxSHR/NHsd
724565 rat Tts5 Tongue tumor susceptibility QTL 5 19 10.04 33581 D19Mit1 10418 D19Mit6 11471 D19Mit9 Tongue tumor susceptibility measured by the number of the tongue carcinomas (TCs) >3 mm ; animals given drinking water containing 0.001% 4NQO at six weeks of age and were killed when they became moribund or on the 180th day 634723 11429048 2503,2944 Nqo1,Junb DA,WF 60997,61007 semidominant Stc1 intercross DAxWF
724566 rat Uae12 Urinary albumin excretion QTL 12 19 5 39128 D19Rat34 66451 D19Uia1 39018 D19Rat29 Renal function urine albumin level determined by SDS-PAGE 634617 12707388 SS/JrMco,SHR/NHsd 724573,724574 intercross SS/JrMcoxSHR/NHsd
724567 rat Tts6 Tongue tumor susceptibility QTL 6 1 6.85 34037 D1Mit1 33959 D1Mit3 39428 D1Rat320 Tongue tumor susceptibility measured by the number of the tongue carcinomas (TCs) >3 mm ; animals given drinking water containing 0.001% 4NQO at six weeks of age and were killed when they became moribund or on the 180th day 634723 11429048 2466 Cyp2b1 DA,WF 60997,61007 semidominant Rtc1 intercross DAxWF
724568 rat Uae13 Urinary albumin excretion QTL 13 2 4.4 35857 D2Rat36 34884 D2Rat57 39374 D2Rat126 Renal function urine albumin level measured by rat-specific ELISA 634633 12799471 SS/Jr,SHR/FubRkb 10041,631696 intercross SS/JrxSHR/Rkb
731164 rat Uae25 Urinary albumin excretion QTL 25 9 3.5 .0001 36984 D9Rat29 36027 D9Rat3 36556 D9Rat10 Renal function urine albumin level measured by rat-specific ELISA 730279 14638907 MWF/Fub,SHR/Fub 731185,731186 backcross MWF/FubxSHR/Fub
731165 rat Uae21 Urinary albumin excretion QTL 21 4 2.4 .0001 38458 D4Rat95 Renal function urine albumin level measured by rat-specific ELISA 730279 14638907 MWF/Fub,SHR/Fub 731185,731186 backcross MWF/FubxSHR/Fub
731166 rat Mcs9 Mammary carcinoma susceptibility QTL 9 2 .0001 33822 D2Mit29 67798 D2Uwm14 Mammary tumor susceptibility treated with 7,12-dimethylbenz(a)anthracene (DMBA) for 15 weeks; total number of mammary carcinomas > 3 x 3 mm in diameter enumerated 724790 14522903 COP,WF 60998,61007 semidominant Mcs1 intercross WFxCOP
734767 rat Niddm57 Non-insulin dependent diabetes mellitus QTL 57 1 37902 D1Rat169 42550 D1Rat459 Body weight body weight (BW) was measured at 16, 20, 24, 28 and 29 weeks; abdominal fat (FW) from mesenteric, epididymal and retroperitoneal tissues, plasma lipids (TC, TG, NEFA) and plasma insulin (INS) were measured on fasting animals at 29 weeks; oral glucose tolerance (OGTT) was measured on fasting animasl at 28 weeks 619679 11355573 OLETF.F344-(D1Rat169-D1Rat459)/Got 734527 Niddm42,Niddm59
734768 rat Niddm59 Non-insulin dependent diabetes mellitus QTL 59 1 40126 D1Rat306 42553 D1Rat461 Body weight body weight (BW) was measured at 16, 20, 24, 28 and 29 weeks; abdominal fat (FW) from mesenteric, epididymal and retroperitoneal tissues, plasma lipids (TC, TG, NEFA) and plasma insulin (INS) were measured on fasting animals at 29 weeks; oral glucose tolerance (OGTT) was measured on fasting animasl at 28 weeks 734465 12190994 OLETF.F344-(D1Rat306-D1Rat461)/Got 734531 Niddm42,Niddm57
734769 rat Niddm58 Non-insulin dependent diabetes mellitus QTL 58 1 36960 D1Rat76 42550 D1Rat459 Body weight body weight (BW) was measured at 16, 20, 24, 28 and 29 weeks; plasma insulin (INS) were measured on fasting animals at 29 weeks; plasma triglycerides were measured at 8, 10, 18, and 29 weeks 619683 11153534 OLETF.BN-(D1Rat76-D1Rat459)/Got 734528 additive Niddm13
737818 rat Hcr12 Hepatocarcinoma resistance QTL 12 3 2.6 35745 D3Rat48 34411 D3Mgh14 35745 D3Rat48 Liver tumor resistance nodule number neoplastic nodules were measured by the method in livers of rats killed at 32 weeks of age following tumor induction by the resistant-hepatocyte protocol of diethylnitrosamine exposure 629566 12154055 F344/Crli,BN/Crli 737690,737691 Hcr9,Hcr10,Hcr11 backcross BN/CrlixF344/Crli
737819 rat Hcs4 Hepatocarcinoma susceptibility QTL 4 16 4.43 33848 D16Mit2 10842 D16Mgh5 Liver tumor susceptibility nodule number neoplastic nodules were measured by the method in livers of rats killed at 32 weeks of age following tumor induction by the resistant-hepatocyte protocol of diethylnitrosamine exposure 629566 12154055 F344/Crli,BN/Crli 737690,737691 Hcs3 backcross BN/CrlixF344/Crli
737820 rat Alc9 Alcohol preference QTL 9 10 2.2 34361 D10Mgh25 39082 D10Rat118 41276 D10Rat182 Consumption level alcohol preference in separate cage with free choice of water or 10% (v/v) of ethanol; consumption scores (grams/kg/day) were averaged; the amounts of ethanol consumed every 3 days over three weeks 731212 14634485 HAD1,LAD1 631844,631845 additive Alc4,Alc5,Alc6,Alc7,Alc8,Alc10,Alc11,Alc12,Alc13 Intercross HAD1xLAD1
737821 rat Hcr9 Hepatocarcinoma resistance QTL 9 4 3.7 35817 D4Rat40 34338 D4Mgh11 34174 D4Mgh7 Liver tumor resistance nodule number neoplastic nodules were measured by the method in livers of rats killed at 32 weeks of age following tumor induction by the resistant-hepatocyte protocol of diethylnitrosamine exposure 629566 12154055 F344/Crli,BN/Crli 737690,737691 Hcr10,Hcr11 backcross BN/CrlixF344/Crli
737822 rat Alc10 Alcohol preference QTL 10 12 2.2 11051 D12Mit2 34086 D12Mgh9 36490 D12Rat18 Consumption level alcohol preference in separate cage with free choice of water or 10% (v/v) of ethanol; consumption scores (grams/kg/day) were averaged; the amounts of ethanol consumed every 3 days over three weeks 731212 14634485 HAD1,LAD1 631844,631845 additive Alc4,Alc5,Alc6,Alc7,Alc8,Alc9,Alc11,Alc12,Alc13 Intercross HAD1xLAD1
737823 rat Alc12 Alcohol preference QTL 12 10 4.5 41276 D10Rat182 35012 D10Rat46 41524 D10Rat180 Consumption level alcohol preference in separate cage with free choice of water or 10% (v/v) of ethanol; consumption scores (grams/kg/day) were averaged; the amounts of ethanol consumed every 3 days over three weeks 731212 14634485 HAD2,LAD2 731187,731188 additive Alc4,Alc5,Alc6,Alc7,Alc8,Alc9,Alc10,Alc11,Alc13 Intercross HAD2xLAD2
737824 rat Hcr10 Hepatocarcinoma resistance QTL 10 8 2.9 36117 D8Rat46 35905 D8Rat21 33973 D8Mit2 Liver tumor resistance nodule number neoplastic nodules were measured by the method in livers of rats killed at 32 weeks of age following tumor induction by the resistant-hepatocyte protocol of diethylnitrosamine exposure 629566,737837 12154055 F344/Crli,BN/Crli 737690,737691 Hcr9,Hcr11,Hcr12 backcross BN/CrlixF344/Crli
737825 rat Alc13 Alcohol preference QTL 13 16 4.5 33848 D16Mit2 37854 D16Rat30 45312 D16Rat124 Consumption level alcohol preference in separate cage with free choice of water or 10% (v/v) of ethanol; consumption scores (grams/kg/day) were averaged; the amounts of ethanol consumed every 3 days over three weeks 731212 14634485 HAD2,LAD2 731187,731188 additive Alc4,Alc5,Alc6,Alc7,Alc8,Alc9,Alc10,Alc11,Alc12 Intercross HAD2xLAD2
737826 rat Alc11 Alcohol preference QTL 11 16 3.2 33848 D16Mit2 40234 D16Rat60 34066 D16Mgh1 Consumption level alcohol preference in separate cage with free choice of water or 10% (v/v) of ethanol; consumption scores (grams/kg/day) were averaged; the amounts of ethanol consumed every 3 days over three weeks 731212 14634485 HAD1,LAD1 631844,631845 additive Alc4,Alc5,Alc6,Alc7,Alc8,Alc9,Alc10,Alc12,Alc13 Intercross HAD1xLAD1
737827 rat Hcr11 Hepatocarcinoma resistance QTL 11 6 4.4 34835 D6Rat28 35198 D6Rat11 36665 D6Rat14 Liver tumor resistance nodule number neoplastic nodules were measured by the method in livers of rats killed at 32 weeks of age following tumor induction by the resistant-hepatocyte protocol of diethylnitrosamine exposure 629566 12154055 F344/Crli,BN/Crli 737690,737691 Hcr9,Hcr10,Hcr12 backcross BN/CrlixF344/Crli
737828 rat Hcs3 Hepatocarcinoma susceptibility QTL 3 1 4.9 33959 D1Mit3 37982 D1Rat223 35615 D1Rat70 Liver tumor susceptibility nodule number neoplastic nodules were measured by the method in livers of rats killed at 32 weeks of age following tumor induction by the resistant-hepatocyte protocol of diethylnitrosamine exposure 629566 12154055 F344/Crli,BN/Crli 737690,737691 Hcs4 backcross BN/CrlixF344/Crli
737856 rat Edpm10 Estrogen-dependent pituitary mass QTL 10 14 2.83 6.5 Gland mass pituitary rats were given subcutaneous implants containing crystalline diethylstilbestrol (DES), 70 days later the pituitaries were removed and weighed 61074 9337394 BN/SsNHsd,F344/NHsd 10008,61109 intercross
1298065 rat Scl16 Serum cholesterol level QTL 16 8 3.8 7 41026 D8Rat153 Lipid level cholesterol plasma cholesterol, HDL-cholesterol, and total triglyceride were determined on euthanized animals following 16 hours fasting 737694 2016 Acat1 SS/Hsd,SR/Hsd 634365,634366
1298066 rat Bp159 Blood pressure QTL 159 13 .004 3804 Syt2 61281 D13M1Mit108 Blood pressure salt-loaded systolic systolic blood pressure was measured by tail-cuff method in male rats fed a diet containing 2% NaCl for 24 days 61047 9271663 Bp25
1298067 rat Scl15 Serum cholesterol level QTL 15 5 4.8 .001 10 33678 D5Mit10 Lipid level cholesterol plasma cholesterol, HDL-cholesterol, and total triglyceride were determined on euthanized animals following 16 hours fasting 737694 SS/Hsd,SR/Hsd 634365,634366
1298068 rat Bp167 Blood pressure QTL 167 3 .004 2534 Edn3 Blood pressure systolic measured using the tail-cuff method; relative heart weight also determined by measuring heart weight and body weight 61042 7963489 2534 Edn3 SR/Jr,SS/Jr 10040,10041 Bp15
1298069 rat Bp168 Blood pressure QTL 168 10 5.5 33632 D10Mit10 66563 D10Mco6 44786 D10Wox6 Blood pressure salt-loaded systolic measured by tail cuff method in rats fed a diet containing 8% NaCl 61040 9685318 3185 Nos2 SS/Jr,LEW 10041,60999 Bp12
1298070 rat Scl18 Serum cholesterol level QTL 18 5 3.7 7 35074 D5Rat23 Lipid level LDL cholesterol plasma cholesterol, HDL-cholesterol, and total triglyceride were determined on euthanized animals following 16 hours fasting 737694 728889 Adfp SS/Hsd,SR/Hsd 634365,634366
1298071 rat Edpm12 Estrogen-dependent pituitary mass QTL 11 X 3.2 36301 DXRat9 Gland mass pituitary pituitaries weighed 70 days after rats given subcutaneous implants containing crystalline diethylstilbestrol (DES) 629550 11003699 BN/SsNHsd,F344/NHsd 10008,61109 backcross
1298072 rat Cia26 Collagen induced arthritis QTL 26 18 33814 D18Mit9 37488 D18Rat60 33814 D18Mit9 Joint/bone inflammation type II collagen-induced 1285224 DA,ACI/N 60997,1298091 intercross
1298073 rat Cm13 Cardiac mass QTL 13 3 2.5 37510 D3Rat100 66449 D3Mco16 60801 D3Wox3 Cardiac mass heart weight measured in rats fed a diet containing 8% NaCl and normalized for population and gender differences 69705 9922389 SR/Jr,SS/Jr 10040,10041 Bp52
1298074 rat Bp164 Blood pressure QTL 164 2 .003 37018 D2Rat14 34461 D2Mgh12 Blood pressure salt-loaded systolic measured in congenic strain SHRSP.WKY-(D2Rat14-D2Mgh12) and compared to parental strain SHRSP 728179 11980293 Bp13,Bp165
1298075 rat Scl17 Serum cholesterol level QTL 17 2 3.4 7 34864 D2Rat67 Lipid level cholesterol plasma cholesterol, HDL-cholesterol, and total triglyceride were determined on euthanized animals following 16 hours fasting 737694 SS/Hsd,SR/Hsd 634365,634366
1298076 rat Bp166 Blood pressure QTL 166 2 .0009 60798 D2Wox9 34461 D2Mgh12 Blood pressure systolic systolic and diastolic blood pressure were measured in a congenic strain SHSRP.WKY-(D2Wox9-D2Mgh12) and compared to blood pressure of the parental strain SHSRP 728179 11980293 2756 Gstm2 Bp14
1298077 rat Bp157 Blood pressure QTL 157 5 36667 D5Rat54 62518 D5UIA8 Blood pressure salt-loaded systolic blood pressure measured on by tail-cuff method on rats fed a diet contining 2%NaCl 619649 11875185 SS.LEW-(D5Rat130-D5Mco10)/Jr,SS.LEW-(D5Uwm14-D5Uwm31)/Jr,SS.LEW-(D5Rat130-D5Rat108)/Jr,SS.LEW-(D5Mco34-D5Mco10)/Jr,SS.LEW-(D5Rat130-D5Mco19)/Jr,SS.LEW-(D5Uia 629578,728135,728145,728156,728157,1298092 Bp7
1298078 rat Sr5 Stress response QTL 5 10 2.99 .00025 9 41394 D10Rat164 41584 D10Rat135 35256 D10Rat11 Hormone level corticosterone late afternoon blood samples obtained from male rats and assayed for corticosterone levels; multiple steps were taken to minimize stress in the animals 737981 15013833 F344/NHsd,LEW/NHsd 61109,1298093
1298079 rat Act2 Activity QTL 2 8 9.5 .000001 29 33858 D8Mit4 10169 D8Wox11 Activity level novel environment activity measured in activity cages at 10 min, 60 min and 24 hour time intervals; open-field test and elevated-plus maze test also performed; endocrine levels were measured 631228 12660808 62388 Htr5b WKY,WKHA 61103,68186 Act1
1298080 rat Bp163 Blood pressure QTL 163 2 .02 33739 D2Mit5 34461 D2Mgh12 Blood pressure systolic systolic, diastolic, and mean arterial blood pressure measured in congenic strain WKY/Gla.SHRSP/Gla-(D2Mit5-D2Mgh12) and compared to blood pressure of parental strain WKY 68910 10642295 Bp132
1298081 rat Cia25 Collagen induced arthritis QTL 25 12 11053 D12Wox12 41962 D12Arb6 11053 D12Wox12 Joint/bone inflammation type II collagen-induced 1285224 DA,ACI/N 60997,1298091 intercross
1298082 rat Sr4 Stress response QTL 4 4 34967 D4Rat15 36143 D4Rat60 36870 D4Rat33 Hormone level corticosterone late afternoon blood samples obtained from male rats and assayed for corticosterone levels; multiple steps were taken to minimize stress in the animals 737981 15013833 F344/NHsd,LEW/NHsd 61109,1298093
1298083 rat Bp158 Blood pressure QTL 158 2 2.62 2167 Atp1a1 2263 Camk2d Blood pressure salt-loaded blood pressure measured by tail-cuff in F2 males maintained on high salt diet 61038 8040284 SS/Jr,MNS 10041,60992 Bp10
1298084 rat Ten4 Thymus enlargement QTL 4 1 10.68 2870 Igf2 11201 D1Mgh11 Gland mass thymus mean thymus ratios calculated for each marker locus and differences in this ratio between homozygous and heterozygous groups was analyzed using a Student's t-test. 70859 10792781 BUF/Mna,WKY/NCrj 61118,61119 Ten1,Ten3
1298085 rat Bp165 Blood pressure QTL 165 2 .0006 37018 D2Rat14 34461 D2Mgh12 Blood pressure salt-loaded systolic measured in congenic strain WKY.SHRSP-(D2Rat14-D2Mgh12) and compared to parental strain WKY 728179 11980293 Bp13,Bp164
1298086 rat Bp156 Blood pressure QTL 156 5 69549 D5Uwm31 34583 D5Rjr1 Blood pressure salt-loaded systolic blood pressure measured on by tail-cuff method on rats fed a diet contining 2%NaCl 619649 11875185 SS.LEW-(D5Rat130-D5Mco10)/Jr,SS.LEW-(D5Uwm14-D5Uwm31)/Jr,SS.LEW-(D5Rat130-D5Rat108)/Jr,SS.LEW-(D5Mco34-D5Mco10)/Jr,SS.LEW-(D5Rat130-D5Mco19)/Jr,SS.LEW-(D5Uia 629578,728135,728145,728156,728157,1298092 Bp7
1298087 rat Iddm18 Insulin dependent diabetes mellitus QTL 18 6 .0001 42809 D6Rat184 39052 D6Rat101 Glucose level insulin-dependent male and female rats examined for development of diabetes up to 30 weeks of age; diabetes determination based on glucosuria followed by measurement of blood glucose concentrations of >300 mg/dl on two consecutive days 619685 11327715 Iddm8,Iddm16
1298088 rat Edpm11 Estrogen-dependent pituitary mass QTL 11 9 2.5 36157 D9Rat31 Gland mass pituitary pituitaries weighed 70 days after rats given subcutaneous implants containing crystalline diethylstilbestrol (DES) 629550 11003699 BN/SsNHsd,F344/NHsd 10008,61109 backcross
1298089 rat Scl14 Serum cholesterol level QTL 14 5 5.8 .0004 12 33680 D5Mit13 Lipid level cholesterol plasma cholesterol, HDL-cholesterol, and total triglyceride were determined on euthanized animals following 16 hours fasting 737694 3642,2479 Scp2,Cyp4a11 SS/Hsd,SR/Hsd 634365,634366
1298090 rat Bp155 Blood pressure QTL 155 5 3.8 58.5 34206 D5Mgh15 34168 D5Mgh22 11002 D5Mit15 Blood pressure mean-arterial systolic, diastolic and mean blood pressure recorded during carotid arterial cannulation using a pressure transducer 731210 14678232 3193 Nppa WKY/Gcrc,SHR/Gcrc 734760,738092
1298404 human OA25_H Osteoarthritis QTL 25 (human) 2 1.23 .0086 1298259 D2S157 1298257 D2S117 1298255 D2S272 Joint/bone inflammation hip osteoarthritis genome-wide scans were conducted in affected sib pairs who had undergone total hip or knee replacement for primary ideopathic osteoarthritis 734502 10817769
1298405 human OA19_H Osteoarthritis QTL 19 (human) 3 1.79 1298116 D3S1562 1298196 D3S1274 1298160 D3S3551 Joint/bone inflammation ideopathic hand osteoarthritis genome-wide scan of Icelandic patients diagnosed with ideopathic arthritis of the hand were compared with unrelated Icelandic control individuals 738123 12736871
1298406 human BP16_H Blood pressure QTL 16 (human) 17 .0004 730951 NOS2A Blood pressure hypertension susceptibility chromosome 17 candidate gene analysis for loci contributing to essential hypertension in 177 affected sibpairs of British descent 1298023 11702222
1298407 human BFD4_H Body fluid distribution QTL 4 (human) 6 2.52 1298251 D6S474 1298296 D6S1009 1298242 D6S1040 Body fluid distribution impedance ratio genome-wide scan for loci affecting body fluid distribution (bioelectrical impedance ratio) in 150 African American affected sib pairs with essential hypertension 738096 12411455
1298408 human BP7_H Blood pressure QTL 7 (human) 12 3.44 1298193 D12S1715 1298188 D12S1591 1298164 D12S1682 Blood pressure hypertension susceptibility genome-wide scan for loci contributing to essential hypertension in a large Chinese kindred and 32 additional Chinese nuclear families with essential hypertension 738126 12761042
1298409 human BP13_H Blood pressure QTL 13 (human) 18 2.09 1298119 D18S844 Blood pressure systolic genome-wide scan for loci contributing to blood pressure in a sample of Mexican American families chosen without regard to blood pressure status 738133 11255245
1298410 human OA24_H Osteoarthritis QTL 24 (human) 4 5.73 1298122 D4S408 1298175 D4S3051 1298155 D4S2924 Joint/bone inflammation Beukes hip dysplasia genome-wide scan was undertaken to find the gene responsible for Beukes hip dysplasia, an autosomal dominant form of premature degenerative osteoarthritis of the hip 1298026 10053028 dominant
1298411 human BFD2_H Body fluid distribution QTL 2 (human) 5 4.49 1298246 D5S1470 1298298 D5S2500 1298276 D5S623 Body fluid distribution impedance ratio genome-wide scan for loci affecting body fluid distribution (bioelectrical impedance ratio) in 150 African American affected sib pairs with essential hypertension 738096 12411455
1298412 human RA1_H Rheumatoid arthritis QTL 1 (human) 1 .0141 1298283 D2S396 Joint/bone inflammation rheumatoid arthritis genome-wide linkage scans were examined in families with at least two siblings diagnosed with rheumatoid arthritis with onset between 18 and 60 years of age 738125 11254450 dominant
1298413 human OA18_H Osteoarthritis QTL 18 (human) 4 2.61 1298181 D4S2982 1298136 D4S3046 1298136 D4S3046 Joint/bone inflammation ideopathic hand osteoarthritis genome-wide scan of Icelandic patients diagnosed with ideopathic arthritis of the hand were compared with unrelated Icelandic control individuals 738123 12736871
1298414 human BFD5_H Body fluid distribution QTL 5 (human) 7 3.16 1298266 D7S2212 1298320 D7S821 1298256 D7S1813 Body fluid distribution impedance ratio genome-wide scan for loci affecting body fluid distribution (bioelectrical impedance ratio) in 150 African American affected sib pairs with essential hypertension 738096 12411455
1298415 human BP24_H Blood pressure QTL 24 (human) 3 2.9 68977 AGTR1 Blood pressure hypertension susceptibility analysis of candidate genes for loci affecting susceptibility to essential hypertension in Finnish hypertensive affected sibling pairs 1298037 10082497 BP36_H
1298416 human OA13_H Osteoarthritis QTL 13 (human) 4 1.89 .0001 733315 Il2 1298110 D4S1644 1298161 D4S2394 Joint/bone inflammation distal interphalangeal joint osteoarthritis genome-wide scan of 64 Finnish patients diagnosed with osteoarthritis of interphalangeal or metacarpophalangeal joints were compared with members of 16 unaffected Finnish core families 738112 10486325 recessive
1298417 human OA26_H Osteoarthritis QTL 26 (human) 4 3.1 1298324 D4S1600 1298331 D4S392 1298309 D4S3253 Joint/bone inflammation hip osteoarthritis genome-wide linkage scans were examined in families with at least two siblings who had undergone total hip or knee replacement for primary ideopathic osteoarthritis 738108 14730605 OA21_H
1298418 human OA28_H Osteoarthritis QTL 28 (human) 16 1.9 Joint/bone inflammation hip osteoarthritis genome-wide linkage scans were examined in families with at least two siblings who had undergone total hip or knee replacement for primary ideopathic osteoarthritis 738108 14730605
1298419 human OA20_H Osteoarthritis QTL 20 (human) 2 1.48 1298157 D2S175 1298100 D2S2201 1298125 D2S146 Joint/bone inflammation ideopathic hand osteoarthritis genome-wide scan of Icelandic patients diagnosed with ideopathic arthritis of the hand were compared with unrelated Icelandic control individuals 738123 12736871
1298420 human OA5_H Osteoarthritis QTL 5 (human) 11 1.6 1298156 D11S2371 1298202 D11S2002 1298156 D11S2371 Joint/bone inflammation hand osteoarthritis two generations of subjects from the Framingham Heart Study diagnosed with joint space narrowing in the hand underwent genome-wide scans for longitudinal study of hand osteoarthritis 1285226 11953971
1298421 human BP35_H Blood pressure QTL 35 (human) 17 .0001 1298263 D17S946 1298171 D17S949 1298308 D17S934 Blood pressure hypertension susceptibility analysis of affected sib pairs for loci affecting blood pressure in a region of human chromosome 17 that has homology to a rat chromosome 10 region containing blood pressure QTLs 1298214 9328471
1298422 human RA14_H Rheumatoid arthritis QTL 14 (human) 8 .0088 1298326 D8S277 Joint/bone inflammation rheumatoid arthritis genome-wide linkage scans were examined in families with at least two siblings diagnosed with rheumatoid arthritis with onset between 18 and 60 years of age 738125 11254450 dominant
1298423 human OA23_H Osteoarthritis QTL 23 (human) 16 2.1 1298187 D16S407 1298200 D16S261 1298143 D16S287 Joint/bone inflammation hip osteoarthritis genome-wide linkage scans were examined in families with at least two siblings who had undergone total hip or knee replacement for primary ideopathic osteoarthritis 1298025 10577938
1298424 human OA21_H Osteoarthritis QTL 21 (human) 4 3.9 1298147 D4S398 1298194 D4S250 Joint/bone inflammation hip osteoarthritis genome-wide linkage scans were examined in families with at least two siblings who had undergone total hip or knee replacement for primary ideopathic osteoarthritis 1298025 10577938
1298425 human OA29_H Osteoarthritis QTL 29 (human) 2 .05 1298262 D2S111 1298284 D2S103 1298281 D2S326 Joint/bone inflammation nodal osteoarthritis genome-wide linkage scans were examined in affected sibling pairs diagnosed with polyarticular interphalangeal osteoartritis with Heberden's nodes in each hand 1298211 8660106
1298426 human BFD3_H Body fluid distribution QTL 3 (human) 6 2.79 1298273 D6S1270 1298206 D6S1021 1298306 D6S1056 Body fluid distribution impedance ratio genome-wide scan for loci affecting body fluid distribution (bioelectrical impedance ratio) in 150 African American affected sib pairs with essential hypertension 738096 12411455
1298427 human RA9_H Rheumatoid arthritis QTL 9 (human) 5 .0066 1298299 D5S1457 Joint/bone inflammation rheumatoid arthritis genome-wide linkage scans were examined in families with at least two siblings diagnosed with rheumatoid arthritis with onset between 18 and 60 years of age 738125 11254450 dominant
1298428 human BP8_H Blood pressure QTL 8 (human) 15 .000016 1298146 D15S203 Blood pressure diastolic multipoint linkage analysis of affected sibling pairs for loci affecting blood pressure in rural Chinese sib pairs concordant for extreme low diastolic blood pressure 738127 10556304
1298429 human BP23_H Blood pressure QTL 23 (human) 2 3.36 1298264 D2S324 1298231 D2S325 Blood pressure diastolic genome wide scan for loci affecting blood pressure in Old Order Amish population 1298033 10859286
1298430 human RA27_H Rheumatoid arthritis QTL 27 (human) 17 .0053 1298314 D17S1308 1298294 D17S1298 Joint/bone inflammation rheumatoid arthritis genome-wide linkage scans were examined in families with at least two siblings diagnosed with rheumatoid arthritis with onset between 18 and 60 years of age 738125 11254450 dominant
1298431 human RA11_H Rheumatoid arthritis QTL 11 (human) 6 .0000024 1298151 D6S1959 1298131 D6S291 1298191 D6S265 Joint/bone inflammation rheumatoid arthritis genome-wide linkage scans were examined in families with at least two siblings diagnosed with rheumatoid arthritis with onset between 18 and 60 years of age 738125 11254450 dominant
1298432 human OA10_H Osteoarthritis QTL 10 (human) 2 2.34 .0001 1298207 D2S2209 1298149 D2S293 735430 IL1R1 Joint/bone inflammation distal interphalangeal joint osteoarthritis genome-wide scan of 64 Finnish patients diagnosed with osteoarthritis of interphalangeal or metacarpophalangeal joints were compared with members of 16 unaffected Finnish core families 738112 10486325 dominant OA11_H,OA12_H
1298433 human BP17_H Blood pressure QTL 17 (human) 1 .0162 1298303 D1S1612 Blood pressure hypertension susceptibility nonparametric analysis of markers near 18 candidate genes for loci affecting young-onset hypertension in Han Chinese affected sib pairs 1298024 11071381
1298434 human BP1_H Blood pressure QTL 1 (human) 4 3.9 1298103 D4S2366 1298180 D4S2397 1298204 D4S2639 Blood pressure systolic genome-wide scan for blood pressure variation in 18 Dutch families with familial combined hyperlipidemia (FCH) in which affected individuals have lipid abnormalities, hypertension, and elevated fasting insulin levels 738095 11641285
1298435 human OA6_H Osteoarthritis QTL 6 (human) 12 1298109 D12S1045 1298101 D12S392 1298101 D12S392 Joint/bone inflammation hand osteoarthritis two generations of subjects from the Framingham Heart Study diagnosed with joint space narrowing in the hand underwent genome-wide scans for longitudinal study of hand osteoarthritis 1285226 11953971
1298436 human OA8_H Osteoarthritis QTL 8 (human) 19 1.82 1298168 D19S433 Joint/bone inflammation hand osteoarthritis two generations of subjects from the Framingham Heart Study diagnosed with joint space narrowing in the hand underwent genome-wide scans for longitudinal study of hand osteoarthritis 1285226 11953971
1298437 human BW19_H Body weight QTL 19 (human) 1 3.7 1298271 D1S518 1298247 D1S3465 1298252 D1S1660 Body weight body mass index body weight and body mass index, plasma insulin, and pancreatic morphology were assessed; body mass index was calculated from body weight and nasoanal body length; plasma glucose concentration was determined by glucose oxidase assay 738096 12411455
1298438 human BP4_H Blood pressure QTL 4 (human) 6 2.5 1298134 D6S1017 1298206 D6S1021 1298166 D6S1031 Blood pressure diastolic genome-wide scan for blood pressure variation in 18 Dutch families with familial combined hyperlipidemia (FCH) in which affected individuals have lipid abnormalities, hypertension, and elevated fasting insulin levels 738095 11641285
1298439 human BP30_H Blood pressure QTL 30 (human) 3 2.03 1298321 D3S2432 1298277 D3S2387 Blood pressure systolic genome-wide linkage scan for loci affecting blood pressure in rural Chinese sibling pairs with blood pressure extremes 1298213 10330357
1298440 human OA11_H Osteoarthritis QTL 11 (human) 2 2.51 1298183 D2S1896 1298113 D2S2254 1298137 D2S410 Joint/bone inflammation distal interphalangeal joint osteoarthritis genome-wide scan of 64 Finnish patients diagnosed with osteoarthritis of interphalangeal or metacarpophalangeal joints were compared with members of 16 unaffected Finnish core families 738112 10486325 dominant OA10_H,OA12_H
1298441 human RA2_H Rheumatoid arthritis QTL 2 (human) 1 .0048 1298318 D1S235 Joint/bone inflammation rheumatoid arthritis genome-wide linkage scans were examined in families with at least two siblings diagnosed with rheumatoid arthritis with onset between 18 and 60 years of age 738125 11254450 dominant
1298442 human RA7_H Rheumatoid arthritis QTL 7 (human) 4 .0001 1298248 D4S1647 Joint/bone inflammation rheumatoid arthritis genome-wide linkage scans were examined in families with at least two siblings diagnosed with rheumatoid arthritis with onset between 18 and 60 years of age 738125 11254450 dominant
1298443 human BP15_H Blood pressure QTL 15 (human) 17 .025 1298144 D17S799 Blood pressure hypertension susceptibility chromosome 17 linkage scan for loci contributing to essential hypertension in 177 affected sibpairs of British descent 1298023 11702222
1298444 human BP32_H Blood pressure QTL 32 (human) 15 2.69 1298332 D15S822 1298311 D15S657 Blood pressure diastolic genome-wide linkage scan for loci affecting blood pressure in rural Chinese sibling pairs with blood pressure extremes 1298213 10330357 BP8_H
1298445 human BW7_H Body weight QTL 7 (human) 8 1.95 .014 1298096 D8S549 Body fat amount genome wide scan for linkage to body fat was determined in individuals with body mass index greater or equal to 30 kg/m*m and were identified through a proband with a bone mineral density Z score less than -1.28 738102 11923910
1298446 human BW4_H Body weight QTL 4 (human) 4 2.09 .00096 1298205 D4S391 1298176 D4S1534 1298203 D4S1592 Body weight body mass index genome wide scan for linkage to body mass index greater or equal to 30 kg/m*m in individuals that were identified through a proband with a bone mineral density Z score less than -1.28 738102 11923910
1298447 human RA17_H Rheumatoid arthritis QTL 17 (human) 9 .0244 1298236 D9S2157 Joint/bone inflammation rheumatoid arthritis genome-wide linkage scans were examined in families with at least two siblings diagnosed with rheumatoid arthritis with onset between 18 and 60 years of age 738125 11254450 dominant
1298448 human BP6_H Blood pressure QTL 6 (human) 10 2.5 1298105 D10S189 1298189 D10S1423 Blood pressure hypertension susceptibility genome-wide scan for loci affecting blood pressure in 1425 sib pairs (concordant and discordant) of Chinese and Japanese origins 738098 12559686
1298449 human UAE2_H Urinary albumin excretion QTL 2 (human) 12 2 .005 735410 PAH Urinary albumin excretion urine albumin:creatinine ratio (ACR) genome-wide scan for loci affecting urinary albumin excretion in 2589 individuals from 805 hypertensive families in the Family Blood Pressure Program 738099 12925555
1298450 human RA8_H Rheumatoid arthritis QTL 8 (human) 5 .043 1298334 D5S2848 Joint/bone inflammation rheumatoid arthritis genome-wide linkage scans were examined in families with at least two siblings diagnosed with rheumatoid arthritis with onset between 18 and 60 years of age 738125 11254450 dominant
1298451 human OA17_H Osteoarthritis QTL 17 (human) 11 2.4 .0004 1298224 TNFRSF1B Joint/bone inflammation osteoarthritis genome-wide scans were conducted in affected sib pairs who had undergone total hip or knee replacement for primary ideopathic osteoarthritis 1285222 10364529
1298452 human OA16_H Osteoarthritis QTL 16 (human) 6 1.85 .0016 1298102 D11S908 1298162 D11S916 1298172 D11S901 Joint/bone inflammation hip osteoarthritis eleven candidate genes were examined in families with at least two siblings who had undergone total hip or knee replacement for primary ideopathic osteoarthritis 738111 10788539
1298453 human BP11_H Blood pressure QTL 11 (human) 8 1.92 1298150 D8S373 Blood pressure diastolic genome-wide scan for loci contributing to blood pressure in a sample of Mexican American families chosen without regard to blood pressure status 738133 11255245
1298454 human BW1_H Body weight QTL 1 (human) 4 9.2 1298205 D4S391 1298141 D4S3040 1298098 D4S3350 Body weight body mass index genome wide search for severe obesity predisposition was performed on clustered pedigrees with a body mass index BMI greater or equal to 35 738101 11957135
1298455 human RA30_H Rheumatoid arthritis QTL 30 (human) 18 .0433 1298292 D18S858 Joint/bone inflammation rheumatoid arthritis genome-wide linkage scans were examined in families with at least two siblings diagnosed with rheumatoid arthritis with onset between 18 and 60 years of age 738125 11254450 dominant
1298456 human BW6_H Body weight QTL 6 (human) 20 1.64 .003 1298199 D20S178 Body fat amount genome wide scan for linkage to body fat was determined in individuals with body mass index greater or equal to 30 kg/m*m and were identified through a proband with a bone mineral density Z score less than -1.28 738102 11923910
1298457 human RA18_H Rheumatoid arthritis QTL 18 (human) 10 .0462 1298228 D10S1419 1298280 D10S2327 Joint/bone inflammation rheumatoid arthritis genome-wide linkage scans were examined in families with at least two siblings diagnosed with rheumatoid arthritis with onset between 18 and 60 years of age 738125 11254450 dominant
1298458 human BW9_H Body weight QTL 9 (human) 6 2.7 .0002 1298151 D6S1959 Body fat amount Genome wide scan for obesity in African Americans who were recruited as part of a blood pressure program 738103 11812767
1298459 human BP19_H Blood pressure QTL 19 (human) 8 .0284 1298274 D8S1145 Blood pressure hypertension susceptibility nonparametric analysis of markers near 18 candidate genes for loci affecting young-onset hypertension in Han Chinese affected sib pairs 1298024 11071381
1298460 human OA7_H Osteoarthritis QTL 7 (human) 13 1.61 1298148 D13S325 Joint/bone inflammation hand osteoarthritis two generations of subjects from the Framingham Heart Study diagnosed with joint space narrowing in the hand underwent genome-wide scans for longitudinal study of hand osteoarthritis 1285226 11953971
1298461 human BP20_H Blood pressure QTL 20 (human) 17 .0256 1298335 D17S2193 Blood pressure hypertension susceptibility nonparametric analysis of markers near 18 candidate genes for loci affecting young-onset hypertension in Han Chinese affected sib pairs 1298024 11071381
1298462 human OA14_H Osteoarthritis QTL 14 (human) 7 1.38 .001 1298179 D7S2201 1298159 D7S673 1298140 D7S513 Joint/bone inflammation distal interphalangeal joint osteoarthritis genome-wide scan of 64 Finnish patients diagnosed with osteoarthritis of interphalangeal or metacarpophalangeal joints were compared with members of 16 unaffected Finnish core families 738112 10486325 dominant
1298463 human BP9_H Blood pressure QTL 9 (human) 1 3.9 1298224 TNFRSF1B Blood pressure hypertension susceptibility study of association between TNFRSF1B and essential hypertension in 200 affected Anglo-Celtic Caucasian sib pairs 738128 10942422
1298464 human BP18_H Blood pressure QTL 18 (human) 1 .0263 1298297 D1S547 Blood pressure hypertension susceptibility nonparametric analysis of markers near 18 candidate genes for loci affecting young-onset hypertension in Han Chinese affected sib pairs 1298024 11071381
1298465 human BP14_H Blood pressure QTL 14 (human) 17 1.9 .0029 1298171 D17S949 Blood pressure hypertension susceptibility chromosome 17 linkage scan for loci contributing to essential hypertension in 177 affected sibpairs of British descent 1298023 11702222
1298466 human RA22_H Rheumatoid arthritis QTL 22 (human) 12 .0227 1298293 D12S1052 Joint/bone inflammation rheumatoid arthritis genome-wide linkage scans were examined in families with at least two siblings diagnosed with rheumatoid arthritis with onset between 18 and 60 years of age 738125 11254450 dominant
1298467 human OA9_H Osteoarthritis QTL 9 (human) 19 1.83 1298198 D19S178 Joint/bone inflammation hand osteoarthritis two generations of subjects from the Framingham Heart Study diagnosed with joint space narrowing in the hand underwent genome-wide scans for longitudinal study of hand osteoarthritis 1285226 11953971
1298468 human BP34_H Blood pressure QTL 34 (human) 17 2.16 1298314 D17S1308 1298335 D17S2193 1298244 D17S1303 Blood pressure systolic genome-wide linkage scan for loci affecting blood pressure in rural Chinese sibling pairs with blood pressure extremes 1298213 10330357
1298469 human RA23_H Rheumatoid arthritis QTL 23 (human) 14 .0174 1298288 D14S1280 Joint/bone inflammation rheumatoid arthritis genome-wide linkage scans were examined in families with at least two siblings diagnosed with rheumatoid arthritis with onset between 18 and 60 years of age 738125 11254450 dominant
1298470 human BW2_H Body weight QTL 2 (human) 2 4.04 28.2 1298127 D2S142 1298201 D2S2333 1298118 D2S347 Body weight body mass index genome wide scan for linkage to body mass index greater or equal to 30 kg/m*m in individuals that were identified through a proband with a bone mineral density Z score less than -1.28 738102 11923910
1298471 human OA4_H Osteoarthritis QTL 4 (human) 9 2.29 1298167 D9S1122 1298120 D9S922 1298167 D9S1122 Joint/bone inflammation hand osteoarthritis two generations of subjects from the Framingham Heart Study diagnosed with joint space narrowing in the hand underwent genome-wide scans for longitudinal study of hand osteoarthritis 1285226 11953971
1298472 human BP21_H Blood pressure QTL 21 (human) 5 .0785 1298302 D5S1480 Blood pressure hypertension susceptibility nonparametric analysis of markers near 18 candidate genes for loci affecting young-onset hypertension in Han Chinese affected sib pairs 1298024 11071381
1298473 human RA12_H Rheumatoid arthritis QTL 12 (human) 6 .0043 1298229 D6S2427 1298275 D6S2439 Joint/bone inflammation rheumatoid arthritis genome-wide linkage scans were examined in families with at least two siblings diagnosed with rheumatoid arthritis with onset between 18 and 60 years of age 738125 11254450 dominant
1298474 human OA30_H Osteoarthritis QTL 29 (human) 2 .05 1298289 D2S128 1298283 D2S396 1298307 D2S126 Joint/bone inflammation nodal osteoarthritis genome-wide linkage scans were examined in affected sibling pairs diagnosed with polyarticular interphalangeal osteoartritis with Heberden's nodes in each hand 1298211 8660106
1298475 human RA6_H Rheumatoid arthritis QTL 6 (human) 3 .0408 1298243 D3S1311 Joint/bone inflammation rheumatoid arthritis genome-wide linkage scans were examined in families with at least two siblings diagnosed with rheumatoid arthritis with onset between 18 and 60 years of age 738125 11254450 dominant
1298476 human BP3_H Blood pressure QTL 3 (human) 19 2.4 1298192 D19S1034 1298107 D19S1166 Blood pressure systolic genome-wide scan for blood pressure variation in 18 Dutch families with familial combined hyperlipidemia (FCH) in which affected individuals have lipid abnormalities, hypertension, and elevated fasting insulin levels 738095 11641285
1298477 human OA1_H Osteoarthritis QTL 1 (human) 1 2.96 1298097 D1S1665 1298097 D1S1665 Joint/bone inflammation hand osteoarthritis two generations of subjects from the Framingham Heart Study diagnosed with joint space narrowing in the hand underwent genome-wide scans for longitudinal study of hand osteoarthritis 1285226 11953971
1298478 human BP12_H Blood pressure QTL 12 (human) 21 2.82 1298173 D21S1440 Blood pressure systolic genome-wide scan for loci contributing to blood pressure in a sample of Mexican American families chosen without regard to blood pressure status 738133 11255245
1298479 human RA5_H Rheumatoid arthritis QTL 5 (human) 3 .0288 1298282 D3S3023 Joint/bone inflammation rheumatoid arthritis genome-wide linkage scans were examined in families with at least two siblings diagnosed with rheumatoid arthritis with onset between 18 and 60 years of age 738125 11254450 dominant
1298480 human RA20_H Rheumatoid arthritis QTL 20 (human) 12 .0031 1298300 D12S373 Joint/bone inflammation rheumatoid arthritis genome-wide linkage scans were examined in families with at least two siblings diagnosed with rheumatoid arthritis with onset between 18 and 60 years of age 738125 11254450
1298481 human OA2_H Osteoarthritis QTL 2 (human) 2 2.23 1298117 D2S405 1298195 D2S1788 1298117 D2S405 Joint/bone inflammation joint space narrowing genome-wide scan for longitudinal study of hand osteoarthritis in two generations of subjects from the Framingham Heart Study 1285226 11953971
1298482 human BP2_H Blood pressure QTL 2 (human) 8 1.8 70836 LPL Blood pressure diastolic genome-wide scan for blood pressure variation in 18 Dutch families with familial combined hyperlipidemia (FCH) in which affected individuals have lipid abnormalities, hypertension, and elevated fasting insulin levels 738095 11641285
1298483 human BP10_H Blood pressure QTL 10 (human) 2 3.92 1298104 D2S1790 Blood pressure diastolic genome-wide scan for loci contributing to blood pressure in a sample of Mexican American families chosen without regard to blood pressure status 738133 11255245
1298484 human RA16_H Rheumatoid arthritis QTL 16 (human) 8 .0084 1298150 D8S373 Joint/bone inflammation rheumatoid arthritis genome-wide linkage scans were examined in families with at least two siblings diagnosed with rheumatoid arthritis with onset between 18 and 60 years of age 738125 11254450
731167 rat Glom4 Glomerulus QTL 4 2 2.4 .0082 37018 D2Rat14 Renal (cell morphology)/ histology number of superficial glomeruli present in the renal cortex corticis zone but without direct surface contact counted in three mid-coronal sections for each animal 730279 14638907 MWF/Fub,SHR/Fub 731185,731186 backcross MWF/FubxSHR/Fub
731168 rat Bp154 Blood pressure QTL 154 1 3.4 2969 Klk5 43424 D1Wox10 621323 Phox2a Blood pressure systolic systolic blood pressure measured by tail-cuff method; diet contained 1% NaCl in drinking water 730283 SHRSP.WKY-(Klk1-D1Rat116)/IzmTkyo 731189 backcross
731169 rat Bp153 Blood pressure QTL 153 1 .001 37974 D1Rat211 36550 D1Rat12 Blood pressure systolic measured by both tail-cuff and radiotelemetry methods; diet consisted of 2% NaCl diet for 24 days 728381 14597851 SS.LEW-(D1Rat211-D1Rat18)/Mco 731190 Bp95 backcross
731170 rat Pur3 Proteinuria QTL 3 15 2.3 .0005 37702 D15Rat66 Renal function urine albumin level total urinary protein excretion was determined by Bradford method 730279 14638907 MWF/Fub,SHR/Fub 731185,731186 backcross MWF/FubxSHR/Fub
731171 rat Glom6 Glomerulus QTL 6 9 2.8 .0003 35691 D9Rat5 Renal (cell morphology)/ histology number of superficial glomeruli present in the renal cortex corticis zone but without direct surface contact counted in three mid-coronal sections for each animal 730279 14638907 MWF/Fub,SHR/Fub 731185,731186 backcross MWF/FubxSHR/Fub
731172 rat Bp151 Blood pressure QTL 151 3 .04 10260 D3Rat52 39050 D3Rat130 Blood pressure 724791 14517349 SS.LEW-(D3Rat52-D3Rat130)/Ayd 731192 backcross
731173 rat Uae22 Urinary albumin excretion QTL 22 6 10.1 38608 D6Rat106 36191 D6Rat6 36990 D6Rat12 Renal function urine albumin level measured by rat-specific ELISA 730279 14638907 70907,3851,2151 Actn1,Tgfb3,Arg2 MWF/Fub,SHR/Fub 731185,731186 backcross MWF/FubxSHR/Fub
731174 rat Uae23 Urinary albumin excretion QTL 23 7 2.4 .0042 35304 D7Rat4 Renal function urine albumin level measured by rat-specific ELISA 730279 14638907 MWF/Fub,SHR/Fub 731185,731186 backcross MWF/FubxSHR/Fub
731175 rat Uae20 Urinary albumin excretion QTL 20 1 3.5 .0018 35909 D1Rat74 38424 D1Rat190 35945 D1Rat75 Renal function urine albumin level measured by rat-specific ELISA 730279 14638907 MWF/Fub,SHR/Fub 731185,731186 backcross MWF/FubxSHR/Fub
731176 rat Glom5 Glomerulus QTL 5 7 2.5 .0035 35118 D7Rat7 Renal (cell morphology)/ histology number of superficial glomeruli present in the renal cortex corticis zone but without direct surface contact counted in three mid-coronal sections for each animal 730279 14638907 MWF/Fub,SHR/Fub 731185,731186 backcross MWF/FubxSHR/Fub
731177 rat Uae26 Urinary albumin excretion QTL 26 15 2.4 .025 40106 D15Rat102 Renal function urine albumin level measured by rat-specific ELISA 730279 14638907 MWF/Fub,SHR/Fub 731185,731186 backcross MWF/FubxSHR/Fub
731178 rat Oia7 Oil induced arthritis QTL 7 4 .0001 60413 D4Got126 60422 D4Got136 Joint/bone inflammation oil induced induced by an intradermal injection of incomplete Freund's adjuvant-oil; arthritis development monitored using a macroscopic scoring system ranging from 0 to 4 for each of the four limbs 730281 12915467 620537,2976,2977,2978,619983 C3ar1,Klrc1,Klrc2,Klrd1,C1s DA.PVG-(D4Rat141-D4Mgh11) 731193 additive Oia2 backcross
731179 rat Mcs10 Mammary carcinoma susceptibility QTL 10 2 .0001 67800 D2Uwm17 36470 D2Rat16 Mammary tumor susceptibility treated with 7,12-dimethylbenz(a)anthracene (DMBA) for 15 weeks; total number of mammary carcinomas > 3 x 3 mm in diameter enumerated 724790 14522903 COP,WF 60998,61007 recessive Mcs1 intercross WFxCOP
731180 rat Bp152 Blood pressure QTL 152 3 .03 728034 D3Chm63 35795 D3Rat26 Blood pressure 724791 14517349 SS.LEW-(D3Chm64-D3Rat17)/Ayd 731194 backcross
731181 rat Uae27 Urinary albumin excretion QTL 27 X 2.7 .0059 36111 DXRat8 Renal function urine albumin level measured by rat-specific ELISA 730279 14638907 MWF/Fub,SHR/Fub 731185,731186 backcross MWF/FubxSHR/Fub
731182 rat Uae24 Urinary albumin excretion QTL 24 8 6.4 35296 D8Rat53 36904 D8Rat19 36235 D8Rat35 Renal function urine albumin level measured by rat-specific ELISA 730279 14638907 MWF/Fub,SHR/Fub 731185,731186 backcross MWF/FubxSHR/Fub
731183 rat Pia20 Pristane induced arthritis QTL 20 14 3.55 35713 D14Rat11 37030 D14Rat3 33551 D14Mit6 Joint/bone inflammation pristane induced arthritis induced by intradermal injection of pristane (2,6,10,14-tetramethylpentadecane) at the base of the tail; secretion of cartilage oligomeric matrix protein (COMP) from new-formed/eroded cartilage to plasma analysed by competitive ELISA 730280 14624754 DA.E3-(D14Wox8-D14Rat64)/Rhd 731195 Pia6 backcross
731184 rat Mcs11 Mammary carcinoma susceptibility QTL 11 2 .0003 36205 D2Rat2 728007 D2M13Mit286 Mammary tumor susceptibility treated with 7,12-dimethylbenz(a)anthracene (DMBA) for 15 weeks; total number of mammary carcinomas > 3 x 3 mm in diameter enumerated 724790 14522903 COP,WF 60998,61007 semidominant Mcs1 intercross WFxCOP
738005 rat Arr11 Anxiety related response QTL 11 18 3.4 37568 D18Rat55 Anxiety response open field inner locomotion performance in elevated plus-maze test for anxiety; this locus concerns the number of times the animal entered into the closed arms of the maze 737695 14739700 SHR/Ola,BN-Lx/Cub 61100,61117 Arr3,Arr4,Arr5,Arr6,Arr7,Arr8,Arr9,Arr10 intercross SHR/OlaxBN-Lx/Cub
738006 rat Arr14 Anxiety related response QTL 14 1 4 .00035 32 34074 D1Mgh8 Anxiety response plus maze-open arm activity was measured in the elevated plus maze; average time spent in the open arms of the maze was analyzed 731213 12972953 WKY,HEP 61103,738038 Arr12,Arr13,Arr15 intercross WKYxHEP
738007 rat Arr7 Anxiety related response QTL 7 2 4.4 41300 D2Rat221 Anxiety response open field inner locomotion performance in elevated plus-maze test for anxiety; this locus concerns the number of times the animal entered into the open and closed arms of the maze 737695 14739700 SHR/Ola,BN-Lx/Cub 61100,61117 Arr3,Arr4,Arr5,Arr6,Arr8,Arr9,Arr10,Arr11 intercross SHR/OlaxBN-Lx/Cub
738008 rat Hcr14 Hepatocarcinoma resistance QTL 14 18 4.3 38146 D18Rat50 39278 D18Rat44 36816 D18Rat12 Liver tumor resistance nodule number number of neoplastic nodules, mean volume of lesions and volume fraction were measured in the liver of rats killed at 32 weeks of age following tumor induction by the resistant-hepatocyte protocol of diethylnitrosamine exposure 737884 15185337 COP,F344/N 60998,70509 intercross
738009 rat Sach4 Saccharine consumption QTL 4 4 4.9 .000016 46 36540 D4Rat24 10048 D4Mit20 37100 D4Rat52 Consumption level saccharin preference in separate cage with free choice of water or 7.5 mM saccharine; consumption scores (grams/kg/day) were averaged; the amounts of saccharine consumed every 2 days over two weeks 731213 12972953 3197 Npy WKY,HEP 61103,738038 Alc14,Alc16,Alc15,Alc17 intercross WKYxHEP
738010 rat Lnnr3 Liver neoplastic nodule remodeling QTL 3 2 2.94 41538 D2Rat199 40786 D2Rat187 Liver neoplastic nodule remodeling frequency liver tumor nodule remodeling is characterized by the presence of irregular nodule margins and irregular GST-P enzyme staining pattern, carried out in livers of rats killed at 32 weeks following tumor induction by the resistant-hepatocyte protocol of diethylnitrosamine exposure 737884 15185337 COP,F344/N 60998,70509 intercross
738011 rat Arr9 Anxiety related response QTL 9 8 6.1 35429 D8Rat7 Anxiety response open field inner locomotion performance in elevated plus-maze test for anxiety; this locus concerns the number of times the animal entered into the open and closed arms of the maze 737695 14739700 SHR/Ola,BN-Lx/Cub 61100,61117 Arr3,Arr4,Arr5,Arr6,Arr7,Arr8,Arr10,Arr11 intercross SHR/OlaxBN-Lx/Cub
738012 rat Arr3 Anxiety related response QTL 3 2 3.8 37880 D2Rat94 Anxiety response open field inner locomotion performance in elevated plus-maze test for anxiety; this locus concerns the number of times the animal entered into the open arms of the maze 737695 14739700 SHR/Ola,BN-Lx/Cub 61100,61117 Arr4,Arr5,Arr6,Arr7,Arr8,Arr9,Arr10,Arr11 intercross SHR/OlaxBN-Lx/Cub
738013 rat Alc15 Alcohol consumption QTL 15 2 4.1 .00022 18 38466 D2Rat118 Consumption level alcohol amount in separate cage animals were given 10% ethanol as sole choice; consumption scores (grams/kg/day) were averaged; the amounts of ethanol consumed were measured over 2 days 731213 12972953 WKY,HEP 61103,738038 Alc14,Alc16,Alc17 intercross WKYxHEP
738014 rat Arr15 Anxiety related response QTL 15 8 3.6 .005 32 36327 D8Rat2 Anxiety response plus maze-center activity was measured in the elevated plus maze; average time spent in the center of the maze was analyzed 731213 12972953 WKY,HEP 61103,738038 Arr12,Arr13,Arr14 intercross WKYxHEP
738015 rat Pia9 Pristane induced arthritis QTL 9 4 .048 10561 D4Wox20 Joint/bone inflammation pristane induced arthritis was induced at the age of 8 to 14 weeks by an intradermal injection at the base of the tail with pristane (2,6,10,14-tetramethylpentadecane) and was monitored by a macroscopic scoring system of the four limbs ranging from 0 to 4 (1 point for swelling and redness of one joint, 2 for two joints involved, 3 for more than two joints and 4 for severe arthritis); observations were made twice weekly for 6 weeks 629560 12571866 DA.PVG.1AV1-(D4Mgh17-D4Rat56) 737859 Pia5
738016 rat Alc16 Alcohol consumption QTL 16 4 3.6 .00015 35 36540 D4Rat24 10048 D4Mit20 35070 D4Rat57 Consumption level alcohol preference in separate cage with free choice of water or 10% ethanol solution; consumption scores (grams/kg/day) were averaged; the amounts of ethanol consumed were measured every 2 days over two weeks 731213 12972953 3197 Npy WKY,HEP 61103,738038 Alc14,Sach4,Alc15,Alc17 intercross WKYxHEP
738017 rat Hcs7 Hepatocarcinoma susceptibility QTL 7 15 2.91 38922 D15Rat38 41114 D15Rat89 35350 D15Rat3 Liver tumor susceptibility nodule number number of neoplastic nodules, mean volume of lesions and volume fraction were measured in the liver of rats killed at 32 weeks of age following tumor induction by the resistant-hepatocyte protocol of diethylnitrosamine exposure 737884 15185337 COP,F344/N 60998,70509 intercross
738018 rat Arr4 Anxiety related response QTL 4 5 5.1 35348 D5Rat45 Anxiety response open field inner locomotion performance in elevated plus-maze test for anxiety; this locus concerns the number of times the animal entered into the open field of the maze 737695 14739700 SHR/Ola,BN-Lx/Cub 61100,61117 Arr3, Arr5, Arr6, Arr7, Arr8, Arr9, Arr10, Arr11 intercross SHR/OlaxBN-Lx/Cub
738019 rat Arr10 Anxiety related response QTL 10 3 3.9 39912 D3Rat180 Anxiety response open field inner locomotion performance in elevated plus-maze test for anxiety; this locus concerns the number of times the animal entered into the open and closed arms of the maze 737695 14739700 SHR/Ola,BN-Lx/Cub 61100,61117 Arr3, Arr4, Arr5, Arr6, Arr7, Arr8, Arr9, Arr11 intercross SHR/OlaxBN-Lx/Cub
738020 rat Pia8 Pristane induced arthritis QTL 8 1 4.7 34035 D1Mit15 11144 D1Wox11 34662 D1Mgh2 Joint/bone inflammation pristane induced arthritis was induced at the age of 8 to 14 weeks by an intradermal injection at the base of the tail with pristane (2,6,10,14-tetramethylpentadecane) and was monitored by a macroscopic scoring system of the four limbs ranging from 0 to 4 (1 point for swelling and redness of one joint, 2 for two joints involved, 3 for more than two joints and 4 for severe arthritis) 629570 11090241 45992 DA,DXE3/Han 60997,631161 dominant intercross
738021 rat Hcr13 Hepatocarcinoma resistance QTL 13 4 4.3 41102 D4Rat151 41578 D4Rat145 Liver tumor resistance nodule number number of neoplastic nodules, mean volume of lesions and volume fraction were measured in the liver of rats killed at 32 weeks of age following tumor induction by the resistant-hepatocyte protocol of diethylnitrosamine exposure 737884 15185337 COP,F344/N 60998,70509 intercross
738022 rat Arr13 Anxiety related response QTL 13 1 4.6 .00039 24 34381 D1Mgh7 Anxiety response open field inner locomotion activity was measured in the open field enclosure; average time spent in the inner squares of the open field was analyzed 731213 12972953 WKY,HEP 61103,738038 Arr12,Arr14,Arr15 intercross WKYxHEP
738023 rat Alc17 Alcohol consumption QTL 17 6 3.1 .003 38 35963 D6Rat46 Consumption level alcohol preference in separate cage with free choice of water or 10% ethanol solution; consumption scores (grams/kg/day) were averaged; the amounts of ethanol consumed was measured every 2 days over two weeks 731213 12972953 WKY,HEP 61103,738038 Alc14,Sach4,Sach5,Alc15,Alc16 intercross WKYxHEP
738024 rat Sach5 Saccharine consumption QTL 5 6 3.9 .00039 31 40624 D6Rat148 Consumption level saccharin preference in separate cage with free choice of water or 7.5 mM saccharine solution; consumption scores (grams/kg/day) were averaged; the amounts of saccharine consumed were measured every 2 days over two weeks 731213 12972953 WKY,HEP 61103,738038 Alc14,Sach4,Alc15,Alc16,Alc17 intercross WKYxHEP
738025 rat Sr3 Stress response QTL 3 X 4.61 .0066 40448 DXRat127 10609 DXWox31 41530 DXRat104 Stress response defensive burying - approach behavioral response to a stressful stimulus was measured with the defensive burying test; this trait concerns the number of approaches made to an electrical stimulus before beginning the defensive burying response 737687 14722724 WKY,F344/N 61103,70509 additive Arr3,Arr4 intercross WKYxF344
738026 rat Lnnr5 Liver neoplastic nodule remodeling QTL 5 13 3.29 33733 D13Mit2 40568 D13Rat152 36506 D13Rat32 Liver neoplastic nodule remodeling frequency liver tumor nodule remodeling is characterized by the presence of irregular nodule margins and irregular GST-P enzyme staining pattern, carried out in livers of rats killed at 32 weeks following tumor induction by the resistant-hepatocyte protocol of diethylnitrosamine exposure 737884 15185337 COP,F344/N 60998,70509 intercross
738027 rat Lnnr6 Liver neoplastic nodule remodeling QTL 6 13 3.3 36506 D13Rat32 40568 D13Rat152 40568 D13Rat152 Liver neoplastic nodule remodeling frequency liver tumor nodule remodeling is characterized by the presence of irregular nodule margins and irregular GST-P enzyme staining pattern, carried out in livers of rats killed at 32 weeks following tumor induction by the resistant-hepatocyte protocol of diethylnitrosamine exposure 737884 15185337 COP,F344/N 60998,70509 intercross
738028 rat Arr12 Anxiety related response QTL 12 1 4.9 .00001 29 34074 D1Mgh8 Anxiety response plus maze-center activity was measured in the elevated plus maze; average time spent in the center of the maze 731213 12972953 WKY,HEP 61103,738038 Arr13,Arr14,Arr15 intercross WKYxHEP
738029 rat Sr2 Stress response QTL 2 X 3.4 .0004 39210 DXRat64 10558 DXWox30 40448 DXRat127 Stress response defensive burying - approach behavioral response to a stressful stimulus was measured with the defensive burying test; the approach trait concerns the number of approaches made to an electrical stimulus before beginning the defensive burying response 737687 14722724 WKY,F344/N 61103,70509 additive Arr3,Arr5 intercross WKYxF344
738030 rat Arr8 Anxiety related response QTL 8 7 4.1 38606 D7Rat110 Anxiety response open field inner locomotion performance in elevated plus-maze test for anxiety; this locus concerns the number of times the animal entered into the open and closed arms of the maze 737695 14739700 SHR/Ola,BN-Lx/Cub 61100,61117 Arr3,Arr4,Arr5,Arr6,Arr7,Arr9,Arr10,Arr11 intercross SHR/OlaxBN-Lx/Cub
738031 rat Alc14 Alcohol consumption QTL 14 4 7.6 .00003 61 36540 D4Rat24 10048 D4Mit20 37868 D4Rat124 Consumption level alcohol preference in separate cage with free choice of water or 5% ethanol; consumption scores (grams/kg/day) were averaged; the amounts of ethanol consumed every 2 days over two weeks 731213 12972953 3197 Npy WKY,HEP 61103,738038 Alc16,Sach4,Alc15,Alc17 intercross WKYxHEP
738032 rat Hcs5 Hepatocarcinoma susceptibility QTL 5 1 3.12 40486 D1Rat437 36169 D1Rat89 35945 D1Rat75 Liver tumor susceptibility nodule number number of neoplastic nodules, mean volume of lesions and volume fraction were measured in the liver of rats killed at 32 weeks of age following tumor induction by the resistant-hepatocyte protocol of diethylnitrosamine exposure 737884 15185337 COP,F344/N 60998,70509 intercross
738033 rat Arr6 Anxiety related response QTL 6 7 4.1 39578 D6Rat117 Anxiety response open field inner locomotion performance in elevated plus-maze test for anxiety; this locus concerns the number of times the animal entered into the open arms of the maze 737695 14739700 SHR/Ola,BN-Lx/Cub 61100,61117 Arr3,Arr4,Arr5,Arr7,Arr8,Arr9,Arr10,Arr11 intercross SHR/OlaxBN-Lx/Cub
738034 rat Arr5 Anxiety related response QTL 5 6 5.9 39578 D6Rat117 Anxiety response open field inner locomotion performance in elevated plus-maze test for anxiety; this locus concerns the number of times the animal entered into the open arms of the maze 737695 14739700 SHR/Ola,BN-Lx/Cub 61100,61117 Arr3,Arr4,Arr6,Arr7,Arr8,Arr9,Arr10,Arr11 intercross SHR/OlaxBN-Lx/Cub
738035 rat Sr1 Stress response QTL 1 X 4.96 .000011 38374 DXRat67 39210 DXRat64 38374 DXRat67 Stress response defensive burying - coping animals behavioral response to a stressful stimulus was measured with the defensive burying test; the coping trait concerns the latency to and duration of the defensive burying response to an electric shock 737687 14722724 WKY,F344/N 61103,70509 Arr4,Arr5 intercross WKYxF344
738036 rat Lnnr4 Liver neoplastic nodule remodeling QTL 4 13 3.64 35543 D13Rat21 35975 D13Rat7 Liver neoplastic nodule remodeling frequency liver tumor nodule remodeling is characterized by the presence of irregular nodule margins and irregular GST-P enzyme staining pattern, carried out in livers of rats killed at 32 weeks following tumor induction by the resistant-hepatocyte protocol of diethylnitrosamine exposure 737884 15185337 COP,F344/N 60998,70509 intercross
738037 rat Hcs6 Hepatocarcinoma susceptibility QTL 6 14 2.93 35713 D14Rat11 41138 D14Rat94 37828 D14Rat39 Liver tumor susceptibility nodule number number of neoplastic nodules, mean volume of lesions and volume fraction were measured in the liver of rats killed at 32 weeks of age following tumor induction by the resistant-hepatocyte protocol of diethylnitrosamine exposure 737884 15185337 COP,F344/N 60998,70509 intercross
1298485 human RA24_H Rheumatoid arthritis QTL 24 (human) 14 .0373 1298291 D14S587 Joint/bone inflammation rheumatoid arthritis genome-wide linkage scans were examined in families with at least two siblings diagnosed with rheumatoid arthritis with onset between 18 and 60 years of age 738125 11254450 dominant
1298486 human BW3_H Body weight QTL 3 (human) 1 2.09 .00095 1298138 D1S468 Body weight body mass index genome wide scan for linkage to body mass index greater or equal to 30 kg/m*m in individuals that were identified through a proband with a bone mineral density Z score less than -1.28 738102 11923910
1298487 human BFD1_H Body fluid distribution QTL 1 (human) 3 3.94 1298321 D3S2432 1298245 D3S2406 1298325 D3S2409 Body fluid distribution impedance ratio genome-wide scan for loci affecting body fluid distribution (bioelectrical impedance ratio) in 150 African American affected sib pairs with essential hypertension 738096 12411455
1298488 human RA26_H Rheumatoid arthritis QTL 26 (human) 16 .0316 1298327 D16S2624 1298258 D16S516 Joint/bone inflammation rheumatoid arthritis genome-wide linkage scans were examined in families with at least two siblings diagnosed with rheumatoid arthritis with onset between 18 and 60 years of age 738125 11254450 dominant
1298489 human RA4_H Rheumatoid arthritis QTL 4 (human) 3 .0283 1298239 D3S1768 1298237 D3S2384 Joint/bone inflammation rheumatoid arthritis genome-wide linkage scans were examined in families with at least two siblings diagnosed with rheumatoid arthritis with onset between 18 and 60 years of age 738125 11254450 dominant
1298490 human OA22_H Osteoarthritis QTL 22 (human) 6 2.9 1298106 D6S1610 1298112 D6S314 1298111 D6S462 Joint/bone inflammation hip osteoarthritis genome-wide linkage scans were examined in families with at least two siblings who had undergone total hip or knee replacement for primary ideopathic osteoarthritis 1298025 10577938 OA16_H
1298491 human BP5_H Blood pressure QTL 5 (human) 1 2.96 1298129 D1S1679 Blood pressure diastolic genome-wide scan for loci affecting blood pressure in 160 white families from the GenNet network of the NHLBI sponsored Family Blood Pressure Program 738097 12559684
1298492 human BP31_H Blood pressure QTL 31 (human) 11 2.07 1298253 D11S1392 1298267 D11S4464 1298333 D11S1985 Blood pressure systolic genome-wide linkage scan for loci affecting blood pressure in rural Chinese sibling pairs with blood pressure extremes 1298213 10330357
1298493 human RA31_H Rheumatoid arthritis QTL 31 (human) X .016 1298286 DXS6807 Joint/bone inflammation rheumatoid arthritis genome-wide linkage scans were examined in families with at least two siblings diagnosed with rheumatoid arthritis with onset between 18 and 60 years of age 738125 11254450 dominant
1298494 human OA12_H Osteoarthritis QTL 12 (human) 2 1.48 .0007 1298197 D2S397 1298121 D2S2184 1298132 D2S1399 Joint/bone inflammation distal interphalangeal joint osteoarthritis genome-wide scan of 64 Finnish patients diagnosed with osteoarthritis of interphalangeal or metacarpophalangeal joints were compared with members of 16 unaffected Finnish core families 738112 10486325 dominant OA10_H,OA11_H
1298495 human OA27_H Osteoarthritis QTL 27 (human) 16 1.7 Joint/bone inflammation hip osteoarthritis genome-wide linkage scans were examined in families with at least two siblings who had undergone total hip or knee replacement for primary ideopathic osteoarthritis 738108 14730605
1298496 human BW11_H Body weight QTL 11 (human) 3 4.3 .000004 1298124 D3S3676 1298169 D3S2427 Body weight body mass index genome-wide linkage analysis for obesity in African American individuals 738104 12716766
737973 rat Pia21 Pristane induced arthritis QTL 21 20 3.3 11428 D20Wox3 37594 D20Rat41 Joint/bone inflammation pristane induced arthritis was induced at the age of 8-12 week by an intradermal injection at the base of the tail with pristane (2,6,10,14-tetramethylpentadecane) and was monitored by a macroscopic scoring system of the four limbs ranging from 0 to 15 (1 point for each swollen or red toe, 1 point for midfoot digit and knuckle, and 5 points for a swollen ankle) DA.E3-(D20Wox3-D20Mgh4)/Rhd 737870 dominant Pia1
737974 rat Bp161 Blood pressure QTL 161 1 .002 10923 D1Wox19 10165 D1Wox34 Blood pressure systolic systolic and diastolic blood pressures measured directly in 25 week old males through arterial cathetor inserted into the lower abdominal aorta 61051 9774356 SHR.WKY-(D1Wox19-D1Wox34),SHR.WKY-(D1Wox19-D1Wox34) 629487,1298094 Bp29, Bp160
737975 rat Niddm60 Non-insulin dependent diabetes mellitus QTL 60 1 9.11 .005 42553 D1Rat461 42550 D1Rat459 35457 D1Rat90 Body weight abdominal fat weight Measurements of animals at 18 weeks of age were taken as an index of obesity 737696 14756694 OLETF.BN-(D1Rat461-D1Rat459)/Got,OLETF.BN-(D1Rat461-D1Rat459)/Got 737869,1298531 Niddm58
737976 rat Pia24 Pristane induced arthritis QTL 24 6 44173 D6Wox5 37718 D6Rat90 Joint/bone inflammation pristane induced arthritis was induced at the age of 8 to 12 week by an intradermal injection at the base of the tail with pristane (2,6,10,14-tetramethylpentadecane) and was monitored by a macroscopic scoring system of the four limbs ranging from 0 to 15 (1 point for each swollen or red toe, 1 point for midfoot digit and knuckle, and 5 points for a swollen ankle) 728382 14611807 DA.E3-(D6Wox5-D6Rat90)/Rhd 737873 Pia3
737977 rat Bp160 Blood pressure QTL 160 1 .001 10923 D1Wox19 34011 D1Mit2 Blood pressure systolic systolic and diastolic blood pressures measured directly in 25 week old males through arterial cathetor inserted into the lower abdominal aorta 61051 9774356 WKY.SHR-(D1Wox19-D1Mit2),WKY.SHR-(D1Wox19-D1Mit2) 629482,1298095 Bp29, Bp161
737978 rat Pia23 Pristane induced arthritis QTL 23 4 5.3 10158 D4Arb16 34338 D4Mgh11 36143 D4Rat60 Joint/bone inflammation pristane induced arthritis was induced at the age of 8 to 12 week by an intradermal injection at the base of the tail with pristane (2,6,10,14-tetramethylpentadecane) and was monitored by a macroscopic scoring system of the four limbs ranging from 0 to 15 (1 point for each swollen or red toe, 1 point for midfoot digit and knuckle, and 5 points for a swollen ankle) DA.E3-(D4Mit16-D4Mgh11)/Rhd 737872 dominant Pia7
737979 rat Pia22 Pristane induced arthritis QTL 22 12 4.1 40986 D12Rat72 Joint/bone inflammation pristane induced arthritis was induced at the age of 8-12 week by an intradermal injection at the base of the tail with pristane (2,6,10,14-tetramethylpentadecane) and was monitored by a macroscopic scoring system of the four limbs ranging from 0 to 15 (1 point for each swollen or red toe, 1 point for midfoot digit and knuckle, and 5 points for a swollen ankle) 61307 Ncf1 DA.E3-(D12Got46-D12Rat26)/Rhd 737871 dominant Pia4
1298497 human BW10_H Body weight QTL 10 (human) 3 1.8 .002 1298153 D3S2477 Body weight body mass index genome wide scan for obesity in African Americans who were recruited as part of a blood pressure program 738103 11812767
1298498 human BP33_H Blood pressure QTL 33 (human) 16 2.74 1298279 D16S748 1298322 D16S2824 1298287 D16S3396 Blood pressure systolic genome-wide linkage scan for loci affecting blood pressure in rural Chinese sibling pairs with blood pressure extremes 1298213 10330357
1298499 human UAE1_H Urinary albumin excretion QTL 1 (human) 19 2.73 .0009 1298107 D19S1166 Urinary albumin excretion urine albumin:creatinine ratio (ACR) genome-wide scan for loci affecting urinary albumin excretion in 2589 individuals from 805 hypertensive families in the Family Blood Pressure Program 738099 12925555
1298500 human RA19_H Rheumatoid arthritis QTL 19 (human) 11 .0258 1298235 D11S1998 Joint/bone inflammation rheumatoid arthritis genome-wide linkage scans were examined in families with at least two siblings diagnosed with rheumatoid arthritis with onset between 18 and 60 years of age 738125 11254450 dominant
1298501 human RA25_H Rheumatoid arthritis QTL 25 (human) 16 .0042 1298329 D16S403 Joint/bone inflammation rheumatoid arthritis genome-wide linkage scans were examined in families with at least two siblings diagnosed with rheumatoid arthritis with onset between 18 and 60 years of age 738125 11254450 dominant
1298502 human OA3_H Osteoarthritis QTL 3 (human) 7 2.32 1298142 D7S1806 1298099 D7S2846 1298114 D7S817 Joint/bone inflammation hand osteoarthritis two generations of subjects from the Framingham Heart Study diagnosed with joint space narrowing in the hand underwent genome-wide scans for longitudinal study of hand osteoarthritis 1285226 11953971
1298503 human BW20_H Body weight QTL 20 (human) 8 3.43 1298265 D8S1179 1298150 D8S373 1298230 D8S1128 Body weight body mass index body weight and body mass index, plasma insulin, and pancreatic morphology were assessed; body mass index was calculated from body weight and nasoanal body length; plasma glucose concentration was determined by glucose oxidase assay 738096 12411455
1298504 human OA15_H Osteoarthritis QTL 15 (human) 9 2.23 .03 1298108 D9S1850 1298115 DBH 1298165 D9S915 Joint/bone inflammation distal interphalangeal joint osteoarthritis genome-wide scan of 64 Finnish patients diagnosed with osteoarthritis of interphalangeal or metacarpophalangeal joints were compared with members of 16 unaffected Finnish core families 738112 10486325 recessive
1298505 human BW5_H Body weight QTL 5 (human) 6 1.77 .0021 1298145 D6S281 Body weight body mass index genome wide scan for linkage to body mass index greater or equal to 30 kg/m*m in individuals that were identified through a proband with a bone mineral density Z score less than -1.28 738102 11923910
1298506 human RA15_H Rheumatoid arthritis QTL 15 (human) 8 .0187 1298285 D8S1110 Joint/bone inflammation rheumatoid arthritis genome-wide linkage scans were examined in families with at least two siblings diagnosed with rheumatoid arthritis with onset between 18 and 60 years of age 738125 11254450 dominant
1298507 human BW8_H Body weight QTL 8 (human) 5 1.9 .0017 1298186 D5S817 Body weight body mass index Genome wide scan for obesity in African Americans who were recruited as part of a blood pressure program 738103 11812767
1298508 human RA10_H Rheumatoid arthritis QTL 10 (human) 5 .0079 1298254 D5S1501 1298261 D5S1462 Joint/bone inflammation rheumatoid arthritis genome-wide linkage scans were examined in families with at least two siblings diagnosed with rheumatoid arthritis with onset between 18 and 60 years of age 738125 11254450 dominant
1298509 human RA21_H Rheumatoid arthritis QTL 21 (human) 12 .0051 1298304 D12S398 Joint/bone inflammation rheumatoid arthritis genome-wide linkage scans were examined in families with at least two siblings diagnosed with rheumatoid arthritis with onset between 18 and 60 years of age 738125 11254450 dominant
1298510 human RA28_H Rheumatoid arthritis QTL 28 (human) 17 .0054 1298272 D17S2180 Joint/bone inflammation rheumatoid arthritis genome-wide linkage scans were examined in families with at least two siblings diagnosed with rheumatoid arthritis with onset between 18 and 60 years of age 738125 11254450 dominant
1298511 human RA3_H Rheumatoid arthritis QTL 3 (human) 3 .0139 1298316 D3S3038 Joint/bone inflammation rheumatoid arthritis genome-wide linkage scans were examined in families with at least two siblings diagnosed with rheumatoid arthritis with onset between 18 and 60 years of age 738125 11254450 dominant
1298512 human RA29_H Rheumatoid arthritis QTL 29 (human) 17 .0017 1298312 D17S1301 Joint/bone inflammation rheumatoid arthritis genome-wide linkage scans were examined in families with at least two siblings diagnosed with rheumatoid arthritis with onset between 18 and 60 years of age 738125 11254450 dominant
1298513 human BP22_H Blood pressure QTL 22 (human) 11 .004 1298323 D11S934 Blood pressure hypertension susceptibility genome wide scan for loci affecting susceptibility to essential hypertension in Caucasian affected sib pairs from East Anglia UK 1298032 10856279
1298514 human RA13_H Rheumatoid arthritis QTL 13 (human) 6 .0075 1298206 D6S1021 Joint/bone inflammation rheumatoid arthritis genome-wide linkage scans were examined in families with at least two siblings diagnosed with rheumatoid arthritis with onset between 18 and 60 years of age 738125 11254450 dominant
1298515 human PEE1_H Pre-eclampsia/eclampsia QTL 1 (human) 2 4.7 1298163 D2S292 1298130 D2S329 1298185 D2S286 Pre-eclampsia/elampsia pre-eclampsia susceptibility genome-wide scan for loci contributing to pre-eclampsia in Icelandic families with 343 affected women 738129 10441346
1298524 rat Oia8 Oil induced arthritis QTL 8 4 34174 D4Mgh7 33778 D4Mit21 34473 D4Mgh10 Joint/bone inflammation oil induced arthritis severity after adjuvant injection was measured via a cumulative scoring system for multiple joints; animals were evaluated twice a week for six weeks 629560 12571866 DA.PVG.1AV1-(D4Rat63-D4Rat203) 737861 Oia2
1298525 rat Cm1 Cardiac mass QTL 1 7 2.7 62494 D7UIA1 66593 D7Mco1 Cardiac mass heart weight was measured in rats fed a diet containing 8% NaCl and was adjusted for 69710 9383281 SR/Jr,SS/Jr 10040,10041 Bp61
1298526 rat Arc3 Aerobic running capacity QTL 3 3 2.2 35981 D3Rat56 38346 D3Rat98 35981 D3Rat56 Aerobic running capacity genome-wide scan of male animals after testing for maximal endurance capacity on a ramped treadmill at a constant slope of 15 degrees; starting velocity of 10 m/min was increased by 1m/min every 2 minutes; rats were run until exhausted 619535 12079278 COP/OlaHsd,DA/OlaHsd 10011,734475 dominant Arc2
1298527 rat Arc2 Aerobic running capacity QTL 2 16 2.9 37174 D16Rat42 36608 D16Rat48 41324 D16Rat55 Aerobic running capacity genome-wide scan of male animals after testing for maximal endurance capacity on a ramped treadmill at a constant slope of 15 degrees; starting velocity of 10 m/min was increased by 1m/min every 2 minutes; rats were run until exhausted 619535 12079278 COP/OlaHsd,DA/OlaHsd 10011,734475 dominant Arc2,Arc3
1298528 rat Bp169 Blood pressure QTL 169 7 .0001 66604 D7Mco7 39956 D7Rat131 Blood pressure salt-loaded systolic systolic blood pressure was measured by tail-cuff method in rats fed a diet containing 2% NaCl 69711 11247666 SS.SR-Cyp11b1/Jr 1298532 Bp61
1298529 rat Arc1 Aerobic running capacity QTL 1 16 4 35280 D16Rat19 39838 D16Rat109 37054 D16Rat17 Aerobic running capacity genome-wide scan of male animals after testing for maximal endurance capacity on a ramped treadmill at a constant slope of 15 degrees; starting velocity of 10 m/min was increased by 1m/min every 2 minutes; rats were run until exhausted 619535 12079278 2061,3199 Adrb3,Npy5r COP/OlaHsd,DA/OlaHsd 10011,734475 dominant Arc2
1299997 human BW17_H Body weight QTL 17 (human) 20 1.5 1298199 D20S178 1298154 D20S149 Body weight body mass index pairwise correlation analyses were conducted on alleles shared identical by descent for independent obese affected sibling pairs 738100 12478478
1299998 human BW12_H Body weight QTL 12 (human) 1 2.32 1298152 D1S214 1298138 D1S468 Body weight body mass index whole-genome scan for obesity in subjects from an osteoporosis database at Creighton University 738106 14764808 Obs3_H
1299999 human BW26_H Body weight QTL 26 (human) 7 2.36 1299890 D7S2847 Body weight body mass index genome wide linkage scan for body mass index in HyperGEN (black) subjects from the National Heart, Lung, and Blood Insititute Family Blood Pressure Program 1285225 11923912
1300000 human BP54_H Blood pressure QTL 54 (human) 14 1.43 .00514 1299943 D14S283 Blood pressure systolic genome-wide scan for loci affecting blood pressure in random and obese families in the Quebec Family Study 1298218 11034945
1300001 human BP26_H Blood pressure QTL 26 (human) 4 3.2 1299893 D4S1572 Blood pressure systolic genome wide scan for loci affecting blood pressure in white Australian sibling pairs from the Victorian Family Heart Study 1298042 11875187
1300002 human BW28_H Body weight QTL 28 (human) 14 2.15 1299930 D14S617 Body weight body mass index genome wide linkage scan for body mass index in HyperGEN (black) subjects from the National Heart, Lung, and Blood Insititute Family Blood Pressure Program 1285225 11923912
1300003 human BW14_H Body weight QTL 14 (human) 6 1.24 1298174 D6S1697 Body fat amount whole-genome scan for obesity in subjects from an osteoporosis database at Creighton University 738106 14764808 Obs5_H
1300004 human BP47_H Blood pressure QTL 47 (human) 5 2.8 .00016 1299894 D5S2488 1298299 D5S1457 1299891 D5S1986 Blood pressure systolic genome-wide scan for loci affecting blood pressure in random and obese families in the Quebec Family Study 1298218 11034945
1300005 human BP49_H Blood pressure QTL 49 (human) 8 2.24 .00066 1299947 D8S1136 1299931 D8S556 730946 CRH Blood pressure systolic genome-wide scan for loci affecting blood pressure in random and obese families in the Quebec Family Study 1298218 11034945
1300006 human BW16_H Body weight QTL 16 (human) 10 1.46 1298123 D10S1646 Body weight body mass index pairwise correlation analyses were conducted on alleles shared identical by descent for independent obese affected sibling pairs 738100 12478478
1300007 human BP29_H Blood pressure QTL 29 (human) 20 736622 PTGIS Blood pressure hypertension susceptibility candidate gene analysis of prostacyclin synthase (human PTGIS) variant in members of a Japanese family with essential hypertension, analysis of other individuals with essential hypertension, and in normal individuals 1298040 12372404
1300008 human BP28_H Blood pressure QTL 28 (human) X 3.3 1299932 DXS993 Blood pressure systolic genome wide scan for loci affecting blood pressure in white Australian sibling pairs from the Victorian Family Heart Study 1298042 11875187
1300009 human BW22_H Body weight QTL 22 (human) 10 2.32 1299888 D10S582 1299925 D10S1766 1299953 TCF8 Body weight body mass index genome-wide scan for linkage to body weight in German obese individuals 1298038 10946912
1300010 human BP27_H Blood pressure QTL 27 (human) 16 3.2 1299892 D16S3068 Blood pressure systolic genome wide scan for loci affecting blood pressure in white Australian sibling pairs from the Victorian Family Heart Study 1298042 11875187
1300011 human BW24_H Body weight QTL 24 (human) 3 2.03 1299906 D3S1259 Body weight body mass index genome wide linkage scan for body mass index in HyperGEN (white) subjects from the National Heart, Lung, and Blood Insititute Family Blood Pressure Program 1285225 11923912
1300012 human BP52_H Blood pressure QTL 52 (human) 10 1.41 .00547 1299918 D10S2325 Blood pressure systolic genome-wide scan for loci affecting blood pressure in random and obese families in the Quebec Family Study 1298218 11034945
1300013 human BP37_H Blood pressure QTL 37 (human) 2 2.96 1298264 D2S324 Blood pressure hypertension susceptibility genome-wide scan for loci affecting hypertension in Finnish affected sib pairs 1298217 11081770
1300014 human BP48_H Blood pressure QTL 48 (human) 7 2.26 .00063 1299946 D7S1875 1299920 D7S3070 1299901 D7S530 Blood pressure systolic genome-wide scan for loci affecting blood pressure in random and obese families in the Quebec Family Study 1298218 11034945
1300015 human BP51_H Blood pressure QTL 51 (human) 3 1.27 .00787 1299926 D3S3045 Blood pressure systolic genome-wide scan for loci affecting blood pressure in random and obese families in the Quebec Family Study 1298218 11034945
1300016 human BW18_H Body weight QTL 18 (human) 7 2.26 .0006 1298158 D7S796 1298178 D7S794 1298139 D7S692 Body weight body mass index linkage and linkage disequilibrium mapping to body mass index in European American families 738105 12765970
1300017 human BW32_H Body weight QTL 32 (human) 18 2.3 .00097 1299911 D18S471 1299942 D18S843 Body weight body mass index genome-wide linkage analysis to identify linkage to obesity in type 2 diabetic Dutch Caucasian siblings 1298537 12727978
1300018 human BW15_H Body weight QTL 15 (human) 4 4.5 .000003 1298204 D4S2639 1298182 D4S1581 1298170 D4S2912 Body weight body mass index genome wide scan for linkage to obesity related traits in Mexican Americans 738107 14740316
1300019 human BP25_H Blood pressure QTL 25 (human) 1 3.5 1299923 D1S2890 Blood pressure systolic genome wide scan for loci affecting blood pressure in white Australian sibling pairs from the Victorian Family Heart Study 1298042 11875187
1300020 human BW31_H Body weight QTL 31 (human) 17 1.87 1299928 D17S2196 Body weight body mass index genome wide linkage scan for body mass index in GENOA (Mexican American) subjects from the National Heart, Lung, and Blood Insititute Family Blood Pressure Program 1285225 11923912
1300021 human BP45_H Blood pressure QTL 45 (human) 1 1.77 .00218 735332 ATP1A1 Blood pressure systolic genome-wide scan for loci affecting blood pressure in random and obese families in the Quebec Family Study 1298218 11034945
1300022 human BW27_H Body weight QTL 27 (human) 7 1.29 1299935 D7S1824 Body weight body mass index genome wide linkage scan for body mass index in GENOA (Mexican American) subjects from the National Heart, Lung, and Blood Insititute Family Blood Pressure Program 1285225 11923912
1300023 human BP46_H Blood pressure QTL 46 (human) 2 2.26 .00062 1299910 D2S2114 1299945 D2S434 1299886 D2S2972 Blood pressure systolic genome-wide scan for loci affecting blood pressure in random and obese families in the Quebec Family Study 1298218 11034945
1300024 human BW25_H Body weight QTL 25 (human) 7 2.66 1299933 D7S3051 Body weight body mass index genome wide linkage scan for body mass index in SAPPHIRe (Asian) subjects from the National Heart, Lung, and Blood Insititute Family Blood Pressure Program 1285225 11923912
1300025 human BP39_H Blood pressure QTL 39 (human) X 2.41 1298241 DXS6810 Blood pressure hypertension susceptibility genome-wide scan for loci affecting hypertension in Finnish affected sib pairs 1298217 11081770
631269 rat Cia22 Type II Collagen induced arthritis QTL 22 10 8.9 34053 D10Mit3 61275 D10Arb22 34485 D10Mgh4 Joint/bone inflammation type II collagen induced 631168 11003387 BN/SsNHsd 10008 Cia5, Cia20, Cia21, Cia23,Cia23
631270 rat Cia23 Type II Collagen induced arthritis QTL 23 10 3.9 34053 D10Mit3 61275 D10Arb22 34485 D10Mgh4 Joint/bone inflammation type II collagen induced 631168 11003387 BN/SsNHsd 10008 Cia5, Cia20, Cia21, Cia22,Cia22
631271 rat Cati1 Cataract Ihara QTL 1 8 .001 36291 D8Rat55 2458 Cyp1a1 Cataract susceptibility the eyes of all the animals were examined from one month after birth for the existence of cataract 68701 11252169 IER,WKY/Izm 631285,631286 recessive intercross IExWKY/Izm
631272 rat Lanf1 Left ventricular atrial natriuretic factor QTL 1 5 12 44.3 39168 D5Rat99 42770 D5Rat245 41070 D5Rat180 Atrial natriuretic factor concentration left ventricular LV apex (1200 mg) were processed in a volume of 2 mL of 0.2 mol/L acetic acid. The extracts were then centrifuged and aliquots of supernatant were assayed 619659 11157676 3193 Nppa WKY/Cfd,WKHA/Cfd 631275,631276 codominant Lvm3 intercross WKY/CfdxWKHA/Cfd
631273 rat Cati2 Cataract Ihara QTL 2 15 .001 37308 D15Rat52 34471 D15Mgh3 Cataract susceptibility time of onset the eyes of all the animals were examined from one month after birth for the existence of cataract 68701 11252169 IER,WKY/Izm 631285,631286 recessive intercross IExWKY/Izm
631274 rat Spl3 Serum phospholipid level QTL 3 18 5.3 33814 D18Mit9 2741 Nr3c1 2715 Gnal Protein level 61055 9199194 BB/OK,SHR/Mol 61107,61110 intercross BB/OK,SHR/Mol
631494 rat Bp95 Blood pressure QTL 95 1 40 .0001 62499 D1UIA8 35517 D1Rat18 37598 D1Rat176 Blood pressure systolic measured once a day for four consecutive days by the tail cuff method on conscious restrained rats 68885 11160999 3720 Slc9a3 SS.LEW-(D1Rat268-D1Got35)/Jr 631571 Bp27,Bp30 intercross SSxLEW
631495 rat Bp96 Blood pressure QTL 96 1 4.52 23.9 34662 D1Mgh2 33686 D1Mit11 34037 D1Mit1 Blood pressure systolic measured by the tail cuff method on conscious rats 619642 9449402 SBH/Ygl,SBN/Ygl 631572,631573 additive intercross SBH/yxSBN/y
631496 rat Bp97 Blood pressure QTL 97 1 3.08 30 34381 D1Mgh7 33646 D1Mit4 34011 D1Mit2 Blood pressure systolic measured by the tail cuff method on conscious rats 619642 9449402 SBH/Ygl,SBN/Ygl 631572,631573 additive intercross SBH/yxSBN/y
631497 rat Bp98 Blood pressure QTL 98 17 3.66 12.6 34369 D17Mgh4 10348 D17Mit4 34120 D17Mgh5 Blood pressure systolic measured by the tail cuff method on conscious rats 619642 9449402 SBH/Ygl,SBN/Ygl 631572,631573 additive intercross SBH/yxSBN/y
631498 rat Bp100 Blood pressure QTL 100 5 4.9 .001 13.5 3193 Nppa 3194 Nppb 3194 Nppb Blood pressure systolic 619655 9171954 SHR,WKY 61000,61103 backcross SHRxWKY
631499 rat Stl1 Serum triglyceride level QTL 1 17 3.6 2091 Aldoc 45450 D17Wox3 34276 D17Mgh2 Lipid level triglyceride 619656 11414700 SHR/Mol,Wild 61110,631574 backcross WildxSHR/Mol
631500 rat Bp99 Blood pressure QTL 99 2 2.5 6.9 2391 Cpb1 3407 Prlr 2071 Agtr1b Blood pressure systolic measured by the tail cuff method 619650 7852741 SS/Jr.AS 631575 intercross SS/JrxAS
631501 rat Bp101 Blood pressure QTL 101 2 2.4 34461 D2Mgh12 33747 D2Mit10 33747 D2Mit10 Blood pressure systolic measured by the tail cuff method on conscious rats 619656 11414700 SHR/Mol,Wild 61110,631574 dominant backcross WildxSHR/Mol
631502 rat Cm26 Cardiac mass QTL 26 17 3.71 34989 D17Rat39 35827 D17Rat52 35827 D17Rat52 Cardiac mass left ventricle at 24 wk of age, ventricular mass was determined by removing the whole heart, excising the atria, and dissecting the right ventricular wall from the LV and interventricular septum; ventricles were blotted dry of blood before they were weighed 619658 11045938 LEW/Crj,SHR/Izm 631576,631577 dominant intercross LEW/CrjxSHR/Izm
631503 rat Bp102 Blood pressure QTL 102 7 1.9 2868 Igf1 Blood pressure systolic measured by the tail cuff method on conscious rats 619656 11414700 SHR/Mol,Wild 61110,631574 recessive backcross WildxSHR/Mol
631504 rat Cm27 Cardiac mass QTL 27 7 3.45 35122 D7Rat9 37258 D7Rat107 37642 D7Rat112 Cardiac mass left ventricle at 24 wk of age, ventricular mass was determined by removing the whole heart, excising the atria, and dissecting the right ventricular wall from the LV and interventricular septum; ventricles were blotted dry of blood before they were weighed; mean arterial pressure was measured by direct intra-arterial method in conscious rats 619658 11045938 LEW/Crj,SHR/Izm 631576,631577 codominant intercross LEW/CrjxSHR/Izm
631505 rat Bp103 Blood pressure QTL 103 5 3.2 3704 Slc2a1 34248 D5Mgh9 34443 D5Mgh8 Blood pressure systolic measured by the tail cuff method on conscious rats 619656 11414700 SHR/Mol,Wild 61110,631574 recessive backcross WildxSHR/Mol
631506 rat Bp104 Blood pressure QTL 104 11 2.8 10376 D11Wox6 34112 D11Mgh4 3761 Sst Blood pressure systolic measured by the tail cuff method on conscious rats 619656 11414700 SHR/Mol,Wild 61110,631574 recessive backcross WildxSHR/Mol
631507 rat Bp105 Blood pressure QTL 105 2 .001 38626 D2Rat171 67315 D2Arb24 Blood pressure arterial blood pressures measured in conscious, unrestrained male rats 619651 11403354 SHR/Ola.BN/Cr-(D2Rat171-D2Arb24)/Ipcv 631578 intercross
631508 rat Sald1 Serum aldosterone level QTL 1 1 3.7 36640 D1Rat14 Hormone level aldosterone, females serum aldosterone levels were measured in fasting blood samples taken from female 11 week old rats fed a high cholesterol|| high oil diet for 4 weeks 629577 12482837 BC/Cpbu,LEW/OlaHsd 10004,631579 BC/CpbuxLEW/OlaHsd
631509 rat Sald2 Serum aldosterone level QTL 2 18 2.9 37568 D18Rat55 35977 D18Rat8 Hormone level aldosterone, females serum aldosterone levels were measured in fasting blood samples taken from female 11 week old rats fed a high cholesterol|| high oil diet for 4 weeks 629577 12482837 BC/Cpbu,LEW/OlaHsd 10004,631579 BC/CpbuxLEW/OlaHsd
631510 rat Spl2 Serum phospholipid level QTL 2 11 4.1 35096 D11Rat10 Lipid level phospholipid serum phospholipids were measured in fasting blood samples taken from 11 week old rats fed a high cholesterol, high oil diet for 4 weeks 629577 12482837 BC/Cpbu,LEW/OlaHsd 10004,631579 BC/CpbuxLEW/OlaHsd
631511 rat Pia7 Pristane induced arthritis QTL 7 4 4.3 10158 D4Arb16 34338 D4Mgh11 36143 D4Rat60 Joint/bone inflammation pristane induced arthritis was induced at the age of 8 to 14 weeks by an intradermal injection at the base of the tail with pristane (2,6,10,14-tetramethylpentadecane) and was monitored by a macroscopic scoring system of the four limbs ranging from 0 to 4 (1 point for swelling and redness of one joint, 2 for two joints involved, 3 for more than two joints and 4 for severe arthritis) 629570 11090241 45974 DA,DXE3/Han 60997,631161 recessive Oia2,Cia13,Oia2 intercross
631512 rat Scl6 Serum cholesterol level QTL 6 1 9.6 35106 D1Rat335 36765 D1Rat27 Lipid level cholesterol baseline serum cholesterol was measured in fasting blood samples taken from 7 week old rats fed a normal (not high fat) diet 629577 12482837 BC/Cpbu,LEW/OlaHsd 10004,631579 BC/CpbuxLEW/OlaHsd
631513 rat Scl7 Serum cholesterol level QTL 7 7 4.1 38198 D7Rat69 Lipid level cholesterol, males baseline serum cholesterol was measured in fasting blood samples taken from 7 week old rats fed a normal (not high fat) diet 629577 12482837 BC/Cpbu,LEW/OlaHsd 10004,631579 BC/CpbuxLEW/OlaHsd
631514 rat Scl8 Serum cholesterol level QTL8 2 4.4 34858 D2Rat69 Lipid level cholesterol post high fat dietary serum cholesterol was measured in fasting blood samples taken from 11 week old rats fed a high cholesterol high oil diet for 4 weeks 629577 12482837 BC/Cpbu,LEW/OlaHsd 10004,631579 BC/CpbuxLEW/OlaHsd
631515 rat Bw10 Body weight QTL 10 10 3.5 10662 D10Wox23 61296 Abp1 34330 D10Mgh2 Body weight body weight was measured at 16, 20, 24, 28 and 29 weeks; plasma insulin were measured on fasting animals at 29 weeks; plasma triglycerides were measured at 8, 10, 18, and 29 weeks 619656 11414700 SHR/Mol,Wild 61110,631574 backcross WildxSHR/Mol
631516 rat Bg1 Blood glucose QTL 1 15 7 34160 D15Mgh5 34471 D15Mgh3 2536 Ednrb Glucose level fasting oral glucose tolerance tests given to male rats to measure fasting and postprandial (30 min after application) plasma glucose levels 619656 11414700 SHR/Mol,Wild 61110,631574 backcross WildxSHR/Mol
631517 rat Scl9 Serum cholesterol level QTL 9 16 3.3 35005 D16Rat6 38370 D16Rat44 Lipid level cholesterol post high fat dietary serum cholesterol was measured in fasting blood samples taken from 11 week old rats fed a high cholesterol high oil diet for 4 weeks 629577 12482837 BC/Cpbu,LEW/OlaHsd 10004,631579 BC/CpbuxLew/OlaHsd
631518 rat Bw11 Body weight QTL 11 18 2.8 3749 Spink1 45561 D18Wox18 45561 D18Wox18 Body weight body weight was measured at 16, 20, 24, 28 and 29 weeks; plasma insulin were measured on fasting animals at 29 weeks; plasma triglycerides were measured at 8, 10, 18, and 29 weeks 619656 11414700 SHR/Mol,Wild 61110,631574 backcross WildxSHR/Mol
631519 rat Pia11 Pristane induced arthritis QTL 11 1 5.3 13 38144 D1Rat185 10951 D1Mit13 34011 D1Mit2 Joint/bone inflammation pristane induced pristane, 150 ul per rat, was injected intradermally at the base of the tail under ether anaesthesia; arthritis development monitored using a microscopic scoring system for each of the four limbs in the entire paw. The maximum total score is thus 16 for each rat by adding up the escores from four paws; rats were observed 1-3 times a week during the experimental period. 631225 12111642 E3,LEW.1F 61013,631581 recessive Pia9 Intercross E3xLEW.1F
631520 rat Bp73 Blood pressure QTL 73 2 .0001 3098 Mme 10584 D2Wox18 Blood pressure systolic 70380,631320 11773968,12661916 70972 Hao2 SS/Jr.WKY-(Mme-D2Wox18)/Mco 631582 Bp10,Bp19 intercross
631521 rat Pia12 Pristane induced arthritis QTL 12 12 8.9 20 35384 D12Rat1 35889 D12Rat10 40986 D12Rat72 Joint/bone inflammation pristane induced pristane, 150 ul per rat, was injected intradermally at the base of the tail under ether anaesthesia; arthritis development monitored using a microscopic scoring system for each of the four limbs in the entire paw; rats were observed 1-3 times a week during the experimental period. 631225 12111642 E3,LEW.1F 61013,631581 recessive Pia4 Intercross E3xLEW.1F
631522 rat Bp74 Blood pressure QTL 74 2 .05 34292 D2Mgh8 34234 D2Mgh9 Blood pressure systolic 70380 11773968 SS/Jr.WKY-(D2Mgh8-D2Mgh9)/Mco 631583 intercross
631523 rat Pia13 Pristane induced arthritis QTL 13 14 3.3 8 34839 D14Rat32 35723 D14Rat25 37230 D14Rat64 Joint/bone inflammation pristane induced pristane, 150 ul per rat, was injected intradermally at the base of the tail under ether anaesthesia; arthritis development monitored using a microscopic scoring system for each of the four limbs in the entire paw. The maximum total score is thus 16 for each rat by adding up the escores from four paws; rats were observed 1-3 times a week during the experimental period. 631225 12111642 E3,LEW.1F 61013,631581 recessive Intercross LEW.1FxE3
631524 rat Bp75 Blood pressure QTL 75 16 .05 35475 D16Rat21 42409 D16Rat112 Blood pressure 70460 11919686 SS.LEW-(D16Uia2-D16Rat12),SS.LEW-(D16Mit2-D16Rat12)/Ayd 631584,631585 backcross
631525 rat Pia14 Pristane induced arthritis QTL 14 16 4.4 19 39390 D16Rat64 60771 D16Wox8 38428 D16Rat53 Joint/bone inflammation pristane induced pristane was injected intradermally at the base of the tail; arthritis development was monitored using a microscopic scoring system for each of the four limbs in the entire paw; maximum total score is thus 16 for each rat by adding up the escores from four paws; rats were observed 1-3 times a week during the experimental period. 631225 12111642 E3,LEW.1F 61013,631581 recessive Pia11 Intercross E3xLEW.1F
631526 rat Bp76 Blood pressure QTL 76 10 .0001 66552 D10Mco1 66563 D10Mco6 3185 Nos2 Blood pressure 619625,619626 9607182,9096100 SS.MNS-(D10Mit11-D10M11Mit119)/Mco,SS/Jr.MNS-(D10Mco17-D10Mco6)/Mco,SS/Jr.MNS-(D10Mco1-D10Mco6)/Mco,SS/Jr.MNS-(D10Mit11-Vamp2)/Mco 629505,631586,631587,631588 backcross
631527 rat Tls1 T-lymphoma susceptibility QTL 1 5 3.5 .001 33981 D5Mit4 11302 D5Mit7 11302 D5Mit7 T-lymphoma susceptibility propylnitrosourea induced T-lymphomas were assayed by both involvement of the thymus and expression of Thy-1.1 antigen on the tumor cells 619600 10360666 F344/N,LEXF 70509,629500 backcross LE/StmxF344
631528 rat Scl11 Serum cholesterol level QTL 11 14 4.9 60764 D14Wox4 2065 Afp 2667 Gc Lipid level cholesterol 619656 11414700 SHR/Mol,Wild 61110,631574 backcross WildxSHR/Mol
631529 rat Tls2 T-lymphoma susceptibility QTL 2 7 13.1 .001 11164 D7Wox24 33648 D7Mit5 33969 D7Mit4 T-lymphoma susceptibility propylnitrosourea induced T-lymphomas were assayed by both involvement of the thymus and expression of Thy-1.1 antigen on the tumor cells 619600 10360666 F344/N,LEXF 70509,629500 backcross LE/StmxF344
631530 rat Tls3 T-lymphoma susceptibility QTL 3 10 6.7 .0001 34100 D10Mgh3 10948 D10Mgh8 34445 D10Mgh6 T-lymphoma susceptibility propylnitrosourea induced T-lymphomas were assayed by both involvement of the thymus and expression of Thy-1.1 antigen on the tumor cells 619600 10360666 F344/N,LEXF 70509,629500 backcross LE/StmxF344
631531 rat Aiid2 Atps induced immunoligical disorder QTL 2 10 6.3 13 35001 D10Rat43 36179 D10Rat34 44715 D10Wox26 Serum IgE level Atps (aurothiopropanol sulfonate) induced F2 rats were injected subcutaneously with 20 mg/Kg body weights of Atps (aurothiopropanol sulfonate) three time a week for 5 weeks 619646 10898507 LEW/Rj,BN/Rj 631593,631594 additive intercross LEW/RjxBN/Rj
631532 rat Cmi1 Cardiac mass index QTL 1 10 6.6 60753 D10Wox3 10949 D10Wox11 34053 D10Mit3 Cardiac mass the cardiac mass index (CMI) was calculated by adjusting the heart weight for body weight by regression within each cross; after sacrificed by an overdose of sodium pentobarbital, the total body weight and heart weight of each rat were measured in grams and milligrams, respectively 619631 10051321 SS/Jr,BN 10041,60985 intercross BN.SS/Jr
631533 rat Aiid3 Atps induced immunoligical disorder QTL 3 9 16.2 31 34264 D9Mgh5 60669 D9Got8 Serum IgE level Atps (aurothiopropanol sulfonate) induced F2 rats were injected subcutaneously with 20 mg/Kg body weights of Atps (aurothiopropanol sulfonate) three time a week for 5 weeks 619646 10898507 LEW/Rj,BN/Rj 631593,631594 additive Eae4 intercross LEW/RjxBN/Rj
631534 rat Lnnr1 Liver neoplastic nodule remodeling QTL 1 7 3.85 .001 36099 D7Rat25 Liver neoplastic nodule remodeling frequency calculation of the percentage of liver tumor nodule remodeling is characterized by the presence of irregular nodule margins and irregular GST-P enzyme staining pattern; carried out in livers of rats killed at 32 weeks following tumor induction by the resistant-hepatocyte protocol of diethylnitrosamine exposure 629574 12672032 3130,2868,3377,2185 Myc,Igf1,Ppp1cc,Avpr1a BN,F344/N 60985,70509 BNxF344
631535 rat Cmi2 Cardiac mass index QTL 2 10 3 10949 D10Wox11 44786 D10Wox6 44773 D10Wox5 Cardiac mass the cardiac mass index (CMI) was calculated by adjusting the heart weight for body weight by regression within each cross; after sacrificed by an overdose of sodium pentobarbital, the total body weight and heart weight of each rat were measured in grams and milligrams, respectively 619631 10051321 SS/Jr,MNS 10041,60992 intercross MNS.SS/Jr
631536 rat Lnnr2 Liver neoplastic nodule remodeling QTL 2 1 2.9 .0005 34194 D1Mgh14 Glucose level 629574 12672032 2456,2056,2059,3400 Cyp17a1,Adra2a,Adrb1,Prkg1 BN,F344/N 60985,70509 recessive BNxF344
631537 rat Oia4 Oil induced arthritis QTL 4 10 35513 D10Rat24 11137 D10Wox17 Joint/bone inflammation oil induced degree of arthritis induction is assayed 14 days after subdermal injection of adjuvant oil squalene; assay consists of scoring animals for degree of joint enlargement at four different joints to form a combined score between 0 and 16 62404 11230175 LEW.1AV1.DA-(D10Rat92-D10Wox17)/Ubc,LEW.1AV1.DA-(D10Rat24-D10Wox17) 631596,737830 Oia3,Oia5,Oia6
631538 rat Oia5 Oil induced arthritis QTL 5 10 11137 D10Wox17 34128 D10Mgh1 Joint/bone inflammation oil induced degree of arthritis induction is assayed 14 days after subdermal injection of adjuvant oil squalene; assay consists of scoring animals for degree of joint enlargement at four different joints to form a combined score between 0 and 16 62404 11230175 LEW.1AV1.DA-(D10Wox17-D10Rat135)/Ubc,LEW.1AV1.DA-(D10Wox17-D10Mgh1) 631597,737829 Oia3,Oia4,Oia6
631539 rat Oia6 Oil induced arthritis QTL 6 10 44836 D10Got154 41584 D10Rat135 Joint/bone inflammation oil induced degree of arthritis induction is assayed 14 days after subdermal injection of adjuvant oil squalene; assay consists of scoring animals for degree of joint enlargement at four different joints to form a combined score between 0 and 16 62404 11230175 LEW.1AV1.DA-(D10Got154-D10Rat135)/Ubc 631598 Oia3,Oia4,Oia5
631540 rat Bw9 Body weight QTL 9 7 4.5 10075 D7Mgh2 34499 D7Mgh7 10937 D7Wox15 Body weight body weight was measured at 16, 20, 24, 28 and 29 weeks; plasma insulin were measured on fasting animals at 29 weeks; plasma triglycerides were measured at 8, 10, 18, and 29 weeks 619631 10051321 SS/Jr,BN 10041,60985 intercross BN.SS/Jr
631541 rat Bp81 Blood pressure QTL 81 3 4 10668 D3Wox4 43691 D3Wox20 34316 D3Mgh2 Blood pressure systolic measured by the tail cuff method with the animals warmed to 28 C either under light ether anesthesia or in a conscious restrained state 619631 10051321 SS/Jr,BN 10041,60985 intercross BNxSS/Jr
631542 rat Bp82 Blood pressure QTL 82 10 6.8 33632 D10Mit10 44839 D10Wox7 11480 D10Wox13 Blood pressure systolic measured by the tail cuff method with the animals warmed to 28 C either under light ether anesthesia or in a conscious restrained state 619631 10051321 SS/Jr,MNS 10041,60992 intercross MNSxSS/Jr
631543 rat Bp83 Blood pressure QTL 83 12 5.8 45014 D12Wox8 33776 D12Mit3 60755 D12Wox16 Blood pressure systolic measured by the tail cuff method with the animals warmed to 28 C either under light ether anesthesia or in a conscious restrained state 619631 10051321 SS/Jr,WKY 10041,61103 intercross MNSxSS/Jr
631544 rat Bp84 Blood pressure QTL 84 1 5.6 21 60784 D1Wox29 3750 Spn 34011 D1Mit2 Blood pressure systolic conscious, restrained animals measured by the tail-cuff method 619634 10604486 WKY/Izm,SHRSP/Izm 631286,631599 intercross SHRSP/IzmxWKY/Izm
631545 rat Bp85 Blood pressure QTL 85 3 3.1 34198 D3Mgh8 34347 D3Mgh16 Blood pressure systolic conscious, restrained animals measured by the tail-cuff method 619634 10604486 WKY/Izm,SHRSP/Izm 631286,631599 intercross SHRSP/IzmxWKY/Izm
631546 rat Bp86 Blood pressure QTL 86 4 3.2 33757 D4Mit2 33905 D4Mit11 Blood pressure systolic conscious, restrained animals measured by the tail-cuff method 619634 10604486 WKY/Izm,SHRSP/Izm 631286,631599 intercross SHRSP/IzmxWKY/Izm
631547 rat Bp87 Blood pressure QTL 87 10 4.5 70513 Gnrhr 33941 D10Mit11 Blood pressure conscious, restrained animals measured by the tail-cuff method 619634 10604486 WKY/Izm,SHRSP/Izm 631286,631599 intercross SHRSP/IzmxWKY/Izm
631548 rat Bp88 Blood pressure QTL 88 1 5 .001 36105 D1Rat51 3640 Scnn1b Blood pressure measured by a radiotelemetric method under anesthesia at 12 weeks of age 619643 10523340 WKY.SHRSP-(Mt1pa-D1Rat200)/Bbb 631600 Bp30 intercross WKYxSHRSP
631549 rat Bp89 Blood pressure QTL 89 1 5.7 36580 D1Rat112 60784 D1Wox29 34011 D1Mit2 Blood pressure 619635 10779121 WKY.SHRSP-(Asgr1-Vamp2) 631601 backcross WKYxSHRSP
631550 rat Bw7 Body weight QTL 7 15 3.6 36313 D15Rat5 40674 D15Rat86 Body weight body weight was measured at 16, 20, 24, 28 and 29 weeks; plasma insulin were measured on fasting animals at 29 weeks; plasma triglycerides were measured at 8, 10, 18, and 29 weeks 629577 12482837 BC/Cpbu,LEW/OlaHsd 10004,631579 BC/CpbuxLEW/OlaHsd
631551 rat Vetf1 Vascular elastic tissue fragility QTL 1 5 5 .0001 37784 D5Rat59 37596 D5Rat118 39686 D5Rat119 Vascular lesion number aorta number of elastic tissue lesions was determined by histological analysis of abdominal aorta dissected from 18 wk old rats 619605 11526202 621017 Lyn GH/Omr,BN/Pit 10016,631602 BN/PitxGH/Omr
631552 rat Vetf2 Vascular elastic tissue fragility QTL 2 10 4.5 .0002 34318 D10Mgh10 10466 D10Mit1 33846 D10Mit2 Vascular lesion number aorta number of elastic tissue lesions was determined by histological analysis of abdominal aorta dissected from 18 wk old rats 619605 11526202 3742 Sparc GH/Omr,BN/Pit 10016,631602 dominant BN/PitxGH/Omr
631553 rat Bp131 Blood pressure QTL 131 5 4.2 .0005 3193 Nppa Blood pressure 69734 11471055 3193 Nppa SHR,WKY 61000,61103 Backcross SHRxWKY
631554 rat Bp133 Blood pressure QTL 133 10 .005 3136 Myh11 3185 Nos2 Blood pressure systolic 619633 7568016 WKY.SHRSP-(Asgr1-Vamp2) 631601 dominant Bp1 backcross WKYxSHRSP
631555 rat Bp134 Blood pressure QTL 134 10 .001 3177 Ngfr 2686 Gh1 Blood pressure salt-loaded systolic 619633 7568016 WKY.SHRSP-(Asgr1-Vamp2) 631601 dominant Bp1 backcross WKYxSHRSP
631556 rat Bp135 Blood pressure QTL 135 4 .05 3197 Npy 3753 Spr 3197 Npy Blood pressure measured three times 24 hours after catheterization in conscious animals 631181 8476428 WKY/Snk,SHR/Snk 631603,631604 dominant intercross WKY/SnkxSHR/Snk
631557 rat Bp136 Blood pressure QTL 136 10 .003 66469 D10Mco58 35513 D10Rat24 Blood pressure 628510 11641286 3185 Nos2 SS/Jr.LEW-(D10Mco38-D10Mco30) 631605 Intercross
631558 rat Bp137 Blood pressure QTL 137 10 .013 35627 D10Rat12 66520 D10Mco70 Blood pressure rats t 40 to 42 days of age were fed a 2% NaCl diet and blood pressure was measured by the tail-cuff method on conscious restrained rats on 4 consecutive days starting on the 24th day on the 2% salt diet. 628510 11641286 SS/Jr.MNS-(D10Mco15-RR1023) 631606 Intercross
631559 rat Hcuc1 Hepatic copper content QTL 1 10 3 Copper level hepatic liver copper concentration (microgram copper per gram dried liver weight) was determined by weighing livers dried overnight at 105 deg after removal from rats at age 11 weeks|| and copper content was assayed using flame atomic absorption spectrophotometry of ashed|| dried tissue dissolved in 6 M HCl 619607 11741328 621684 Atox1 HXB-1-43 68049 SHR/OlaIpcv||BN-Lx/Cub
631560 rat Apr1 Acute phase response QTL 1 12 6.1 11396 D12Mgh11 Alpha1 acid glycoprotein level pristane induced serum level of alpha1 acid glycoprotein determined on day 14 after subdermal injection of pristane 629561 11817600 DA,E3 60997,61013 recessive E3xDA
631561 rat Hcuc2 Hepatic copper content QTL 2 16 2.8 10885 D16Wox9 Copper level hepatic liver copper content was measured by determining wet weight of the liver at age 11 weeks|| dry weight of the same tissue after drying|| and copper content of the dried tissue was assayed by dissolving the tissue in 6 M HCl and using spectrophotometry 619607 11741328 HXB-1-43 68049 SHR/OlaIpcvxBN-Lx/Cub
631562 rat Apr2 Acute phase response QTL 2 5 3.7 11001 D5Wox10 Alpha1 acid glycoprotein level pristane induced serum level of alpha1 inhibitor 3 determined on day 14 after subdermal injection of pristane 629561 11817600 DA,E3 60997,61013 dominant E3xDA
631563 rat Hcuc3 Hepatic copper content QTL 3 2 3.87 37552 D2Rat185 40128 D2Rat241 Copper level hepatic liver copper concentration was determined dried livers from female rats at age 11 weeks|| and copper content was assayed using spectrophotometry of ashed|| dried tissue 629572 12094018 2838 Hsd3b BC/Cpbu,LEW/OlaHsd 10004,631579 recessive BC/CpbuxLEW/OlaHsd
631564 rat Apr3 Acute phase response QTL 3 10 3.9 10794 D10Mgh9 IL-6 level pristane induced 629561 11817600 DA,E3 60997,61013 additive E3xDA
631565 rat Hcuc4 Hepatic copper content QTL 4 10 4.15 36203 D10Rat27 38936 D10Rat98 Copper level hepatic liver copper concentration was determined dried livers from male rats at age 11 weeks|| and copper content was assayed using spectrophotometry of ashed|| dried tissue 629572 12094018 621684 Atox1 BC/Cpbu,LEW/OlaHsd 10004,631579 recessive Hcuc1 BC/CpbuxLEW/OlaHsd
631566 rat Bp90 Blood pressure QTL 90 2 .0001 61323 D2N35 3098 Mme Blood pressure systolic measured daily for four consecutive days by the tail cuff method on the conscious rats 619640 9541488 SS/Jr.WKY-(D2N35-Mme)/Mco 631607 backcross SS/JrxWKY
631567 rat Bp91 Blood pressure QTL 91 10 .0001 33941 D10Mit11 Blood pressure systolic measured daily for four consecutive days by the tail cuff method on the conscious rats 619640 9541488 SS.MNS-(D10Mit11-D10M11Mit119)/Mco 629505 backcross SS/JrxMNS
631568 rat Bp92 Blood pressure QTL 92 3 2.2 35609 D3Rat53 35947 D3Rat45 35609 D3Rat53 Blood pressure salt-loaded systolic measured on two separate days by the tail cuff method on the ether-anesthetized rats fed a diet containing 8% NaCl 61516 11015598 SS/Jr,SHR 10041,61000 additive Bp52 intercross SS/JrxSHR
631569 rat Bp93 Blood pressure QTL 93 1 .0001 34381 D1Mgh7 66611 D1Mco36 Blood pressure systolic measured once a day for four consecutive days by the tail cuff method on conscious restrained rats 68885 11160999 SS.LEW-(D1Got71-D1Mco37) 631609 additive Bp27,Bp30 intercross SSxLEW
631570 rat Bp94 Blood pressure QTL 94 1 .0001 36432 D1Rat35 38296 D1Rat131 Blood pressure systolic measured once a day for four consecutive days by the tail cuff method on conscious restrained rats 68885 11160999 SS.LEW-(D1Rat39-D1Rat131) 631610 additive Bp27,Bp30 backcross SSxLEW
631642 rat Stl2 Serum triglyceride level QTL 2 4 3.3 33656 D4Mit9 2901 Il6 Lipid level triglyceride measured in an automatic analyzer using blood samples obtained by ophthalamic venous plexus puncture in 12 week old males 619667 9633608 BB/OK,SHR/Mol 61107,61110 SHR/MolxBB/OK
631643 rat Bp120 Blood pressure QTL 120 9 3 Blood pressure systolic measured at 13 weeks of age by the tail-cuff method by using the average of three measurements 629623 12569259 WKY/Izm,SHRSP/A3Izm 631286,631691 SHRSP/A3IzmxWKY/Izm
631645 rat Bp121 Blood pressure QTL 121 13 3.3 34351 D13Mgh4 Blood pressure systolic measured at 13 weeks of age by the tail-cuff method by using the average of three measurements 629623 12569259 WKY/Izm,SHRSP/A3Izm 631286,631691 SHRSP/A3IzmxWKY/Izm
631646 rat Stl4 Serum triglyceride level QTL 4 4 6.5 .0001 17.9 33711 D4Mit5 34001 D4Mit17 Lipid level triglyceride tail vein blood was obtained after overnight starvation and triglyceride concentrations measured 631174 12687333 hHTG 631692 intercross hHTGxBN
631647 rat Bp122 Blood pressure QTL 122 3 6.2 34146 D3Mgh6 Blood pressure salt-loaded systolic measured by the tail-cuff method using the average of three measurements in six month old females after 1 month of salt loading by giving the rats drinking water with 1% NaCl 629623 12569259 WKY/Izm,SHRSP/A3Izm 631286,631691 SHRSP/A3IzmxWKY/Izm
631648 rat Stl5 Serum triglyceride level QTL 5 8 4 .0003 41522 D8Rat164 44441 D8Wox3 33913 D8Mit13 Lipid level triglyceride tail vein blood was obtained after overnight starvation and triglyceride concentrations measured 631174 12687333 hHTG 631692 additive intercross hHTGxBN
631649 rat Bp123 Blood pressure QTL 123 3 3.2 34250 D3Mgh12 Blood pressure salt-loaded systolic measured by the tail-cuff method using the average of three measurements in six month old males and females after 1 month of salt loading by giving the rats drinking water with 1% NaCl 629623 12569259 WKY/Izm,SHRSP/A3Izm 631286,631691 SHRSP/A3IzmxWKY/Izm
631650 rat Stl6 Serum triglyceride level QTL 6 8 4 .0019 36235 D8Rat35 34180 D8Mgh1 34415 D8Mgh6 Lipid level triglyceride tail vein blood was obtained after overnight starvation and triglyceride concentrations measured 631174 12687333 hHTG 631692 additive intercross hHTGxBN
631651 rat Bp124 Blood pressure QTL 124 4 3 35409 D4Rat34 Blood pressure systolic measured in male rats at age 8 weeks of age by the tail-cuff method 629623 12569259 WKY/Izm,SHRSP/A3Izm 631286,631691 SHRSP/A3IzmxWKY/Izm
631652 rat Bp106 Blood pressure QTL 106 10 Blood pressure systolic measured after salt loading via radio telemetric transducers implanted in the rat abdominal cavitiy which measured abdominal aortic blood pressure 629620 12566390 WKY.SHRSP-(Shbg-Atp1b2)/Bbb,WKY.SHRSP-(D1Rat200-D1Rat216)/Bbb,WKY.SHRSP-(D1Rat200-D1Rat216)(Shbg-Atp1b2)/Bbb 631693,631694,728139
631653 rat Bp125 Blood pressure QTL 125 8 3.3 33895 D8Mit1 Blood pressure systolic measured at 10 weeks of age by the tail-cuff method 629623 12569259 WKY/Izm,SHRSP/A3Izm 631286,631691 SHRSP/A3IzmxWKY/Izm
631654 rat Bp107 Blood pressure QTL 107 1 Blood pressure systolic measured after salt loading via radio telemetric transducers implanted in the rat abdominal cavitiy which measured abdominal aortic blood pressure 629620 12566390 WKY.SHRSP-(D1Rat200-D1Rat216)/Bbb,WKY.SHRSP-(D1Rat200-D1Rat216)(Shbg-Atp1b2)/Bbb 631694,728139
631655 rat Bp126 Blood pressure QTL 126 15 4 2536 Ednrb Blood pressure systolic measured at 10 weeks of age by the tail-cuff method 629623 12569259 WKY/Izm,SHRSP/A3Izm 631286,631691 SHRSP/A3IzmxWKY/Izm
631656 rat Bp108 Blood pressure QTL 108 9 5.97 .0001 36556 D9Rat10 Blood pressure salt-loaded systolic measured by tail cuff method in 14 week old male rats fed a high salt (4%w/w ) diet from 6 to 14 weeks of age 629621 12775577 SS/JrRkb,SHR/FubRkb 631695,631696 SS/JrRkbxSHR/Rkb
631658 rat Cm7 Cardiac mass QTL 7 1 5.32 .0001 36866 D1Rat73 Cardiac mass aorta relative weight of the dissected descending aorta per body weight was measured in samples dissected from rats killed at 15 weeks of age who were fed a high salt (4% w/w) diet from 6 to 14 weeks of age 629621 12775577 SS/JrRkb,SHR/FubRkb 631695,631696 SS/JrRkbxSHR/Rkb
631660 rat Hcr1 Hepatocarcinoma resistance QTL 1 10 3.4 .0001 34318 D10Mgh10 38062 D10Rat96 36542 D10Rat51 Liver tumor resistance nodule volume neoplastic nodules were measured by the method in livers of rats killed at 32 weeks of age following tumor induction by the resistant-hepatocyte protocol of diethylnitrosamine exposure 619598 10493520 3112,3889 Abcc1,Tp53 BN,F344/N 60985,70509 dominant BNxF344
631662 rat Hcr2 Hepatocarcinoma resistance QTL 2 4 3.1 .0003 11011 D4Mgh4 36554 D4Rat47 35817 D4Rat40 Liver tumor resistance nodule volume neoplastic nodules were measured by the method in livers of rats killed at 32 weeks of age following tumor induction by the resistant-hepatocyte protocol of diethylnitrosamine exposure 619598 10493520 2794,3082,3849 Hgf,Met,Tgfa BN,F344/N 60985,70509 BNxF344
631663 rat Bw6 Body weight QTL 6 7 3.4 39048 D7Rat94 35921 D7Rat12 Body weight body weight was measured at 16, 20, 24, 28 and 29 weeks; plasma insulin were measured on fasting animals at 29 weeks; plasma triglycerides were measured at 8, 10, 18, and 29 weeks 629577 12482837 BC/Cpbu,LEW/OlaHsd 10004,631579 BC/CpbuxLew/OlaHsd
631664 rat Hcr3 Hepatocarcinoma resistance QTL 3 8 2.9 .0005 36161 D8Rat36 11222 D8Mgh3 34870 D8Rat18 Liver tumor resistance nodule volume neoplastic nodules were measured by the method in livers of rats killed at 32 weeks of age following tumor induction by the resistant-hepatocyte protocol of diethylnitrosamine exposure 619598 10493520 2458,2459,3845 Cyp1a1,Cyp1a2,Tf BN,F344/N 60985,70509 BNxF344
631665 rat Bw8 Body weight QTL 8 3 5.5 11499 D3Wox23 11261 D3Wox9 34242 D3Mgh13 Body weight body weight was measured at 16, 20, 24, 28 and 29 weeks; plasma insulin were measured on fasting animals at 29 weeks; plasma triglycerides were measured at 8, 10, 18, and 29 weeks 619631 10051321 SS/Jr,MNS 10041,60992 intercross MNS.SS/Jr
631666 rat Iddm5 Insulin dependent diabetes mellitus QTL 5 X Insulin level 625443 8586150
631667 rat Iddm6 Insulin dependent diabetes mellitus QTL 6 1 Insulin level 625443 8586150
631668 rat Iddm7 Insulin dependent diabetes mellitus QTL 7 X Insulin level 631165 9080298 BBDP/Hri,BN/Mol 631697,631698 BB-DP/HrixBN/Mol
631669 rat Iddm9 Insulin dependent diabetes mellitus QTL 9 1 2.8 .039 10674 D1Mgh12 33844 D1Mit14 10805 D1Mgh13 Insulin level measured by puncturing the opthalmic venous plexus every two weeks from age 12 weeks to 34 weeks in non-diabetics and until diabetes onset in diabetics BB/OK,SHR/Mol 61107,61110 backcross BB/OKxSHR/Mol
631670 rat Iddm10 Insulin dependent diabetes mellitus QTL 10 1 1.9 62086 Sah 3643 Sct 3750 Spn Insulin level measured by puncturing the opthalmic venous plexus every two weeks from age 12 weeks to 34 weeks in non-diabetics and until diabetes onset in diabetics 619674 9858659 BB/OK,SHR/Mol 61107,61110 BB/OKxSHR/Mol
631671 rat Iddm11 Insulin dependent diabetes mellitus QTL 11 4 3.6 43795 D4Wox10 11012 D4Wox22 33711 D4Mit5 Insulin level 61480 9892222 BBDP,WF 10002,61007 WFxBB/DF
631672 rat Iddm12 Insulin dependent diabetes mellitus QTL 12 13 2.2 .0032 33923 D13Mit1 34371 D13Mgh3 34076 D13Mgh1 Insulin level 61480 9892222 2199 Bcl2 BBDP,WF 10002,61007 WFxBB/DF
631673 rat Iddm13 Insulin dependent diabetes mellitus QTL 13 3 1.1 .014 33808 D3Mit4 34240 D3Mgh1 10502 D3Mgh10 Insulin level 61480 9892222 BBDP,WF 10002,61007
631674 rat Iddm14 Insulin dependent diabetes mellitus QTL 14 4 42164 D4Arb29 10524 D4Mit3 Insulin level 61479 10535446 BBDR,WF 10003,61007 BB/DRxWF
631675 rat Iddm15 Insulin dependent diabetes mellitus QTL 15 18 Insulin level rats were diagnosed as diabetic if exhibited glycosuria as measured by Diabur-Test 5000 and displayed a blood glucose concentration of >300mg/dl on two consecutive days 619685 11327715 BB/OK.SHR-(Gnal-D18Mit9) 631700 BB/OKxSHR
631676 rat Cm8 Cardiac mass QTL 8 3 7.03 .0001 34336 D3Mgh7 Cardiac mass aorta relative weight of the dissected descending aorta per body weight was measured in samples dissected from rats killed at 15 weeks of age who were fed a high salt (4% w/w) diet from 6 to 14 weeks of age 629621 12775577 SS/JrRkb,SHR/FubRkb 631695,631696 SS/JrRkbxSHR/Rkb
631677 rat Iddm16 Insulin dependent diabetes mellitus QTL 16 6 Insulin level 61077 9571179 DA,BB/OK 60997,61107 backcross BB/OKxDA
631678 rat Cm9 Cardiac mass QTL 9 19 4.27 .0001 35567 D19Rat18 Cardiac mass aorta relative weight of the dissected descending aorta per body weight was measured in samples dissected from rats killed at 15 weeks of age who were fed a high salt (4% w/w) diet from 6 to 14 weeks of age 629621 12775577 SS/JrRkb,SHR/FubRkb 631695,631696 Bp114 SS/JrRkbxSHR/Rkb
631679 rat Cm10 Cardiac mass QTL 10 3 7.34 .0001 34186 D3Mgh9 Cardiac mass left ventricle relative weight of the left ventricle (including septum) per body weight was measured in samples dissected from rats killed at 15 weeks of age who were fed a high salt (4% w/w) diet from 6 to 14 weeks of age 629621 12775577 SS/JrRkb,SHR/FubRkb 631695,631696 SS/JrRkbxSHR/Rkb
631680 rat Cm11 Cardiac mass QTL 11 9 3.1 .00089 39812 D9Rat125 Cardiac mass left ventricle relative weight of the left ventricle (including septum) per body weight was measured in samples dissected from rats killed at 15 weeks of age who were fed a high salt (4%w/w) diet from 6 to 14 weeks of age 629621 12775577 SS/JrRkb,SHR/FubRkb 631695,631696 SS/JrRkbxSHR/Rkb
631681 rat Cm12 Cardiac mass QTL 12 19 3.33 .00053 35567 D19Rat18 Cardiac mass left ventricle relative weight of the left ventricle (including septum) per body weight was measured in samples dissected from rats killed at 15 weeks of age who were fed a high salt (4% w/w) diet from 6 to 14 weeks of age 629621 12775577 SS/JrRkb,SHR/FubRkb 631695,631696 Bp111 SS/JrRkbxSHR/Rkb
631682 rat Bp115 Blood pressure QTL 115 2 4.3 .0001 66484 D2Uia17 Blood pressure salt-loaded systolic measured 3 times per animal over a 5 day period by tail cuff method in 188 male rats who were fed a high salt diet (8% NaCl) for a period of 5 weeks starting from 37 days of age 629622 12473864 3043,3329,69413,2845 Map1b,Pik3r1,Rasgrf2,Htr1a SS/Jr,AS 10041,67958 additive SS/JrxAS
631683 rat Bp116 Blood pressure QTL 116 4 .0001 36143 D4Rat60 Blood pressure salt-loaded systolic measured 3 times per animal over a 5 day period by tail cuff method in male rats fed a high salt diet (8% NaCl) for a period of 5 weeks starting from 37 days of age 629622 12473864 621141,2360,2949,2042,2096,3826,3371,62017,2933,3418,2256 Prkwnk1,Clcn1,Kcna1,Add2,Alox5,Tbxas1,Pparg,Pbp,Itpr1,Prss2,Cald1 SS/Jr,AS 10041,67958 dominant SS/JrxAS
631684 rat Bp117 Blood pressure QTL 117 1 8.3 34011 D1Mit2 Blood pressure systolic measured at 13 weeks of age by the tail-cuff method by using the average of three measurements 629623 12569259 WKY/Izm,SHRSP/A3Izm 631286,631691 SHRSP/A3IzmxWKY/Izm
631685 rat Bp118 Blood pressure QTL 118 3 3.2 37166 D3Rat110 Blood pressure systolic measured at 13 weeks of age by the tail-cuff method by using the average of three measurements 629623 12569259 WKY/Izm,SHRSP/A3Izm 631286,631691 SHRSP/A3IzmxWKY/Izm
631686 rat Bp119 Blood pressure QTL 119 5 3.8 11072 D5Mgh2 Blood pressure systolic measured at 13 weeks of age by the tail-cuff method by using the average of three measurements 629623 12569259 WKY/Izm,SHRSP/A3Izm 631286,631691 SHRSP/A3IzmxWKY/Izm
631687 rat Hcs1 Hepatocarcinoma susceptibility QTL 1 7 3.9 .001 36193 D7Rat3 34555 D7Mgh6 37802 D7Rat78 Liver tumor susceptibility nodule volume fraction neoplastic nodules were measured by the method in livers of rats killed at 32 weeks of age following tumor induction by the resistant-hepatocyte protocol of diethylnitrosamine exposure 619598 10493520 3130,3458 Myc,Pvt1 BN,F344/N 60985,70509 dominant BNxF344
631688 rat Hcs2 Hepatocarcinoma susceptibility QTL 2 1 3 .0001 43175 D1Mgh16 35166 D1Rat33 34433 D1Mgh3 Liver tumor susceptibility nodule number neoplastic nodules were measured by the method in livers of rats killed at 32 weeks of age following tumor induction by the resistant-hepatocyte protocol of diethylnitrosamine exposure 619598 10493520 BN,F344/N 60985,70509 dominant BNxF344
631689 rat Scl4 Serum cholesterol level QTL 4 4 1.9 .008 3753 Spr Lipid level cholesterol serum total cholesterol was measured in an automatic analyzer using blood samples obtained by ophthalamic venous plexus puncture in 12 week old males 619667 9633608 BB/OK,SHR/Mol 61107,61110 SHR/MolxBB/OK
631690 rat Scl5 Serum cholesterol level QTL 5 1 2.1 33844 D1Mit14 Lipid level cholesterol serum total cholesterol was measured in an automatic analyzer using blood samples obtained by ophthalamic venous plexus puncture in 12 week old males 619667 9633608 BB/OK,SHR/Mol 61107,61110 SHR/MolxBB/OK
631827 rat Alc4 Alcohol preference QTL 4 5 3.5 3 40718 D5Rat120 39756 D5Rat123 34387 D5Mgh17 Consumption level alcohol preference in separate cage with free choice of water or 10% (v/v) of ethanol; consumption scores (grams/kg/day) were averaged; the amounts of ethanol consumed every 3 days over three weeks 631230,724636 10979603,12960747 HAD1,LAD1,HAD2 631844,631845,731187 additive Intercross HDA1 x LDA1, HAD2 x LAD2,HAD2xLAD2
1300834 mouse Cia20_m collagen induced arthritis 20 (mouse) 1 Not determined
1300835 mouse Mwq1_m molecular weight of quadriceps QTL 1 (mouse) 7 Not determined
1300836 mouse Cafq3_m caffeine metabolism QTL 3 (mouse) 9 Not determined
1300837 mouse Vmbic1_m ventral midbrain iron content 1 (mouse) 1 Not determined
1300838 mouse Orgwq3_m organ weight QTL 3 (mouse) 2 Not determined
1300839 mouse Dyscalc2_m dystrophic cardiac calcinosis 2 (mouse) 4 Not determined
1300840 mouse Cdcs3_m cytokine deficiency colitis susceptibility 3 (mouse) 2 Not determined
1300841 mouse Ssial1_m susceptibility to sialadenitis 1 (mouse) 1 Not determined
1300842 mouse Sle9_m systematic lupus erythematosus susceptibility 9 (mouse) 1 Not determined
1300843 mouse Aaq2_m alcohol acceptance QTL 2 (mouse) 12 Not determined
1300844 mouse Emo2_m emotionality 2 (mouse) 15 Not determined
1300845 mouse Leg1_m longevity extending gene 1 (mouse) 8 Not determined
1300846 mouse Pbwg11_m postnatal body weight growth 11 (mouse) 2 Not determined
1300847 mouse Par1_m pulmonary adenoma resistance 1 (mouse) 11 Not determined
1300848 mouse Skull13_m skull morphology 13 (mouse) 9 Not determined
1300849 mouse Sles4_m systemic lupus erythmatosus suppressor 4 (mouse) 9 Not determined
1300850 mouse Mwq4_m molecular weight of quadriceps QTL 4 (mouse) 12 Not determined
1300851 mouse Heal4_m wound healing/regeneration 4 (mouse) 15 Not determined
1300852 mouse Lmr14_m leishmaniasis resistance 14 (mouse) 2 Not determined
1300853 mouse Aggr2_m aggression 2 (mouse) X Not determined
1300854 mouse Lmr3_m leishmaniasis resistance 3 (mouse) 5 Not determined
1300855 mouse Pcir5_m periosteal circumference 5 (mouse) X Not determined
1300856 mouse Nobq2_m New Zealand obese QTL 2 (mouse) 19 Not determined
1300857 mouse Lwq6_m liver weight QTL 6 (mouse) 7 Not determined
1300858 mouse Tafat_m tally ho associated mesenteric fat pad weight (mouse) 4 Not determined
1300859 mouse Skull8_m skull morphology 8 (mouse) 6 Not determined
1300860 mouse Tshp11_m tooth shape 11 (mouse) 12 Not determined
1300861 mouse Bfq1_m body fat QTL 1 (mouse) 2 Not determined
1300862 mouse Cfbw5_m cystic fibrosis body weight 5 (mouse) 13 Not determined
1300863 mouse Ltsd4_m lung tumor shape-determining 4 (mouse) 4 Not determined
1300864 mouse Eae25_m susceptibility to experimental allergic encephalomyelitis 25 (mouse) 18 Not determined
1300865 mouse Pvcan1_m protection against vaginal candidiasis 1 (mouse) 8 Not determined
1300866 mouse Manh17_m mandible shape 17 (mouse) 12 Not determined
1300867 mouse Lore2_m loss of righting induced by ethanol 2 (mouse) 2 Not determined
1300868 mouse Tlf_m T lymphocyte fraction (mouse) 9 Not determined
1300869 mouse Stheal5_m soft tissue heal 5 (mouse) 6 Not determined
1300870 mouse Ath18_m atherosclerosis 18 (mouse) 12 Not determined
1300871 mouse Mob5_m multigenic obesity 5 (mouse) 2 Not determined
1300872 mouse Afpq2_m abdominal fat percent QTL 2 (mouse) 4 Not determined
1300873 mouse Alcw7_m alcohol withdrawal 7 (mouse) 14 Not determined
1300874 mouse Gasa2_m gastritis type A susceptibility locus 2 (mouse) 4 Not determined
1300875 mouse Taste1_m taste-saccharin preference 1 (mouse) 2 Not determined
1300876 mouse Tanidd2_m tally ho associated non-insulin dependednt diabetes mellitus 2 (mouse) 13 Not determined
1300877 mouse Adip8_m adiposity 8 (mouse) 18 Not determined
1300878 mouse Skts1_m skin tumor susceptibility 1 (mouse) 7 Not determined
1300879 mouse Sle1b_m systematic lupus erythematosus susceptibility 1b (mouse) 1 Not determined
1300880 mouse Ofca1_m open field activity and conditioned avoidance 1 (mouse) 3 Not determined
1300881 mouse Sluc29_m susceptibility to lung cancer 29 (mouse) 10 Not determined
1300882 mouse Ath17_m atherosclerosis 17 (mouse) 10 Not determined
1300883 mouse Ath21_m atherosclerosis 21 (mouse) 12 Not determined
1300884 mouse Sluc11_m susceptibility to lung cancer 11 (mouse) 9 Not determined
1300885 mouse Mbis4_m Mycobacterium bovis-induced systemic lupus erythematosus 4 (mouse) 17 Not determined
1300886 mouse Bw6_m body weight QTL 6 (mouse) 2 Not determined
1300887 mouse Pabr1_m plasma apolipoprotein B (human) regulator 1 (mouse) 6 Not determined
1300888 mouse Berr1_m berghei resistance locus 1 (mouse) 1 Not determined
1300889 mouse Lith9_m lithogenic gene 9 (mouse) 17 Not determined
1300890 mouse Bhr3_m bronchial hyperresponsiveness 3 (mouse) 17 Not determined
1300891 mouse Obq8_m obesity QTL 8 (mouse) 1 Not determined
1300892 mouse Szs10_m seizure susceptibility 10 (mouse) 11 Not determined
1300893 mouse Orch1_m autoimmune orchitis resistance 1 (mouse) 17 Not determined
1300894 mouse Capop_m cyclophosphamide induced apoptosis (mouse) 1 Not determined
1300895 mouse Hdl5_m HDL level 5 (mouse) 3 Not determined
1300896 mouse Sluc2_m susceptibility to lung cancer 2 (mouse) 2 Not determined
1300075 rat Glom7 Glomerulus QTL 7 6 5.6 .0000002 33987 D6Mit8 Renal function glomerulus number number of superficial glomeruli present in the renal cortex corticis zone but without direct surface contact counted in three mid-coronal sections for each animal 730279 14638907 MWF/Fub,SHR/Fub 731185,731186
1300076 rat Glom8 Glomerulus QTL 8 6 7 .000000009 36990 D6Rat12 Renal function glomerulus number measured by counting the number of surface glomeruli per section with direct contact to the surface 730279 14638907 MWF/Fub,SHR/Fub 731185,731186
1300528 mouse Ssial3_m susceptibility to sialadenitis 3 (mouse) 7 Not determined
1300529 mouse Idd9.3_m insulin dependent diabetes susceptibility 9.3 (mouse) 4 Not determined
1300530 mouse Livq2_m percent liver QTL 2 (mouse) 11 Not determined
1300531 mouse Tmevd3_m Theiler's murine encephalomyelitis virus induced demyelinating disease susceptibility 3 (mouse) 14 Not determined
1300532 mouse Tbs2_m tuberculosis severity 2 (mouse) 9 Not determined
1300533 mouse Aem3_m anti-erythrocyte autoantibody modifier 3 (mouse) 10 Not determined
1300534 mouse Bmd15_m bone mineral density 15 (mouse) 16 Not determined
1300535 mouse Char3_m P. chabaudi malaria resistance QTL 3 (mouse) 17 Not determined
1300536 mouse Daq6_m directional asymmetry QTL 6 (mouse) 10 Not determined
1300537 mouse Ap3q_m alcohol preference 3 QTL (mouse) 4 Not determined
1300538 mouse Disso2_m dissociation of activity 2 (mouse) 15 Not determined
1300539 mouse Manh19_m mandible shape 19 (mouse) 13 Not determined
1300540 mouse Igfbp3q1_m insulin-like growth factor binding protein 3 QTL 1 (mouse) 5 Not determined
1300541 mouse Tshp7_m tooth shape 7 (mouse) 7 Not determined
1300542 mouse Lbm7_m lean body mass 7 (mouse) 9 Not determined
1300543 mouse Scpro3_m stem cell proliferation 3 (mouse) 10 Not determined
1300544 mouse Hypn_m hyperinsulinemia (mouse) 14 Not determined
1300545 mouse Lifespan3_m life span 3 (mouse) 12 Not determined
1300546 mouse Ssta3_m susceptibility to Salmonella typhimurium antigens 3 (mouse) 6 Not determined
1300547 mouse Cypr2_m cytokine production 2 (mouse) 1 Not determined
1300548 mouse Adaz1_m anti-dsDNA antibody production in NZM 1 (mouse) 4 Not determined
1300549 mouse Bbaa17_m B. burgdorferi-associated arthritis 17 (mouse) 9 Not determined
1300550 mouse Szv2_m seizure severity 2 (mouse) 7 Not determined
1300551 mouse Lprm3_m lymphoproliferation modifier 3 (mouse) 14 Not determined
1300552 mouse Lrnx8_m learning-contextual 8 (mouse) 10 Not determined
1300553 mouse Athsq1_m atherosclerosis susceptibility QTL 1 (mouse) 4 Not determined
1300554 mouse Giq1_m glucose intolerance QTL 1 (mouse) 8 Not determined
1300555 mouse Angle2_m angle of entrainment 2 (mouse) 12 Not determined
1300556 mouse Cia6_m collagen induced arthritis QTL 6 (mouse) 6 Not determined
1300557 mouse Aaiq1_m aromatase activity QTL 1 (mouse) 4 Not determined
1300558 mouse Bw5_m body weight QTL 5 (mouse) 1 Not determined
1300559 mouse Thypr3_m thymocyte proliferative response 3 (mouse) 3 Not determined
1300560 mouse Tgl1_m triglyceride level 1 (mouse) 8 Not determined
1300561 mouse Heal7_m wound healing/regeneration 7 (mouse) 13 Not determined
1300562 mouse Actvty1_m activity 1 (mouse) 16 Not determined
1300563 mouse Pgia5_m proteoglycan induced arthritis 5 (mouse) 9 Not determined
1300564 mouse Hlq5_m heat loss QTL 5 (mouse) 7 Not determined
1300565 mouse Batq1_m brown fat QTL 1 (mouse) 1 Not determined
1300566 mouse Sluc8_m susceptibility to lung cancer 8 (mouse) 7 Not determined
1300567 mouse Bwq3_m body weight (mouse) 8 Not determined
1300568 mouse Hdl1_m high density lipoprotein (HDL) level 1 (mouse) 2 Not determined
1300569 mouse Eae6b_m susceptibility to experimental allergic encephalomyelitis 6b (mouse) 11 Not determined
1300570 mouse Etohcta10_m ethanol conditioned taste aversion 10 (mouse) 17 Not determined
1300571 mouse Opfa_m open field activity (mouse) 1 Not determined
1300572 mouse Lore3_m loss of righting induced by ethanol 3 (mouse) 8 Not determined
1300573 mouse Elsgp2_m elevated serum gp70 2 (mouse) 13 Not determined
1300574 mouse Im2_m immunoregulatory 2 (mouse) 4 Not determined
1300575 mouse Cocrb15_m cocaine related behavior 15 (mouse) 15 Not determined
1300576 mouse Yaail_m Yaa interacting locus (mouse) 7 Not determined
1300577 mouse Capsq1_m capsaicin sensitivity related QTL 1 (mouse) 2 Not determined
1300578 mouse Cd8ts3_m CD8 T cell subset 3 (mouse) 15 Not determined
1300579 mouse Thypr1_m thymocyte proliferative response 1 (mouse) 11 Not determined
1300580 mouse Lbw2_m lupus NZB x NZW 2 (mouse) 4 Not determined
1300581 mouse Tbrs1_m tuberculosis resistance 1 (mouse) 1 Not determined
1300582 mouse Cocrb7_m cocaine related behavior 7 (mouse) 6 Not determined
1300583 mouse Pbwg2_m postnatal body weight growth 2 (mouse) 4 Not determined
1300584 mouse Lwq8_m liver weight QTL 8 (mouse) X Not determined
1300585 mouse Pgia12_m proteoglycan induced arthritis 12 (mouse) 19 Not determined
1300586 mouse Cdcs5_m cytokine deficiency colitis susceptibility 5 (mouse) 17 Not determined
1300587 mouse Aod2_m autoimmune ovarian dysgenesis 2 (mouse) 3 Not determined
1300588 mouse Daq5_m directional asymmetry QTL 5 (mouse) 10 Not determined
1300589 mouse Myaa2_m modifier of Yaa 2 (mouse) 17 Not determined
1300107 rat Rf18 Renal function QTL 18 10 3.4 39226 D10Rat86 40488 D10Rat201 34896 D10Rat17 Renal function salt loaded urine volume 10-week old rats were given a high-salt diet (8% NaCl), fitted with a femoral catheter, and housed in metabolic cages, allowing multiple traits related to blood pressure and cardiac function to be measured in a conscious unrestrained way 727992 BN/SsNHsd,SS/JrHsdMcwi 10008,61499
1300108 rat Rf8 Renal function QTL 8 1 3.75 40028 D1Rat301 35457 D1Rat90 35457 D1Rat90 Renal function salt loaded renal vascular resistance 10-week old rats were given a high-salt diet (8% NaCl), fitted with a femoral catheter, and housed in metabolic cages, allowing multiple traits related to cardiac and renal function to be measured in a conscious unrestrained way 727992 BN/SsNHsd,SS/JrHsdMcwi 10008,61499 Rf6,Rf7
1300109 rat Rf13 Renal function QTL 13 4 3.91 35879 D4Rat67 36655 D4Rat70 39414 D4Rat204 Renal function salt loaded renal blood flow 10-week old rats were given a high-salt diet (8% NaCl), fitted with a femoral catheter, and housed in metabolic cages, allowing multiple traits related to cardiac and renal function to be measured in a conscious unrestrained way 727992 BN/SsNHsd,SS/JrHsdMcwi 10008,61499
1300110 rat Stl7 Serum triglyceride level QTL 7 11 4.64 35483 D11Rat15 10375 D11Mgh1 35955 D11Rat38 Lipid level salt loaded triglyceride level 10-week old rats were given a high-salt diet (8% NaCl), fitted with a femoral catheter, and housed in metabolic cages, allowing multiple traits related to blood pressure and cardiac function to be measured in a conscious unrestrained way 727992 BN/SsNHsd,SS/JrHsdMcwi 10008,61499
1300111 rat Rf12 Renal function QTL 12 3 3.78 39912 D3Rat180 36717 D3Rat17 39408 D3Rat169 Renal function salt loaded renal blood flow 10-week old rats were given a high-salt diet (8% NaCl), fitted with a femoral catheter, and housed in metabolic cages, allowing multiple traits related to cardiac and renal function to be measured in a conscious unrestrained way 727992 BN/SsNHsd,SS/JrHsdMcwi 10008,61499 Rf10,Rf11,Kw4
1300112 rat Bp183 Blood pressure QTL 183 7 3.51 35559 D7Rat13 37774 D7Rat80 37774 D7Rat80 Blood pressure salt loaded time series calculation 10-week old rats were given a high-salt diet (8% NaCl), fitted with a femoral catheter, and housed in metabolic cages, allowing multiple traits related to blood pressure and cardiac function to be measured in a conscious unrestrained way 727992 BN/SsNHsd,SS/JrHsdMcwi 10008,61499
1300113 rat Bp176 Blood pressure QTL 176 3 3.9 36584 D3Rat6 40676 D3Rat142 37980 D3Rat114 Blood pressure salt loaded time series calculation 10-week old rats were given a high-salt diet (8% NaCl), fitted with a femoral catheter, and housed in metabolic cages, allowing multiple traits related to blood pressure and cardiac function to be measured in a conscious unrestrained way 727992 BN/SsNHsd,SS/JrHsdMcwi 10008,61499 Bp177
1300114 rat Srn2 Serum renin concentration QTL 2 14 3.27 36536 D14Rat1 41990 D14Arb16 35965 D14Rat6 Renin concentration salt loaded 10-week old rats were given a high-salt diet (8% NaCl), fitted with a femoral catheter, and housed in metabolic cages, allowing multiple traits related to blood pressure and cardiac function to be measured in a conscious unrestrained way 727992 BN/SsNHsd,SS/JrHsdMcwi 10008,61499
1300116 rat Hr5 Heart rate QTL 5 4 3.76 38344 D4Rat106 41568 D4Rat200 34174 D4Mgh7 Heart rate salt loaded 10-week old rats were given a high-salt diet (8% NaCl), fitted with a femoral catheter, and housed in metabolic cages, allowing multiple traits related to blood pressure and cardiac function to be measured in a conscious unrestrained way 727992 BN/SsNHsd,SS/JrHsdMcwi 10008,61499
1300118 rat Bp190 Blood pressure QTL 190 15 2.94 34409 D15Mgh9 40516 D15Rat106 40516 D15Rat106 Blood pressure salt loaded diastolic 10-week old rats were given a high-salt diet (8% NaCl), fitted with a femoral catheter, and housed in metabolic cages, allowing multiple traits related to blood pressure and cardiac function to be measured in a conscious unrestrained way 727992 BN/SsNHsd,SS/JrHsdMcwi 10008,61499
1300119 rat Bp180 Blood pressure QTL 180 5 3.82 39176 D5Rat103 41798 D5Rat246 39168 D5Rat99 Blood pressure salt loaded time series calculation 10-week old rats were given a high-salt diet (8% NaCl), fitted with a femoral catheter, and housed in metabolic cages, allowing multiple traits related to blood pressure and cardiac function to be measured in a conscious unrestrained way 727992 BN/SsNHsd,SS/JrHsdMcwi 10008,61499 Hr7,Hr8
1300120 rat Km7 Kidney mass 7 15 3.55 34409 D15Mgh9 40516 D15Rat106 35497 D15Rat25 Kidney mass salt loaded 10-week old rats were given a high-salt diet (8% NaCl), fitted with a femoral catheter, and housed in metabolic cages, allowing multiple traits related to blood pressure and cardiac function to be measured in a conscious unrestrained way 727992 BN/SsNHsd,SS/JrHsdMcwi 10008,61499
1300121 rat Hr1 Heart rate QTL 1 1 3.7 34037 D1Mit1 35166 D1Rat33 41374 D1Rat265 Heart rate salt loaded 10-week old rats were given a high-salt diet (8% NaCl), fitted with a femoral catheter, and housed in metabolic cages, allowing multiple traits related to blood pressure and cardiac function to be measured in a conscious unrestrained way 727992 BN/SsNHsd,SS/JrHsdMcwi 10008,61499 Hr2
1300122 rat Wbc1 White blood cell count QTL 1 5 2.75 40992 D5Rat148 38510 D5Rat63 38828 D5Rat90 White blood cell count salt loaded 10-week old rats were given a high-salt diet (8% NaCl), fitted with a femoral catheter, and housed in metabolic cages, allowing multiple traits related to blood pressure and cardiac function to be measured in a conscious unrestrained way 727992 BN/SsNHsd,SS/JrHsdMcwi 10008,61499
1300124 rat Cm4 Cardiac mass QTL 4 9 3.55 38604 D9Rat101 35819 D9Rat26 40170 D9Rat135 Cardiac mass salt-loaded 10-week old rats were given a high-salt diet (8% NaCl), fitted with a femoral catheter, and housed in metabolic cages, allowing multiple traits related to blood pressure and cardiac function to be measured in a conscious unrestrained way 727992 BN/SsNHsd,SS/JrHsdMcwi 10008,61499
1300127 rat Srn1 Serum renin concentration QTL 1 7 3.49 34880 D7Rat31 41186 D7Rat139 38794 D7Rat73 Renin concentration salt loaded 10-week old rats were given a high-salt diet (8% NaCl), fitted with a femoral catheter, and housed in metabolic cages, allowing multiple traits related to blood pressure and cardiac function to be measured in a conscious unrestrained way 727992 BN/SsNHsd,SS/JrHsdMcwi 10008,61499
1300128 rat Rf16 Renal function QTL 16 6 3.89 35963 D6Rat46 35396 D6Rat35 39124 D6Rat62 Renal function salt loaded renal blood flow 10-week old rats were given a high-salt diet (8% NaCl), fitted with a femoral catheter, and housed in metabolic cages, allowing multiple traits related to cardiac and renal function to be measured in a conscious unrestrained way 727992 BN/SsNHsd,SS/JrHsdMcwi 10008,61499
1300129 rat Rf25 Renal function QTL 25 17 3.03 35274 D17Rat45 35827 D17Rat52 35687 D17Rat47 Renal function salt loaded creatinine clearance 10-week old rats were given a high-salt diet (8% NaCl), fitted with a femoral catheter, and housed in metabolic cages, allowing multiple traits related to blood pressure and cardiac function to be measured in a conscious unrestrained way 727992 BN/SsNHsd,SS/JrHsdMcwi 10008,61499
1300130 rat Rf20 Renal function QTL 20 11 4.44 35483 D11Rat15 35955 D11Rat38 40546 D11Rat71 Renal function hypertension related glomerular damage 10-week old rats were given a high-salt diet (8% NaCl), fitted with a femoral catheter, and housed in metabolic cages, allowing multiple traits related to blood pressure and cardiac function to be measured in a conscious unrestrained way 727992 BN/SsNHsd,SS/JrHsdMcwi 10008,61499
1300131 rat Bp193 Blood pressure QTL 193 17 3.3 35258 D17Rat36 35687 D17Rat47 35274 D17Rat45 Blood pressure salt loaded mean arterial 10-week old rats were given a high-salt diet (8% NaCl), fitted with a femoral catheter, and housed in metabolic cages, allowing multiple traits related to blood pressure and cardiac function to be measured in a conscious unrestrained way 727992 BN/SsNHsd,SS/JrHsdMcwi 10008,61499
1300133 rat Rf24 Renal function QTL 24 16 3.64 40724 D16Rat87 39586 D16Rat76 40724 D16Rat87 Renal function salt loaded creatinine clearance 10-week old rats were given a high-salt diet (8% NaCl), fitted with a femoral catheter, and housed in metabolic cages, allowing multiple traits related to blood pressure and cardiac function to be measured in a conscious unrestrained way 727992 BN/SsNHsd,SS/JrHsdMcwi 10008,61499
1300135 rat Rf19 Renal function QTL 19 11 3.38 40546 D11Rat71 10375 D11Mgh1 36065 D11Rat6 Renal function salt loaded creatinine clearance 10-week old rats were given a high-salt diet (8% NaCl), fitted with a femoral catheter, and housed in metabolic cages, allowing multiple traits related to blood pressure and cardiac function to be measured in a conscious unrestrained way 727992 BN/SsNHsd,SS/JrHsdMcwi 10008,61499
1300136 rat Rf22 Renal function QTL 22 14 3.9 35319 D14Rat16 40140 D14Rat95 40852 D14Rat90 Renal function salt loaded renal vascular resistance 10-week old rats were given a high-salt diet (8% NaCl), fitted with a femoral catheter, and housed in metabolic cages, allowing multiple traits related to blood pressure and cardiac function to be measured in a conscious unrestrained way 727992 BN/SsNHsd,SS/JrHsdMcwi 10008,61499
1300137 rat Bp186 Blood pressure QTL 186 10 3.57 34896 D10Rat17 35254 D10Rat2 35254 D10Rat2 Blood pressure salt loaded time series calculation 10-week old rats were given a high-salt diet (8% NaCl), fitted with a femoral catheter, and housed in metabolic cages, allowing multiple traits related to blood pressure and cardiac function to be measured in a conscious unrestrained way 727992 BN/SsNHsd,SS/JrHsdMcwi 10008,61499
1300138 rat Hr9 Heart rate QTL 9 7 4.72 36691 D7Rat27 38794 D7Rat73 42215 D7Arb16 Heart rate salt loaded 10-week old rats were given a high-salt diet (8% NaCl), fitted with a femoral catheter, and housed in metabolic cages, allowing multiple traits related to blood pressure and cardiac function to be measured in a conscious unrestrained way 727992 BN/SsNHsd,SS/JrHsdMcwi 10008,61499
1300139 rat Hr6 Heart rate QTL 6 4 2.85 34238 D4Mgh2 38344 D4Rat106 41200 D4Rat169 Heart rate salt loaded 10-week old rats were given a high-salt diet (8% NaCl), fitted with a femoral catheter, and housed in metabolic cages, allowing multiple traits related to blood pressure and cardiac function to be measured in a conscious unrestrained way 727992 BN/SsNHsd,SS/JrHsdMcwi 10008,61499 Hr5
1300140 rat Srn3 Serum renin concentration QTL 3 14 3.19 35965 D14Rat6 34965 D14Rat10 36520 D14Rat7 Renin concentration salt loaded 10-week old rats were given a low-salt diet, fitted with a femoral catheter, and housed in metabolic cages, allowing multiple traits related to blood pressure and cardiac function to be measured in a conscious unrestrained way 727992 BN/SsNHsd,SS/JrHsdMcwi 10008,61499
1300142 rat Bp191 Blood pressure QTL 191 15 3.14 40434 D15Rat114 38696 D15Rat75 40434 D15Rat114 Blood pressure salt loaded mean arterial 10-week old rats were given a high-salt diet (8% NaCl), fitted with a femoral catheter, and housed in metabolic cages, allowing multiple traits related to blood pressure and cardiac function to be measured in a conscious unrestrained way 727992 BN/SsNHsd,SS/JrHsdMcwi 10008,61499
1300143 rat Rf14 Renal function QTL 14 6 2.92 35396 D6Rat35 41416 D6Rat126 36586 D6Rat26 Renal function salt loaded renal blood flow 10-week old rats were given a high-salt diet (8% NaCl), fitted with a femoral catheter, and housed in metabolic cages, allowing multiple traits related to cardiac and renal function to be measured in a conscious unrestrained way 727992 BN/SsNHsd,SS/JrHsdMcwi 10008,61499
1300144 rat Rf23 Renal function QTL 23 15 3.61 34910 D15Rat14 40516 D15Rat106 34409 D15Mgh9 Renal function salt loaded renal vascular resistance 10-week old rats were given a high-salt diet (8% NaCl), fitted with a femoral catheter, and housed in metabolic cages, allowing multiple traits related to blood pressure and cardiac function to be measured in a conscious unrestrained way 727992 BN/SsNHsd,SS/JrHsdMcwi 10008,61499
1300145 rat Rf7 Renal function QTL 7 1 2.96 37556 D1Rat130 35909 D1Rat74 40230 D1Rat295 Renal function salt loaded urine creatinine concentration 10-week old rats were given a high-salt diet (8% NaCl), fitted with a femoral catheter, and housed in metabolic cages, allowing multiple traits related to cardiac and renal function to be measured in a conscious unrestrained way 727992 BN/SsNHsd,SS/JrHsdMcwi 10008,61499 Rf6,Rf8
1300146 rat Rf17 Renal function QTL 17 8 2.9 35663 D8Rat51 41122 D8Rat159 36673 D8Rat49 Renal function salt loaded renal blood flow 10-week old rats were given a high-salt diet (8% NaCl), fitted with a femoral catheter, and housed in metabolic cages, allowing multiple traits related to blood pressure and cardiac function to be measured in a conscious unrestrained way 727992 BN/SsNHsd,SS/JrHsdMcwi 10008,61499
1300147 rat Bp187 Blood pressure QTL 187 11 3.67 35957 D11Rat22 41256 D11Rat61 35483 D11Rat15 Blood pressure salt loaded time series calculation 10-week old rats were given a high-salt diet (8% NaCl), fitted with a femoral catheter, and housed in metabolic cages, allowing multiple traits related to blood pressure and cardiac function to be measured in a conscious unrestrained way 727992 BN/SsNHsd,SS/JrHsdMcwi 10008,61499
1300148 rat Bp192 Blood pressure QTL 192 17 3.47 35697 D17Rat16 35687 D17Rat47 35258 D17Rat36 Renal function salt loaded time series calculation 10-week old rats were given a high-salt diet (8% NaCl), fitted with a femoral catheter, and housed in metabolic cages, allowing multiple traits related to blood pressure and cardiac function to be measured in a conscious unrestrained way 727992 BN/SsNHsd,SS/JrHsdMcwi 10008,61499
1300149 rat Cm6 Cardiac mass QTL 6 7 4.09 41130 D7Rat136 42215 D7Arb16 35068 D7Rat32 Cardiac mass salt-loaded left ventricle 10-week old rats were given a high-salt diet (8% NaCl), fitted with a femoral catheter, and housed in metabolic cages, allowing multiple traits related to blood pressure and cardiac function to be measured in a conscious unrestrained way 727992 BN/SsNHsd,SS/JrHsdMcwi 10008,61499
1300150 rat Cm3 Cardiac mass QTL 3 8 3.97 41454 D8Rat149 36161 D8Rat36 41122 D8Rat159 Cardiac mass salt-loaded 10-week old rats were given a high-salt diet (8% NaCl), fitted with a femoral catheter, and housed in metabolic cages, allowing multiple traits related to blood pressure and cardiac function to be measured in a conscious unrestrained way 727992 BN/SsNHsd,SS/JrHsdMcwi 10008,61499
1300152 rat Bp195 Blood pressure QTL 195 20 3.46 34749 D20UW1 34908 D20Rat2 34749 D20UW1 Blood pressure salt loaded systolic 10-week old rats were given a high-salt diet (8% NaCl), fitted with a femoral catheter, and housed in metabolic cages, allowing multiple traits related to blood pressure and cardiac function to be measured in a conscious unrestrained way 727992 BN/SsNHsd,SS/JrHsdMcwi 10008,61499
1300154 rat Bp189 Blood pressure QTL 189 14 3.04 34965 D14Rat10 40852 D14Rat90 36287 D14Rat12 Blood pressure salt loaded diastolic 10-week old rats were given a high-salt diet (8% NaCl), fitted with a femoral catheter, and housed in metabolic cages, allowing multiple traits related to blood pressure and cardiac function to be measured in a conscious unrestrained way 727992 BN/SsNHsd,SS/JrHsdMcwi 10008,61499
1300157 rat Rf21 Renal function QTL 21 12 4.42 35501 D12Rat2 37830 D12Rat36 34729 D12Mgh5 Renal function salt loaded renal blood flow 10-week old rats were given a high-salt diet (8% NaCl), fitted with a femoral catheter, and housed in metabolic cages, allowing multiple traits related to blood pressure and cardiac function to be measured in a conscious unrestrained way 727992 BN/SsNHsd,SS/JrHsdMcwi 10008,61499
1300158 rat Bp173 Blood pressure QTL 173 1 3.48 35166 D1Rat33 37556 D1Rat130 38878 D1Rat139 Blood pressure salt loaded time series calculation 10-week old rats were given a high-salt diet (8% NaCl), fitted with a femoral catheter, and housed in metabolic cages, allowing multiple traits related to blood pressure and cardiac function to be measured in a conscious unrestrained way 727992 BN/SsNHsd,SS/JrHsdMcwi 10008,61499 Bp170,Bp171,Bp172
1300159 rat Km4 Kidney mass 4 3 3.83 36717 D3Rat17 40676 D3Rat142 36584 D3Rat6 Kidney mass hypertension related 10-week old rats were given a high-salt diet (8% NaCl), fitted with a femoral catheter, and housed in metabolic cages, allowing multiple traits related to cardiac and renal function to be measured in a conscious unrestrained way 727992 BN/SsNHsd,SS/JrHsdMcwi 10008,61499 Rf10,Rf11,Rf12
1300160 rat Hr3 Heart rate QTL 3 2 3.62 40242 D2Rat194 40672 D2Rat202 37018 D2Rat14 Heart rate salt loaded 10-week old rats were given a high-salt diet (8% NaCl), fitted with a femoral catheter, and housed in metabolic cages, allowing multiple traits related to blood pressure and cardiac function to be measured in a conscious unrestrained way 727992 BN/SsNHsd,SS/JrHsdMcwi 10008,61499
1300161 rat Rf10 Renal function QTL 10 3 3.57 41322 D3Rat137 38456 D3Rat77 36797 D3Rat11 Renal function hypertension related renal vascular resistance 10-week old rats were given a high-salt diet (8% NaCl), fitted with a femoral catheter, and housed in metabolic cages, allowing multiple traits related to cardiac and renal function to be measured in a conscious unrestrained way 727992 BN/SsNHsd,SS/JrHsdMcwi 10008,61499 Rf11,Rf12,Rf13
1300163 rat Cc1 Cardiac cell morphology QTL 1 13 4.18 36922 D13Rat4 38240 D13Rat91 36922 D13Rat4 Cardiac function salt loaded aortic lesions 10-week old rats were given a high-salt diet (8% NaCl), fitted with a femoral catheter, and housed in metabolic cages, allowing multiple traits related to blood pressure and cardiac function to be measured in a conscious unrestrained way 727992 BN/SsNHsd,SS/JrHsdMcwi 10008,61499
1300165 rat Rf9 Renal function QTL 9 2 3.28 37456 D2Rat147 34461 D2Mgh12 36213 D2Rat40 Renal function hypertension related glomerular damage 10-week old rats were given a high-salt diet (8% NaCl), fitted with a femoral catheter, and housed in metabolic cages, allowing multiple traits related to cardiac and renal function to be measured in a conscious unrestrained way 727992 BN/SsNHsd,SS/JrHsdMcwi 10008,61499
1300167 rat Hr2 Heart rate QTL 2 1 4.35 36568 D1Rat4 34037 D1Mit1 38782 D1Rat136 Heart rate salt loaded 10-week old rats were given a high-salt diet (8% NaCl), fitted with a femoral catheter, and housed in metabolic cages, allowing multiple traits related to blood pressure and cardiac function to be measured in a conscious unrestrained way 727992 BN/SsNHsd,SS/JrHsdMcwi 10008,61499 Hr1
1300172 rat Bp172 Blood pressure QTL 172 1 3.56 37598 D1Rat176 41374 D1Rat265 34037 D1Mit1 Blood pressure salt loaded diastolic 10-week old rats were given a high-salt diet (8% NaCl), fitted with a femoral catheter, and housed in metabolic cages, allowing multiple traits related to blood pressure and cardiac function to be measured in a conscious unrestrained way 727992 BN/SsNHsd,SS/JrHsdMcwi 10008,61499 Bp170,Bp171,Bp173
1300173 rat Rf11 Renal function QTL 11 3 3.38 36717 D3Rat17 36584 D3Rat6 36797 D3Rat11 Renal function hypertension related renal blood flow 10-week old rats were given a high-salt diet (8% NaCl), fitted with a femoral catheter, and housed in metabolic cages, allowing multiple traits related to cardiac and renal function to be measured in a conscious unrestrained way 727992 BN/SsNHsd,SS/JrHsdMcwi 10008,61499 Rf10,Rf12,Rf13
1300174 rat Bw15 Body weight QTL 15 12 2.93 40394 D12Rat89 35501 D12Rat2 40394 D12Rat89 Body weight salt-loaded 10-week old rats were given a high-salt diet (8% NaCl), fitted with a femoral catheter, and housed in metabolic cages, allowing multiple traits related to blood pressure and cardiac function to be measured in a conscious unrestrained way 727992 BN/SsNHsd,SS/JrHsdMcwi 10008,61499
1300175 rat Cm5 Cardiac mass QTL 5 12 3.78 34729 D12Mgh5 35431 D12Rat22 37830 D12Rat36 Cardiac mass salt-loaded left ventricle 10-week old rats were given a high-salt diet (8% NaCl), fitted with a femoral catheter, and housed in metabolic cages, allowing multiple traits related to blood pressure and cardiac function to be measured in a conscious unrestrained way 727992 BN/SsNHsd,SS/JrHsdMcwi 10008,61499
1300176 rat Hr10 Heart rate QTL 10 7 3.19 35382 D7Rat36 34880 D7Rat31 35382 D7Rat36 Heart rate salt loaded 10-week old rats were given a high-salt diet (8% NaCl), fitted with a femoral catheter, and housed in metabolic cages, allowing multiple traits related to blood pressure and cardiac function to be measured in a conscious unrestrained way 727992 BN/SsNHsd,SS/JrHsdMcwi 10008,61499
1300179 rat Km5 Kidney mass 5 7 3.51 42215 D7Arb16 35559 D7Rat13 41186 D7Rat139 Kidney mass salt loaded 10-week old rats were given a high-salt diet (8% NaCl), fitted with a femoral catheter, and housed in metabolic cages, allowing multiple traits related to blood pressure and cardiac function to be measured in a conscious unrestrained way 727992 BN/SsNHsd,SS/JrHsdMcwi 10008,61499
1300590 mouse Taste10_m taste bitterness sensitivity 10 (mouse) 8 Not determined
1300591 mouse Pas3_m pulmonary adenoma susceptibility 3 (mouse) 19 Not determined
1300592 mouse Pcyts5_m plasmacytoma susceptibility 5 (mouse) 17 Not determined
1300593 mouse Skull4_m skull morphology 4 (mouse) 3 Not determined
1300594 mouse Eae2_m susceptibility to experimental allergic encephalomyelitis 2 (mouse) 15 Not determined
1300595 mouse Tmevd2_m Theiler's murine encephalomyelitis virus induced demyelinating disease susceptibility 2 (mouse) 3 Not determined
1300596 mouse Musz1_m muscle size 1 (mouse) 7 Not determined
1300597 mouse Skull14_m skull morphology 14 (mouse) 10 Not determined
1300598 mouse Disso1_m dissociation of activity 1 (mouse) 12 Not determined
1300599 mouse Cocrb11_m cocaine related behavior 11 (mouse) 11 Not determined
1300600 mouse Hdl2_m high density lipoprotein (HDL) level 2 (mouse) 5 Not determined
1300601 mouse Tlsr1_m thymic lymphoma suppressor region 1 (mouse) 4 Not determined
1300602 mouse Eye2_m eye weight 2 (mouse) 17 Not determined
1300603 mouse Cd8ts2_m CD8 T cell subset 2 (mouse) 8 Not determined
1300604 mouse Mndl1_m mandible length 1 (mouse) 11 Not determined
1300605 mouse El5_m epilepsy 5 (mouse) 14 Not determined
1300606 mouse Axtofa6_m anxiety-open field activity 6 (mouse) 18 Not determined
1300607 mouse Tnbs2_m tri-nitrobenzene sulfonic acid susceptible 2 (mouse) 11 Not determined
1300608 mouse Cocrb10_m cocaine related behavior 10 (mouse) 9 Not determined
1300609 mouse Cia12_m collagen induced arthritis 12 (mouse) 19 Not determined
1300610 mouse Lepq1_m leptin QTL 1 (mouse) 14 Not determined
1300611 mouse Tlln_m tail length (mouse) 1 Not determined
1300612 mouse Idd13_m insulin dependent diabetes susceptibility 13 (mouse) 2 Not determined
1300613 mouse Pcyts4_m plasmacytoma susceptibility 4 (mouse) 17 Not determined
1300614 mouse Afw6_m abdominal fat weight QTL 6 (mouse) 13 Not determined
1300615 mouse Hpic4_m haloperidol induced catalepsy 4 (mouse) 14 Not determined
1300616 mouse Mpsq1_m Mycoplasma pulmonis susceptibility QTL 1 (mouse) 4 Not determined
1300617 mouse Naq1_m nurturing ability QTL 1 (mouse) 5 Not determined
1300618 mouse Pgia19_m proteoglycan induced arthritis 19 (mouse) 6 Not determined
1300619 mouse Cdcs1_m cytokine deficiency colitis susceptibility 1 (mouse) 3 Not determined
1300620 mouse Pgia21_m proteoglycan induced arthritis 21 (mouse) 7 Not determined
1300621 mouse Tpnr1_m thermal pain response 1 (mouse) 4 Not determined
1300622 mouse Cfld1_m cystic fibrosis lung disease 1 (mouse) 2 Not determined
1300623 mouse Bwtq3_m body weight QTL 3 (mouse) 6 Not determined
1300624 mouse Insq7_m insulin QTL 7 (mouse) 2 Not determined
1300625 mouse Cosz2_m cocaine seizure 2 (mouse) 14 Not determined
1300626 mouse Idd9.2_m insulin dependent diabetes susceptibility 9.2 (mouse) 4 Not determined
1300627 mouse Sluc26_m susceptibility to lung cancer 26 (mouse) 15 Not determined
1300628 mouse Lgth6_m body length 6 (mouse) 11 Not determined
1300629 mouse Fbgl2_m fasting blood glucose 2 (mouse) 15 Not determined
1300630 mouse Livq3_m percent liver QTL 3 (mouse) 12 Not determined
1300631 mouse Lore6_m loss of righting induced by ethanol 6 (mouse) 18 Not determined
1300632 mouse Loca2_m locomotor activity 2 (mouse) 16 Not determined
1300633 mouse Cdcs7_m cytokine deficiency colitis susceptibility 7 (mouse) 12 Not determined
1300634 mouse Sluc25_m susceptibility to lung cancer 25 (mouse) 15 Not determined
1300635 mouse Dice2_m determination of interleukin 4 commitment 2 (mouse) 7 Not determined
1300636 mouse Gct2_m granulosa cell tumorigenesis 2 (mouse) 12 Not determined
1300637 mouse Batq2_m brown fat QTL 2 (mouse) 3 Not determined
1300638 mouse Im7_m immunoregulatory 7 (mouse) 18 Not determined
1300639 mouse Oss2_m osteosarcoma suppressor 2 (mouse) 9 Not determined
1300640 mouse Taste12_m taste bitterness sensitivity 12 (mouse) 9 Not determined
1300641 mouse Thyls_m thymic lymphoma susceptibility (mouse) 4 Not determined
1300642 mouse Taste2_m taste-saccharin preference 2 (mouse) 2 Not determined
1300643 mouse Pvcan2_m protection against vaginal candidiasis 2 (mouse) 9 Not determined
1300644 mouse Fob3_m F-line obesity QTL 3 (mouse) 15 Not determined
1300645 mouse Alcp1_m alcohol preference locus 1 (mouse) 2 Not determined
1300646 mouse Rapop4_m radiation-induced apoptosis 4 (mouse) 11 Not determined
1300647 mouse Nktcn2_m natural killer T cell numbers 2 (mouse) 2 Not determined
1300648 mouse Dbsty4_m diabesity 4 (mouse) 15 Not determined
1300649 mouse Crhq1_m compensatory renal hypertrophy QTL 1 (mouse) 11 Not determined
1300650 mouse Bw18_m body weight QTL 18 (mouse) 6 Not determined
1300651 mouse Pcyts3_m plasmacytoma susceptibility 3 (mouse) 11 Not determined
1300652 mouse Vmbic9_m ventral midbrain iron content 9 (mouse) 17 Not determined
1300653 mouse Imh1_m IgM hypergammaglobulinemia 1 (mouse) 4 Not determined
1300654 mouse Bomd1_m bone mineral density 1 (mouse) 7 Not determined
1300655 mouse Nidds_m non-insulin-dependent diabetes mellitus in SJL (mouse) 4 Not determined
1300656 mouse Bgeq15_m body growth early QTL 15 (mouse) 16 Not determined
1300657 mouse Cia11_m collagen induced arthritis 11 (mouse) 13 Not determined
1300658 mouse Cara1_m carcass ash in high growth mice 1 (mouse) 2 Not determined
1300659 mouse Pcd8ts1_m p-glycoprotein positive CD8 T cell subset 1 (mouse) 5 Not determined
1300660 mouse Swq5_m spleen weight QTL 5 (mouse) 10 Not determined
1300661 mouse Lmr6_m leishmaniasis resistance 6 (mouse) 11 Not determined
1300662 mouse Etohila_m ethanol induced locomotor activity (mouse) 2 Not determined
1300663 mouse Start2_m startle response 2 (mouse) 4 Not determined
1300664 mouse Etohcta9_m ethanol conditioned taste aversion 9 (mouse) 11 Not determined
1300665 mouse Pbw2_m pentobarbital withdrawal QTL 2 (mouse) 4 Not determined
1300666 mouse Fembm2_m femoral bone morphometry 2 (mouse) 14 Not determined
1300667 mouse Lbw4_m lupus NZB x NZW 4 (mouse) 6 Not determined
1300668 mouse Pas10_m pulmonary adenoma susceptibility 10 (mouse) 13 Not determined
1300669 mouse Daq13_m directional asymmetry QTL 13 (mouse) 15 Not determined
1300670 mouse Sluc19_m susceptibility to lung cancer 19 (mouse) 7 Not determined
1300671 mouse Cia4_m collagen induced arthritis QTL 4 (mouse) 2 Not determined
1300672 mouse Hdlq26_m HDL QTL 26 (mouse) 10 Not determined
1300673 mouse Cosz1_m cocaine seizure 1 (mouse) 9 Not determined
1300674 mouse Nidd3n_m non-insulin-dependent diabetes mellitus 3 in NSY (mouse) 6 Not determined
1300675 mouse Laq1_m lupus associated arthritis quantitative trait locus 1 (mouse) 1 Not determined
1300676 mouse Prdt2_m prion disease incubation time 2 (mouse) 2 Not determined
1300677 mouse Bmd9_m bone mineral density 9 (mouse) 7 Not determined
1300678 mouse Leg2_m longevity extending gene 2 (mouse) 10 Not determined
1300679 mouse Nociq2_m nociceptive sensitivity inflammatory QTL 2 (mouse) 10 Not determined
1300680 mouse Kwq6_m kidney weight QTL 6 (mouse) 2 Not determined
1300681 mouse Pgia22_m proteoglycan induced arthritis 22 (mouse) 8 Not determined
1300682 mouse Splrn2_m spatial learning 2 (mouse) 12 Not determined
1300683 mouse Fembm7_m femoral bone morphometry 7 (mouse) 19 Not determined
1300684 mouse Bis3_m beta-carboline-induced seizures 3 (mouse) 9 Not determined
1300685 mouse Scc5_m colon tumor susceptibility 5 (mouse) 18 Not determined
1300686 mouse C10bw4_m castaneus 10 week body weight 4 (mouse) 13 Not determined
1300687 mouse Mlviq2_m murine leukemia virus infection QTL (mouse) 19 Not determined
1300688 mouse Nidd2k_m Nidd2 on KK-A (mouse) 2 Not determined
1300689 mouse Dob1_m dietary obesity 1 (mouse) 4 Not determined
1300690 mouse Etohcta2_m ethanol conditioned taste aversion 2 (mouse) 2 Not determined
1300691 mouse Skmw3_m skeletal muscle weight 3 (mouse) 1 Not determined
1300692 mouse Blmpf1_m bleomycin-induced pulmonary fibrosis 1 (mouse) 17 Not determined
1300693 mouse Mmtg3_m modifier of mammary tumor growth 3 (mouse) 7 Not determined
1300694 mouse Tmevd7_m Theiler's murine encephalomyelitis virus induced demyelinating disease susceptibility 7 (mouse) 5 Not determined
1300695 mouse Cocrb3_m cocaine related behavior 3 (mouse) 2 Not determined
1300696 mouse Bpq2_m blood pressure QTL 2 (mouse) 1 Not determined
1300697 mouse Sle2_m systemic lupus erythmatosus susceptibility 2 (mouse) 4 Not determined
1300698 mouse Etohcta5_m ethanol conditioned taste aversion 5 (mouse) 4 Not determined
1300699 mouse Daq18_m directional asymmetry QTL 18 (mouse) 2 Not determined
1300700 mouse Sprol1_m spontaneous proliferation 1 (mouse) 4 Not determined
1300701 mouse Cd8ts1_m CD8 T cell subset 1 (mouse) 5 Not determined
1300702 mouse Fcsa4_m femoral cross-sectional area 4 (mouse) X Not determined
1300703 mouse Uvbi2_m UVB induced immunosuppression 2 (mouse) 17 Not determined
1300704 mouse Cia3_m collagen induced arthritis QTL 3 (mouse) 6 Not determined
1300705 mouse Lipq2_m lipoprotein QTL 2 (mouse) 13 Not determined
1300706 mouse Alan1_m alloantigen response 1 (mouse) 17 Not determined
1300707 mouse Kwq3_m kidney weight QTL 3 (mouse) 9 Not determined
1300708 mouse Pbwm_m pentobarbital withdrawal modifier (mouse) 1 Not determined
1300709 mouse Igf1q1_m insulin-like growth factor 1 QTL 1 (mouse) 10 Not determined
1300710 mouse Pcd4ts2_m p-glycoprotein positive CD4 T cell subset 2 (mouse) 13 Not determined
1300711 mouse Pbwg8_m postnatal body weight growth 8 (mouse) 6 Not determined
1300712 mouse El2_m epilepsy 2 (mouse) 2 Not determined
1300713 mouse Vmbic10_m ventral midbrain iron content 10 (mouse) 11 Not determined
1300714 mouse Idd7_m insulin dependent diabetes susceptibility 7 (mouse) 7 Not determined
1300026 human BP36_H Blood pressure QTL 36 (human) 3 4.04 1298249 D3S1308 68977 AGTR1 Blood pressure hypertension susceptibility genome-wide scan for loci affecting hypertension in affected sib pairs from the Finnish Twin Cohort Study 1298217 11081770 BP24_H
1300027 human BW34_H Body weight QTL 34 (human) 19 1.5 .0063 1299912 D19S400 1299939 D19S245 Body weight body mass index genome-wide linkage analysis to identify linkage to obesity in type 2 diabetic Dutch Caucasian siblings 1298537 12727978
1300028 human BP53_H Blood pressure QTL 53 (human) 12 1.33 .00673 1299937 D12S372 Blood pressure systolic genome-wide scan for loci affecting blood pressure in random and obese families in the Quebec Family Study 1298218 11034945
1300029 human BW13_H Body weight QTL 13 (human) 2 3.42 1298184 D2S112 1298201 D2S2333 1298118 D2S347 Body weight body mass index whole-genome scan for obesity in subjects from an osteoporosis database at Creighton University 738106 14764808 Obs2_H
1300030 human BW23_H Body weight QTL 23 (human) 3 3.45 1299921 D3S1764 Body weight body mass index genome wide linkage scan for body mass index in GENOA (black) subjects from the National Heart, Lung, and Blood Insititute Family Blood Pressure Program 1285225 11923912
1300031 human BP55_H Blood pressure QTL 55 (human) 22 1.54 .00383 1299924 D22S274 Blood pressure diastolic genome-wide scan for loci affecting blood pressure in random and obese families in the Quebec Family Study 1298218 11034945
1300032 human BW33_H Body weight QTL 33 (human) 2 1.5 .0075 1299938 D2S436 1299936 D2S1888 Body weight body mass index genome-wide linkage analysis to identify linkage to obesity in type 2 diabetic Dutch Caucasian siblings 1298537 12727978
1300033 human BP38_H Blood pressure QTL 38 (human) 22 2.07 1298301 D22S685 Blood pressure hypertension susceptibility genome-wide scan for loci affecting hypertension in Finnish affected sib pairs 1298217 11081770
1300034 human BP50_H Blood pressure QTL 50 (human) 19 2.1 .00094 735594 LDLR 1299905 D19S247 Blood pressure systolic genome-wide scan for loci affecting blood pressure in random and obese families in the Quebec Family Study 1298218 11034945
1300035 human BW30_H Body weight QTL 30 (human) 17 2.47 1299913 D17S947 Body weight body mass index genome wide linkage scan for body mass index in GENOA (white) subjects from the National Heart, Lung, and Blood Insititute Family Blood Pressure Program 1285225 11923912
1300036 human BW29_H Body weight QTL 29 (human) 16 2.55 1299900 GATA67G11 Body weight body mass index genome wide linkage scan for body mass index in GENOA (white) subjects from the National Heart, Lung, and Blood Insititute Family Blood Pressure Program 1285225 11923912
1300715 mouse Lrnpcs1_m learning-preconditioned stimulus 1 (mouse) 12 Not determined
1300716 mouse Cd4ts4_m CD4 T cell subset 4 (mouse) 9 Not determined
1300717 mouse Taste9_m taste bitterness sensitivity 9 (mouse) 6 Not determined
1300718 mouse Afpq10_m abdominal fat percent QTL 10 (mouse) 12 Not determined
1300719 mouse Iba5_m induction of brown adipocytes 5 (mouse) 5 Not determined
1300720 mouse Skl2_m skeletal size (tail length) 2 (mouse) 2 Not determined
1300721 mouse Cfbw3_m cystic fibrosis body weight 3 (mouse) 7 Not determined
1300722 mouse Sle3_m systemic lupus erythmatosus susceptibility 3 (mouse) 7 Not determined
1300723 mouse Splrn1_m spatial learning 1 (mouse) 4 Not determined
1300724 mouse Idd5a_m insulin dependent diabetes susceptibility 5a (mouse) 1 Not determined
1300725 mouse Remslp5_m rapid eye movement sleep 5 (mouse) 17 Not determined
1300726 mouse Pitm4_m prion incubation time 4 (mouse) 15 Not determined
1300727 mouse Mptp1_m MPTP sensitivity 1 (mouse) 1 Not determined
1300728 mouse Afw11_m abdominal fat weight QTL 11 (mouse) X Not determined
1300729 mouse Paam2_m progression of autoimmune arthritis in MRL mice 2 (mouse) 19 Not determined
1300730 mouse Bslm2_m basal locomotor activity 2 (mouse) 19 Not determined
1300731 mouse Smdq3_m segregation of mitochondrial DNA QTL 3 (mouse) 6 Not determined
1300732 mouse Melm2_m melanoma modifier 2 (mouse) 1 Not determined
1300733 mouse Sbnt2_m spacial bias during navigation task 2 (mouse) 13 Not determined
1300734 mouse Hdlq25_m HDL QTL 25 (mouse) 8 Not determined
1300735 mouse Pgia20_m proteoglycan induced arthritis 20 (mouse) 17 Not determined
1300736 mouse Drb6_m dopamine receptor binding 6 (mouse) 12 Not determined
1300737 mouse Bhr4_m bronchial hyperresponsiveness 4 (mouse) 13 Not determined
1300738 mouse Oss1_m osteosarcoma suppressor 1 (mouse) 9 Not determined
1300739 mouse Taste5_m taste-saccharin preference 5 (mouse) 6 Not determined
1300740 mouse Tne1_m total number errors (mouse) 1 Not determined
1300741 mouse Idd17_m insulin dependent diabetes susceptibility 17 (mouse) 3 Not determined
1300742 mouse Faq6_m fluctuating asymmetry QTL 6 (mouse) 12 Not determined
1300743 mouse Skull6_m skull morphology 6 (mouse) 4 Not determined
1300744 mouse Tshp10_m tooth shape 10 (mouse) 11 Not determined
1300745 mouse Gvhd1_m graft-versus-host disease 1 (mouse) 1 Not determined
1300746 mouse Skl1_m skeletal size (tail length) 1 (mouse) 1 Not determined
1300747 mouse Skts2_m skin tumor susceptibility 2 (mouse) 7 Not determined
1300748 mouse Cocrb4_m cocaine related behavior 4 (mouse) 3 Not determined
1300749 mouse Pbbcp2_m peripheral blood B cell percentage 2 (mouse) 1 Not determined
1300750 mouse Lrnx1_m learning contextual 1 (mouse) 1 Not determined
1300751 mouse Bdt1_m bone density traits 1 (mouse) 2 Not determined
1300752 mouse Ap6q_m alcohol preference 6 QTL (mouse) 3 Not determined
1300753 mouse Eae10_m susceptibility to experimental allergic encephalomyelitis 10 (mouse) 3 Not determined
1300754 mouse Lith4_m lithogenic gene 4 (mouse) X Not determined
1300755 mouse Wg3_m weight gain in high growth mice 3 (mouse) 8 Not determined
1300756 mouse Pgia16_m proteoglycan induced arthritis 16 (mouse) 5 Not determined
1300757 mouse Cocia9_m cocaine induced activation 9 (mouse) 7 Not determined
1300758 mouse Bomd4_m bone mineral density 4 (mouse) 7 Not determined
1300759 mouse Geot_m geotaxia (mouse) 10 Not determined
1300760 mouse Nobq1_m New Zealand obese QTL 1 (mouse) 5 Not determined
1300761 mouse Lgth1_m body length 1 (mouse) 2 Not determined
1300762 mouse Taste3_m taste-saccharin preference 3 (mouse) 3 Not determined
1300763 mouse Fdpref_m food preference (mouse) 8 Not determined
1300764 mouse Tshp17_m tooth shape 17 (mouse) 16 Not determined
1300765 mouse Bbaa4_m B.burgdorferi-associated arthritis 4 (mouse) 11 Not determined
1300766 mouse Skull16_m skull morphology 16 (mouse) 11 Not determined
1300767 mouse Aliq4_m acute lung injury QTL 4 (mouse) 6 Not determined
1300768 mouse Tshp9_m tooth shape 9 (mouse) 11 Not determined
1300769 mouse Pcyts2_m plasmacytoma susceptibility 2 (mouse) 4 Not determined
1300770 mouse Ltsd6_m lung tumor shape-determining 6 (mouse) 19 Not determined
1300771 mouse Fob2_m F-line obesity QTL 2 (mouse) 12 Not determined
1300772 mouse Bglq16_m body growth late QTL 16 (mouse) 15 Not determined
1300773 mouse Asbb2_m autoimmune susceptibility in C57BL/6J and BALB/c 2 (mouse) 12 Not determined
1300774 mouse Pgia7_m proteoglycan induced arthritis 7 (mouse) 11 Not determined
1300775 mouse Scpro1_m stem cell proliferation 1 (mouse) 7 Not determined
1300776 mouse Lfp3_m long free running period 3 (mouse) 19 Not determined
1300777 mouse Chol10_m cholesterol 10 (mouse) 9 Not determined
1300778 mouse Lprm4_m lymphoproliferation modifier 4 (mouse) 5 Not determined
1300779 mouse Dyscalc4_m dystrophic cardiac calcinosis 4 (mouse) 14 Not determined
1300780 mouse Cocrb16_m cocaine related behavior 16 (mouse) 4 Not determined
1300781 mouse Lith8_m lithogenic gene 8 (mouse) 4 Not determined
1300782 mouse Rear1_m rearing 1 (mouse) 6 Not determined
1300783 mouse Etmr_m ethanol metabolism rate (mouse) 17 Not determined
1300784 mouse Prdt3_m prion disease incubation time 3 (mouse) 11 Not determined
1300785 mouse Manh3_m mandible shape 3 (mouse) 2 Not determined
1300786 mouse Bw7_m body weight QTL 7 (mouse) 4 Not determined
1300787 mouse Cd8mts5_m CD8 memory T cell subset 5 (mouse) 17 Not determined
1300788 mouse Cia2_m collagen induced arthritis QTL 2 (mouse) 2 Not determined
1300789 mouse Idd18_m insulin dependent diabetes susceptibility 18 (mouse) 3 Not determined
1300790 mouse Pgia6_m proteoglycan induced arthritis 6 (mouse) 10 Not determined
1300791 mouse Abbp3_m A/J and C57BL/6 blood pressure 3 (mouse) 7 Not determined
1300792 mouse Ltsd8_m lung tumor shape-determining 8 (mouse) 6 Not determined
1300793 mouse Pcfm2_m periosteal circumference and femur length 2 (mouse) 2 Not determined
1300794 mouse Spha2_m sperm head anomaly 2 (mouse) X Not determined
1300795 mouse Stia2_m serum transfer induced arthritis 2 (mouse) 2 Not determined
1300796 mouse Lmr5_m leishmaniasis resistance 5 (mouse) 10 Not determined
1300797 mouse Sluc22_m susceptibility to lung cancer 22 (mouse) 10 Not determined
1300798 mouse Actre3_m activity response to ethanol 3 (mouse) 2 Not determined
1300799 mouse Cfld2_m cystic fibrosis lung disease 2 (mouse) 6 Not determined
1300800 mouse Ses3_m salmonella enteritidis susceptibility 3 (mouse) 15 Not determined
1300801 mouse Drb2_m dopamine receptor binding 2 (mouse) 5 Not determined
1300802 mouse Daq3_m directional asymmetry QTL 3 (mouse) 5 Not determined
1300803 mouse Sluc6_m susceptibility to lung cancer 6 (mouse) 4 Not determined
1300804 mouse Bw15_m body weight QTL 15 (mouse) 13 Not determined
1300805 mouse Mors3_m modifier of obesity related sterility 3 (mouse) 14 Not determined
1300806 mouse Aod4_m autoimmune ovarian dysgenesis 4 (mouse) 2 Not determined
1300807 mouse Nidd1k_m Nidd1 on KK-A (mouse) 7 Not determined
1300808 mouse Afw3_m abdominal fat weight QTL 3 (mouse) 5 Not determined
1300809 mouse Ccrs2_m corpus callosum hemisphere surface size 2 (mouse) 4 Not determined
1300810 mouse Bgeq12_m body growth early QTL 12 (mouse) 13 Not determined
1300811 mouse Obq3_m obesity QTL 3 (mouse) 2 Not determined
1300812 mouse Oriq1_m ovulation rate QTL 1 (mouse) 9 Not determined
1300813 mouse Lcho4_m liver cholesterol 4 (mouse) 15 Not determined
1300814 mouse Artles_m arterial lesions (mouse) 6 Not determined
1300815 mouse Aliq2_m acute lung injury QTL 2 (mouse) 13 Not determined
1300816 mouse Hacu_m high affinity choline uptake (mouse) 17 Not determined
1300817 mouse Orgwq6_m organ weight QTL 6 (mouse) 4 Not determined
1300818 mouse Bbaa10_m B.burgdorferi-associated arthritis 10 (mouse) 12 Not determined
1300819 mouse Hpic3_m haloperidol induced catalepsy 3 (mouse) 14 Not determined
1300820 mouse Char6_m P. chabaudi malaria resistance QTL 6 (mouse) 5 Not determined
1300821 mouse Lore1_m loss of righting induced by ethanol 1 (mouse) 1 Not determined
1300822 mouse Esmr_m experimental severe malaria resistance (mouse) 18 Not determined
1300823 mouse Ath9_m atherosclerosis 9 (mouse) 1 Not determined
1300824 mouse Ltq_m lung tumor QTL (mouse) 8 Not determined
1300825 mouse Wg1_m weight gain in high growth mice 1 (mouse) 2 Not determined
1300826 mouse Lrnx5_m learning contextual 5 (mouse) 19 Not determined
1300827 mouse Cora1_m correlation in cytokine production 1 (mouse) 5 Not determined
1300828 mouse Aod3_m autoimmune ovarian dysgenesis 3 (mouse) 1 Not determined
1300829 mouse Drb4_m dopamine receptor binding 4 (mouse) 12 Not determined
1300830 mouse Bgeq1_m body growth early QTL 1 (mouse) 1 Not determined
1300831 mouse Hdlq8_m HDL QTL 8 (mouse) 5 Not determined
1300832 mouse Dautb1_m dopamine uptake transporter binding 1 (mouse) 1 Not determined
1300833 mouse Pid1_m prior incubation determinant 1 (mouse) 17 Not determined
1300961 mouse Bh4p_m bar holding four paws (mouse) 3 Not determined
1300962 mouse Cd8mts4_m CD8 memory T cell subset 4 (mouse) 11 Not determined
1300963 mouse Hrl_m herpes resistance locus (mouse) 6 Not determined
1300964 mouse Hdlq22_m HDL QTL 22 (mouse) 5 Not determined
1300965 mouse Cocrb13_m cocaine related behavior 13 (mouse) 12 Not determined
1300966 mouse Pabr2_m plasma apolipoprotein B (human) regulator 2 (mouse) 4 Not determined
1300967 mouse Bdt6_m bone density traits 6 (mouse) 15 Not determined
1300968 mouse Skts4_m skin tumor susceptibility 4 (mouse) 5 Not determined
1300969 mouse Sluc5_m susceptibility to lung cancer 5 (mouse) 1 Not determined
1300970 mouse Cdcs4_m cytokine deficiency colitis susceptibility 4 (mouse) 8 Not determined
1300971 mouse Pgia14_m proteoglycan induced arthritis 14 (mouse) 12 Not determined
1300972 mouse Cocia11_m cocaine induced activation 11 (mouse) 13 Not determined
1300973 mouse Abmm_m antibody mediated myocarditis (mouse) 12 Not determined
1300974 mouse Pgia9_m proteoglycan induced arthritis 9 (mouse) 15 Not determined
1300975 mouse Fembrs3_m femur breaking strength 3 (mouse) 10 Not determined
1300976 mouse Bmd19_m bone mineral density 19 (mouse) 1 Not determined
1300977 mouse Mopkd1_m modifier of polycystic kidney disease progression 1 (mouse) 4 Not determined
1300978 mouse Pas6_m pulmonary adenoma susceptibility 6 (mouse) 2 Not determined
1300979 mouse Sbmd3_m spinal bone mineral density 3 (mouse) 7 Not determined
1300980 mouse Tshp18_m tooth shape 18 (mouse) 18 Not determined
1300981 mouse Cplaq1_m circadian period of locomotor activity 1 (mouse) 3 Not determined
1300982 mouse Lmr11_m leishmaniasis resistance 11 (mouse) 3 Not determined
1300983 mouse Sluc4_m susceptibility to lung cancer 4 (mouse) 11 Not determined
1300984 mouse Start1_m startle response 1 (mouse) 4 Not determined
1300985 mouse Bmd13_m bone mineral density 13 (mouse) 13 Not determined
1300986 mouse Hdlq2_m HDL QTL 2 (mouse) 5 Not determined
1300987 mouse Skull23_m skull morphology 23 (mouse) 16 Not determined
1300988 mouse Cons4_m consumption-saccharin intake 4 (mouse) 11 Not determined
1300989 mouse Lrdg1_m light induced retinal degeneration 1 (mouse) 1 Not determined
1300990 mouse Bits3_m bitterness sensitivity 3 (mouse) 11 Not determined
1300991 mouse Cpfd4_m cerebellum pattern fissures (mouse) 9 Not determined
1300992 mouse Cocia14_m cocaine induced activation 14 (mouse) 18 Not determined
1300993 mouse Hycdc_m hypercapnic duty cycle (mouse) 5 Not determined
1300994 mouse Pvcan3_m protection against vaginal candidiasis 3 (mouse) 18 Not determined
1300995 mouse Fembrs4_m femur breaking strength 4 (mouse) 17 Not determined
1300996 mouse Aorls2_m aortic lesion size 2 (mouse) 7 Not determined
1300997 mouse Eae15_m susceptibility to experimental allergic encephalomyelitis 15 (mouse) 10 Not determined
1300998 mouse Cia17_m collagen induced arthritis 17 (mouse) 14 Not determined
1300999 mouse Carp1_m carcass protein in high growth mice 1 (mouse) 2 Not determined
1301000 mouse Obq5_m obesity QTL 5 (mouse) 9 Not determined
1301001 mouse Daq7_m directional asymmetry QTL 7 (mouse) 12 Not determined
1301002 mouse Kwq4_m kidney weight QTL 4 (mouse) 13 Not determined
1301003 mouse Lmblgq4_m limb length QTL 4 (mouse) 10 Not determined
1301004 mouse Hdlq27_m HDL QTL 27 (mouse) 15 Not determined
1301005 mouse Idd16_m insulin dependent diabetes susceptibility 16 (mouse) 17 Not determined
1301006 mouse Hfib1_m hepatic fibrogenesis 1 (mouse) 15 Not determined
1301007 mouse Pid2_m prion incubation determinant 2 (mouse) 9 Not determined
1301008 mouse Bwob_m body weight of obese males (mouse) 5 Not determined
1301009 mouse Pbwg7_m postnatal body weight growth 7 (mouse) X Not determined
1301010 mouse ahl2_m age related hearing loss 2 (mouse) 5 Not determined
1301011 mouse Cplaq4_m circadian period of locomotor activity 4 (mouse) 1 Not determined
1301012 mouse Vispl_m visual placing (mouse) 11 Not determined
1301013 mouse Capsq4_m capsaicin sensitivity related QTL 4 (mouse) 8 Not determined
1301014 mouse Dob7_m dietary obesity 7 (mouse) X Not determined
1301015 mouse Sysbp2_m systolic blood pressure 2 (mouse) 13 Not determined
1301016 mouse Szs1_m seizure susceptibility 1 (mouse) 1 Not determined
1301017 mouse Bwfq1_m body weight and fat QTL 1 (mouse) 2 Not determined
1301018 mouse Kwq1_m kidney weight QTL 1 (mouse) 2 Not determined
1301019 mouse Bmd6_m bone mineral density 6 (mouse) 2 Not determined
1301020 mouse Pheo_m pheomelanin (mouse) 15 Not determined
1301021 mouse Nfbg_m non-fasting blood glucose (mouse) 10 Not determined
1301022 mouse Morph4_m morphine antinociception 4 (mouse) 10 Not determined
1301023 mouse Sluc24_m susceptibility to lung cancer 24 (mouse) 15 Not determined
1301024 mouse Tbrs2_m tuberculosis resistance 2 (mouse) 3 Not determined
1301025 mouse Lbw7_m lupus NZB x NZW 7 (mouse) 1 Not determined
1301026 mouse Cocrb9_m cocaine related behavior 9 (mouse) 9 Not determined
1301350 mouse Nidd4k_m Nidd4 on KK-A (mouse) 7 Not determined
1301351 mouse Obq6_m obesity QTL 6 (mouse) X Not determined
1301352 mouse Bis4_m beta-carboline induced seizures 4 (mouse) 7 Not determined
1301353 mouse Lbw6_m lupus NZB x NZW 6 (mouse) 18 Not determined
1301354 mouse Hcs4_m hepatocarcinogenesis susceptibility 4 (mouse) 2 Not determined
1301355 mouse Hipp2_m hippocampal weight 2 (mouse) 5 Not determined
1301356 mouse Idd8_m insulin dependent diabetes susceptibility 8 (mouse) 14 Not determined
1301357 mouse Hdlq32_m HDL QTL 32 (mouse) 19 Not determined
1301358 mouse Eae20_m experimental allergic encephalomyelitis 20 (mouse) 3 Not determined
1301359 mouse Remslp2_m rapid eye movement sleep 2 (mouse) 16 Not determined
1301360 mouse Stheal1_m soft tissue heal 1 (mouse) 1 Not determined
1301361 mouse Idd14_m insulin dependent diabetes susceptibility 14 (mouse) 13 Not determined
1301362 mouse Prnr1_m prion resistance 1 (mouse) 5 Not determined
1301363 mouse Pbwg13_m postnatal body weight growth 13 (mouse) 5 Not determined
1301364 mouse Lith14_m lithogenic gene 14 (mouse) 16 Not determined
1301365 mouse Ap5q_m alcohol preference 5 QTL (mouse) 9 Not determined
1301366 mouse Cplaq6_m circadian period of locomotor activity 6 (mouse) 5 Not determined
1301367 mouse Twq1_m testis weight QTL 1 (mouse) 13 Not determined
1301368 mouse Par2_m pulmonary adenoma resistance 2 (mouse) 18 Not determined
1301369 mouse Im4_m immunoregulatory 4 (mouse) 6 Not determined
1301370 mouse Adip1_m adiposity 1 (mouse) 1 Not determined
1301371 mouse Afw4_m abdominal fat weight QTL 4 (mouse) 9 Not determined
1301372 mouse Sluc13_m susceptibility to lung cancer 13 (mouse) 14 Not determined
1301373 mouse Vent2_m ventricular size 2 (mouse) 4 Not determined
1301374 mouse Cplaq7_m circadian period of locomotor activity 7 (mouse) 2 Not determined
1301375 mouse Tria4_m T-cell receptor induced activation 4 (mouse) 7 Not determined
1301376 mouse Etohc1_m ethanol consumption 1 (mouse) 2 Not determined
1301377 mouse Mprf_m maternal performance (mouse) 7 Not determined
1301378 mouse Hpdty_m hindlimb polydactyly (mouse) 2 Not determined
1301379 mouse Sials_m sialoadenitis susceptibility (mouse) 4 Not determined
1301380 mouse Cia8_m collagen induced arthritis QTL 8 (mouse) 10 Not determined
1301381 mouse Bomb1_m bone marrow pre-B 1 (mouse) 3 Not determined
1301382 mouse Arvm2_m autoimmune renal vasculitis 2 (mouse) 4 Not determined
1301383 mouse Aem2_m anti-erythrocyte autoantibody modifier 2 (mouse) 7 Not determined
1301384 mouse Dice1_m determination of interleukin 4 commitment 1 (mouse) 16 Not determined
1301385 mouse Radpf2_m radiation pulmonary fibrosis 2 (mouse) 1 Not determined
1301386 mouse Sysbp1_m systolic blood pressure 1 (mouse) 10 Not determined
1301387 mouse Chol8_m cholesterol 8 (mouse) 4 Not determined
1301388 mouse Hdlq21_m HDL QTL 21 (mouse) 3 Not determined
1301389 mouse Etohcta3_m ethanol conditioned taste aversion 3 (mouse) 3 Not determined
1301390 mouse Hpnr6_m Heligmosomoides polygyrus nematode resistance 6 (mouse) 12 Not determined
1301391 mouse Manh14_m mandible shape 14 (mouse) 10 Not determined
1301392 mouse Eae3_m susceptibility to experimental allergic encephalomyelitis 3 (mouse) 3 Not determined
1301393 mouse Dyscalc3_m dystrophic cardiac calcinosis 3 (mouse) 12 Not determined
1301394 mouse Eae11_m susceptibility to experimental allergic encephalomyelitis 11 (mouse) 16 Not determined
1301395 mouse Wt10q3_m body weight (mouse) 11 Not determined
1301396 mouse Apmt2_m accelerator of polyoma-induced mammary tumors 2 (mouse) 9 Not determined
1301397 mouse Amp2_m amplitude of circadian rhythm 2 (mouse) 1 Not determined
1301398 mouse Rapop3_m radiation-induced apoptosis 3 (mouse) 3 Not determined
1301399 mouse Cpfd3_m cerebellum pattern fissures (mouse) 5 Not determined
1301400 mouse Lmr13_m leishmaniasis resistance 13 (mouse) 18 Not determined
1301401 mouse Odsm1_m ocular degeneration with sex reversal modifier 1 (mouse) 18 Not determined
1301402 mouse Ap2q_m alcohol preference 2 QTL (mouse) 2 Not determined
1301403 mouse Alcp9_m alcohol preference locus 9 (mouse) 5 Not determined
1301404 mouse Sbmd4_m spinal bone mineral density 4 (mouse) 11 Not determined
1301405 mouse Etohr_m ethanol response acute (mouse) 2 Not determined
1301406 mouse Egrd2_m early growth rate (mouse) 15 Not determined
1301407 mouse Rapop2_m radiation-induced apoptosis 2 (mouse) 9 Not determined
1301408 mouse Lore8_m loss of righting induced by ethanol 8 (mouse) 1 Not determined
1301409 mouse Lvic1_m liver iron content 1 (mouse) 2 Not determined
1301410 mouse Cd8mts6_m CD8 memory T cell subset 6 (mouse) 19 Not determined
1301411 mouse Pitm1_m prion incubation time 1 (mouse) 2 Not determined
1301412 mouse Manh13_m mandible shape 13 (mouse) 10 Not determined
1301027 mouse Hdlq12_m HDL QTL 12 (mouse) 6 Not determined
1301028 mouse Lgth7_m body length 7 (mouse) 13 Not determined
1301029 mouse T2dm3_m type 2 diabetes mellitus 3 (mouse) 2 Not determined
1301030 mouse Bw4_m body weight QTL 4 (mouse) 11 Not determined
1301031 mouse Bdln3_m body length 3 (mouse) 2 Not determined
1301032 mouse Tauph_m tau phosphorylation (mouse) 16 Not determined
1301033 mouse Abbp2_m A/J and C57BL/6 blood pressure 2 (mouse) 4 Not determined
1301034 mouse Egrm2_m early growth rate (mouse) 6 Not determined
1301035 mouse Lcho2_m liver cholesterol 2 (mouse) 3 Not determined
1301036 mouse Axtofd4_m anxiety-open field defecation 4 (mouse) X Not determined
1301037 mouse Cd4ts5_m CD4 T cell subset 5 (mouse) 12 Not determined
1301038 mouse C10bw3_m castaneus 10 week body weight 3 (mouse) 11 Not determined
1301039 mouse Cbm4_m cerebellum weight 4 (mouse) 19 Not determined
1301040 mouse Remslp1_m rapid eye movement sleep 1 (mouse) 4 Not determined
1301041 mouse Prnr2_m prion resistance 2 (mouse) 7 Not determined
1301042 mouse Elmaz1_m elevated maze behavior 1 (mouse) 5 Not determined
1301043 mouse Aaiq2_m aromatase activity QTL 2 (mouse) 4 Not determined
1301044 mouse Manh15_m mandible shape 15 (mouse) 11 Not determined
1301045 mouse Sluc10_m susceptibility to lung cancer 10 (mouse) 9 Not determined
1301046 mouse Par3_m pulmonary adenoma resistance 3 (mouse) 12 Not determined
1301047 mouse Bglq9_m body growth late QTL 9 (mouse) 12 Not determined
1301048 mouse Actre2_m activity response to ethanol 2 (mouse) 2 Not determined
1301049 mouse El4_m epilepsy 4 (mouse) 9 Not determined
1301050 mouse Igf1q2_m insulin-like growth factor 1 QTL 2 (mouse) 18 Not determined
1301051 mouse Eae9_m susceptibility to experimental allergic encephalomyelitis 9 (mouse) 9 Not determined
1301052 mouse Bhr6_m bronchial hyperresponsiveness 6 (mouse) 7 Not determined
1301053 mouse Idd6_m insulin dependent diabetes susceptibility 6 (mouse) 6 Not determined
1301054 mouse Pcpila3_m PCP induced locomotor activity 3 (mouse) 15 Not determined
1301055 mouse Bwtq6_m body weight QTL 6 (mouse) 15 Not determined
1301056 mouse Pas2_m pulmonary adenoma susceptibility 2 (mouse) 17 Not determined
1301057 mouse Nidd4_m non-insulin-dependent diabetes mellitus 4 (mouse) 11 Not determined
1301058 mouse Musz2_m muscle size 2 (mouse) 14 Not determined
1301059 mouse Hrtfm1_m heart failure modifier 1 (mouse) 2 Not determined
1301060 mouse Cocrb12_m cocaine related behavior 12 (mouse) 11 Not determined
1301061 mouse Nidd5_m non-insulin-dependent diabetes mellitus 5 (mouse) 2 Not determined
1301062 mouse Pltpq4_m phospholipid transfer protein activity QTL 4 (mouse) 15 Not determined
1301063 mouse Dob4_m dietary obesity 4 (mouse) 15 Not determined
1301064 mouse Bwq4_m body weight (mouse) 18 Not determined
1301065 mouse Morph3_m morphine antinociception 3 (mouse) 9 Not determined
1301066 mouse Otx2m2_m orthodenticle homolog 2 (Drosophila) modifier 2 (mouse) 2 Not determined
1301067 mouse Daq17_m directional asymmetry QTL 17 (mouse) 2 Not determined
1301068 mouse Kwq2_m kidney weight QTL 2 (mouse) 3 Not determined
1301069 mouse Bw10_m body weight QTL 10 (mouse) 13 Not determined
1301070 mouse Cypr1_m cytokine production 1 (mouse) 16 Not determined
1301071 mouse Chol1_m cholesterol 1 (mouse) 7 Not determined
1301072 mouse Eae22_m experimental allergic encephalomyelitis 22 (mouse) 11 Not determined
1301073 mouse Orch5_m autoimmune orchitis resistance 5 (mouse) 1 Not determined
1301074 mouse Axtofa3_m anxiety-open field activity 3 (mouse) 7 Not determined
1301075 mouse Obq10_m obesity QTL 10 (mouse) 2 Not determined
1301076 mouse Idd10_m insulin dependent diabetes susceptibility 10 (mouse) 3 Not determined
1301077 mouse Pcpila1_m PCP induced locomotor activity 1 (mouse) 1 Not determined
1301078 mouse Alcp2_m alcohol preference locus 2 (mouse) 11 Not determined
1301079 mouse Tmevd4_m Theiler's murine encephalomyelitis virus induced demyelinating disease susceptibility 4 (mouse) 14 Not determined
1301080 mouse Sluc9_m susceptibility to lung cancer 9 (mouse) 8 Not determined
1301081 mouse Cfsw3_m cystic fibrosis survival to weaning 3 (mouse) X Not determined
1301082 mouse Bbaa16_m B.burgdorferi-associated arthritis 16 (mouse) 7 Not determined
1301083 mouse Bhr5_m bronchial hyperresponsiveness 5 (mouse) 6 Not determined
1301084 mouse Bpq5_m blood pressure QTL 5 (mouse) 6 Not determined
1301085 mouse Lrnx10_m learning-contextual 10 (mouse) 2 Not determined
1301086 mouse Lprm5_m lymphoproliferation modifier 5 (mouse) 16 Not determined
1301087 mouse Bbaa15_m B.burgdorferi-associated arthritis 15 (mouse) 2 Not determined
1301088 mouse Alcw6_m alcohol withdrawal 6 (mouse) 8 Not determined
1301089 mouse Insq1_m insulin QTL 1 (mouse) 4 Not determined
1301090 mouse Eae23_m experimental allergic encephalomyelitis 23 (mouse) 11 Not determined
1301091 mouse Bbaa21_m B.burgdorferi-associated arthritis 21 (mouse) 14 Not determined
1301092 mouse Taste6_m taste-saccharin preference 6 (mouse) 11 Not determined
1301093 mouse Igfbp3q2_m insulin-like growth factor binding protein 3 QTL 2 (mouse) 10 Not determined
1301094 mouse Ath3_m atherosclerosis 3 (mouse) 7 Not determined
1301095 mouse El6_m epilepsy 6 (mouse) 11 Not determined
1301096 mouse Obq1_m obesity QTL 1 (mouse) 7 Not determined
1301097 mouse Bplpf1_m bleomycin pulmonary fibrosis 1 (mouse) 17 Not determined
1301098 mouse Cd8mts3_m CD8 memory T cell subset 3 (mouse) 2 Not determined
1301099 mouse Cbm2_m cerebellum weight 2 (mouse) 8 Not determined
1301100 mouse Bdt2_m bone density traits 2 (mouse) 3 Not determined
1301101 mouse Hpnr4_m Heligmosomoides polygyrus nematode resistance 4 (mouse) 1 Not determined
1301102 mouse Cia14_m collagen induced arthritis 14 (mouse) 5 Not determined
1301103 mouse Pgia11_m proteoglycan induced arthritis 11 (mouse) 18 Not determined
1301104 mouse Fpdty_m forelimb polydactyly (mouse) 8 Not determined
1301105 mouse Cfld4_m cystic fibrosis lung disease 4 (mouse) 7 Not determined
1301106 mouse Skts7_m skin tumor susceptibility 7 (mouse) 4 Not determined
1301107 mouse Scc4_m colon tumor susceptibility 4 (mouse) 17 Not determined
1301108 mouse Scon2_m sucrose consumption 2 (mouse) 4 Not determined
1301109 mouse Dntcs2_m dental caries susceptibility 2 (mouse) 2 Not determined
1301110 mouse Mors4_m modifier of obesity related sterility 4 (mouse) 14 Not determined
1301111 mouse Mwq2_m molecular weight of quadriceps QTL 2 (mouse) 11 Not determined
1301112 mouse Szs9_m seizure susceptibility 9 (mouse) 10 Not determined
1301113 mouse Lore7_m loss of righting induced by ethanol 7 (mouse) 7 Not determined
1301114 mouse Ssial2_m susceptibility to sialadenitis 2 (mouse) 3 Not determined
1301115 mouse Lrdm1_m lymphoproliferation (Fas) renal disease modifier 1 (mouse) 7 Not determined
1301116 mouse Hdlq5_m HDL QTL 5 (mouse) 1 Not determined
1301117 mouse Fecq1_m fecundity QTL 1 (mouse) 2 Not determined
1301118 mouse Bbaa23_m B.burgdorferi-associated arthritis 23 (mouse) 4 Not determined
1301119 mouse Drb7_m dopamine receptor binding 7 (mouse) 15 Not determined
1301120 mouse Manh9_m mandible shape 9 (mouse) 7 Not determined
1301121 mouse Obq13_m obesity QTL 13 (mouse) 6 Not determined
1301122 mouse Cd8mts1_m CD8 T memory cell subset 1 (mouse) 1 Not determined
1301123 mouse Cd8mts2_m CD8 memory T cell subset 2 (mouse) 1 Not determined
1301124 mouse Bgeq11_m body growth early QTL 11 (mouse) 12 Not determined
1301125 mouse Sluc27_m susceptibility to lung cancer 27 (mouse) 16 Not determined
1301126 mouse Bwem1_m body weight day 30 males 1 (mouse) 5 Not determined
1301127 mouse Hpnr2_m Heligmosomoides polygyrus nematode resistance 2 (mouse) 17 Not determined
1301128 mouse Sluc20_m susceptibility to lung cancer 20 (mouse) 8 Not determined
1301129 mouse Alcp15_m alcohol preference locus 15 (mouse) 10 Not determined
1301130 mouse Sle1a_m systematic lupus erythematosus susceptibility 1a (mouse) 1 Not determined
1301131 mouse Chol2_m cholesterol 2 (mouse) 6 Not determined
1301132 mouse Mors1_m modifier of obesity related sterility 1 (mouse) 1 Not determined
1301133 mouse Mob8_m multigenic obesity 8 (mouse) 9 Not determined
1301134 mouse Bmd1_m bone mineral density 1 (mouse) 1 Not determined
1301135 mouse Pas8_m pulmonary adenoma susceptibility 8 (mouse) 1 Not determined
1301136 mouse Pgia8_m proteoglycan induced arthritis 8 (mouse) 15 Not determined
1301137 mouse Cocia8_m cocaine induced activation 8 (mouse) 6 Not determined
1301138 mouse Pcd4ts3_m p-glycoprotein positive CD4 T cell subset 3 (mouse) 16 Not determined
1301139 mouse Lmr10_m leishmaniasis resistance 10 (mouse) 8 Not determined
1301140 mouse Bbaa12_m B.burgdorferi-associated arthritis 12 (mouse) 1 Not determined
1301141 mouse Faq5_m fluctuating asymmetry QTL 5 (mouse) 12 Not determined
1301142 mouse Heal2_m wound healing/regeneration 2 (mouse) 13 Not determined
1301143 mouse Skull17_m skull morphology 17 (mouse) 12 Not determined
1301144 mouse Faq4_m fluctuating asymmetry QTL 4 (mouse) 11 Not determined
1301145 mouse Mob2_m multigenic obesity 2 (mouse) 6 Not determined
1301146 mouse Obq11_m obesity QTL 11 (mouse) 5 Not determined
1301147 mouse Diet1_m variability in response to cholestrol enriched atherogenic diet (mouse) 2 Not determined
1301148 mouse Tshp14_m tooth shape 14 (mouse) 13 Not determined
1301149 mouse Lrnx12_m learning-contextual 12 (mouse) 1 Not determined
1301150 mouse Cara3_m carcass ash in high growth mice 3 (mouse) 17 Not determined
1301151 mouse Hdlq14_m HDL QTL 14 (mouse) 1 Not determined
1301152 mouse Athsq2_m atherosclerosis susceptibility QTL 2 (mouse) 6 Not determined
1301153 mouse Estq3_m estradiol regulated response QTL 3 (mouse) 11 Not determined
1301154 mouse Idd5_m insulin dependent diabetes susceptibility 5 (mouse) 1 Not determined
1301155 mouse Bpq7_m blood pressure QTL 7 (mouse) 7 Not determined
1301156 mouse Lbm1_m lean body mass 1 (mouse) 2 Not determined
1301157 mouse Wt10q1_m body weight (mouse) 1 Not determined
1301158 mouse Eae4_m susceptibility to experimental allergic encephalomyelitis 4 (mouse) 7 Not determined
1301159 mouse Fob4_m F-line obesity QTL 4 (mouse) X Not determined
1301160 mouse Eae14_m susceptibility to experimental allergic encephalomyelitis 14 (mouse) 8 Not determined
1301161 mouse Slthsr_m semilethal sex-restricted (mouse) 11 Not determined
1301162 mouse Skull1_m skull morphology 1 (mouse) 1 Not determined
1301163 mouse Eae16_m susceptibility to experimental allergic encephalomyelitis 16 (mouse) 12 Not determined
1301164 mouse Tir3c_m trypansomiasis infection response 3c (mouse) 1 Not determined
1301165 mouse Lith7_m lithogenic gene 7 (mouse) 10 Not determined
1301166 mouse Thypr2_m thymocyte proliferative response 2 (mouse) 1 Not determined
1301167 mouse Bgeq2_m body growth early QTL 2 (mouse) 2 Not determined
1301168 mouse Cdav_m conditioned avoidance (mouse) 1 Not determined
1301169 mouse Corn2_m corneal disease 2 (mouse) 11 Not determined
1301170 mouse Lith13_m lithogenic gene 13 (mouse) 5 Not determined
1301171 mouse Brm2_m brachyury modifier 2 (mouse) 15 Not determined
1301172 mouse Fembrs6_m femur breaking strength 6 (mouse) 9 Not determined
1301173 mouse Embl2_m embryonic lethal 2 (mouse) 11 Not determined
1301174 mouse Pctr1_m plasmacytoma resistance 1 (mouse) 4 Not determined
1301175 mouse Ap7q_m alcohol preference 7 QTL (mouse) 7 Not determined
1301176 mouse Manh1_m mandible shape 1 (mouse) 1 Not determined
1301177 mouse Vent3_m ventricular size 3 (mouse) 7 Not determined
1301178 mouse Lith10_m lithogenic gene 10 (mouse) 6 Not determined
1301179 mouse Fembm4_m femoral bone morphometry 4 (mouse) 2 Not determined
1301180 mouse Faq1_m fluctuating asymmetry QTL 1 (mouse) 4 Not determined
1301181 mouse Lbm6_m lean body mass 6 (mouse) 9 Not determined
1301182 mouse Vmbic6_m ventral midbrain iron content 6 (mouse) 11 Not determined
1301183 mouse Cadfar_m cadmium-induced forelimb autopod reduction defect (mouse) 6 Not determined
1301184 mouse Bdln4_m body length 4 (mouse) 9 Not determined
1301185 mouse Hdlq4_m HDL QTL 4 (mouse) 15 Not determined
1301186 mouse Hlq2_m heat loss QTL 2 (mouse) 2 Not determined
1301187 mouse Adip9_m adiposity 9 (mouse) 16 Not determined
1301188 mouse Heal6_m wound healing/regeneration 6 (mouse) 7 Not determined
1301189 mouse Lmr8_m leishmaniasis resistance 8 (mouse) 1 Not determined
1301190 mouse Cd4ts2_m CD4 T cell subset 2 (mouse) 4 Not determined
1301191 mouse Stia1_m serum transfer induced arthritis 1 (mouse) 1 Not determined
1301192 mouse Skts6_m skin tumor susceptibility 6 (mouse) 9 Not determined
1301193 mouse Lxw3_m lupus BXSB x NZW 3 (mouse) 1 Not determined
1301194 mouse Manz3_m mandible size 3 (mouse) 4 Not determined
1301195 mouse Mlviq1_m murine leukemia virus infection QTL (mouse) 7 Not determined
1301196 mouse Mnif1_m macronutrient intake (mouse) 8 Not determined
1301197 mouse Tlyr1_m thymic lymphoma resistance 1 (mouse) 19 Not determined
1301198 mouse Hdlq3_m HDL QTL 3 (mouse) 18 Not determined
1301199 mouse Many1_m mandible asymmetry 1 (mouse) 10 Not determined
1301200 mouse Mob1_m multigenic obesity 1 (mouse) 7 Not determined
1301201 mouse Chab1_m cholesterol absorption 1 (mouse) 2 Not determined
1301202 mouse Yaa4_m Y-linked autoimmune acceleration 4 (mouse) 1 Not determined
1301203 mouse Alcp8_m alcohol preference locus 8 (mouse) 4 Not determined
1301204 mouse Mob4_m multigenic obesity 4 (mouse) 15 Not determined
1301205 mouse Cms2_m resistance to Coccidioides immitis 2 (mouse) 6 Not determined
1301206 mouse Idd12_m insulin dependent diabetes susceptibility 12 (mouse) 14 Not determined
1301207 mouse Circp1_m circadian photosensitivity 1 (mouse) 12 Not determined
1301208 mouse Sbnt1_m spacial bias during navigation task 1 (mouse) 5 Not determined
1301209 mouse Cia19_m collagen induced arthritis 19 (mouse) X Not determined
1301210 mouse Krcn_m keratoconus (mouse) 17 Not determined
1301211 mouse Bbaa11_m B.burgdorferi-associated arthritis 11 (mouse) 1 Not determined
1301212 mouse Bw19_m body weight QTL 19 (mouse) X Not determined
1301213 mouse Lgth3_m body length 3 (mouse) 4 Not determined
1301214 mouse Manh18_m mandible shape 18 (mouse) 12 Not determined
1301215 mouse Thcr_m T helper cell response (mouse) 18 Not determined
1301216 mouse Cbm1_m cerebellum weight 1 (mouse) 1 Not determined
1301217 mouse Bslm1_m basal locomotor activity 1 (mouse) 9 Not determined
1301218 mouse Letohc1_m low ethanol consumption 1 (mouse) 3 Not determined
1301219 mouse Tshp8_m tooth shape 8 (mouse) 7 Not determined
1301220 mouse Chol4_m cholesterol 4 (mouse) 1 Not determined
1301221 mouse Hrtfm2_m heart failure modifier 2 (mouse) 3 Not determined
1301222 mouse Scc7_m colon tumor susceptibility 7 (mouse) 3 Not determined
1301223 mouse Hdlq7_m HDL QTL 7 (mouse) 5 Not determined
1301224 mouse Carfhg1_m carcass fat in high growth mice 1 (mouse) 5 Not determined
1301225 mouse Sle7_m systematic lupus erythematosus susceptibility 7 (mouse) 1 Not determined
1301226 mouse Bbaa2_m B.burgdorferi-associated arthritis 2 (mouse) 5 Not determined
1301227 mouse Skull19_m skull morphology 19 (mouse) 13 Not determined
1301228 mouse Iba4_m induction of brown adipocytes 4 (mouse) 19 Not determined
1301229 mouse Bpq1_m blood pressure QTL 1 (mouse) 1 Not determined
1301230 mouse Idd5b_m insulin dependent diabetes susceptibility 5b (mouse) 1 Not determined
1301231 mouse Chab6_m cholesterol absorption 6 (mouse) 1 Not determined
1301232 mouse Hcs7_m hepatocarcinogenesis susceptibility 7 (mouse) 1 Not determined
1301233 mouse Sbw2_m splenomegaly-NZB x NZW 2 (mouse) 4 Not determined
1301234 mouse Hscfr_m hematopoietic stem cell frequency regulator (mouse) 17 Not determined
1301235 mouse Alcw4_m alcohol withdrawal 4 (mouse) 2 Not determined
1301236 mouse Afpq6_m abdominal fat percent QTL 6 (mouse) 17 Not determined
1301237 mouse Alcp7_m alcohol preference locus 7 (mouse) 4 Not determined
1301238 mouse Pas5_m pulmonary adenoma susceptibility 5 (mouse) 11 Not determined
1301239 mouse Lrnpcs2_m learning-preconditioned stimulus 2 (mouse) 3 Not determined
1301240 mouse Sluc15_m susceptibility to lung cancer 15 (mouse) 1 Not determined
1301241 mouse Renf1_m renal failure 1 (mouse) 9 Not determined
1301242 mouse Lbm5_m lean body mass 5 (mouse) 7 Not determined
1301243 mouse Bmd2_m bone mineral density 2 (mouse) 5 Not determined
1301244 mouse Ichs_m immediate cutaneous hypersensitivity QTL (mouse) 6 Not determined
1301245 mouse Afpq3_m abdominal fat percent QTL 3 (mouse) 5 Not determined
1301246 mouse Hpic5_m haloperidol-induced catelepsy 5 (mouse) 9 Not determined
1301247 mouse Chol3_m cholesterol 3 (mouse) 1 Not determined
1301248 mouse Alaa1_m alopecia areata (mouse) 17 Not determined
1301249 mouse Sbw1_m splenomegaly-NZB x NZW 1 (mouse) 1 Not determined
1301250 mouse Afpq5_m abdominal fat percent QTL 5 (mouse) 11 Not determined
1301251 mouse Scc3_m colon tumor susceptibility 3 (mouse) 1 Not determined
1301252 mouse Etohc3_m ethanol consumption 3 (mouse) 9 Not determined
1301253 mouse Skmw2_m skeletal muscle weight 2 (mouse) 8 Not determined
1301254 mouse Skts11_m skin tumor susceptibility 11 (mouse) 6 Not determined
1301255 mouse Cd4ts6_m CD4 T cell subset 6 (mouse) 13 Not determined
1301256 mouse Skmw1_m skeletal muscle weight 1 (mouse) 3 Not determined
1301257 mouse Yaa3_m Y-linked autoimmune acceleration 3 (mouse) 1 Not determined
1301258 mouse Cons3_m consumption-saccharin intake 3 (mouse) 8 Not determined
1301259 mouse Hcs2_m hepatocarcinogenesis susceptibility 2 (mouse) 8 Not determined
1301260 mouse Exen1_m exencephaly 1 (mouse) 13 Not determined
1301261 mouse Hdl4_m high density lipoprotein (HDL) level 4 (mouse) 17 Not determined
1301262 mouse Gasa3_m gastritis type A susceptibility locus 3 (mouse) 6 Not determined
1301263 mouse Szs11_m seizure susceptibility 11 (mouse) 5 Not determined
1301264 mouse Cocia6_m cocaine induced activation 6 (mouse) 5 Not determined
1301265 mouse Idd21_m insulin dependent diabetes susceptibility 21 (mouse) 18 Not determined
1301266 mouse Lmr4_m leishmaniasis resistance 4 (mouse) 6 Not determined
1301267 mouse Bcmd2_m B cell maturation defect 2 (mouse) 4 Not determined
1301268 mouse Bmd14_m bone mineral density 14 (mouse) 14 Not determined
1301269 mouse Sluc12_m susceptibility to lung cancer 12 (mouse) 12 Not determined
1301270 mouse Dloc1_m duration of locomotor activity 1 (mouse) 2 Not determined
1301271 mouse Datd_m dopamine transporter density (mouse) 19 Not determined
1301272 mouse Cfsw1_m cystic fibrosis survival to weaning 1 (mouse) 3 Not determined
1301273 mouse Wt6q1_m body weight (mouse) 1 Not determined
1301274 mouse Lmr9_m leishmaniasis resistance 9 (mouse) 4 Not determined
1301275 mouse Sle10_m systematic lupus erythematosus susceptibility 10 (mouse) 1 Not determined
1301276 mouse Tswt_m testis weight (mouse) X Not determined
1301277 mouse nctm1_m Nakano cataract modifier 1 (mouse) 3 Not determined
1301278 mouse Bdln1_m body length 1 (mouse) X Not determined
1301279 mouse Obq4_m obesity QTL 4 (mouse) 17 Not determined
1301280 mouse Bglq2_m body growth late QTL 2 (mouse) 2 Not determined
1301281 mouse Frp2_m free running period 2 (mouse) 5 Not determined
1301282 mouse Ses1_m salmonella enteritidis susceptibility 1 (mouse) 1 Not determined
1301283 mouse Alcw3_m alcohol withdrawal 3 (mouse) 11 Not determined
1301284 mouse Cosz3_m cocaine seizure 3 (mouse) 15 Not determined
1301285 mouse Manh2_m mandible shape 2 (mouse) 1 Not determined
1301286 mouse Axtofd2_m anxiety-open field defecation 2 (mouse) 7 Not determined
1301287 mouse Feml2_m femur length in high growth mice 2 (mouse) 9 Not determined
1301288 mouse Bw13_m body weight QTL 13 (mouse) 5 Not determined
1301289 mouse Axtofa1_m anxiety-open field activity 1 (mouse) 1 Not determined
1301290 mouse Smgd1_m submucosal gland distribution 1 (mouse) 9 Not determined
1301291 mouse Szs3_m seizure susceptibility 3 (mouse) 11 Not determined
1301292 mouse Cfbw2_m cystic fibrosis body weight 2 (mouse) 6 Not determined
1301293 mouse Pgia13_m proteoglycan induced arthritis 13 (mouse) 4 Not determined
1301294 mouse Hrtfm5_m heart failure modifier 5 (mouse) 2 Not determined
1301295 mouse Prdt1_m prion disease incubation time 1 (mouse) 2 Not determined
1301296 mouse Cia1_m collagen induced arthritis QTL 1 (mouse) 17 Not determined
1301297 mouse Lcho1_m liver cholesterol 1 (mouse) 9 Not determined
1301298 mouse Pgia4_m proteoglycan induced arthritis 4 (mouse) 8 Not determined
1301299 mouse Sluc23_m susceptibility to lung cancer 23 (mouse) 13 Not determined
1301300 mouse Lbm3_m lean body mass 3 (mouse) 6 Not determined
1301301 mouse Sle1_m systemic lupus erythmatosus susceptibility 1 (mouse) 1 Not determined
1301302 mouse Pas4_m pulmonary adenoma susceptibility 4 (mouse) 9 Not determined
1301303 mouse Alcp4_m alcohol preference locus 4 (mouse) 1 Not determined
1301304 mouse Hrq3_m heart rate quantitative locus 3 (mouse) 1 Not determined
1301305 mouse Lwq1_m liver weight QTL 1 (mouse) 4 Not determined
1301306 mouse Pgia17_m proteoglycan induced arthritis 17 (mouse) 17 Not determined
1301307 mouse Phospq1_m phospholipid QTL 1 (mouse) 18 Not determined
1301308 mouse Prdt4_m prion disease incubation time 4 (mouse) 12 Not determined
1301309 mouse Emo1_m emotionality 1 (mouse) 1 Not determined
1301310 mouse Tmevd5_m Theiler's murine encephalomyelitis virus induced demyelinating disease susceptibility 5 (mouse) 11 Not determined
1301311 mouse Manh12_m mandible shape 12 (mouse) 9 Not determined
1301312 mouse Hsm1_m hereditary spherocytosis modifer 1 (mouse) 12 Not determined
1301313 mouse Pas5a_m pulmonary adenoma susceptibility 5a (mouse) 11 Not determined
1301314 mouse Drb3_m dopamine receptor binding 3 (mouse) 9 Not determined
1301315 mouse Pnef_m plasma NEFA (non-esterified fatty acids) (mouse) 9 Not determined
1301316 mouse Dntcs1_m dental caries susceptibility 1 (mouse) 8 Not determined
1301317 mouse Ritls_m radiation induced thymic lymphoma susceptibility (mouse) 16 Not determined
1301318 mouse Lwq5_m liver weight QTL 5 (mouse) 15 Not determined
1301319 mouse Dautb4_m dopamine uptake transporter binding 4 (mouse) 11 Not determined
1301320 mouse Ots1_m ovarian teratoma susceptibility 1 (mouse) 6 Not determined
1301321 mouse Bslm3_m basal locomotor activity 3 (mouse) 1 Not determined
1301322 mouse Lbm2_m lean body mass 2 (mouse) 2 Not determined
1301323 mouse Asm2_m autoimmune sialadenitis in MRL mice 2 (mouse) 4 Not determined
1301324 mouse Cdif_m color difference (mouse) 15 Not determined
1301325 mouse Pgia15_m proteoglycan induced arthritis 15 (mouse) 13 Not determined
1301326 mouse Trbv4c2_m T cell receptor beta variable 4 (mouse) 6 Not determined
1301327 mouse Lmr7_m leishmaniasis resistance 7 (mouse) 17 Not determined
1301328 mouse Mol4_m modifier of LPS-response 4 (mouse) 11 Not determined
1301329 mouse Ofca2_m open field activity and conditioned avoidance 2 (mouse) 7 Not determined
1301330 mouse Tbbmd2_m total body bone mineral density 2 (mouse) 2 Not determined
1301331 mouse Lbw1_m lupus NZB x NZW 1 (mouse) 17 Not determined
1301332 mouse Estq1_m estradiol regulated response QTL 1 (mouse) 4 Not determined
1301333 mouse Mop3_m morphine preference 3 (mouse) 1 Not determined
1301334 mouse Cocia10_m cocaine induced activation 10 (mouse) 9 Not determined
1301335 mouse Axtofa4_m anxiety-open field activity 4 (mouse) 12 Not determined
1301336 mouse Alcp23_m alcohol preference locus 23 (mouse) 19 Not determined
1301337 mouse Cdcs8_m cytokine deficiency colitis susceptibility 8 (mouse) 12 Not determined
1301338 mouse Lmr1_m leishmaniasis resistance 1 (mouse) 17 Not determined
1301339 mouse Hdlq15_m HDL QTL 15 (mouse) 1 Not determined
1301340 mouse Bw16_m body weight QTL 16 (mouse) 11 Not determined
1301341 mouse Many3_m mandible asymmetry 3 (mouse) 5 Not determined
1301342 mouse Bgeq3_m body growth early QTL 3 (mouse) 4 Not determined
1301343 mouse Tshp15_m tooth shape 15 (mouse) 15 Not determined
1301344 mouse Lith1_m lithogenic gene 1 (mouse) 2 Not determined
1301345 mouse Bgeq14_m body growth early QTL 14 (mouse) 15 Not determined
1301346 mouse Tmevd8_m Theiler's murine encephalomyelitis virus induced demyelinating disease susceptibility 8 (mouse) 15 Not determined
1301347 mouse Fpli_m fasting plasma insulin (mouse) 3 Not determined
1301348 mouse Alcp5_m alcohol preference locus 5 (mouse) 2 Not determined
1301349 mouse Pgia26_m proteoglycan induced arthritis 26 (mouse) 3 Not determined
1300897 mouse Cocia12_m cocaine induced activation 12 (mouse) 16 Not determined
1300898 mouse Cfid_m cystic fibrosis intestinal distress (mouse) 10 Not determined
1300899 mouse Chol6_m cholesterol 6 (mouse) 9 Not determined
1300900 mouse Afpq1_m abdominal fat percent QTL 1 (mouse) 3 Not determined
1300901 mouse Skts10_m skin tumor susceptibility 10 (mouse) 17 Not determined
1300902 mouse Hdl3_m high density lipoprotein (HDL) level 3 (mouse) 16 Not determined
1300903 mouse Lskcn_m LSK cell number (mouse) 4 Not determined
1300904 mouse Chab5_m cholesterol absorption 5 (mouse) 19 Not determined
1300905 mouse Scc6_m colon tumor susceptibility 6 (mouse) 11 Not determined
1300906 mouse Ap8q_m alcohol preference 8 QTL (mouse) 8 Not determined
1300907 mouse Daq4_m directional asymmetry QTL 4 (mouse) 10 Not determined
1300908 mouse Insq4_m insulin QTL 4 (mouse) 10 Not determined
1300909 mouse Ath13_m atherosclerosis 13 (mouse) 14 Not determined
1300910 mouse Taste11_m taste bitterness sensitivity 11 (mouse) 9 Not determined
1300911 mouse Idd19_m insulin dependent diabetes susceptibility 19 (mouse) 6 Not determined
1300912 mouse Daq19_m directional asymmetry QTL 19 (mouse) 8 Not determined
1300913 mouse Bwefm_m body weight females and males day 10 (mouse) 5 Not determined
1300914 mouse Pcir4_m periosteal circumference 4 (mouse) 17 Not determined
1300915 mouse Lmr12_m leishmaniasis resistance 12 (mouse) 16 Not determined
1300916 mouse Mobe2_m modifier of obesity 2 (mouse) 13 Not determined
1300917 mouse Gasa1_m gastritis type A susceptibility locus 1 (mouse) 4 Not determined
1300918 mouse Stheal4_m soft tissue heal 4 (mouse) 4 Not determined
1300919 mouse Nidd2_m non-insulin-dependent diabetes mellitus 2 (mouse) 18 Not determined
1300920 mouse Pitm3_m prion incubation time 3 (mouse) 8 Not determined
1300921 mouse Skl4_m skeletal size (tail length) 4 (mouse) 10 Not determined
1300922 mouse Actd1_m activity-distance traveled 1 (mouse) 1 Not determined
1300923 mouse Bits4_m bitterness sensitivity 4 (mouse) 19 Not determined
1300924 mouse Ity2_m immunity to S. typhimurium 2 (mouse) 1 Not determined
1300925 mouse Lbm4_m lean body mass 4 (mouse) 6 Not determined
1300926 mouse Hpi2_m hepatic PMN infiltration 2 (mouse) 5 Not determined
1300927 mouse Bw8_m body weight QTL 8 (mouse) 5 Not determined
1300928 mouse Etia_m ethanol induced activation (mouse) 16 Not determined
1300929 mouse Pcyts1_m plasmacytoma susceptibility 1 (mouse) 2 Not determined
1300930 mouse Musz4_m muscle size 4 (mouse) 15 Not determined
1300931 mouse Cocrb6_m cocaine related behavior 6 (mouse) 5 Not determined
1300932 mouse Hdlq17_m HDL QTL 17 (mouse) 9 Not determined
1300933 mouse Cdcs9_m cytokine deficiency colitis susceptibility 9 (mouse) 4 Not determined
1300934 mouse Cfbw1_m cystic fibrosis body weight 1 (mouse) 1 Not determined
1300935 mouse Aod1_m autoimmune ovarian dysgenesis 1 (mouse) 16 Not determined
1300936 mouse Dloc2_m duration of locomotor activity 2 (mouse) 18 Not determined
1300937 mouse Mobe3_m modifier of obesity 3 (mouse) 5 Not determined
1300938 mouse Bulb3_m bulb size 3 (mouse) 11 Not determined
1300939 mouse Hrtfm6_m heart failure modifier 6 (mouse) 13 Not determined
1300940 mouse Actd3_m activity-distance traveled 3 (mouse) 5 Not determined
1300941 mouse Skl6_m skeletal size (tail length) 6 (mouse) 13 Not determined
1300942 mouse Drb9_m dopamine receptor binding 9 (mouse) 16 Not determined
1300943 mouse Skts9_m skin tumor susceptibility 9 (mouse) 16 Not determined
1300944 mouse Alcp20_m alcohol preference locus 20 (mouse) 11 Not determined
1300945 mouse Bglq7_m body growth late QTL 7 (mouse) 9 Not determined
1300946 mouse Sle1c_m systematic lupus erythematosus susceptibility 1c (mouse) 1 Not determined
1300947 mouse Char5_m P. chabaudi malaria resistance QTL 5 (mouse) 5 Not determined
1300948 mouse Fglu2_m fasting glucose 2 (mouse) 1 Not determined
1300949 mouse Lore5_m loss of righting induced by ethanol 5 (mouse) 15 Not determined
1300950 mouse Omlr_m om-linked responder (mouse) 11 Not determined
1300951 mouse Gbvq1_m gallstone bladder volume QTL 1 (mouse) 5 Not determined
1300952 mouse Hcs1_m hepatocarcinogenesis susceptibility 1 (mouse) 7 Not determined
1300953 mouse Bdt5_m bone density traits 5 (mouse) 15 Not determined
1300954 mouse Fcsa1_m femoral cross-sectional area 1 (mouse) 6 Not determined
1300955 mouse Pcpila2_m PCP induced locomotor activity 2 (mouse) 14 Not determined
1300956 mouse Sle15_m systematic lupus erythematosus susceptibility 15 (mouse) 4 Not determined
1300957 mouse Pbd1_m peak bone density 1 (mouse) 11 Not determined
1300958 mouse Tmevd1_m Theiler's murine encephalomyelitis virus induced demyelinating disease susceptibility 1 (mouse) 6 Not determined
1300959 mouse Lxw2_m lupus BXSB x NZW 2 (mouse) 6 Not determined
1300960 mouse Hpic2_m haloperidol induced catalepsy 2 (mouse) 1 Not determined
1301806 mouse Actd2_m activity-distance traveled 2 (mouse) 5 Not determined
1301807 mouse Alcp19_m alcohol preference locus 19 (mouse) 11 Not determined
1301808 mouse Nhdlq1_m non-HDL QTL 1 (mouse) 8 Not determined
1301809 mouse Axtofd1_m anxiety-open field defecation 1 (mouse) 1 Not determined
1301810 mouse Lwq2_m liver weight QTL 2 (mouse) 5 Not determined
1301811 mouse Tshp6_m tooth shape 6 (mouse) 4 Not determined
1301812 mouse Hpnr3_m Heligmosomoides polygyrus nematode resistance 3 (mouse) 17 Not determined
1301813 mouse Skl3_m skeletal size (tail length) 3 (mouse) 6 Not determined
1301814 mouse Bbaa7_m B.burgdorferi-associated arthritis 7 (mouse) 11 Not determined
1301815 mouse Sles2_m systemic lupus erythmatosus suppressor 2 (mouse) 4 Not determined
1301816 mouse Cocia7_m cocaine induced activation 7 (mouse) 5 Not determined
1301817 mouse Swq4_m spleen weight QTL 4 (mouse) 17 Not determined
1301818 mouse Ap1q_m alcohol preference 1 QTL (mouse) 1 Not determined
1301819 mouse Abhr1_m antigen-induced bronchial hyperresponsiveness 1 (mouse) 2 Not determined
1301820 mouse Mop1_m morphine preference 1 (mouse) 6 Not determined
1301821 mouse Tapr_m T-cell and airway phenotype regulator (mouse) 11 Not determined
1301822 mouse Pgia2_m proteoglycan induced arthritis 2 (mouse) 2 Not determined
1301823 mouse Bmd7_m bone mineral density 7 (mouse) 4 Not determined
1301824 mouse Susp_m suppressor of superoxide production (mouse) 3 Not determined
1301825 mouse Pbrgcsf1_m peripheral blood stem cell response to granulocyte colony stimulating factor 1 (mouse) 2 Not determined
1301826 mouse Pgia3_m proteoglycan induced arthritis 3 (mouse) 7 Not determined
1301827 mouse Cocrb5_m cocaine related behavior 5 (mouse) 4 Not determined
1301828 mouse Insq5_m insulin QTL 5 (mouse) 17 Not determined
1301829 mouse Thyls2_m thymic lymphoma susceptibility 2 (mouse) 5 Not determined
1301830 mouse Ssta4_m susceptibility to Salmonella typhimurium antigens 4 (mouse) 11 Not determined
1301831 mouse Abhr2_m antigen-induced bronchial hyperresponsiveness 2 (mouse) 2 Not determined
1301832 mouse Bw17_m body weight QTL 17 (mouse) 1 Not determined
1301833 mouse Tbbmd5_m total body bone mineral density 5 (mouse) 11 Not determined
1301834 mouse Bits1_m bitterness sensitivity 1 (mouse) 2 Not determined
1301835 mouse Carp3_m carcass protein in high growth mice 3 (mouse) 17 Not determined
1301836 mouse Heal5_m wound healing/regeneration 5 (mouse) 12 Not determined
1301837 mouse Alcw2_m alcohol withdrawal 2 (mouse) 4 Not determined
1301838 mouse Sluc16_m susceptibility to lung cancer 16 (mouse) 2 Not determined
1301839 mouse Bomd2_m bone mineral density 2 (mouse) 14 Not determined
1301840 mouse Ssial4_m susceptibility to sialadenitiss 4 (mouse) 17 Not determined
1301841 mouse Lrnx9_m learning-contextual 9 (mouse) 16 Not determined
1301842 mouse Gvhd4_m graft-versus host disease 4 (mouse) 11 Not determined
1301843 mouse Listr1_m listeriosis resistance 1 (mouse) 5 Not determined
1301844 mouse Pgia29_m proteoglycan induced arthritis 29 (mouse) 14 Not determined
1301845 mouse Lxw4_m lupus BXSB x NZW 4 (mouse) 5 Not determined
1301846 mouse Afpq4_m abdominal fat percent QTL 4 (mouse) 13 Not determined
1301847 mouse Fecq2_m fecundity QTL 2 (mouse) 4 Not determined
1301848 mouse Bglq12_m body growth late QTL 12 (mouse) 18 Not determined
1301849 mouse Derm1_m dermititis 1 (mouse) 9 Not determined
1301850 mouse Fglu_m fasting glucose (mouse) 6 Not determined
1301851 mouse Tria5_m T-cell receptor induced activation 5 (mouse) 9 Not determined
1301852 mouse Ltry_m laterality (mouse) 4 Not determined
1301853 mouse Heal9_m wound healing/regeneration 9 (mouse) 18 Not determined
1301854 mouse Cons2_m consumption-saccharin intake 2 (mouse) 7 Not determined
1301855 mouse Lrnx4_m learning contextual 4 (mouse) 11 Not determined
1301856 mouse Manh10_m mandible shape 10 (mouse) 7 Not determined
1301857 mouse Bglq14_m body growth late QTL 14 (mouse) 5 Not determined
1301858 mouse Smdq1_m segregation of mitochondrial DNA QTL 1 (mouse) 5 Not determined
1301859 mouse Manh7_m mandible shape 7 (mouse) 6 Not determined
1301860 mouse Gct3_m granulosa cell tumorigenesis 3 (mouse) 15 Not determined
1301861 mouse Scpro2_m stem cell proliferation 2 (mouse) 11 Not determined
1301862 mouse Tchol1_m total cholesterol level 1 (mouse) 3 Not determined
1301863 mouse Skull5_m skull morphology 5 (mouse) 4 Not determined
1301864 mouse Afw9_m abdominal fat weight QTL 9 (mouse) 7 Not determined
1301865 mouse Hdlq19_m HDL QTL 19 (mouse) 2 Not determined
1301866 mouse Cplaq3_m circadian period of locomotor activity 3 (mouse) 1 Not determined
1301867 mouse Idd11_m insulin dependent diabetes susceptibility 11 (mouse) 4 Not determined
1301868 mouse Fbgl1_m fasting blood glucose 1 (mouse) 12 Not determined
1301869 mouse Tbbmd4_m total body bone mineral density 4 (mouse) 9 Not determined
1301413 mouse Daq14_m directional asymmetry QTL 14 (mouse) 15 Not determined
1301414 mouse Heal10_m wound healing/regeneration 10 (mouse) 11 Not determined
1301415 mouse Actre4_m activity response to ethanol 4 (mouse) 2 Not determined
1301416 mouse Cia13_m collagen induced arthritis 13 (mouse) 5 Not determined
1301417 mouse Ltsd5_m lung tumor shape-determining 5 (mouse) 7 Not determined
1301418 mouse Itbq1_m inspiratory timing at baseline QTL 1 (mouse) 3 Not determined
1301419 mouse Cypr3_m cytokine production 3 (mouse) 5 Not determined
1301420 mouse Swq1_m spleen weight QTL 1 (mouse) 11 Not determined
1301421 mouse Lgth4_m body length 4 (mouse) 9 Not determined
1301422 mouse Sle11_m systematic lupus erythematosus susceptibility 11 (mouse) 3 Not determined
1301423 mouse Drb5_m dopamine receptor binding 5 (mouse) 12 Not determined
1301424 mouse Skull21_m skull morphology 21 (mouse) 14 Not determined
1301425 mouse Bglq11_m body growth late QTL 11 (mouse) 14 Not determined
1301426 mouse Desp2_m despair 2 (mouse) 11 Not determined
1301427 mouse Tlsr6_m thymic lymphoma suppressor region 6 (mouse) 12 Not determined
1301428 mouse Etoms_m etomidate sensitivity (mouse) 12 Not determined
1301429 mouse Pcir3_m periosteal circumference 3 (mouse) 15 Not determined
1301430 mouse Cdcs2_m cytokine deficiency colitis susceptibility 2 (mouse) 1 Not determined
1301431 mouse Pcho1_m plasma cholesterol 1 (mouse) 1 Not determined
1301432 mouse Hpnr1_m Heligmosomoides polygyrus nematode resistance 1 (mouse) 1 Not determined
1301433 mouse Rapop5_m radiation-induced apoptosis 5 (mouse) 15 Not determined
1301434 mouse Tshp3_m tooth shape 3 (mouse) 2 Not determined
1301435 mouse Trigq1_m triglyceride QTL 1 (mouse) 9 Not determined
1301436 mouse Wg2_m weight gain in high growth mice 2 (mouse) 2 Not determined
1301437 mouse Scon1_m sucrose consumption 1 (mouse) 4 Not determined
1301438 mouse Ltsd2_m lung tumor shape-determining 2 (mouse) 2 Not determined
1301439 mouse Morph2_m morphine antinociception 2 (mouse) 9 Not determined
1301440 mouse Manh24_m mandible shape 24 (mouse) 18 Not determined
1301441 mouse Skull11_m skull morphology 11 (mouse) 8 Not determined
1301442 mouse Pltpq1_m phospholipid transfer protein activity QTL 1 (mouse) 3 Not determined
1301443 mouse Mopkd2_m modifier of polycystic kidney disease progression 2 (mouse) 16 Not determined
1301444 mouse Alcw5_m alcohol withdrawal 5 (mouse) 1 Not determined
1301445 mouse Listr2_m listeriosis resistance 2 (mouse) 13 Not determined
1301446 mouse Elsgp4_m elevated serum gp70 4 (mouse) 12 Not determined
1301447 mouse Fembm3_m femoral bone morphometry 3 (mouse) 7 Not determined
1301448 mouse Pas11_m pulmonary adenoma susceptibility 11 (mouse) 10 Not determined
1301449 mouse Cia10_m collagen induced arthritis 10 (mouse) 13 Not determined
1301450 mouse Bpq6_m blood pressure QTL 6 (mouse) 15 Not determined
1301451 mouse Ath16_m atherosclerosis 16 (mouse) 19 Not determined
1301452 mouse Elsgp1_m elevated serum gp70 1 (mouse) 4 Not determined
1301453 mouse Bgeq8_m body growth early QTL 8 (mouse) 10 Not determined
1301454 mouse Eae5_m susceptibility to experimental allergic encephalomyelitis 5 (mouse) 17 Not determined
1301455 mouse Bmd3_m bone mineral density 3 (mouse) 13 Not determined
1301456 mouse Adip5_m adiposity 5 (mouse) 9 Not determined
1301457 mouse Cfsw2_m cystic fibrosis survival to weaning 2 (mouse) 5 Not determined
1301458 mouse Skts8_m skin tumor susceptibility 8 (mouse) 1 Not determined
1301459 mouse Remslp4_m rapid eye movement sleep 4 (mouse) 17 Not determined
1301460 mouse C10bw6_m castaneus 10 week body weight 6 (mouse) X Not determined
1301461 mouse Chol9_m cholesterol 9 (mouse) 17 Not determined
1301462 mouse Nhdlq2_m non-HDL QTL 2 (mouse) X Not determined
1301463 mouse Szs5_m seizure susceptibility 5 (mouse) 1 Not determined
1301464 mouse Lgth5_m body length 5 (mouse) 9 Not determined
1301465 mouse Egrm3_m early growth rate (mouse) 7 Not determined
1301466 mouse T2dm2_m type 2 diabetes mellitus 2 (mouse) 19 Not determined
1301467 mouse Pcir1_m periosteal circumference 1 (mouse) 1 Not determined
1301468 mouse Eye1_m eye weight 1 (mouse) 5 Not determined
1301469 mouse Cara2_m carcass ash in high growth mice 2 (mouse) 11 Not determined
1301470 mouse Vmbic3_m ventral midbrain iron content 3 (mouse) 7 Not determined
1301471 mouse Obq2_m obesity QTL 2 (mouse) 1 Not determined
1301472 mouse Pain1_m pain 1 (mouse) 15 Not determined
1301473 mouse Triglq1_m triglyceride QTL 1 (mouse) 4 Not determined
1301474 mouse Hcbip2_m hexachlorobenzene induced porphyria 2 (mouse) 17 Not determined
1301475 mouse Tnbs1_m tri-nitrobenzene sulfonic acid susceptible 1 (mouse) 9 Not determined
1301476 mouse Pbwg12_m postnatal body weight growth 12 (mouse) 12 Not determined
1301477 mouse Rencd_m renal cystic disease severity (mouse) 6 Not determined
1301478 mouse Eae26_m susceptibility to experimental allergic encephalomyelitis 26 (mouse) 7 Not determined
1301479 mouse Sluc1_m susceptibility to lung cancer 1 (mouse) 19 Not determined
1301480 mouse Pbwg1_m postnatal body weight growth 1 (mouse) 2 Not determined
1301481 mouse Lith11_m lithogenic gene 11 (mouse) 8 Not determined
1301482 mouse Morph1_m morphine antinociception 1 (mouse) 1 Not determined
1301483 mouse Obq12_m obesity QTL 12 (mouse) 5 Not determined
1301484 mouse Bwq6_m body weight (mouse) 9 Not determined
1301485 mouse Asthm1_m asthma 1 (mouse) 10 Not determined
1301486 mouse Tshp16_m tooth shape 16 (mouse) 15 Not determined
1301487 mouse Nociq1_m nociceptive sensitivity inflammatory QTL 1 (mouse) 9 Not determined
1301488 mouse Tir3b_m trypansomiasis infection response 3b (mouse) 1 Not determined
1301489 mouse Lbm10_m lean body mass 10 (mouse) 14 Not determined
1301490 mouse Pltpq2_m phospholipid transfer protein activity QTL 2 (mouse) 10 Not determined
1301491 mouse Abbp4_m A/J and C57BL/6 blood pressure 4 (mouse) 11 Not determined
1301492 mouse Dbsty3_m diabesity 3 (mouse) 12 Not determined
1301493 mouse Manz2_m mandible size 2 (mouse) 3 Not determined
1301494 mouse Tlsr5_m thymic lymphoma suppressor region 5 (mouse) 4 Not determined
1301495 mouse Cocia13_m cocaine induced activation 13 (mouse) 17 Not determined
1301496 mouse Aod5_m autoimmune ovarian dysgenesis 5 (mouse) 7 Not determined
1301497 mouse Tgls1_m triglyceride level suppressor 1 (mouse) 4 Not determined
1301498 mouse Oriq2_m ovulation rate QTL 2 (mouse) 2 Not determined
1301499 mouse Bdln2_m body length 2 (mouse) 15 Not determined
1301500 mouse Szs4_m seizure susceptibility 4 (mouse) 18 Not determined
1301501 mouse Lmr2_m leishmaniasis resistance 2 (mouse) 9 Not determined
1301502 mouse Eae17_m susceptibility to experimental allergic encephalomyelitis 17 (mouse) 10 Not determined
1301503 mouse Bgeq7_m body growth early QTL 7 (mouse) 8 Not determined
1301504 mouse Faq11_m fluctuating asymmetry QTL 11 (mouse) 19 Not determined
1301505 mouse Tir1_m trypanosome infection response 1 (mouse) 17 Not determined
1301506 mouse Aevm1_m autoimmune extremity vasculitis in MRL mice 1 (mouse) 8 Not determined
1301507 mouse Actre1_m activity response to ethanol 1 (mouse) 1 Not determined
1301508 mouse Bulb4_m bulb size 4 (mouse) 17 Not determined
1301509 mouse Sluc3_m susceptibility to lung cancer 3 (mouse) 6 Not determined
1301510 mouse Bbaa13_m B.burgdorferi-associated arthritis 13 (mouse) 4 Not determined
1301511 mouse Manh4_m mandible shape 4 (mouse) 3 Not determined
1301512 mouse Manh21_m mandible shape 21 (mouse) 15 Not determined
1301513 mouse Idd9_m insulin dependent diabetes susceptibility 9 (mouse) 4 Not determined
1301514 mouse Rigs1_m radiation induced gastroschisis 1 (mouse) 7 Not determined
1301515 mouse Fembm1_m femoral bone morphometry 1 (mouse) 3 Not determined
1301516 mouse Alan2_m alloantigen response 2 (mouse) 4 Not determined
1301517 mouse Manh6_m mandible shape 6 (mouse) 5 Not determined
1301518 mouse Bbaa5_m B.burgdorferi-associated arthritis 5 (mouse) 6 Not determined
1301519 mouse Mbis1_m Mycobacterium bovis-induced systemic lupus erythematosus 1 (mouse) 1 Not determined
1301520 mouse Uvbi1_m UVB induced immunosuppression 1 (mouse) 10 Not determined
1301521 mouse Pas1c_m pulmonary adenoma susceptibility 1c (mouse) 6 Not determined
1301522 mouse Bwq1_m body weight QTL 1 (mouse) 4 Not determined
1301523 mouse Ccrs1_m corpus callosum hemisphere surface size 1 (mouse) 1 Not determined
1301524 mouse Lmb2_m lupus in MRL and B6 F2 cross (mouse) 5 Not determined
1301525 mouse Lmb1_m lupus in MRL and B6 F2 cross (mouse) 4 Not determined
1301526 mouse Pgia24_m proteoglycan induced arthritis 24 (mouse) X Not determined
1301527 mouse Vmbic8_m ventral midbrain iron content 8 (mouse) 14 Not determined
1301528 mouse Loco1_m locomotor activity 1 (mouse) 3 Not determined
1301529 mouse Nnc1_m neuron number control 1 (mouse) 11 Not determined
1301530 mouse Bglu2_m blood glucose level 2 (mouse) 13 Not determined
1301531 mouse Musz5_m muscle size 5 (mouse) 17 Not determined
1301532 mouse Scc8_m colon tumor susceptibility 8 (mouse) 8 Not determined
1301533 mouse Manz6_m mandible size 6 (mouse) 10 Not determined
1301534 mouse Idd20_m insulin dependent diabetes susceptibility 20 (mouse) 6 Not determined
1301535 mouse Pas5b_m pulmonary adenoma susceptibility 5b (mouse) 11 Not determined
1301536 mouse Pbbcp1_m peripheral blood B cell percentage 1 (mouse) 1 Not determined
1301537 mouse Ihtw1_m interspecific hybrid testis weight 1 (mouse) X Not determined
1301538 mouse Trbv4c1_m T cell receptor beta variable 4 (mouse) 17 Not determined
1301539 mouse Mwq5_m molecular weight of quadriceps QTL 5 (mouse) 13 Not determined
1301540 mouse Axtofa2_m anxiety-open field activity 2 (mouse) 4 Not determined
1301541 mouse Bel_m brain etomidate level (mouse) 6 Not determined
1301542 mouse Paam1_m progression of autoimmune arthritis in MRL mice 1 (mouse) 15 Not determined
1301543 mouse Hypch_m hypercholesterolemia (mouse) 5 Not determined
1301544 mouse Iba3_m induction of brown adipocytes 3 (mouse) 8 Not determined
1301545 mouse Gauc_m glucose area under curve (mouse) 4 Not determined
1301546 mouse Pcir2_m periosteal circumference 2 (mouse) 11 Not determined
1301547 mouse Bgeq6_m body growth early QTL 6 (mouse) 7 Not determined
1301548 mouse Idd4_m insulin dependent diabetes susceptibility 4 (mouse) 11 Not determined
1301549 mouse Bbaa9_m B.burgdorferi-associated arthritis 9 (mouse) 9 Not determined
1301550 mouse Fembrs2_m femur breaking strength 2 (mouse) 8 Not determined
1301551 mouse Spha1_m sperm head anomaly 1 (mouse) X Not determined
1301552 mouse Etohcta7_m ethanol conditioned taste aversion 7 (mouse) 7 Not determined
1301553 mouse Etlm2_m ethanol induced locomotion 2 (mouse) 2 Not determined
1301554 mouse Fatq1_m percent fat (mouse) 1 Not determined
1301555 mouse Alcp10_m alcohol preference locus 10 (mouse) 5 Not determined
1301556 mouse Cd4vts1_m CD4 virgin T cell subset 1 (mouse) 4 Not determined
1301557 mouse Bbaa22_m B.burgdorferi-associated arthritis 22 (mouse) 15 Not determined
1301558 mouse Stheal8_m soft tissue heal 8 (mouse) 9 Not determined
1301559 mouse Bbaa19_m B.burgdorferi-associated arthritis 19 (mouse) 16 Not determined
1301560 mouse Siafq1_m stress induced analgesia (mouse) 8 Not determined
1301561 mouse Chab2_m cholesterol absorption 2 (mouse) 10 Not determined
1301562 mouse Hwq1_m heart weight quantitative locus 1 (mouse) 14 Not determined
1301563 mouse Alcp3_m alcohol preference locus 3 (mouse) 3 Not determined
1301564 mouse Pltpq3_m phospholipid transfer protein activity QTL 3 (mouse) 9 Not determined
1301565 mouse Mnotch_m modifier of Notch (mouse) 1 Not determined
1301566 mouse Adip3_m adiposity 3 (mouse) 7 Not determined
1301567 mouse Cocia3_m cocaine induced activation 3 (mouse) 17 Not determined
1301568 mouse Tria2_m T-cell receptor induced activation 2 (mouse) 15 Not determined
1301569 mouse Axtofd3_m anxiety-open field defecation 3 (mouse) 14 Not determined
1301570 mouse Sluc14_m susceptibility to lung cancer 14 (mouse) 18 Not determined
1301571 mouse Arrd1_m age-related retinal degeneration 1 (mouse) 6 Not determined
1301572 mouse Sluc30_m susceptibility to lung cancer 30 (mouse) 7 Not determined
1301573 mouse Etohcta8_m ethanol conditioned taste aversion 8 (mouse) 9 Not determined
1301574 mouse Lmblgq5_m limb length QTL 5 (mouse) 12 Not determined
1301575 mouse Tanidd3_m tally ho associated non-insulin dependednt diabetes mellitus 3 (mouse) 16 Not determined
1301576 mouse Wt6q2_m body weight (mouse) 1 Not determined
1301577 mouse Bplpf2_m bleomycin pulmonary fibrosis 2 (mouse) 11 Not determined
1301578 mouse Feml3_m femur length in high growth mice 3 (mouse) 17 Not determined
1301579 mouse Kwq7_m kidney weight QTL 7 (mouse) 7 Not determined
1301580 mouse Hrq2_m heart rate quantitative locus 2 (mouse) 15 Not determined
1301581 mouse Char2_m P. chabaudi malaria resistance QTL 2 (mouse) 8 Not determined
1301582 mouse Bwtq2_m body weight QTL 2 (mouse) 4 Not determined
1301583 mouse Lrncs2_m learning-conditioned stimulus 2 (mouse) 1 Not determined
1301584 mouse Lrdg2_m light induced retinal degeneration 2 (mouse) 4 Not determined
1301585 mouse Cd4ts1_m CD4 T cell subset 1 (mouse) 3 Not determined
1301586 mouse Stheal3_m soft tissue heal 3 (mouse) 4 Not determined
1301587 mouse Rrodp2_m rotarod performance 2 (mouse) 2 Not determined
1301588 mouse Hrec_m hemotopoietic response to early cytokines (mouse) 2 Not determined
1301589 mouse Obq14_m obesity QTL 14 (mouse) 6 Not determined
1301590 mouse Pbwg3_m postnatal body weight growth 3 (mouse) 7 Not determined
1301591 mouse Chol7_m cholesterol 7 (mouse) 1 Not determined
1301592 mouse Lwq7_m liver weight QTL 7 (mouse) 9 Not determined
1301593 mouse Heal8_m wound healing/regeneration 8 (mouse) 13 Not determined
1301594 mouse Aod1b_m autoimmune ovarian dysgenesis 1b (mouse) 16 Not determined
1301595 mouse Wt3q1_m body weight (mouse) 1 Not determined
1301596 mouse Elnt_m escape latencies during navigation task (mouse) 1 Not determined
1301597 mouse Anxty_m anxiety (mouse) 4 Not determined
1301598 mouse Renf2_m renal failure 2 (mouse) 16 Not determined
1301599 mouse Fembm6_m femoral bone morphometry 6 (mouse) 6 Not determined
1301600 mouse Hdlq29_m HDL QTL 29 (mouse) 17 Not determined
1301601 mouse Faq9_m fluctuating asymmetry QTL 9 (mouse) 15 Not determined
1301602 mouse Bslm4_m basal locomotor activity 4 (mouse) 1 Not determined
1301603 mouse Hdl6_m HDL level 6 (mouse) 6 Not determined
1301604 mouse Eae1_m susceptibility to experimental allergic encephalomyelitis 1 (mouse) 17 Not determined
1301605 mouse Lscc1_m lung squamous cell carcinoma 1 (mouse) 1 Not determined
1301606 mouse Hdlq6_m HDL QTL 6 (mouse) 1 Not determined
1301607 mouse Ofca4_m open field activity and conditioned avoidance 4 (mouse) 19 Not determined
1301608 mouse Emo3_m emotionality 3 (mouse) 1 Not determined
1301609 mouse Lscc2_m lung squamous cell carcinoma 2 (mouse) 3 Not determined
1301610 mouse Dps1_m delta power in slow-wave sleep 1 (mouse) 13 Not determined
1301611 mouse Lrnx3_m learning contextual 3 (mouse) 9 Not determined
1301612 mouse Skmw4_m skeletal muscle weight 4 (mouse) 2 Not determined
1301613 mouse Fibrs1_m fibrosarcoma susceptibility 1 (mouse) 4 Not determined
1301614 mouse Cgnz1_m chronic glomerulonephritis in NZM 1 (mouse) 1 Not determined
1301615 mouse Cfld3_m cystic fibrosis lung disease 3 (mouse) 17 Not determined
1301616 mouse Yaa2_m Y-linked autoimmune acceleration 2 (mouse) 1 Not determined
1301617 mouse Afw8_m abdominal fat weight QTL 8 (mouse) 19 Not determined
1301618 mouse Bglu1_m blood glucose level 1 (mouse) 2 Not determined
1301619 mouse Cafq1_m caffeine metabolism QTL 1 (mouse) 1 Not determined
1301620 mouse Insq8_m insulin QTL 8 (mouse) 6 Not determined
1301621 mouse Hpic1_m haloperidol-induced catalepsy 1 (mouse) 9 Not determined
1301622 mouse Eae12_m susceptibility to experimental allergic encephalomyelitis 12 (mouse) 7 Not determined
1301623 mouse Hipp1_m hippocampal weight 1 (mouse) 1 Not determined
1301624 mouse Aevm2_m autoimmune extremity vasculitis in MRL mice 2 (mouse) 5 Not determined
1301625 mouse Tshp5_m tooth shape 5 (mouse) 4 Not determined
1301626 mouse Ltsd7_m lung tumor shape-determining 7 (mouse) 16 Not determined
1301627 mouse Vmbic4_m ventral midbrain iron content 4 (mouse) 7 Not determined
1301628 mouse Cocrb2_m cocaine related behavior 2 (mouse) 1 Not determined
1301629 mouse Obq7_m obesity QTL 7 (mouse) 1 Not determined
1301630 mouse Aaiq4_m aromatase activity QTL 4 (mouse) 2 Not determined
1301631 mouse Orgwq7_m organ weight QTL 7 (mouse) 9 Not determined
1301632 mouse Bw8q1_m body weight at 8 weeks QTL 1 (mouse) 1 Not determined
1301633 mouse Alcp24_m alcohol preference locus 24 (mouse) 19 Not determined
1301634 mouse Eae6a_m susceptibility to experimental allergic encephalomyelitis 6a (mouse) 11 Not determined
1301635 mouse Tlsr7_m thymic lymphoma suppressor region 7 (mouse) 16 Not determined
1301636 mouse Lith5_m lithogenic gene 5 (mouse) 9 Not determined
1301637 mouse Fibrs3_m fibrosarcoma susceptibility 3 (mouse) 13 Not determined
1301638 mouse Tshp12_m tooth shape 12 (mouse) 12 Not determined
1301639 mouse Stnn_m striatal neuron number (mouse) 19 Not determined
1301640 mouse Lore4_m loss of righting induced by ethanol 4 (mouse) 11 Not determined
1301641 mouse Sbmd2_m spinal bone mineral density 2 (mouse) 2 Not determined
1301642 mouse Hdlq20_m HDL QTL 20 (mouse) 1 Not determined
1301643 mouse Melm3_m melanoma modifier 3 (mouse) 11 Not determined
1301644 mouse Lrnx7_m learning-contextual 7 (mouse) 3 Not determined
1301645 mouse Loca1_m locomotor activity 1 (mouse) 12 Not determined
1301646 mouse Bw9_m body weight QTL 9 (mouse) 12 Not determined
1301647 mouse Elpt_m elevated leptin (mouse) 7 Not determined
1301648 mouse Bw11_m body weight QTL 11 (mouse) 15 Not determined
1301649 mouse Psl1_m promotion susceptibility QTL 1 (mouse) 9 Not determined
1301650 mouse Asbb1_m autoimmune susceptibility in C57BL/6J and BALB/c 1 (mouse) 9 Not determined
1301651 mouse Tlf2_m T lymphocyte fraction 2 (mouse) 9 Not determined
1301652 mouse Cpfd2_m cerebellum pattern fissures (mouse) 1 Not determined
1301653 mouse Obq15_m obesity QTL 15 (mouse) 7 Not determined
1301654 mouse Aliq1_m acute lung injury QTL 1 (mouse) 11 Not determined
1301655 mouse Bmd12_m bone mineral density 12 (mouse) 12 Not determined
1301656 mouse Hpnr5_m Heligmosomoides polygyrus nematode resistance 5 (mouse) 2 Not determined
1301657 mouse Afw2_m abdominal fat weight QTL 2 (mouse) 4 Not determined
1301658 mouse Radpf3_m radiation pulmonary fibrosis 3 (mouse) 6 Not determined
1301659 mouse Arrd2_m age-related retinal degeneration 2 (mouse) 10 Not determined
1301660 mouse Iba1_m induction of brown adipocytes 1 (mouse) 2 Not determined
1301661 mouse Tshp13_m tooth shape 13 (mouse) 13 Not determined
1301662 mouse Faq8_m fluctuating asymmetry QTL 8 (mouse) 15 Not determined
1301663 mouse Skull9_m skull morphology 9 (mouse) 7 Not determined
1301664 mouse Feml1_m femur length in high growth mice 1 (mouse) 2 Not determined
1301665 mouse Bglq10_m body growth late QTL 10 (mouse) 13 Not determined
1301666 mouse Eae13_m susceptibility to experimental allergic encephalomyelitis 13 (mouse) 13 Not determined
1301667 mouse Lxw5_m lupus BXSB x NZW 5 (mouse) 1 Not determined
1301668 mouse nctm2_m Nakano cataract modifier 2 (mouse) 10 Not determined
1301669 mouse Hdlq28_m HDL QTL 28 (mouse) 16 Not determined
1301670 mouse Ssta1_m susceptibility to Salmonella typhimurium antigens 1 (mouse) 1 Not determined
1301671 mouse Lorp1_m loss of righting due to propofol 1 (mouse) 7 Not determined
1301672 mouse Lipq1_m lipoprotein QTL 1 (mouse) 6 Not determined
1301673 mouse Gvhd5_m graft-versus host disease 5 (mouse) 4 Not determined
1301674 mouse Asthm2_m asthma 2 (mouse) 11 Not determined
1301675 mouse Etlm3_m ethanol induced locomotion 3 (mouse) 6 Not determined
1301676 mouse Nidd6_m non-insulin-dependent diabetes mellitus 6 (mouse) 1 Not determined
1301677 mouse Alcp6_m alcohol preference locus 6 (mouse) 2 Not determined
1301678 mouse Abpr_m aberrant B cell proliferation (mouse) 2 Not determined
1301679 mouse Bglq13_m body growth late QTL 13 (mouse) 19 Not determined
1301680 mouse Vpantd_m VPA induced neural tube defect (mouse) 7 Not determined
1301681 mouse Sle13_m systematic lupus erythematosus susceptibility 13 (mouse) 11 Not determined
1301682 mouse Bglq5_m body growth late QTL 5 (mouse) 6 Not determined
1301683 mouse Daq8_m directional asymmetry QTL 8 (mouse) 13 Not determined
1301684 mouse Angle4_m angle of entrainment 4 (mouse) 7 Not determined
1301685 mouse Estq2_m estradiol regulated response QTL 2 (mouse) 5 Not determined
1301686 mouse Trmq1_m T cell ratio modifier QTL 1 (mouse) 6 Not determined
1301687 mouse Mnic2_m macronutrient intake (mouse) 6 Not determined
1301688 mouse Orch6_m autoimmune orchitis resistance 6 (mouse) 8 Not determined
1301689 mouse Skull18_m skull morphology 18 (mouse) 12 Not determined
1301690 mouse Hdlq9_m HDL QTL 9 (mouse) 16 Not determined
1301691 mouse Cdcs10_m cytokine deficiency colitis susceptibility 10 (mouse) 5 Not determined
1301692 mouse Hts_m hypothermia sensitivity (mouse) 9 Not determined
1301693 mouse Sle6_m systemic lupus erythematosus susceptibility 6 (mouse) 5 Not determined
1301694 mouse Rear2_m rearing 2 (mouse) 12 Not determined
1301695 mouse Manz5_m mandible size 5 (mouse) 7 Not determined
1301696 mouse Wt6q3_m body weight (mouse) 11 Not determined
1301697 mouse Sluc18_m susceptibility to lung cancer 18 (mouse) 4 Not determined
1301698 mouse Pcfm4_m periosteal circumference and femur length 4 (mouse) 5 Not determined
1301699 mouse Pbwg6_m postnatal body weight growth 6 (mouse) 13 Not determined
1301700 mouse Pctr2_m plasmacytoma resistance 2 (mouse) 4 Not determined
1301701 mouse Aggr1_m aggression 1 (mouse) 10 Not determined
1301702 mouse Brm1_m brachyury modifier 1 (mouse) 9 Not determined
1301703 mouse Bomd3_m bone mineral density 3 (mouse) 2 Not determined
1301704 mouse Dbsty1_m diabesity 1 (mouse) 1 Not determined
1301705 mouse Sles3_m systemic lupus erythmatosus suppressor 3 (mouse) 3 Not determined
1301706 mouse Cdcs6_m cytokine deficiency colitis susceptibility 6 (mouse) 18 Not determined
1301707 mouse Mwq3_m molecular weight of quadriceps QTL 3 (mouse) 11 Not determined
1301708 mouse Cocrb14_m cocaine related behavior 14 (mouse) 15 Not determined
1301709 mouse Bdt4_m bone density traits 4 (mouse) 7 Not determined
1301710 mouse Bmd5_m bone mineral density 5 (mouse) 1 Not determined
1301711 mouse Tbrs3_m tuberculosis resistance 3 (mouse) 7 Not determined
1301712 mouse Idd9.1_m insulin dependent diabetes susceptibility 9.1 (mouse) 4 Not determined
1301713 mouse Dbsty2_m diabesity 2 (mouse) 5 Not determined
1301714 mouse Vertcling_m vertical clinging (mouse) 1 Not determined
1301715 mouse Elmaz2_m elevated maze behavior 2 (mouse) 5 Not determined
1301716 mouse Aeyo_m age of eyelid opening (mouse) 5 Not determined
1301717 mouse Adip4_m adiposity 4 (mouse) 8 Not determined
1301718 mouse Pbw3_m pentobarbital withdrawal QTL 3 (mouse) 11 Not determined
1301719 mouse Remslp3_m rapid eye movement sleep 3 (mouse) 16 Not determined
1301720 mouse Hpnr8_m Heligmosomoides polygyrus nematode resistance 8 (mouse) 19 Not determined
1301721 mouse Lipq3_m lipoprotein QTL 3 (mouse) 15 Not determined
1301722 mouse Cia9_m collagen induced arthritis QTL 9 (mouse) 1 Not determined
1301723 mouse Fcsa7_m femoral cross-sectional area 7 (mouse) 12 Not determined
1301724 mouse Pcd4ts1_m p-glycoprotein positive CD4 T cell subset 1 (mouse) 6 Not determined
1301725 mouse Lifespan1_m life span 1 (mouse) 9 Not determined
1301726 mouse Tlq1_m telomere length QTL 1 (mouse) 2 Not determined
1301727 mouse T2dm1_m type 2 diabetes mellitus 1 (mouse) 16 Not determined
1301728 mouse Ffal1_m free fatty acid level 1 (mouse) 17 Not determined
1301729 mouse Faq7_m fluctuating asymmetry QTL 7 (mouse) 13 Not determined
1301730 mouse Szv3_m seizure severity 3 (mouse) 15 Not determined
1301731 mouse Cafq2_m caffeine metabolism QTL 2 (mouse) 4 Not determined
1301732 mouse Char1_m P. chabaudi malaria resistance QTL 1 (mouse) 9 Not determined
1301733 mouse Heal3_m wound healing/regeneration 3 (mouse) 13 Not determined
1301734 mouse Acsns2_m Angiostrongylus costaricensis nematode susceptibility 2 (mouse) 13 Not determined
1301735 mouse Mhsvr1_m malignant histiocytosis sarcoma virus resistance 1 (mouse) 13 Not determined
1301736 mouse Faq3_m fluctuating asymmetry QTL 3 (mouse) 7 Not determined
1301737 mouse Insq9_m insulin QTL 9 (mouse) 10 Not determined
1301738 mouse Rhs1_m resistance to herpes simplex virus 1 (mouse) 6 Not determined
1301739 mouse Pitm2_m prion incubation time 2 (mouse) 4 Not determined
1301740 mouse Bwq2_m body weight QTL 2 (mouse) 6 Not determined
1301741 mouse Lith2_m lithogenic gene 2 (mouse) 19 Not determined
1301742 mouse Tnfp_m tumor necrosis factor protection (mouse) 12 Not determined
1301743 mouse Kwq5_m kidney weight QTL 5 (mouse) X Not determined
1301744 mouse Hdlq11_m HDL QTL 11 (mouse) 6 Not determined
1301745 mouse Lcho3_m liver cholesterol 3 (mouse) 13 Not determined
1301746 mouse Pgia18_m proteoglycan induced arthritis 18 (mouse) 5 Not determined
1301747 mouse Eae21_m experimental allergic encephalomyelitis 21 (mouse) 2 Not determined
1301748 mouse Abbp1_m A/J and C57BL/6 blood pressure 1 (mouse) 1 Not determined
1301749 mouse Orgwq1_m organ weight QTL 1 (mouse) 1 Not determined
1301750 mouse Embl1_m embryonic lethal 1 (mouse) 11 Not determined
1301751 mouse Bwtq1_m body weight QTL 1 (mouse) 1 Not determined
1301752 mouse Cplaq2_m circadian period of locomotor activity 2 (mouse) 16 Not determined
1301753 mouse Tir3a_m trypansomiasis infection response 3a (mouse) 1 Not determined
1301754 mouse Cocia5_m cocaine induced activation 5 (mouse) 1 Not determined
1301755 mouse Hrq1_m heart rate quantitative locus 1 (mouse) 2 Not determined
1301756 mouse Pgia1_m proteoglycan induced arthritis 1 (mouse) 1 Not determined
1301757 mouse Tlsr4_m thymic lymphoma suppressor region 4 (mouse) 4 Not determined
1301758 mouse Fcsa3_m femoral cross-sectional area 3 (mouse) 10 Not determined
1301759 mouse Sles1_m systemic lupus erythmatosus suppressor 1 (mouse) 17 Not determined
1301760 mouse Dob9_m dietary obesity 9 (mouse) 15 Not determined
1301761 mouse Drb1_m dopamine receptor binding 1 (mouse) 5 Not determined
1301762 mouse Nidd2n_m non-insulin-dependent diabetes mellitus 2 in NSY (mouse) 14 Not determined
1301763 mouse Hdlq1_m HDL QTL 1 (mouse) 5 Not determined
1301764 mouse Chab4_m cholesterol absorption 4 (mouse) 15 Not determined
1301765 mouse Skull15_m skull morphology 15 (mouse) 11 Not determined
1301766 mouse Desp1_m despair 1 (mouse) 8 Not determined
1301767 mouse Fcsa2_m femoral cross-sectional area 2 (mouse) 8 Not determined
1301768 mouse Bw14_m body weight QTL 14 (mouse) 7 Not determined
1301769 mouse Orgwq2_m organ weight QTL 2 (mouse) 2 Not determined
1301770 mouse Bgeq10_m body growth early QTL 10 (mouse) 11 Not determined
1301771 mouse Pcyts6_m plasmacytoma susceptibility 6 (mouse) 18 Not determined
1301772 mouse Skull3_m skull morphology 3 (mouse) 2 Not determined
1301773 mouse Stheal7_m soft tissue heal 7 (mouse) 7 Not determined
1301774 mouse Swq2_m spleen weight QTL 2 (mouse) 12 Not determined
1301775 mouse Hdis_m horizontal distance traveled (mouse) 1 Not determined
1301776 mouse Skts3_m skin tumor susceptibility 3 (mouse) 5 Not determined
1301777 mouse Bglq15_m body growth late QTL 15 (mouse) 14 Not determined
1301778 mouse Afw10_m abdominal fat weight QTL 10 (mouse) 12 Not determined
1301779 mouse Dpml_m dopamine loss (mouse) 15 Not determined
1301780 mouse Tir3_m trypanosome infection response 3 (mouse) 1 Not determined
1301781 mouse Capsq3_m capsaicin sensitivity related QTL 3 (mouse) 7 Not determined
1301782 mouse Chol11_m cholesterol 11 (mouse) 9 Not determined
1301783 mouse Bhr1_m bronchial hyperresponsiveness 1 (mouse) 2 Not determined
1301784 mouse Ses2_m salmonella enteritidis susceptibility 2 (mouse) 7 Not determined
1301785 mouse Lmblgq1_m limb length QTL 1 (mouse) 1 Not determined
1301786 mouse Bpq3_m blood pressure QTL 3 (mouse) 4 Not determined
1301787 mouse Bsc1_m brain size control 1 (mouse) 10 Not determined
1301788 mouse Lbw8_m lupus NZB x NZW 8 (mouse) 11 Not determined
1301789 mouse Pbwg4_m postnatal body weight growth 4 (mouse) 9 Not determined
1301790 mouse Pcfm1_m periosteal circumference and femur length 1 (mouse) 2 Not determined
1301791 mouse Char4_m P. chabaudi malaria resistance QTL 4 (mouse) 3 Not determined
1301792 mouse Hdlq10_m HDL QTL 10 (mouse) 4 Not determined
1301793 mouse Tlsr3_m thymic lymphoma suppressor region 3 (mouse) 4 Not determined
1301794 mouse Daq12_m directional asymmetry QTL 12 (mouse) 15 Not determined
1301795 mouse Cbm3_m cerebellum weight 3 (mouse) 14 Not determined
1301796 mouse Mop2_m morphine preference 2 (mouse) 10 Not determined
1301797 mouse Idd1_m insulin dependent diabetes susceptibility 1 (mouse) 17 Not determined
1301798 mouse Hdlq31_m HDL QTL 31 (mouse) 18 Not determined
1301799 mouse Tshp2_m tooth shape 2 (mouse) 1 Not determined
1301800 mouse Faq10_m fluctuating asymmetry QTL 10 (mouse) 19 Not determined
1301801 mouse Cpfd5_m cerebellum pattern fissures (mouse) 13 Not determined
1301802 mouse Bglq8_m body growth late QTL 8 (mouse) 11 Not determined
1301803 mouse Stheal9_m soft tissue heal 9 (mouse) 9 Not determined
1301804 mouse Bulb2_m bulb size 2 (mouse) 6 Not determined
1301805 mouse Mors2_m modifier of obesity related sterility 2 (mouse) 3 Not determined
1301937 mouse Skull10_m skull morphology 10 (mouse) 7 Not determined
1301938 mouse Daq2_m directional asymmetry QTL 2 (mouse) 3 Not determined
1301939 mouse Ptz1a_m pentylenetetrazol induced seizure susceptibility 1a (mouse) 2 Not determined
1301940 mouse Carp2_m carcass protein in high growth mice 2 (mouse) 11 Not determined
1301941 mouse Mmtg1_m modifier of mammary tumor growth 1 (mouse) 4 Not determined
1301942 mouse Pas13_m pulmonary adenoma susceptibility 13 (mouse) 19 Not determined
1301943 mouse Exq3_m exploratory and excitability QTL 3 (mouse) 1 Not determined
1301944 mouse Lmblgq3_m limb length QTL 3 (mouse) 7 Not determined
1301945 mouse Skl7_m skeletal size (tail length) 7 (mouse) 16 Not determined
1301946 mouse Prxsh_m preaxial shift (mouse) 8 Not determined
1301947 mouse Pcfm3_m periosteal circumference and femur length 3 (mouse) 3 Not determined
1301948 mouse Elsgp3_m elevated serum gp70 3 (mouse) 2 Not determined
1301949 mouse Skull20_m skull morphology 20 (mouse) 13 Not determined
1301950 mouse Otx2m1_m orthodenticle homolog 2 (Drosophila) modifier 1 (mouse) 18 Not determined
1301951 mouse Eila3_m ethanol induced locomotor activity 3 (mouse) 15 Not determined
1301952 mouse Im3_m immunoregulatory 3 (mouse) 8 Not determined
1301953 mouse Tmevd9_m Theiler's murine encephalomyelitis virus induced demyelinating disease susceptibility 9 (mouse) 1 Not determined
1301954 mouse Lrnx11_m learning-contextual 11 (mouse) 1 Not determined
1301955 mouse Amp1_m amplitude of circadian rhythm 1 (mouse) 4 Not determined
1301956 mouse Orch3_m autoimmune orchitis resistance 3 (mouse) 11 Not determined
1301957 mouse Lwq4_m liver weight QTL 4 (mouse) 11 Not determined
1301958 mouse Alcp18_m alcohol preference locus 18 (mouse) 11 Not determined
1301959 mouse Afw5_m abdominal fat weight QTL 5 (mouse) 11 Not determined
1301960 mouse Vmbic7_m ventral midbrain iron content 7 (mouse) 13 Not determined
1301961 mouse Bts1_m bladder tumor susceptibility 1 (mouse) 2 Not determined
1301962 mouse Eila2_m ethanol induced locomotor activity 2 (mouse) 6 Not determined
1301963 mouse Cons6_m consumption-saccharin intake 6 (mouse) 19 Not determined
1301964 mouse Bw8q2_m body weight at 8 weeks QTL 2 (mouse) 4 Not determined
1301965 mouse Vmbic5_m ventral midbrain iron content 5 (mouse) 9 Not determined
1301966 mouse Lifespan2_m life span 2 (mouse) 10 Not determined
1301967 mouse Hlq4_m heat loss QTL 4 (mouse) 3 Not determined
1301968 mouse Estq4_m estradiol regulated response QTL 4 (mouse) 10 Not determined
1301969 mouse Lbw5_m lupus NZB x NZW 5 (mouse) 7 Not determined
1301970 mouse Heal11_m wound healing/regeneration 11 (mouse) 16 Not determined
1301971 mouse Cia5_m collagen induced arthritis QTL 5 (mouse) 3 Not determined
1301972 mouse Cocrb8_m cocaine related behavior 8 (mouse) 9 Not determined
1301973 mouse Wg4_m weight gain in high growth mice 4 (mouse) 11 Not determined
1301974 mouse Chab7_m cholesterol absorption 7 (mouse) 5 Not determined
1301975 mouse Mol1_m modifier of LPS-response 1 (mouse) 7 Not determined
1301976 mouse Taste8_m taste bitterness sensitivity 8 (mouse) 6 Not determined
1301977 mouse Szs8_m seizure susceptibility 8 (mouse) 2 Not determined
1301978 mouse Tmevd6_m Theiler's murine encephalomyelitis virus induced demyelinating disease susceptibility 6 (mouse) 1 Not determined
1301979 mouse Melm1_m melanoma modifier 1 (mouse) 1 Not determined
1301980 mouse Fcsa5_m femoral cross-sectional area 5 (mouse) 2 Not determined
1301981 mouse Aaq1_m alcohol acceptance QTL 1 (mouse) 15 Not determined
1301982 mouse Pltiq1_m phospholipid transfer protein inducibility QTL 1 (mouse) 4 Not determined
1301983 mouse Berr2_m berghei resistance locus 2 (mouse) 11 Not determined
1301984 mouse Pbd2_m peak bone density 2 (mouse) 13 Not determined
1301985 mouse Manh23_m mandible shape 23 (mouse) 16 Not determined
1301986 mouse Bpq4_m blood pressure QTL 4 (mouse) 5 Not determined
1301987 mouse Pid3_m prior incubation determinant 3 (mouse) 11 Not determined
1301988 mouse Bmd11_m bone mineral density 11 (mouse) 11 Not determined
1301989 mouse Hdlq18_m HDL QTL 18 (mouse) 12 Not determined
1301990 mouse Arvm1_m autoimmune renal vasculitis 1 (mouse) 4 Not determined
1301991 mouse Wta3_m weight adult 3 (mouse) 14 Not determined
1301992 mouse Bgeq13_m body growth early QTL 13 (mouse) 14 Not determined
1301993 mouse Cocia4_m cocaine induced activation 4 (mouse) 1 Not determined
1301994 mouse Ksc2_m keratinocyte stem cell locus 2 (mouse) 4 Not determined
1301995 mouse Lprm1_m lymphoproliferation modifier 1 (mouse) 4 Not determined
1301996 mouse Mmtg2_m modifier of mammary tumor growth 2 (mouse) 4 Not determined
1301997 mouse Cia7_m collagen induced arthritis QTL 7 (mouse) 7 Not determined
1301998 mouse Bts2_m bladder tumor susceptibility 2 (mouse) 6 Not determined
1301999 mouse Lmr15_m leishmaniasis resistance 15 (mouse) 11 Not determined
1302000 mouse Pgia25_m proteoglycan induced arthritis 2 (mouse) X Not determined
1302404 rat Cia27 Collagen induced arthritis QTL 27 ACI.DA-(D10Rat2-D10Rat19) 1302416
1302001 mouse Bdln5_m body length 5 (mouse) 9 Not determined
1302002 mouse Cocia2_m cocaine induced activation 2 (mouse) 15 Not determined
1302003 mouse Sluc17_m susceptibility to lung cancer 17 (mouse) 2 Not determined
1302004 mouse Lfp2_m long free running period 2 (mouse) 19 Not determined
1302005 mouse Loco2_m locomotor activity 2 (mouse) 17 Not determined
1302006 mouse Szs2_m seizure susceptibility 2 (mouse) 4 Not determined
1302007 mouse Bbaa14_m B.burgdorferi-associated arthritis 14 (mouse) 15 Not determined
1302008 mouse Gasa4_m gastritis type A susceptibility locus 4 (mouse) 17 Not determined
1302009 mouse Sbmd1_m spinal bone mineral density 1 (mouse) 2 Not determined
1302010 mouse Wta1_m weight adult 1 (mouse) 4 Not determined
1302011 mouse Grdhq1_m growth retardation in Dh male mice (mouse) X Not determined
1302012 mouse Char7_m P. chabaudi malaria resistance QTL 7 (mouse) 17 Not determined
1302013 mouse Tbbmd3_m total body bone mineral density 3 (mouse) 2 Not determined
1302014 mouse Hdlq23_m HDL QTL 23 (mouse) 6 Not determined
1302015 mouse C10bw2_m castaneus 10 week body weight 2 (mouse) 9 Not determined
1302016 mouse Ltsd1_m lung tumor shape-determining 1 (mouse) 18 Not determined
1302017 mouse Aliq3_m acute lung injury QTL 3 (mouse) 17 Not determined
1302018 mouse Wt3q2_m body weight (mouse) 1 Not determined
1302019 mouse Pgia23_m proteoglycan induced arthritis 23 (mouse) 19 Not determined
1302020 mouse Bbaa20_m B.burgdorferi-associated arthritis 20 (mouse) 6 Not determined
1302021 mouse Nidd1n_m non-insulin-dependent diabetes mellitus 1 in NSY (mouse) 11 Not determined
1302022 mouse Lrnx6_m learning contextual 6 (mouse) 19 Not determined
1302023 mouse Orch4_m autoimmune orchitis resistance 4 (mouse) 1 Not determined
1302024 mouse Skull7_m skull morphology 7 (mouse) 6 Not determined
1302025 mouse Pas1_m pulmonary adenoma susceptibility 1 (mouse) 6 Not determined
1302026 mouse Lrnpcs3_m learning-preconditioned stimulus 3 (mouse) 13 Not determined
1302027 mouse Bw12_m body weight QTL 12 (mouse) X Not determined
1302028 mouse Asbb3_m autoimmune susceptibility in C57BL/6J and BALB/c 3 (mouse) 17 Not determined
1302029 mouse Sst1_m susceptibility to tuberculosis 1 (mouse) 1 Not determined
1302030 mouse Lmb3_m lupus in MRL and B6 F2 cross (mouse) 7 Not determined
1302031 mouse Bulb1_m bulb size 1 (mouse) 4 Not determined
1302032 mouse Alcp12_m alcohol preference locus 12 (mouse) 7 Not determined
1302033 mouse Nsv1_m Neuroadapted Sindbis viral RNA level 1 (mouse) 2 Not determined
1302034 mouse Pkccl_m protein kinase C content in lungs (mouse) 11 Not determined
1302035 mouse Lmb4_m lupus in MRL and B6 F2 cross (mouse) 10 Not determined
1302036 mouse Lrncs3_m learning-conditioned stimulus 3 (mouse) 1 Not determined
1302037 mouse Nktcn1_m natural killer T cell numbers 1 (mouse) 1 Not determined
1302038 mouse Radpf1_m radiation pulmonary fibrosis 1 (mouse) 17 Not determined
1302039 mouse Oriq4_m ovulation rate QTL 4 (mouse) X Not determined
1302040 mouse Mobe4_m modifier of obesity 4 (mouse) 17 Not determined
1302041 mouse Tcsz2_m tooth central size 2 (mouse) 7 Not determined
1302042 mouse Acsns3_m Angiostrongylus costaricensis nematode susceptibility 3 (mouse) 17 Not determined
1302043 mouse Dautb2_m dopamine uptake transporter binding 2 (mouse) 7 Not determined
1302044 mouse Nss1_m NOD Sjogren's syndrome 1 (mouse) 4 Not determined
1302045 mouse Cia16_m collagen induced arthritis 16 (mouse) 8 Not determined
1302046 mouse Taste7_m taste bitterness sensitivity 7 (mouse) 3 Not determined
1302047 mouse Fubi1_m failure of ureteric bud invasion 1 (mouse) 2 Not determined
1302048 mouse T1pdty_m type I polydactyly (mouse) 17 Not determined
1302049 mouse Heal1_m wound healing/regeneration 1 (mouse) 8 Not determined
1302050 mouse Radpf4_m radiation pulmonary fibrosis 4 (mouse) 18 Not determined
1302051 mouse Sluc7_m susceptibility to lung cancer 7 (mouse) 6 Not determined
1302052 mouse Etohcta4_m ethanol conditioned taste aversion 4 (mouse) 3 Not determined
1302053 mouse Actvty2_m activity 2 (mouse) X Not determined
1302054 mouse Gct4_m granulosa cell tumorigenesis 4 (mouse) X Not determined
1302055 mouse Mob6_m multigenic obesity 6 (mouse) 2 Not determined
1302056 mouse Orgwq4_m organ weight QTL 4 (mouse) 3 Not determined
1302057 mouse Pgia27_m proteoglycan induced arthritis 27 (mouse) 4 Not determined
1302058 mouse Hrtfm3_m heart failure modifier 3 (mouse) 4 Not determined
1302059 mouse Bwtq4_m body weight QTL 4 (mouse) 9 Not determined
1302060 mouse El3_m epilepsy 3 (mouse) 10 Not determined
1302061 mouse Szv1_m seizure severity 1 (mouse) 5 Not determined
1302062 mouse Stheal6_m soft tissue heal 6 (mouse) 7 Not determined
1302063 mouse Eae19_m experimental allergic encephalomyelitis 19 (mouse) 19 Not determined
1302064 mouse Pbwg5_m postnatal body weight growth 5 (mouse) 10 Not determined
1302065 mouse El1_m epilepsy 1 (mouse) 9 Not determined
1302066 mouse Insq2_m insulin QTL 2 (mouse) 1 Not determined
1302067 mouse Scc9_m colon tumor susceptibility 9 (mouse) 10 Not determined
1302068 mouse Epd1_m autoimmune epididymitis resistance 1 (mouse) 16 Not determined
1302069 mouse Bbaa8_m B.burgdorferi-associated arthritis 8 (mouse) 17 Not determined
1302070 mouse Tbbmd7_m total body bone mineral density 7 (mouse) 17 Not determined
1302071 mouse Fembrs1_m femur breaking strength 1 (mouse) 2 Not determined
1302072 mouse Axtofa7_m anxiety-open field activity 7 (mouse) X Not determined
1302073 mouse Pgct1_m primordial germ cell tumor locus 1 (mouse) 13 Not determined
1302074 mouse Bmd4_m bone mineral density 4 (mouse) 15 Not determined
1302075 mouse Bdln6_m body length 6 (mouse) 4 Not determined
1302076 mouse Vmbic2_m ventral midbrain iron content 2 (mouse) 5 Not determined
1302077 mouse Bglq4_m body growth late QTL 4 (mouse) 4 Not determined
1302078 mouse Sluc21_m susceptibility to lung cancer 21 (mouse) 4 Not determined
1302079 mouse Lbw3_m lupus NZB x NZW 3 (mouse) 5 Not determined
1302080 mouse Szs13_m seizure susceptibility 13 (mouse) 15 Not determined
1302081 mouse Dautb3_m dopamine uptake transporter binding 3 (mouse) 11 Not determined
1302082 mouse Manz4_m mandible size 4 (mouse) 6 Not determined
1302083 mouse Gusr_m gutter shaped root (mouse) 17 Not determined
1302084 mouse Ckds_m cystic kidney disease severity (mouse) 4 Not determined
1302085 mouse Mobe1_m modifier of obesity 1 (mouse) 2 Not determined
1302086 mouse Obq9_m obesity QTL 9 (mouse) 1 Not determined
1302087 mouse Axtofa5_m anxiety-open field activity 5 (mouse) 15 Not determined
1302088 mouse Gvhd2_m graft-versus-host disease 2 (mouse) 4 Not determined
1302089 mouse Wta2_m weight adult 2 (mouse) 6 Not determined
1302090 mouse Bdt3_m bone density traits 3 (mouse) 6 Not determined
1302091 mouse Pidys_m particle-induced immune disfunction (mouse) 17 Not determined
1302092 mouse Ath11_m atherosclerosis 11 (mouse) 10 Not determined
1302093 mouse Orgwq5_m organ weight QTL 5 (mouse) 3 Not determined
1302094 mouse Rrodp1_m rotarod performance 1 (mouse) 1 Not determined
1302095 mouse Yaa1_m Y-linked autoimmune acceleration QTL 1 (mouse) 13 Not determined
1302096 mouse Aod1a_m autoimmune ovarian dysgenesis 1a (mouse) 16 Not determined
1302097 mouse Swq3_m spleen weight QTL 3 (mouse) 14 Not determined
1302098 mouse Eila1_m ethanol induced locomotor activity 1 (mouse) 1 Not determined
1302099 mouse Hdlq30_m HDL QTL 30 (mouse) 18 Not determined
1302100 mouse Circp2_m circadian photosensitivity 2 (mouse) 17 Not determined
1302101 mouse Axtrb3_m anxiety-related behavior 3 (mouse) 14 Not determined
1302102 mouse Bis1_m beta-carboline-induced seizures 1 (mouse) 4 Not determined
1302103 mouse Dob2_m dietary obesity 2 (mouse) 9 Not determined
1302104 mouse Lfp1_m long free running period 1 (mouse) 19 Not determined
1302105 mouse Im1_m Immunoregulatory 1 (mouse) 8 Not determined
1302106 mouse Rapop1_m radiation-induced apoptosis 1 (mouse) 16 Not determined
1302107 mouse Bglq6_m body growth late QTL 6 (mouse) 7 Not determined
1302108 mouse Skl5_m skeletal size (tail length) 5 (mouse) 11 Not determined
1302109 mouse Sluc28_m susceptibility to lung cancer 28 (mouse) 18 Not determined
1302110 mouse Szs12_m seizure susceptibility 12 (mouse) 13 Not determined
1302111 mouse Manh11_m mandible shape 11 (mouse) 9 Not determined
1302112 mouse Gct_m granulosa cell tumorigenesis (mouse) 4 Not determined
1302113 mouse Chol5_m cholesterol 5 (mouse) 3 Not determined
1302114 mouse Tbs1_m tuberculosis severity 1 (mouse) 3 Not determined
1302115 mouse Abhr3_m allergen-induced bronchial hyperresponsiveness 3 (mouse) 7 Not determined
1302116 mouse Bbaa1_m B.burgdorferi-associated arthritis 1 (mouse) 4 Not determined
1302117 mouse Idd3_m insulin dependent diabetes susceptibility 3 (mouse) 3 Not determined
1302118 mouse Alcp17_m alcohol preference locus 17 (mouse) 11 Not determined
1302119 mouse Cia15_m collagen induced arthritis 15 (mouse) 1 Not determined
1302120 mouse Etohcta1_m ethanol conditioned taste aversion 1 (mouse) 1 Not determined
1302121 mouse Cliff_m cliff drop aversion (mouse) 15 Not determined
1302122 mouse Eae8_m susceptibility to experimental allergic encephalomyelitis 8 (mouse) 2 Not determined
1302123 mouse Tlsr8_m thymic lymphoma suppressor region 8 (mouse) 19 Not determined
1302124 mouse Eae7_m susceptibility to experimental allergic encephalomyelitis 7 (mouse) 11 Not determined
1302125 mouse Lxw1_m lupus BXSB x NZW 1 (mouse) 4 Not determined
1302126 mouse Skull26_m skull morphology 26 (mouse) 19 Not determined
1302127 mouse Hlq3_m heat loss QTL 3 (mouse) 3 Not determined
1302128 mouse Ity3_m immunity to S. typhimurium 3 (mouse) 11 Not determined
1302129 mouse Ramt1_m recognized antigen from MCA-induced tumor 1 (mouse) 4 Not determined
1302130 mouse Fembm5_m femoral bone morphometry 5 (mouse) 4 Not determined
1302131 mouse Bmd8_m bone mineral density 8 (mouse) 6 Not determined
1302132 mouse Pbw1_m pentobarbital withdrawal QTL 1 (mouse) 1 Not determined
1302133 mouse Alcp16_m alcohol preference locus 16 (mouse) 10 Not determined
1302134 mouse Lscc3_m lung squamous cell carcinoma 3 (mouse) 18 Not determined
1302135 mouse Bglq3_m body growth late QTL 3 (mouse) 3 Not determined
1302136 mouse Insq3_m insulin QTL 3 (mouse) 3 Not determined
1302137 mouse Livq1_m percent liver QTL 1 (mouse) 7 Not determined
1302138 mouse Im6_m immunoregulatory 6 (mouse) 12 Not determined
1302139 mouse Bwtq5_m body weight QTL 5 (mouse) 11 Not determined
1302140 mouse Wta4_m weight adult 4 (mouse) 17 Not determined
1302141 mouse Fcsa6_m femoral cross-sectional area 6 (mouse) 7 Not determined
1302142 mouse Pas12_m pulmonary adenoma susceptibility 12 (mouse) 17 Not determined
1302143 mouse Bwq5_m body weight (mouse) 2 Not determined
1302144 mouse Oriq3_m ovulation rate QTL 3 (mouse) 6 Not determined
1302145 mouse Triglq2_m triglyceride QTL 2 (mouse) 11 Not determined
1302146 mouse Cocrb1_m cocaine related behavior 1 (mouse) 1 Not determined
1302147 mouse Skts12_m skin tumor susceptibility 12 (mouse) 6 Not determined
1302148 mouse Cocia1_m cocaine induced activation 1 (mouse) 12 Not determined
1302149 mouse Tlsr2_m thymic lymphoma suppressor region 2 (mouse) 4 Not determined
1302150 mouse Bbaa18_m B.burgdorferi-associated arthritis 18 (mouse) 10 Not determined
1302151 mouse Lprm2_m lymphoproliferation modifier 2 (mouse) 3 Not determined
1302152 mouse Skull25_m skull morphology 25 (mouse) 17 Not determined
1302153 mouse Fob1_m F-line obesity QTL 1 (mouse) 2 Not determined
1302154 mouse Skmw5_m skeletal muscle weight 5 (mouse) 17 Not determined
1302155 mouse Alcp11_m alcohol preference locus 11 (mouse) 7 Not determined
1302156 mouse Ath1_m atherosclerosis 1 (mouse) 1 Not determined
1302157 mouse Bwem2_m body weight day 30 males 2 (mouse) 13 Not determined
1302158 mouse Fembrs5_m femur breaking strength 5 (mouse) 1 Not determined
1302159 mouse Sle8_m systematic lupus erythematosus susceptibility 8 (mouse) 1 Not determined
1302160 mouse Mbis2_m Mycobacterium bovis-induced systemic lupus erythematosus 2 (mouse) 10 Not determined
1302161 mouse Exq2_m exploratory and excitability QTL 2 (mouse) 1 Not determined
1302162 mouse Ednrbm1_m endothelin receptor type B modifier 1 (mouse) 10 Not determined
1302163 mouse Bmd16_m bone mineral density 16 (mouse) 18 Not determined
1302164 mouse Psl2_m promotion susceptibility QTL 2 (mouse) 2 Not determined
1302165 mouse Yv_m yellow value (mouse) 15 Not determined
1302166 mouse Bwfq2_m body weight and fat QTL 2 (mouse) 2 Not determined
1302167 mouse Aaiq3_m aromatase activity QTL 3 (mouse) 2 Not determined
1302168 mouse Imgt1_m impaired glucose tolerance 1 (mouse) 6 Not determined
1302169 mouse Ptz1b_m pentylenetetrazol induced seizure susceptibility 1b (mouse) 2 Not determined
1302170 mouse Tanidd1_m tally ho associated non-insulin dependednt diabetes mellitus 1 (mouse) 19 Not determined
1302171 mouse Pgia28_m proteoglycan induced arthritis 28 (mouse) 11 Not determined
1302172 mouse Skts5_m skin tumor susceptibility 5 (mouse) 12 Not determined
1302173 mouse Vent1_m ventricular size 1 (mouse) 8 Not determined
1302174 mouse Dssc2_m dextran sodium sulfate induced colitis QTL2 (mouse) 2 Not determined
1302175 mouse Dssc1_m dextran sodium sulfate induced colitis QTL1 (mouse) 5 Not determined
1302176 mouse Afw1_m abdominal fat weight QTL 1 (mouse) 3 Not determined
1302177 mouse Dps2_m delta power in slow-wave sleep 2 (mouse) 12 Not determined
1302178 mouse Tshp1_m tooth shape 1 (mouse) 1 Not determined
1302179 mouse Mndl2_m mandible length 2 (mouse) 11 Not determined
1302180 mouse Actd4_m activity-distance traveled 4 (mouse) 9 Not determined
1302181 mouse Lvic2_m liver iron content 2 (mouse) 3 Not determined
1302182 mouse Mob7_m multigenic obesity 7 (mouse) 2 Not determined
1302183 mouse Pas7_m pulmonary adenoma susceptibility 7 (mouse) 18 Not determined
1302184 mouse Aaom1_m autoimmune aoritis in MRL mice 1 (mouse) 4 Not determined
1302185 mouse Pkcal_m protein kinase C activity in lungs (mouse) 3 Not determined
1302186 mouse Blmpf2_m bleomycin-induced pulmonary fibrosis 2 (mouse) 11 Not determined
1302187 mouse Par4_m pulmonary adenoma resistance 4 (mouse) 6 Not determined
1302188 mouse Lxw6_m lupus BXSB x NZW 6 (mouse) 7 Not determined
1302189 mouse Dps3_m delta power in slow-wave sleep 3 (mouse) 17 Not determined
1302190 mouse Drb8_m dopamine receptor binding 8 (mouse) 15 Not determined
1302191 mouse Mtes1_m Metastasis efficiency suppressor gene 1 (mouse) 19 Not determined
1302192 mouse Tir2_m trypanosome infection response 2 (mouse) 5 Not determined
1302193 mouse Cpfd1_m cerebellum pattern fissures (mouse) 1 Not determined
1302194 mouse Pgia10_m proteoglycan induced arthritis 10 (mouse) 16 Not determined
1302195 mouse Pbwg10_m postnatal body weight growth 10 (mouse) X Not determined
1302196 mouse Myaa1_m modifier of Yaa 1 (mouse) 17 Not determined
1302197 mouse Bhr2_m bronchial hyperresponsiveness 2 (mouse) 15 Not determined
1302198 mouse Lrncs1_m learning-conditioned stimulus 1 (mouse) 1 Not determined
1302199 mouse Mob3_m multigenic obesity 3 (mouse) 12 Not determined
1302200 mouse Sle12_m systematic lupus erythematosus susceptibility 12 (mouse) 10 Not determined
1302201 mouse Alcw1_m alcohol withdrawal 1 (mouse) 1 Not determined
1302202 mouse Dob3_m dietary obesity 3 (mouse) 15 Not determined
1302203 mouse Gvhd3_m graft-versus host disease 3 (mouse) 2 Not determined
1302204 mouse Spm1_m splenomegaly modifier (mouse) 4 Not determined
1300156 rat Bp179 Blood pressure QTL 179 4 2.85 35847 D4Rat12 34238 D4Mgh2 38908 D4Rat126 Blood pressure salt loaded mean arterial 10-week old rats were given a high-salt diet (8% NaCl), fitted with a femoral catheter, and housed in metabolic cages, allowing multiple traits related to blood pressure and cardiac function to be measured in a conscious unrestrained way 727992 BN/SsNHsd,SS/JrHsdMcwi 10008,61499 Bp178
1300141 rat Bp178 Blood pressure QTL 178 4 36504 D4Rat2 34238 D4Mgh2 38908 D4Rat126 Blood pressure salt loaded mean arterial 10-week old rats were given a high-salt diet (8% NaCl), fitted with a femoral catheter, and housed in metabolic cages, allowing multiple traits related to blood pressure and cardiac function to be measured in a conscious unrestrained way 727992 BN/SsNHsd,SS/JrHsdMcwi 10008,61499 Bp179
1300178 rat Hr4 Heart rate QTL 4 3 3.74 41780 D3Rat227 40016 D3Rat168 39912 D3Rat180 Heart rate salt loaded 10-week old rats were given a high-salt diet (8% NaCl), fitted with a femoral catheter, and housed in metabolic cages, allowing multiple traits related to blood pressure and cardiac function to be measured in a conscious unrestrained way 727992 BN/SsNHsd,SS/JrHsdMcwi 10008,61499
1300155 rat Bp174 Blood pressure QTL 174 2 4.09 37018 D2Rat14 41400 D2Rat216 40672 D2Rat202 Blood pressure salt loaded mean arterial 10-week old rats were given a high-salt diet (8% NaCl), fitted with a femoral catheter, and housed in metabolic cages, allowing multiple traits related to blood pressure and cardiac function to be measured in a conscious unrestrained way 727992 BN/SsNHsd,SS/JrHsdMcwi 10008,61499 Bp175
1300180 rat Bw14 Body weight QTL 14 9 3.776 40738 D9Rat130 34815 D9Rat16 35819 D9Rat26 Body weight salt-loaded 10-week old rats were given a high-salt diet (8% NaCl), fitted with a femoral catheter, and housed in metabolic cages, allowing multiple traits related to blood pressure and cardiac function to be measured in a conscious unrestrained way 727992 BN/SsNHsd,SS/JrHsdMcwi 10008,61499
1300170 rat Rf6 Renal function QTL 6 1 3.14 37610 D1Rat167 36568 D1Rat4 37610 D1Rat167 Renal function salt loaded renal blood flow 10-week old rats were given a high-salt diet (8% NaCl), fitted with a femoral catheter, and housed in metabolic cages, allowing multiple traits related to cardiac and renal function to be measured in a conscious unrestrained way 727992 BN/SsNHsd,SS/JrHsdMcwi 10008,61499 Rf7
1300132 rat Bp182 Blood pressure QTL 182 7 3.87 36691 D7Rat27 41186 D7Rat139 38794 D7Rat73 Blood pressure salt loaded time series calculation 10-week old rats were given a high-salt diet (8% NaCl), fitted with a femoral catheter, and housed in metabolic cages, allowing multiple traits related to blood pressure and cardiac function to be measured in a conscious unrestrained way 727992 BN/SsNHsd,SS/JrHsdMcwi 10008,61499 Bp181
1300123 rat Bp194 Blood pressure QTL 194 17 2.82 35116 D17Rat53 35697 D17Rat16 38348 D17Rat59 Blood pressure salt loaded mean arterial 10-week old rats were given a high-salt diet (8% NaCl), fitted with a femoral catheter, and housed in metabolic cages, allowing multiple traits related to blood pressure and cardiac function to be measured in a conscious unrestrained way 727992 BN/SsNHsd,SS/JrHsdMcwi 10008,61499
1300153 rat Bp171 Blood pressure QTL 171 1 3.37 41374 D1Rat265 37970 D1Rat210 37930 D1Rat183 Blood pressure salt loaded diastolic 10-week old rats were given a high-salt diet (8% NaCl), fitted with a femoral catheter, and housed in metabolic cages, allowing multiple traits related to blood pressure and cardiac function to be measured in a conscious unrestrained way 727992 BN/SsNHsd,SS/JrHsdMcwi 10008,61499 Bp170,Bp172,Bp173
1300126 rat Bp175 Blood pressure QTL 175 2 3.46 35290 D2Rat60 36241 D2Rat72 34858 D2Rat69 Blood pressure salt loaded time series calculation 10-week old rats were given a high-salt diet (8% NaCl), fitted with a femoral catheter, and housed in metabolic cages, allowing multiple traits related to blood pressure and cardiac function to be measured in a conscious unrestrained way 727992 BN/SsNHsd,SS/JrHsdMcwi 10008,61499 Bp174
1300166 rat Km6 Kidney mass 6 13 3.93 37844 D13Rat85 33644 D13Mit4 33644 D13Mit4 Kidney mass salt-loaded 10-week old rats were given a high-salt diet (8% NaCl), fitted with a femoral catheter, and housed in metabolic cages, allowing multiple traits related to blood pressure and cardiac function to be measured in a conscious unrestrained way 727992 BN/SsNHsd,SS/JrHsdMcwi 10008,61499
1300171 rat Bp184 Blood pressure QTL 184 8 3.66 38670 D8Rat114 36327 D8Rat2 34180 D8Mgh1 Blood pressure salt loaded time series calculation 10-week old rats were given a high-salt diet (8% NaCl), fitted with a femoral catheter, and housed in metabolic cages, allowing multiple traits related to blood pressure and cardiac function to be measured in a conscious unrestrained way 727992 BN/SsNHsd,SS/JrHsdMcwi 10008,61499
1300115 rat Hr7 Heart rate QTL 7 5 2.76 36279 D5Rat4 40992 D5Rat148 34216 D5Mgh6 Heart rate salt loaded 10-week old rats were given a high-salt diet (8% NaCl), fitted with a femoral catheter, and housed in metabolic cages, allowing multiple traits related to blood pressure and cardiac function to be measured in a conscious unrestrained way 727992 BN/SsNHsd,SS/JrHsdMcwi 10008,61499 Hr8,Bp180
1300169 rat Bp177 Blood pressure QTL 177 3 2.96 38346 D3Rat98 39912 D3Rat180 41780 D3Rat227 Blood pressure salt loaded time series calculation 10-week old rats were given a high-salt diet (8% NaCl), fitted with a femoral catheter, and housed in metabolic cages, allowing multiple traits related to blood pressure and cardiac function to be measured in a conscious unrestrained way 727992 BN/SsNHsd,SS/JrHsdMcwi 10008,61499 Bp176
1300117 rat Hr8 Heart rate QTL 8 5 3.49 39686 D5Rat119 36279 D5Rat4 36618 D5Rat2 Heart rate salt loaded 10-week old rats were given a high-salt diet (8% NaCl), fitted with a femoral catheter, and housed in metabolic cages, allowing multiple traits related to blood pressure and cardiac function to be measured in a conscious unrestrained way 727992 BN/SsNHsd,SS/JrHsdMcwi 10008,61499 Hr7,Bp180
1300162 rat Bp188 Blood pressure QTL 188 12 3.19 37830 D12Rat36 35431 D12Rat22 35431 D12Rat22 Blood pressure salt loaded systolic 10-week old rats were given a high-salt diet (8% NaCl), fitted with a femoral catheter, and housed in metabolic cages, allowing multiple traits related to blood pressure and cardiac function to be measured in a conscious unrestrained way 727992 BN/SsNHsd,SS/JrHsdMcwi 10008,61499
1300177 rat Cm2 Cardiac mass QTL 2 8 3.65 41122 D8Rat159 36003 D8Rat14 36809 D8Rat23 Cardiac mass salt-loaded 10-week old rats were given a high-salt diet (8% NaCl), fitted with a femoral catheter, and housed in metabolic cages, allowing multiple traits related to blood pressure and cardiac function to be measured in a conscious unrestrained way 727992 BN/SsNHsd,SS/JrHsdMcwi 10008,61499
1300151 rat Bp181 Blood pressure QTL 181 7 3.36 38794 D7Rat73 40966 D7Rat133 41186 D7Rat139 Blood pressure salt loaded diastolic 10-week old rats were given a high-salt diet (8% NaCl), fitted with a femoral catheter, and housed in metabolic cages, allowing multiple traits related to blood pressure and cardiac function to be measured in a conscious unrestrained way 727992 BN/SsNHsd,SS/JrHsdMcwi 10008,61499
1300125 rat Rf26 Renal function QTL 26 18 3.2 34182 D18Mgh3 37568 D18Rat55 39610 D18Rat91 Renal function salt loaded potassium excretion 10-week old rats were given a high-salt diet (8% NaCl), fitted with a femoral catheter, and housed in metabolic cages, allowing multiple traits related to blood pressure and cardiac function to be measured in a conscious unrestrained way 727992 BN/SsNHsd,SS/JrHsdMcwi 10008,61499
1300164 rat Rf15 Renal function QTL 15 6 35963 D6Rat46 36586 D6Rat26 35653 D6Rat42 Renal function salt loaded renal blood flow 10-week old rats were given a high-salt diet (8% NaCl), fitted with a femoral catheter, and housed in metabolic cages, allowing multiple traits related to cardiac and renal function to be measured in a conscious unrestrained way 727992 BN/SsNHsd,SS/JrHsdMcwi 10008,61499
1300168 rat Bp170 Blood pressure QTL 170 1 2.76 40230 D1Rat295 40028 D1Rat301 35909 D1Rat74 Blood pressure salt loaded mean arterial 10-week old rats were given a high-salt diet (8% NaCl), fitted with a femoral catheter, and housed in metabolic cages, allowing multiple traits related to blood pressure and cardiac function to be measured in a conscious unrestrained way 727992 BN/SsNHsd,SS/JrHsdMcwi 10008,61499 Bp171,Bp172,Bp173
1300134 rat Bp185 Blood pressure QTL 185 9 3.73 34815 D9Rat16 39380 D9Rat108 36908 D9Rat4 Blood pressure salt loaded mean arterial 10-week old rats were given a high-salt diet (8% NaCl), fitted with a femoral catheter, and housed in metabolic cages, allowing multiple traits related to blood pressure and cardiac function to be measured in a conscious unrestrained way 727992 BN/SsNHsd,SS/JrHsdMcwi 10008,61499
1302786 rat Km8 Kidney mass QTL 8 5 28.15 33678 D5Mit10 Kidney mass kidney wet weight and plasma urea concentration were determined in (PKDxWOK)F1xWOK backcross rats sacrificed at 2 months of age, polycystic kidney disease status was assigned by histological analysis of kidney tissue in which animals were considered to be affected if cysts up to the diameter of two glomeruli were observed in several visual fields 629573 9097967 3334 Pkdr1 PKD,WOK 68118,728168 dominant
1302787 rat Tgl10 Triglyceride level QTL 10 1 2.7 .0073 36592 D1Rat64 36757 D1Rat71 Lipid level triglyceride level rats were fitted with carotid artery and jugular vein catheters, and measured at 5-6 months of age for plasma triglycerides, total cholesterol, blood pressures, and body weight 1299960 14709677 LEW,HTG 60999,1302795 intercross
1302788 rat Scl19 Serum cholesterol QTL 19 1 4.6 .001 38792 D1Rat137 36432 D1Rat35 36765 D1Rat27 Lipid level cholesterol level rats were fitted with carotid artery and jugular vein catheters, and measured at 5-6 months of age for plasma triglycerides, total cholesterol, blood pressures, and body weight 1299960 14709677 LEW,HTG 60999,1302795 intercross
1302789 rat Tgl8 Triglyceride level QTL 8 2 3.1 .0035 35693 D2Rat55 37424 D2Rat111 35915 D2Rat61 Lipid level triglyceride level rats were fitted with carotid artery and jugular vein catheters, and measured at 5-6 months of age for plasma triglycerides, total cholesterol, blood pressures, and body weight 1299960 14709677 LEW,HTG 60999,1302795 intercross
1302790 rat Scl20 Serum cholesterol QTL 20 5 6.4 .0001 41318 D5Rat147 36237 D5Rat49 38338 D5Rat108 Lipid level cholesterol level rats were fitted with carotid artery and jugular vein catheters, and measured at 5-6 months of age for plasma triglycerides, total cholesterol, blood pressures, and body weight 1299960 14709677 LEW,HTG 60999,1302795 intercross
1302791 rat Tgl9 Triglyceride level QTL 9 13 3.3 .0011 45079 D13Wox8 33644 D13Mit4 37088 D13Rat34 Lipid level triglyceride level rats were fitted with carotid artery and jugular vein catheters, and measured at 5-6 months of age for plasma triglycerides, total cholesterol, blood pressures, and body weight 1299960 14709677 LEW,HTG 60999,1302795
1302792 rat Scl21 Serum cholesterol QTL 21 12 3.8 .0011 35923 D12Rat12 38952 D12Rat40 34898 D12Rat20 Lipid level cholesterol level rats were fitted with carotid artery and jugular vein catheters, and measured at 5-6 months of age for plasma triglycerides, total cholesterol, blood pressures, and body weight 1299960 14709677 LEW,HTG 60999,1302795
1302793 rat Bw16 Body weight QTL 16 2 5 .0001 38266 D2Rat136 34234 D2Mgh9 Body weight 1299960 14709677 LEW,HTG 60999,1302795 intercross
1302794 rat Tgl7 Triglyceride level QTL 7 2 4.4 .0001 38576 D2Rat182 34005 D2Mit8 39512 D2Rat210 Lipid level triglyceride level rats were fitted with carotid artery and jugular vein catheters, and measured at 5-6 months of age for plasma triglycerides, total cholesterol, blood pressures, and body weight 1299960 14709677 LEW,HTG 60999,1302795 intercross
1331635 human COPD19_H Chronic obstructive pulmonary disease QTL 19 (human) 2 4.12 1331574 D1S1649 1331557 D2S2968 1331561 D2S1363 Chronic airflow obstruction FEV1/FVC ratio genome-wide scan for irreversible airflow obstruction in relatives of probands with severe early-onset COPD; COPD was measured by spirometric indices, including forced expiratory volume at 1 second (FEV1) and the ratio of FEV1 to forced vital capacity (FVC) 1331515 11914989
1331636 human COPD13_H Chronic obstructive pulmonary disease QTL 13 (human) 4 1.56 1298203 D4S1592 1299895 D4S2951 1331573 D4S1625 Chronic airflow obstruction postBD FEV1 minus preBD FEV1 genome wide scan for loci affecting persistent airflow obstruction in 72 pedigrees with probands having severe early onset COPD 1331518 12719384
1331637 human COPD2_H Chronic obstructive pulmonary disease QTL 2 (human) 8 1.36 1331569 D8S507 Chronic airflow obstruction FEV1 <80% predicted and FEV/FVC<90% predicted genome-wide multipoint non-parametric linkage analysis performed on 585 members of 72 pedigree that had early-onset COPD probands without severe alpha1-antitrypsin deficiency 1331516 11912177
1331638 human COPD14_H Chronic obstructive pulmonary disease QTL 14 (human) 3 1.5 1299934 D3S1561 1298169 D3S2427 1331571 D3S4529 Chronic airflow obstruction postBD FEV1 minus preBD FEV1 genome wide scan for loci affecting persistent airflow obstruction in 72 pedigrees with probands having severe early onset COPD 1331518 12719384
1331639 human COPD3_H Chronic obstructive pulmonary disease QTL 3 (human) 19 1.54 1331582 D19S432 Chronic airflow obstruction FEV1 <80% predicted and FEV/FVC<90% predicted genome-wide multipoint non-parametric linkage analysis performed on 585 members of 72 pedigree that had early-onset COPD probands without severe alpha1-antitrypsin deficiency 1331516 11912177
1331640 human COPD11_H Chronic obstructive pulmonary disease QTL 11 (human) 1 2.52 1331568 D1S551 1331563 G15725 Chronic airflow obstruction post-bronchodilator FEV1/FVC genome wide scan for loci affecting persistent airflow obstruction in 72 pedigrees with probands having severe early onset COPD 1331518 12719384
1331641 human COPD25_H Chronic obstructive pulmonary disease QTL 25 (human) 6 2.4 24 1331585 D6S953 1331575 D6S1590 1331575 D6S1590 Chronic airflow obstruction FEV1 genome wide scan for lung function where spirometric measurements of FEV1, FVC and ratio of FEV1 to FVC were taken during adulthood in each generation of these pedigrees 1331517 11897646
1331642 human AASTH6_H Allergic/atopic asthma related QTL 6 (human) 12 2.46 .0004 1331611 PAH 1299944 D12S2070 1299944 D12S2070 Reversible airflow obstruction post-bronchodilator FEV1 segregation analysis and variance-component analysis for high total serum IgE performed on 108 probands and their families 1331539 11023809 recessive
1331643 human COPD16_H Chronic obstructive pulmonary disease QTL 16 (human) 3 1.07 1298237 D3S2384 1331560 D3S1746 Chronic airflow obstruction postBD FEV1 minus preBD FEV1/preBD FEV1 x 100 genome wide scan for loci affecting persistent airflow obstruction in 72 pedigrees with probands having severe early onset COPD 1331518 12719384
1331644 human AASTH7_H Allergic/atopic asthma related QTL 7 (human) 12 2.29 1331605 D12S357 1331602 D12S92 1331609 D12S97 Reversible airflow obstruction asthma score linkage analysis was performed was performed on a population that was evaluated for asthma related qualitative scores. They were evaluated by written and video questionaire, wheezing, skin prick testing, bronchial reactivity, FEV1 ratio, Eczema, Hay fever, total IgE, specific IgE, Asthma score(combination of wheezing, video questionaire, bronchial response, and FEV1 ratio) and Asthma affection(Asthma score with predisposition among normals and severity factored in) 1331541 9799590
1331645 human COPD18_H Chronic obstructive pulmonary disease QTL 18 (human) 1 1.92 1298097 D1S1665 1331565 D1S1653 1331563 G15725 Chronic airflow obstruction FEV1/FVC ratio genome-wide scan for irreversible airflow obstruction in relatives of probands with severe early-onset COPD; COPD was measured by spirometric indices, including forced expiratory volume at 1 second (FEV1) and the ratio of FEV1 to forced vital capacity (FVC) 1331515 11914989
1331646 human COPD21_H Chronic obstructive pulmonary disease QTL 21 (human) 12 2.43 1331584 D12S1581 1331577 D12S1066 1331548 D12S1630 Chronic airflow obstruction FEV1 genome-wide scan for irreversible airflow obstruction in relatives of probands with severe early-onset COPD; COPD was measured by spirometric indices, including forced expiratory volume at 1 second (FEV1) and the ratio of FEV1 to forced vital capacity (FVC) 1331515 11914989
1331647 human COPD4_H Chronic obstructive pulmonary disease QTL 4 (human) 22 1.37 1331587 D22S278 Chronic airflow obstruction FEV1 <80% predicted and FEV/FVC<90% predicted genome-wide multipoint non-parametric linkage analysis performed on 585 members of 72 pedigree that had early-onset COPD probands without severe alpha1-antitrypsin deficiency 1331516 11912177
1331648 human COPD8_H Chronic obstructive pulmonary disease QTL 8 (human) 8 2.01 1331581 D8S1108 1298150 D8S373 1298150 D8S373 Chronic airflow obstruction post-bronchodilator FEV1 genome wide scan for loci affecting persistent airflow obstruction in 72 pedigrees with probands having severe early onset COPD 1331518 12719384
1331649 human COPD22_H Chronic obstructive pulmonary disease QTL 22 (human) 17 2.68 1331576 D17S1294 1298272 D17S2180 1298272 D17S2180 Chronic airflow obstruction FEV1/FVC ratio genome-wide scan for irreversible airflow obstruction in relatives of probands with severe early-onset COPD; COPD was measured by spirometric indices, including forced expiratory volume at 1 second (FEV1) and the ratio of FEV1 to forced vital capacity (FVC) 1331515 11914989
1331650 human COPD15_H Chronic obstructive pulmonary disease QTL 15 (human) 4 1.28 1298203 D4S1592 1298155 D4S2924 1298103 D4S2366 Chronic airflow obstruction postBD FEV1 minus preBD FEV1/preBDFEV1 x 100 genome wide scan for loci affecting persistent airflow obstruction in 72 pedigrees with probands having severe early onset COPD 1331518 12719384
1331651 human COPD12_H Chronic obstructive pulmonary disease QTL 12 (human) 17 2.44 1298244 D17S1303 1298335 D17S2193 1298272 D17S2180 Chronic airflow obstruction post-bronchodilator FEV1/FVC genome wide scan for loci affecting persistent airflow obstruction in 72 pedigrees with probands having severe early onset COPD 1331518 12719384
1331652 human COPD17_H Chronic obstructive pulmonary disease QTL 17 (human) 1 1.28 1298138 D1S468 1331547 D1S3669 1298303 D1S1612 Chronic airflow obstruction FEV1 genome-wide scan for irreversible airflow obstruction in relatives of probands with severe early-onset COPD; COPD was measured by spirometric indices, including forced expiratory volume at 1 second (FEV1) and the ratio of FEV1 to forced vital capacity (FVC) 1331515 11914989
1331653 human AASTH5_H Allergic/atopic asthma related QTL 5 (human) 7 3.36 .00004 39 1331594 D7S820 1298320 D7S821 1298320 D7S821 Reversible airflow obstruction post-bronchodilator FEV1 segregation analysis and variance-component analysis for high total serum IgE performed on 108 probands and their families 1331539 11023809 recessive
1331654 human COPD28_H Chronic obstructive pulmonary disease QTL 28 (human) 18 2.88 1298292 D18S858 Chronic airflow obstruction FVC genome-wide scan for linkage of FEV1, FVC, and FEV1/FVC measurements was performed on 2,178 individuals in 391 pedigrees participating in the NHLBI Family Heart Study, as well as 702 additional individuals who contributed genotyping data. 1331519 12637344 COPD26_H
1331655 human COPD20_H Chronic obstructive pulmonary disease QTL 20 (human) 11 1.53 1298156 D11S2371 1299908 D11S2000 1298202 D11S2002 Chronic airflow obstruction FVC genome-wide scan for irreversible airflow obstruction in relatives of probands with severe early-onset COPD; COPD was measured by spirometric indices, including forced expiratory volume at 1 second (FEV1) and the ratio of FEV1 to forced vital capacity (FVC) 1331515 11914989
1331656 human COPD26_H Chronic obstructive pulmonary disease QTL 26 (human) 21 2.6 26 1298173 D21S1440 Chronic airflow obstruction FVC genome wide scan for lung function where spirometric measurements of FEV1, FVC and ratio of FEV1 to FVC were taken during adulthood in each generation of these pedigrees 1331517 11897646
1331657 human COPD9_H Chronic obstructive pulmonary disease QTL 9 (human) 19 1.94 1299977 D19S221 1331606 D19S404 1331586 D19S246 Chronic airflow obstruction post-bronchodilator FEV1 genome wide scan for loci affecting persistent airflow obstruction in 72 pedigrees with probands having severe early onset COPD 1331518 12719384
1331658 human COPD27_H Chronic obstructive pulmonary disease QTL 27 (human) 18 2.31 1299942 D18S843 Chronic airflow obstruction FEV1 genome-wide scan for linkage of FEV1, FVC, and FEV1/FVC measurements was performed on 2,178 individuals in 391 pedigrees participating in the NHLBI Family Heart Study, as well as 702 additional individuals who contributed genotyping data. 1331519 12637344 COPD25_H
1331659 human AASTH4_H Allergic/atopic asthma related QTL 4 (human) 5 2.73 .0002 37 1331601 D5S666 1331598 D5S402 Reversible airflow obstruction post-bronchodilator FEV1 segregation analysis and variance-component analysis for high total serum IgE performed on 108 probands and their families 1331539 11023809 recessive
1331660 human AASTH3_H Allergic/atopic asthma related QTL 3 (human) 5 3.73 .000017 1331599 D5S2040 1331595 D5S1456 1331600 D5S1471 Reversible airflow obstruction genome-wide scan for linkage to childhood atopic allergy to the house-dust mite Dermatophagoides farinae; affected individuals showed Df-specific RAST scores >3 and total serum IgE levels >1 standard deviation above the age-matched population mean 1331538 10860660 AASTH2_H
1331661 human COPD10_H Chronic obstructive pulmonary disease QTL 10 (human) 2 4.42 1299945 D2S434 1331561 D2S1363 Chronic airflow obstruction post-bronchodilator FEV1/FVC genome wide scan for loci affecting persistent airflow obstruction in 72 pedigrees with probands having severe early onset COPD 1331518 12719384
1331662 human COPD29_H Chronic obstructive pulmonary disease QTL 29 (human) 4 3.51 1331562 D4S1511 1331564 D4S403 Chronic airflow obstruction FEV1/FVC ratio genome-wide scan for linkage of FEV1, FVC, and FEV1/FVC measurements was performed on 2,178 individuals in 391 pedigrees participating in the NHLBI Family Heart Study, as well as 702 additional individuals who contributed genotyping data. 1331519 12637344
1331663 human COPD1_H Chronic obstructive pulmonary disease QTL 1 (human) 12 2.61 1331555 D12S269 1298164 D12S1682 1298193 D12S1715 Chronic airflow obstruction FEV1 <80% predicted and FEV/FVC<90% predicted genome-wide multipoint non-parametric linkage analysis performed on 585 members of 72 pedigree that had early-onset COPD probands without severe alpha1-antitrypsin deficiency 1331516 11912177 dominant
1331664 human COPD6_H Chronic obstructive pulmonary disease QTL 6 (human) 8 3.3 1331550 D8S1458 1331550 D8S1458 Chronic airflow obstruction post-bronchodilator FEV1 genome wide scan for loci affecting persistent airflow obstruction in 72 pedigrees with probands having severe early onset COPD 1331518 12719384
1331665 human AASTH2_H Allergic/atopic asthma related QTL 2 (human) 5 4.73 .0000013 1331607 D5S2013 1331608 D5S422 1331610 D5S820 Reversible airflow obstruction genome-wide scan for linkage to childhood atopic allergy to the house-dust mite Dermatophagoides farinae; affected individuals showed Df-specific RAST scores >3 and total serum IgE levels >1 standard deviation above the age-matched population mean 1331538 10860660 AASTH3_H
1331666 human COPD5_H Chronic obstructive pulmonary disease QTL 5 (human) 19 3.3 1331567 D19S215 1331580 D19S589 1331558 D19S220 Chronic airflow obstruction pre-bronchodilator FEV1 fine mapping of a QTL found in the genome-wide scan of a group of families participating in the Boston Early-Onset COPD Study. Measurements included pre- and post-bronchodilator forced expiratory volume in 1 second (FEV1), forced vital capacity (FVC) and the ratio FEV1/FCV 1331520 15175276
1331667 human COPD24_H Chronic obstructive pulmonary disease QTL 24 (human) 4 1.6 1331603 D4S416 Chronic airflow obstruction FEV1 genome wide scan for lung function where spirometric measurements of FEV1, FVC and ratio of FEV1 to FVC were taken during adulthood in each generation of these pedigrees 1331517 11897646
1301870 mouse Bglq1_m body growth late QTL 1 (mouse) 1 Not determined
1301871 mouse Frp1_m free running period 1 (mouse) 4 Not determined
1301872 mouse Cd4ts3_m CD4 T cell subset 3 (mouse) 8 Not determined
1301873 mouse Hsl1_m hyperoxia susceptibility locus 1 (mouse) 2 Not determined
1301874 mouse Hdlq16_m HDL QTL 16 (mouse) 8 Not determined
1301875 mouse Apmt1_m accelerator of polyoma-induced mammary tumors 1 (mouse) 15 Not determined
1301876 mouse Bits2_m bitterness sensitivity 2 (mouse) 6 Not determined
1301877 mouse Bbaa3_m B.burgdorferi-associated arthritis 3 (mouse) 5 Not determined
1301878 mouse Alcp13_m alcohol preference locus 13 (mouse) 7 Not determined
1301879 mouse Insq10_m insulin QTL 10 (mouse) 12 Not determined
1301880 mouse Hypt_m hypertension (mouse) 13 Not determined
1301881 mouse Trmq2_m T cell ratio modifier QTL 2 (mouse) 2 Not determined
1301882 mouse Etohc2_m ethanol consumption 2 (mouse) 2 Not determined
1301883 mouse Skull12_m skull morphology 12 (mouse) 9 Not determined
1301884 mouse Musz3_m muscle size 3 (mouse) 14 Not determined
1301885 mouse Angle3_m angle of entrainment 3 (mouse) 18 Not determined
1301886 mouse Hdlq24_m HDL QTL 24 (mouse) 6 Not determined
1301887 mouse Nidd4n_m non-insulin-dependent diabetes mellitus 4 in NSY (mouse) 11 Not determined
1301888 mouse Lwq3_m liver weight QTL 3 (mouse) 10 Not determined
1301889 mouse Tcsz3_m tooth central size 3 (mouse) 14 Not determined
1301890 mouse Adip7_m adiposity 7 (mouse) 13 Not determined
1301891 mouse Alcp25_m alcohol preference locus 25 (mouse) 1 Not determined
1301892 mouse Szs6_m seizure susceptibility 6 (mouse) 5 Not determined
1301893 mouse Cfcd_m contextual fear conditioning (mouse) 1 Not determined
1301894 mouse Skull2_m skull morphology 2 (mouse) 1 Not determined
1301895 mouse Exq1_m exploratory and excitability QTL 1 (mouse) 10 Not determined
1301896 mouse Tria1_m T-cell receptor induced activation 1 (mouse) 11 Not determined
1301897 mouse Scc2_m colon tumor susceptibility 2 (mouse) 2 Not determined
1301898 mouse Alcp14_m alcohol preference locus 14 (mouse) 7 Not determined
1301899 mouse Bgeq4_m body growth early QTL 4 (mouse) 6 Not determined
1301900 mouse Angle1_m angle of entrainment 1 (mouse) 12 Not determined
1301901 mouse Im5_m immunoregulatory 5 (mouse) 10 Not determined
1301902 mouse Hrtfm4_m heart failure modifier 4 (mouse) 18 Not determined
1301903 mouse Tlsm1_m thymic lymphoma susceptible 1 (mouse) 7 Not determined
1301904 mouse Iba2_m induction of brown adipocytes 2 (mouse) 3 Not determined
1301905 mouse Lgth2_m body length 2 (mouse) 2 Not determined
1301906 mouse Bgeq9_m body growth early QTL 9 (mouse) 11 Not determined
1301907 mouse Rends_m renal disease susceptibility (mouse) 2 Not determined
1301908 mouse Lrdm2_m lymphoproliferation (Fas) renal disease modifier 2 (mouse) 12 Not determined
1301909 mouse Smdq2_m segregation of mitochondrial DNA QTL 2 (mouse) 2 Not determined
1301910 mouse Etlm1_m ethanol induced locomotion 1 (mouse) 1 Not determined
1301911 mouse Lbm9_m lean body mass 9 (mouse) 13 Not determined
1301912 mouse Oriq5_m ovulation rate QTL 5 (mouse) 10 Not determined
1301913 mouse Frp3_m free running period 3 (mouse) 12 Not determined
1301914 mouse Ksc1_m keratinocyte stem cell locus 1 (mouse) 9 Not determined
1301915 mouse Chab3_m cholesterol absorption 3 (mouse) 6 Not determined
1301916 mouse Cons5_m consumption-saccharin intake 5 (mouse) 14 Not determined
1301917 mouse Tshp4_m tooth shape 4 (mouse) 3 Not determined
1301918 mouse Skull22_m skull morphology 22 (mouse) 15 Not determined
1301919 mouse Mnek1b_m modifier of Nek1 (NIMA-related expressed kinase 1 (mouse) 2 Not determined
1301920 mouse Hpnr7_m Heligmosomoides polygyrus nematode resistance 7 (mouse) 17 Not determined
1301921 mouse Stheal2_m soft tissue heal 2 (mouse) 3 Not determined
1301922 mouse Bbaa6_m B.burgdorferi-associated arthritis 6 (mouse) 12 Not determined
1301923 mouse Lith6_m lithogenic gene 6 (mouse) 6 Not determined
1301924 mouse Bmd10_m bone mineral density 10 (mouse) 9 Not determined
1301925 mouse Ath6_m atherosclerosis 6 (mouse) 12 Not determined
1301926 mouse Adip6_m adiposity 6 (mouse) 12 Not determined
1301927 mouse Etohcta6_m ethanol conditioned taste aversion 6 (mouse) 6 Not determined
1301928 mouse Ltsd3_m lung tumor shape-determining 3 (mouse) 8 Not determined
1301929 mouse Eae24_m susceptibility to experimental allergic encephalomyelitis 24 (mouse) 8 Not determined
1301930 mouse Papg1_m pulmonary adenoma progression 1 (mouse) 4 Not determined
1301931 mouse Pas9_m pulmonary adenoma susceptibility 9 (mouse) 4 Not determined
1301932 mouse Ssta2_m susceptibility to Salmonella typhimurium antigens 2 (mouse) 1 Not determined
1301933 mouse Insq6_m insulin QTL 6 (mouse) 1 Not determined
1301934 mouse Adip2_m adiposity 2 (mouse) 6 Not determined
1301935 mouse Skull24_m skull morphology 24 (mouse) 17 Not determined
1301936 mouse Trigq2_m triglyceride QTL 2 (mouse) 8 Not determined